submitter_id;state;ajcc_pathologic_m;morphology;year_of_diagnosis;icd_10_code;diagnosis_id;site_of_resection_or_biopsy;days_to_recurrence;tissue_or_organ_of_origin;ajcc_pathologic_stage;primary_diagnosis;updated_datetime;ajcc_pathologic_t;synchronous_malignancy;prior_malignancy;ajcc_pathologic_n;age_at_diagnosis;tumor_stage;days_to_last_known_disease_status;ajcc_staging_system_edition;days_to_last_follow_up;progression_or_recurrence;classification_of_tumor;days_to_diagnosis;prior_treatment;last_known_disease_status;tumor_grade;created_datetime;weight;pack_years_smoked;alcohol_intensity;height;bmi;alcohol_history;years_smoked;exposure_id;cigarettes_per_day;race;vital_status;demographic_id;age_at_index;ethnicity;gender;days_to_birth;year_of_death;year_of_birth;days_to_death;treatments_pharmaceutical_treatment_type;treatments_pharmaceutical_treatment_id;treatments_pharmaceutical_treatment_or_therapy;treatments_pharmaceutical_treatment_intent_type;treatments_pharmaceutical_therapeutic_agents;treatments_pharmaceutical_treatment_outcome;treatments_pharmaceutical_treatment_effect;treatments_pharmaceutical_days_to_treatment_start;treatments_pharmaceutical_days_to_treatment_end;treatments_pharmaceutical_regimen_or_line_of_therapy;treatments_pharmaceutical_treatment_anatomic_site;treatments_pharmaceutical_initial_disease_status;treatments_radiation_treatment_type;treatments_radiation_treatment_id;treatments_radiation_treatment_or_therapy;treatments_radiation_treatment_intent_type;treatments_radiation_therapeutic_agents;treatments_radiation_treatment_outcome;treatments_radiation_treatment_effect;treatments_radiation_days_to_treatment_start;treatments_radiation_days_to_treatment_end;treatments_radiation_regimen_or_line_of_therapy;treatments_radiation_treatment_anatomic_site;treatments_radiation_initial_disease_status;bcr_patient_barcode;disease
TCGA-97-8174;released;M0;8260/3;2011;C34.1;3016cbaa-0b61-519d-9318-8a7f2826c04b;Upper lobe, lung;NA;Upper lobe, lung;Stage IIA;Papillary adenocarcinoma, NOS;2019-08-08T17:10:53.779981-05:00;T2b;No;no;N0;24725;stage iia;NA;7th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;40;NA;NA;NA;Not Reported;20;b305e2e9-e166-5c55-831e-41ac3cf0ecb1;219.178.082.191.781;white;Dead;f7892669-bf13-5e6f-a179-721bc8848238;67;not hispanic or latino;male;-24725;2011;1944;164;Pharmaceutical Therapy, NOS;212412a2-eb09-592c-bdd6-832427633eb4;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;158a0ead-f55f-51dd-b230-18f473663689;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-97-8174;LUAD
TCGA-MP-A4TF;released;M0;8140/3;2010;C34.1;4b03a6c5-0fbb-5cc3-9a61-7c72ac5910d1;Upper lobe, lung;NA;Upper lobe, lung;Stage IIA;Adenocarcinoma, NOS;2019-08-08T17:11:15.269506-05:00;T2b;No;no;N0;21387;stage iia;NA;7th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;40;NA;NA;NA;Not Reported;40;6c734fb9-9765-59ab-875b-dbd082b5043a;219.178.082.191.781;white;Dead;bbfe7da8-460d-5645-95a6-4aa847f35f10;58;not hispanic or latino;female;-21387;2010;1952;336;Pharmaceutical Therapy, NOS;21a4bbee-ebd8-5e7b-8adc-102b650052d5;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;e0d3d53f-3cdf-5baf-b3a5-66111b4d7321;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-MP-A4TF;LUAD
TCGA-86-7714;released;M0;8255/3;2011;C34.3;eca6e0b2-f470-5fe8-a9f3-1e4304bf5aa2;Lower lobe, lung;NA;Lower lobe, lung;Stage IIIA;Adenocarcinoma with mixed subtypes;2019-08-08T17:10:09.373179-05:00;T1b;No;no;N2;22619;stage iiia;NA;7th;0;not reported;not reported;0;No;not reported;not reported;NA;NA;43;NA;NA;NA;Not Reported;NA;2d263edc-c9f8-5992-b6d5-9b7f507a16e8;235.616.438.356.164;black or african american;Dead;6ab970bb-90db-57f8-bf0b-fe99a1e3aac9;61;not hispanic or latino;female;-22619;NA;1950;625;Pharmaceutical Therapy, NOS;178c90f1-11e6-5a10-a107-dfb83b32d092;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;27cf6f12-a465-5488-ad34-a3e6568f92a4;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-86-7714;LUAD
TCGA-62-8397;released;M0;8255/3;2008;C34.3;f13a871d-abf3-524e-9550-e5001beb7cbb;Lower lobe, lung;NA;Lower lobe, lung;Stage IIB;Adenocarcinoma with mixed subtypes;2019-08-08T17:09:29.022095-05:00;T3;No;no;N0;25728;stage iib;NA;6th;1289;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;dd168899-4433-51b0-a9d7-bd2eb7c89958;NA;white;Alive;956526bb-8ed8-5711-90ae-be0a6a6b3f56;70;not hispanic or latino;female;-25728;NA;1938;NA;Pharmaceutical Therapy, NOS;125323ce-83af-5f72-844e-2c95ce6b9f57;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;058d6d30-ffbe-54d9-8315-3eb4e67003fe;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-62-8397;LUAD
TCGA-49-AARR;released;MX;8140/3;2001;C34.1;11f75402-3cc9-5475-a20f-2d0215596fa5;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:08:24.604398-05:00;T1;No;no;N0;24942;stage ia;NA;5th;4992;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;1bf4d2b4-3a69-5b36-bae0-856d61ff2cc3;NA;black or african american;Alive;c7b3e86f-ecab-5184-99e4-830222c900cd;68;not hispanic or latino;male;-24942;NA;1933;NA;Pharmaceutical Therapy, NOS;b4338a8f-d177-54e0-91b9-13ba155bbf34;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;278abdfc-9094-5732-a42e-d8615f7a7f3c;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-49-AARR;LUAD
TCGA-05-4425;released;M1;8255/3;2008;C34.2;0925da4f-1cd7-5a8c-9343-f017e2b1e8be;Middle lobe, lung;NA;Middle lobe, lung;Stage IV;Adenocarcinoma with mixed subtypes;2019-08-08T17:07:40.762038-05:00;T2;No;no;N0;25902;stage iv;NA;6th;669;not reported;not reported;0;No;not reported;not reported;NA;NA;28;NA;NA;NA;Not Reported;NA;d26682df-2e19-5a3b-a19e-70dbace985f7;153.424.657.534.247;not reported;Alive;133d6d60-54c7-5098-9d54-8f8288879cc1;70;not reported;female;-25902;NA;1938;NA;Pharmaceutical Therapy, NOS;6f94fb5d-c349-5ae1-a786-ac70aac2bb25;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;e334c240-e55b-5d85-95a7-38d33ec13b68;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-05-4425;LUAD
TCGA-53-7813;released;M0;8252/3;2008;C34.1;24f44b3f-bba2-535b-b0ec-4e4281035c5e;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIB;Bronchiolo-alveolar carcinoma, non-mucinous;2019-08-08T17:08:47.535141-05:00;T4;No;no;N0;18875;stage iiib;NA;6th;424;not reported;not reported;0;No;not reported;not reported;NA;NA;35;NA;NA;NA;Not Reported;35;7c9a48e5-6233-531f-b15f-28627d9d5aaa;191.780.821.917.808;white;Alive;d7718e48-cd2d-56c3-9803-1ca47ab24656;51;not hispanic or latino;female;-18875;NA;1957;NA;Pharmaceutical Therapy, NOS;3b861810-64f2-57e7-9330-f650421e49ba;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;0a3260e3-c556-5709-a931-8e667e944575;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-53-7813;LUAD
TCGA-75-5147;released;M0;8252/3;NA;C34.1;e2cd2d18-8b7c-5895-b6bc-a7b3d1177f51;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Bronchiolo-alveolar carcinoma, non-mucinous;2019-08-08T17:09:51.361836-05:00;T2;No;no;N0;NA;stage ib;NA;6th;1333;not reported;not reported;NA;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;8c8397b8-0ccf-5840-98a8-723e21a59731;NA;not reported;Alive;bcf9767d-3646-54cb-a8a5-8ccddcb4f64c;NA;not reported;female;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;4562ea64-0ca3-5ae5-b1b6-c29f4f94cdc5;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;08737307-5bcc-5a3c-8928-a1ce87f512b3;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-75-5147;LUAD
TCGA-55-A4DG;released;MX;8140/3;2012;C34.1;ed66bcf7-1a57-5445-98b0-a1c8538ea40b;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:09:29.022095-05:00;T1b;No;no;N0;26044;stage ia;NA;7th;608;not reported;not reported;0;No;not reported;not reported;NA;NA;100;NA;NA;NA;Not Reported;NA;4fbe26c5-986d-5d76-b5c0-0ee48c55848a;547.945.205.479.452;white;Alive;af6e31aa-3d32-5d03-b25b-cd51de1ed563;71;not hispanic or latino;male;-26044;NA;1941;NA;Pharmaceutical Therapy, NOS;efaabd2c-feb9-555d-8e21-bd5a459ced56;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;194bf039-e2e4-5297-8c3c-88a4c7d685ac;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-A4DG;LUAD
TCGA-97-A4M5;released;M0;8255/3;2012;C34.1;8bae00a6-f0da-59e7-a7e3-fc02336c202a;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma with mixed subtypes;2019-08-08T17:10:53.779981-05:00;T1b;No;no;N0;30665;stage ia;NA;7th;634;not reported;not reported;0;No;not reported;not reported;NA;NA;6;NA;NA;NA;Not Reported;30;e7da633d-af71-5f54-a54e-891ddf788002;0.328767123287671;white;Alive;75592919-7f31-5bdf-9df5-e3a4f96d8afe;83;not hispanic or latino;male;-30665;NA;1929;NA;Pharmaceutical Therapy, NOS;0dc19e8e-9a0b-5634-a83a-e32f7d75dd66;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;2d4fb9a0-af64-5522-91d7-e9e0f635c33c;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-97-A4M5;LUAD
TCGA-62-A472;released;M0;8140/3;2011;C34.3;8dd42d9b-6cfe-5f3b-bc8b-4a20d946230e;Lower lobe, lung;NA;Lower lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:09:29.022095-05:00;T3;No;no;N0;25893;stage iib;NA;7th;910;not reported;not reported;0;No;not reported;not reported;NA;NA;60;NA;NA;NA;Not Reported;NA;54e3acc3-0619-5265-b7bd-ce4a80f80296;328.767.123.287.671;white;Alive;99d3b54f-ae1d-5328-8a05-17f44c1b9370;70;not hispanic or latino;male;-25893;NA;1941;NA;Pharmaceutical Therapy, NOS;784d91fe-955a-5485-be40-c8e35799039f;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;2a144b2d-2dc2-5ac0-958e-748f8b725002;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-62-A472;LUAD
TCGA-44-8117;released;M0;8140/3;2011;C34.1;f86b9b90-0009-56d6-afa2-b57635c9f168;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T2a;No;no;N0;19855;stage ib;NA;7th;385;not reported;not reported;0;No;not reported;not reported;NA;NA;54;NA;NA;NA;Not Reported;36;cc92b3af-cbe1-5a17-8eab-93a6cd6a6b93;295.890.410.958.904;white;Alive;37435a10-39c6-5b05-85dc-4511664352f2;54;not hispanic or latino;female;-19855;NA;1957;NA;Pharmaceutical Therapy, NOS;98c1ba6b-40e9-569c-a0ca-cd0db387c5d2;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;0df460db-e33a-529f-9883-a175753dec0c;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-8117;LUAD
TCGA-55-7725;released;MX;8140/3;2011;C34.3;940f183d-1be7-5dd9-b897-ca7ef4219e29;Lower lobe, lung;NA;Lower lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:08:47.535141-05:00;T1a;Not Reported;yes;N0;24848;stage ia;NA;7th;442;not reported;not reported;0;No;not reported;not reported;NA;NA;16;NA;NA;NA;Not Reported;31;d4532e3c-b0dc-5b2e-9b02-ea9e1401574a;0.876712328767123;white;Alive;e8696ba2-8645-5c4d-885b-fa4d7d24a610;68;not hispanic or latino;female;-24848;NA;1943;NA;Pharmaceutical Therapy, NOS;e4f00791-dfe2-5b14-a529-4b3372c6869d;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;41380f4e-5c34-53b7-b73f-707cf977c7e0;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-7725;LUAD
TCGA-NJ-A55O;released;M0;8480/3;2011;C34.1;e1496a85-ffa2-5afc-bfee-8a6a3fb437fb;Upper lobe, lung;NA;Upper lobe, lung;Stage IIA;Mucinous adenocarcinoma;2019-08-08T17:11:15.269506-05:00;T1b;No;no;N1;20628;stage iia;NA;7th;13;not reported;not reported;0;No;not reported;not reported;NA;NA;30;NA;NA;NA;Not Reported;NA;4962e30c-d5fd-5a9e-97de-fc39a2592ead;164.383.561.643.836;white;Alive;2e73ef5b-16bc-5d96-8e41-401d09a4302e;56;not hispanic or latino;female;-20628;NA;1955;NA;Pharmaceutical Therapy, NOS;87faf8d8-7276-5374-aa33-75dfb6035aa9;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;454a69fc-b68f-5332-941c-88efdfb9782b;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-NJ-A55O;LUAD
TCGA-99-7458;released;M0;8252/3;2010;C34.3;d1b1fc20-9d74-5d7c-afff-e741a00a805d;Lower lobe, lung;NA;Lower lobe, lung;Stage IIIA;Bronchiolo-alveolar carcinoma, non-mucinous;2019-08-08T17:10:53.779981-05:00;T4;No;no;N0;27359;stage iiia;NA;7th;747;not reported;not reported;0;No;not reported;not reported;NA;NA;52;NA;NA;NA;Not Reported;52;46b6d2bb-ab93-56a4-b8d2-aefb7f7b0980;284.931.506.849.315;white;Alive;3e57d4a0-391e-5f2c-a647-5b52b5566708;74;not hispanic or latino;female;-27359;NA;1936;NA;Pharmaceutical Therapy, NOS;e8e6928d-50a1-5319-b42e-8c5bcb85949b;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;e101ed70-d725-5284-a7e1-fc672b11501e;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-99-7458;LUAD
TCGA-64-1680;released;M1;8255/3;2007;C34.8;08cbc5b4-e4ab-5cea-ae51-d6c5bfc715bc;Overlapping lesion of lung;NA;Overlapping lesion of lung;Stage IV;Adenocarcinoma with mixed subtypes;2019-08-08T17:09:29.022095-05:00;T2a;No;no;N2;23267;stage iv;NA;6th;1126;not reported;not reported;0;No;not reported;not reported;NA;NA;50;NA;NA;NA;Not Reported;20;3f0d7849-5a37-521e-9d80-234fabb341b7;273.972.602.739.726;white;Alive;86837914-8555-529e-8bf6-7a4e3304d152;63;not hispanic or latino;male;-23267;NA;1944;NA;Pharmaceutical Therapy, NOS;b32483f2-5a67-5038-ab2f-92a8b0175da0;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;4582bc89-bc40-5b1c-81a7-07b4c5ff9f77;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-64-1680;LUAD
TCGA-73-4662;released;M0;8140/3;2007;C34.1;73c5fd2f-6888-5615-b87d-d4d87ca9a600;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:09:51.361836-05:00;T1;No;no;N0;23762;stage ia;NA;6th;2515;not reported;not reported;0;No;not reported;not reported;NA;NA;10;NA;NA;NA;Not Reported;17;e88525f4-7f60-5c4f-9ca2-27c1499bba93;0.547945205479452;white;Alive;76544ae1-4778-501e-9619-c506a34bfdb5;65;not hispanic or latino;female;-23762;NA;1942;NA;Pharmaceutical Therapy, NOS;3a07a969-166e-5840-8047-f9de1fc1a842;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;39844ed2-a52d-5101-a2cd-fd93ef3032df;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-73-4662;LUAD
TCGA-78-7147;released;M0;8140/3;2001;C34.1;174884bb-00c0-5a0a-a5a1-6f4671b240e7;Upper lobe, lung;NA;Upper lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:09:51.361836-05:00;T2;No;no;N1;24809;stage iib;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;50;NA;NA;NA;Not Reported;NA;fe9a40b8-aba6-500a-a936-77783d646cee;273.972.602.739.726;white;Dead;dc9c3d23-aa95-51b5-9d95-9cdbbaf6cb15;67;not reported;female;-24809;2002;1934;586;Pharmaceutical Therapy, NOS;93694ff8-46e5-5b5d-9598-3ff9223c04b3;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;ea82cb10-176e-5502-951f-1c57af29ea89;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-78-7147;LUAD
TCGA-55-6979;released;M0;8140/3;2006;C34.1;a327a5b6-b6b1-54f1-ade0-148081f87cac;Upper lobe, lung;NA;Upper lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:08:47.535141-05:00;T2;Not Reported;yes;N1;21780;stage iib;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;51a2365e-a87f-5406-866c-62b113cdd9da;NA;white;Dead;2f74fbca-6aad-5c2a-9ba1-4df0c5f572bc;59;not reported;female;-21780;2006;1947;237;Pharmaceutical Therapy, NOS;33a89ae7-93be-54d7-8a35-d56e670c0dbc;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;6b7a5af4-f931-5548-be75-319a1bda489a;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-6979;LUAD
TCGA-91-A4BC;released;MX;8140/3;2012;C34.1;2e06f6e2-099d-57a2-88dc-2fced81217b9;Upper lobe, lung;NA;Upper lobe, lung;Stage IIA;Adenocarcinoma, NOS;2019-08-08T17:10:31.173893-05:00;T2b;Yes;no;N0;21565;stage iia;NA;7th;44;not reported;not reported;0;No;not reported;not reported;NA;NA;30;NA;NA;NA;Not Reported;25;555f8657-ad05-599f-a429-665b414dea48;164.383.561.643.836;white;Alive;7a3adc9b-b085-5204-bbb8-eb243eefa43f;59;not hispanic or latino;male;-21565;NA;1953;NA;Pharmaceutical Therapy, NOS;4b82324b-76ac-54c8-a27b-f17c37cf161b;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;734fd43a-c5d7-5ebc-8476-e509a97e08d2;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-91-A4BC;LUAD
TCGA-50-5045;released;M0;8140/3;2004;C34.3;194327a8-2c67-50d3-a613-46db5f917d5f;Lower lobe, lung;NA;Lower lobe, lung;NA;Adenocarcinoma, NOS;2019-08-08T17:08:24.604398-05:00;T2;No;no;N1;20961;not reported;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;4912b338-d978-5b1b-97b2-4c6feaf48603;NA;black or african american;Dead;fa01b4df-a7ed-5231-92fe-8e5a43420978;57;not hispanic or latino;female;-20961;2009;1947;2174;Pharmaceutical Therapy, NOS;46d4493a-9d2e-5c77-b58b-1ca82e27961a;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;d9f36840-bd60-52bb-b9e1-9f8e3862ed44;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-50-5045;LUAD
TCGA-44-A479;released;MX;8140/3;2012;C34.1;5a49829c-3527-52c7-8de3-b148782f84f4;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T2;No;no;N0;27024;stage ib;NA;7th;486;not reported;not reported;0;No;not reported;not reported;NA;NA;40;NA;NA;NA;Not Reported;40;8dafe222-ab00-5b74-ace1-e317d189be14;219.178.082.191.781;black or african american;Alive;f1797926-fb45-506d-b23b-3343c56f72ec;73;not hispanic or latino;female;-27024;NA;1939;NA;Pharmaceutical Therapy, NOS;b6affc1e-a3e5-5af9-9591-3c29b66410cb;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;b5a7895c-5134-5911-9b31-188732a5e1aa;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-A479;LUAD
TCGA-J2-A4AD;released;MX;8140/3;2012;C34.1;3f5b76d8-fcc0-5859-bc23-e9dec05d649a;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:10:53.779981-05:00;T1a;No;no;N0;22414;stage ia;NA;7th;287;not reported;not reported;0;No;not reported;not reported;NA;NA;120;NA;NA;NA;Not Reported;NA;fa2736aa-8d27-5903-9c06-46ad6851ab99;657.534.246.575.342;white;Dead;4c7d0cf8-e1b3-5c33-aa46-a2d6c87401fa;61;not hispanic or latino;female;-22414;NA;1951;550;Pharmaceutical Therapy, NOS;1624aa7e-8c18-522c-b880-61b62fcb28cf;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;cdb78779-eab3-5a8f-9863-d51617f6b825;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-J2-A4AD;LUAD
TCGA-69-8255;released;M0;8230/3;2011;C34.1;542a465e-6dd1-57a2-8f64-bd05584b2a73;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Solid carcinoma, NOS;2019-08-08T17:09:51.361836-05:00;T1a;No;no;N0;26289;stage ia;NA;7th;129;not reported;not reported;0;No;not reported;not reported;NA;NA;40;NA;NA;NA;Not Reported;NA;b7b12da2-d11a-53c7-bc5b-af55ecbc94c5;219.178.082.191.781;white;Alive;2689800d-9349-535c-b022-60c173bc4150;71;hispanic or latino;male;-26289;NA;1940;NA;Pharmaceutical Therapy, NOS;2887f273-efaa-57a3-a07d-572036c876f1;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;ce1b75e1-014b-5c28-98b7-d0d83ab82767;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-69-8255;LUAD
TCGA-95-7944;released;M0;8140/3;2011;C34.3;c7e25352-38b8-5bb7-978d-cb4967b13f2b;Lower lobe, lung;NA;Lower lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:10:31.173893-05:00;T1a;No;no;N0;26003;stage ia;NA;7th;377;not reported;not reported;0;No;not reported;not reported;NA;NA;50;NA;NA;NA;Not Reported;NA;75bb3f37-5d61-5584-b442-a57da9ee1929;273.972.602.739.726;white;Alive;a69fed60-cf3a-5c60-b3fd-d2ceeddec204;71;not hispanic or latino;male;-26003;NA;1940;NA;Pharmaceutical Therapy, NOS;42cd2144-3841-5f0c-9b20-616429143c98;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;5050135f-07be-5793-b44c-82c37b0e4b0d;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-95-7944;LUAD
TCGA-05-5428;released;M0;8255/3;2010;C34.9;03ad29be-90ed-56cf-9a2b-a4ddde89341f;Lung, NOS;NA;Lung, NOS;Stage IIA;Adenocarcinoma with mixed subtypes;2019-08-08T17:07:40.762038-05:00;T1b;No;no;N1;21061;stage iia;NA;7th;670;not reported;not reported;0;No;not reported;not reported;NA;NA;30;NA;NA;NA;Not Reported;24;d6d56787-8f58-5798-90c9-1c20b915cbd5;164.383.561.643.836;not reported;Alive;99b9b9a4-3f15-5d69-a197-f3da55b6ae3e;57;not reported;male;-21061;NA;1953;NA;Pharmaceutical Therapy, NOS;6d02c9dd-9b2d-5365-98bc-6bff75535820;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;bfd00da5-04ee-5edb-a9cd-d2a73bb28ad9;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-05-5428;LUAD
TCGA-64-1676;released;M0;8140/3;2005;C34.3;5c419873-433f-5191-b238-0a5b09e6cd28;Lower lobe, lung;NA;Lower lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:09:29.022095-05:00;T1a;No;no;N0;21428;stage ia;NA;NA;1728;not reported;not reported;0;No;not reported;not reported;NA;NA;60;NA;NA;NA;Not Reported;NA;08daaff6-08a1-521d-89ee-b1eeb4e76dd6;328.767.123.287.671;white;Alive;20897392-1ab3-52f9-a737-1a2490ffd388;58;not hispanic or latino;male;-21428;NA;1947;NA;Pharmaceutical Therapy, NOS;e41704ca-407f-53e8-92ac-6265e695005f;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;5b8bebdc-1baf-5f00-888f-7c1c87c4c039;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-64-1676;LUAD
TCGA-75-6207;released;M0;8140/3;2007;C34.1;a70d1af1-a56d-521e-8917-88cb0b350570;Lung, NOS;NA;Lung, NOS;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:09:51.361836-05:00;T2;No;no;N2;NA;stage iiia;NA;6th;NA;not reported;not reported;NA;No;not reported;not reported;NA;NA;10;NA;NA;NA;Not Reported;NA;bce4b2b7-cc13-5136-9e90-3058974522f3;0.547945205479452;not reported;Dead;3710fd61-4841-5015-bc6f-1e21eeebf885;NA;not reported;male;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;e6a7654b-a4af-537a-8236-3f49f370d1d5;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;75b63d24-1700-52dc-98c2-18ba0597cf4f;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-75-6207;LUAD
TCGA-86-8668;released;M0;8253/3;2012;C34.3;a5cc9bfc-5508-59de-8fbb-6191acc51a2b;Lower lobe, lung;NA;Lower lobe, lung;Stage IA;Bronchio-alveolar carcinoma, mucinous;2019-08-08T17:10:09.373179-05:00;T1b;No;no;N0;22383;stage ia;NA;7th;423;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;0eed42a3-5c7a-5acd-a320-52cf03117788;NA;white;Alive;e279a0dc-071e-580b-bd34-adbc3dd176ab;61;not hispanic or latino;female;-22383;NA;1951;NA;Pharmaceutical Therapy, NOS;bf8bf7d6-487a-5e2e-8073-f9595c6da78c;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;c87617d4-422f-53f1-8ba0-5520a150c606;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-86-8668;LUAD
TCGA-78-7152;released;M0;8255/3;2003;C34.1;09c59a9b-6a67-5ed4-a04d-ae22311df0ca;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma with mixed subtypes;2019-08-08T17:09:51.361836-05:00;T2;No;no;N0;23782;stage ib;NA;6th;1202;not reported;not reported;0;No;not reported;not reported;NA;NA;40;NA;NA;NA;Not Reported;40;9dc18290-5ee3-53ff-b0a8-252a340f72da;219.178.082.191.781;white;Dead;b5bc4e26-ddbb-5903-9be0-61d9cb0804cd;65;not reported;male;-23782;NA;1938;1215;Pharmaceutical Therapy, NOS;cd773ef9-7ba3-5162-8542-f7f1aa26b4ad;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;6c1fc184-cd22-5e8b-af5f-e0a960de804b;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-78-7152;LUAD
TCGA-55-A48X;released;M0;8140/3;2012;C34.3;b40b0b2e-be0a-5a95-a43a-518b8311f611;Lower lobe, lung;NA;Lower lobe, lung;Stage IIA;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T1b;No;yes;N1;23341;stage iia;NA;7th;689;not reported;not reported;0;No;not reported;not reported;NA;NA;36;NA;NA;NA;Not Reported;36;5cfa6547-c92f-5d8b-8e70-095f01656812;197.260.273.972.603;white;Alive;e095eb8f-faff-502b-bb15-4ff105080ba0;63;not hispanic or latino;female;-23341;NA;1949;NA;Pharmaceutical Therapy, NOS;d64775f4-012b-5dd4-ab83-14faa6f08dee;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;f4f5773c-c84a-5424-9f37-be733d29a815;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-A48X;LUAD
TCGA-55-8508;released;MX;8480/3;2012;C34.1;01d3a6b0-a59d-5e74-ac52-04bd2fd747fe;Upper lobe, lung;NA;Upper lobe, lung;Stage IIA;Mucinous adenocarcinoma;2019-08-08T17:09:08.225653-05:00;T2a;No;no;N1;22159;stage iia;NA;7th;617;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;844f8fd2-6bc5-5b5f-b2b2-45015f9c083c;NA;black or african american;Alive;c15fcef9-c8fd-512e-bb13-2995f1d4d7f2;60;not hispanic or latino;female;-22159;NA;1952;NA;Pharmaceutical Therapy, NOS;a5ec9ded-acf3-5702-8ff7-8fd329e92d5f;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;56fcdbf2-7280-5b68-a26f-8f909a272675;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-8508;LUAD
TCGA-05-4403;released;M0;8255/3;2006;C34.1;6bb4d500-47b2-5686-b276-9fc67e4c9ce0;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma with mixed subtypes;2019-08-08T17:07:40.762038-05:00;T2;No;no;N0;27881;stage ib;NA;5th;578;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;f154ccb7-ef97-505e-aa5e-89a0c11cfdcb;NA;not reported;Alive;3b781506-d343-5c71-925a-64b713c2c120;76;not reported;male;-27881;NA;1930;NA;Pharmaceutical Therapy, NOS;115543ac-a2a8-52ac-a110-67b341d09930;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;d6fbe5a7-061f-59b7-99b0-cdd2cd8347d5;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-05-4403;LUAD
TCGA-55-8301;released;MX;8140/3;2012;C34.3;d6366e9f-8251-5f23-a60d-041f332e6e67;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T2a;No;no;N0;21535;stage ib;NA;7th;534;not reported;not reported;0;No;not reported;not reported;NA;NA;100;NA;NA;NA;Not Reported;NA;dd3883da-6c40-5a37-846b-f1fafdedf10a;547.945.205.479.452;white;Alive;076e36b0-4792-5937-84b4-49064cec809d;58;not hispanic or latino;male;-21535;NA;1954;NA;Pharmaceutical Therapy, NOS;94371474-d71f-59c7-a593-032fe7361569;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;dbc4a15f-d1ce-5f60-b7b9-03c4cb0b0c15;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-8301;LUAD
TCGA-78-7143;released;M0;8252/3;1992;C34.1;02cfbecb-9e58-5563-94b9-43becbab6367;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Bronchiolo-alveolar carcinoma, non-mucinous;2019-08-08T17:09:51.361836-05:00;T2;No;no;N0;22673;stage ib;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;bb3dc582-bf90-5cd6-bc7e-6c339eec901a;NA;white;Dead;6431275e-fb63-585b-9942-4b89b05b940f;62;not reported;female;-22673;2005;1930;4961;Pharmaceutical Therapy, NOS;600616b9-1a35-53b8-a5a8-6fb27e69d568;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;dda93ff6-e37e-5cfe-b3d6-b20c822edfee;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-78-7143;LUAD
TCGA-73-4659;released;M0;8140/3;2006;C34.1;28287ed6-5c08-570e-a9d1-2e41547ad187;Lung, NOS;NA;Lung, NOS;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:09:51.361836-05:00;T2;No;no;N2;24253;stage iiia;NA;6th;711;not reported;not reported;0;No;not reported;not reported;NA;NA;12;NA;NA;NA;Not Reported;12;a815b8f1-85c7-56cd-a6ae-822d3c5d29be;0.657534246575342;white;Dead;ec90791b-e6c0-5e62-8dc4-7b721ae1e5db;66;not hispanic or latino;male;-24253;2007;1940;711;Pharmaceutical Therapy, NOS;8a9af4bb-f343-5a97-9554-0076ec2a3c63;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;c18830d1-ed85-5248-a842-a7e7550bd2b2;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-73-4659;LUAD
TCGA-49-4490;released;M0;8140/3;1993;C34.1;6c4db7a9-8274-53cd-b2bd-2840a37c46fe;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:08:24.604398-05:00;T3;No;no;N2;16634;stage iiia;NA;4th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;5;NA;NA;NA;Not Reported;NA;4c9dc087-9677-5461-9726-35b75c3fd160;0.273972602739726;white;Dead;0393aec7-4bda-5842-b872-034e44c7e685;45;not hispanic or latino;female;-16634;1994;1948;385;Pharmaceutical Therapy, NOS;fcce15e0-e731-5d97-92ce-5db807506a0e;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;6b0f9198-a344-51a9-83c1-8b9ee6225eb8;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-49-4490;LUAD
TCGA-L9-A443;released;MX;8140/3;2012;C34.3;b4550694-6b07-55eb-aa1c-a22ef9346cd2;Lower lobe, lung;NA;Lower lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:10:53.779981-05:00;T1a;No;yes;N0;23062;stage ia;NA;7th;116;not reported;not reported;0;No;not reported;not reported;NA;NA;90;NA;NA;NA;Not Reported;45;a65eac99-e0a1-52bc-8756-4a138f53ccd1;493.150.684.931.507;white;Dead;f440aff4-6068-5d83-8c09-0c6bcbf15c99;63;not hispanic or latino;female;-23062;NA;1949;193;Pharmaceutical Therapy, NOS;75a9f0ed-6b10-5804-aec0-4316a3d3ed4a;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;22cf426d-4a8f-5391-b51b-4be8cd05b66f;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-L9-A443;LUAD
TCGA-38-4626;released;M0;8140/3;2003;C34.1;9d7b9152-61ec-5cd7-b3bc-a5604728c3ac;Upper lobe, lung;NA;Upper lobe, lung;NA;Adenocarcinoma, NOS;2019-08-08T17:07:40.762038-05:00;T2b;No;no;N0;20903;not reported;NA;6th;3674;not reported;not reported;0;No;not reported;not reported;NA;NA;40;NA;NA;NA;Not Reported;NA;e2646e08-5486-500a-910e-64815d70cd09;219.178.082.191.781;white;Alive;9396dcdc-045a-5ef3-9f41-efe3902f0dd0;57;not hispanic or latino;female;-20903;NA;1946;NA;Pharmaceutical Therapy, NOS;c9d28151-ee9e-5091-9268-b8f897bb8bca;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;03838326-3d38-5151-9616-f86a1fdd4404;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-38-4626;LUAD
TCGA-73-7498;released;M0;8252/3;2010;C34.3;580754c0-a6e3-59f2-acb2-100dca8ab3f0;Lower lobe, lung;NA;Lower lobe, lung;Stage IA;Bronchiolo-alveolar carcinoma, non-mucinous;2019-08-08T17:09:51.361836-05:00;T1b;Yes;no;N0;21527;stage ia;NA;7th;1189;not reported;not reported;0;No;not reported;not reported;NA;NA;28;NA;NA;NA;Not Reported;28;a5aa19ab-196d-556d-9710-b23fa7f6ce37;153.424.657.534.247;white;Alive;1cde668e-cd8e-59f1-b297-5983ad812be9;58;not hispanic or latino;female;-21527;NA;1952;NA;Pharmaceutical Therapy, NOS;dde4832a-e47e-57b7-be69-40bc87975eba;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;c9436fce-beed-5051-ad23-3b54c46ba808;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-73-7498;LUAD
TCGA-91-6830;released;MX;8140/3;2002;C34.1;5e4bb363-fd0c-5357-831d-a311b878fd38;Upper lobe, lung;NA;Upper lobe, lung;Stage IIA;Adenocarcinoma, NOS;2019-08-08T17:10:31.173893-05:00;T1;No;no;N1;23922;stage iia;NA;5th;60;not reported;not reported;0;No;not reported;not reported;NA;NA;12;NA;NA;NA;Not Reported;12;db2bcb2c-f035-5590-89a1-c41c005edd49;0.657534246575342;white;Alive;169219e7-d79e-5540-b208-e41e4cd7fd17;65;not hispanic or latino;female;-23922;NA;1937;NA;Pharmaceutical Therapy, NOS;60baca55-4163-5c49-aaa6-f228be5c8579;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;2484e623-6f7a-5af8-9355-55107de1faeb;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-91-6830;LUAD
TCGA-L9-A743;released;M0;8140/3;2013;C34.1;843692cb-f0c0-565b-bc54-c465572c95bc;Upper lobe, lung;NA;Upper lobe, lung;Stage IIA;Adenocarcinoma, NOS;2019-08-08T17:10:53.779981-05:00;T2a;No;yes;N1;20780;stage iia;NA;7th;664;not reported;not reported;0;No;not reported;not reported;NA;NA;40.5;NA;NA;NA;Not Reported;NA;8e94aa20-acdc-55b1-8a5f-325547e3e096;221.917.808.219.178;black or african american;Alive;1eb0166e-724b-5750-a648-c8b6c5cafb51;56;not hispanic or latino;male;-20780;NA;1957;NA;Pharmaceutical Therapy, NOS;c80b5327-fd61-52c1-905b-56eff4faf442;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;a61ca7f4-bde0-5778-8ce2-85cb32f7ef79;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-L9-A743;LUAD
TCGA-55-6543;released;MX;8253/3;2010;C34.1;f53fcad4-b6d4-5777-8a75-4e97ed95c785;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Bronchio-alveolar carcinoma, mucinous;2019-08-08T17:08:47.535141-05:00;T1b;No;no;N0;NA;stage ia;NA;7th;435;not reported;not reported;0;No;not reported;not reported;NA;NA;60;NA;NA;NA;Not Reported;NA;ea501879-0aa0-58b0-a951-0a07af9587eb;328.767.123.287.671;white;Alive;77ae36e6-e891-5c98-a5b8-74001c71a397;60;not reported;female;NA;NA;1950;NA;Pharmaceutical Therapy, NOS;708f7c89-9a27-5775-9f44-1d3f4c06111e;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;8888f418-b6ed-5552-ba3e-789e96ce3263;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-6543;LUAD
TCGA-62-A46S;released;M0;8260/3;2007;C34.1;0f2a0d69-4f53-5177-96cb-5432be0c6266;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Papillary adenocarcinoma, NOS;2019-08-08T17:09:29.022095-05:00;T2;No;no;N0;26825;stage ib;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;40;NA;NA;NA;Not Reported;NA;2d931ace-aec9-56fc-9906-fdf686761150;219.178.082.191.781;white;Dead;e0c9bfdf-cc04-5086-8704-c1e257c170a4;73;not hispanic or latino;male;-26825;2011;1934;1653;Pharmaceutical Therapy, NOS;3e34a8f5-696d-5616-9e55-baade9dd8bf3;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;52136391-5d03-5c83-a14a-943b344ab7a5;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-62-A46S;LUAD
TCGA-97-7553;released;MX;8252/3;2007;C34.3;d111d053-f0c5-5ead-98b9-292c2d2b2276;Lower lobe, lung;NA;Lower lobe, lung;Stage IA;Bronchiolo-alveolar carcinoma, non-mucinous;2019-08-08T17:10:31.173893-05:00;T1;No;no;N0;21518;stage ia;NA;6th;1870;not reported;not reported;0;No;not reported;not reported;NA;NA;20;NA;NA;NA;Not Reported;NA;0e277ec7-1751-5f52-95d2-34d4aecf0637;10.958.904.109.589;white;Alive;6086c8df-afb2-5edc-bfbe-f4721ff34a07;58;not hispanic or latino;female;-21518;NA;1949;NA;Pharmaceutical Therapy, NOS;b03c4b9d-15e7-57d1-b3d5-78a72b263380;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;39a09d01-37b0-5e34-ae5e-a3e9f5df6d83;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-97-7553;LUAD
TCGA-55-1595;released;M0;8310/3;2004;C34.3;ed623db2-1a20-599e-b07d-209e3dbe14da;Lower lobe, lung;NA;Lower lobe, lung;Stage IA;Clear cell adenocarcinoma, NOS;2019-08-08T17:08:47.535141-05:00;T1;Not Reported;yes;N0;NA;stage ia;NA;6th;1479;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;29;abb63f82-9a5c-5903-85ba-9489531de95b;NA;asian;Alive;f18d4042-1df7-5c94-aa22-be24c3f23236;74;not hispanic or latino;female;NA;NA;1930;NA;Pharmaceutical Therapy, NOS;522659d2-0964-5b63-bca4-e788d6466e19;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;9fb0ee03-8ce6-55ff-a65c-cdb5734feb45;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-1595;LUAD
TCGA-MP-A4SV;released;M0;8140/3;2001;C34.3;77c1cfc3-0a92-507b-80b5-edf20d005785;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:10:53.779981-05:00;T2;No;no;N0;24516;stage ib;NA;5th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;110;NA;NA;NA;Not Reported;NA;297fda55-20a3-5a31-94d0-b253fd0b9a15;602.739.726.027.397;not reported;Dead;53ba217f-641e-5486-8cdc-985111493363;67;not reported;male;-24516;2008;1934;2620;Pharmaceutical Therapy, NOS;aaa17f9b-ff8f-5a21-8817-37ae11071942;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;850a4d99-3c2a-534c-bfe3-8fbd91530c3d;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-MP-A4SV;LUAD
TCGA-MN-A4N4;released;M0;8140/3;2010;C34.1;4c6182ff-c45f-51fd-bf09-15c2a93a3fc9;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:10:53.779981-05:00;T1b;No;no;N0;20888;stage ia;NA;7th;1175;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;50fc25ab-33ce-5d11-a25a-a3bf108a44ff;NA;white;Alive;17131553-dff0-5b14-b75a-7a68fdbf575b;57;not hispanic or latino;male;-20888;NA;1953;NA;Pharmaceutical Therapy, NOS;aa610753-e08c-5c6c-9508-5b9dd21dc462;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;6f92d14e-698d-57fe-a59a-f4d5ef42c01d;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-MN-A4N4;LUAD
TCGA-97-7547;released;MX;8260/3;2007;C34.1;a2f5a405-2f6b-52d8-9c21-12cecb0d50b6;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Papillary adenocarcinoma, NOS;2019-08-08T17:10:31.173893-05:00;T2;No;no;N0;24737;stage ib;NA;6th;1965;not reported;not reported;0;No;not reported;not reported;NA;NA;30;NA;NA;NA;Not Reported;NA;673faeca-02c7-5053-a2fa-40a565c2e0b2;164.383.561.643.836;white;Alive;77f019ea-5621-5481-9dce-10eda902c629;67;not hispanic or latino;female;-24737;NA;1940;NA;Pharmaceutical Therapy, NOS;280fe9b9-c353-55b5-8e5f-ff7bf1592d25;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;3dd510ad-360f-5855-a2f3-7c9e59d612fd;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-97-7547;LUAD
TCGA-05-4398;released;M0;8255/3;2006;C34.1;1610896c-b01c-5504-8b62-888c8765fd8c;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIB;Adenocarcinoma with mixed subtypes;2019-08-08T17:07:40.762038-05:00;T4;No;no;N3;17471;stage iiib;NA;5th;1431;not reported;not reported;0;No;not reported;not reported;NA;NA;72;NA;NA;NA;Not Reported;NA;7e6d5f1d-b00a-5ab6-902f-d1b9728493d5;394.520.547.945.205;not reported;Alive;983b8254-3ed9-5282-9e65-52ab01cf7cf3;47;not reported;female;-17471;NA;1959;NA;Pharmaceutical Therapy, NOS;0999c60f-7bb1-5a47-948d-ab9fc49474ae;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;440e3191-97d7-57a5-b6b7-113ee1d7ea5f;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-05-4398;LUAD
TCGA-91-6849;released;MX;8140/3;2009;C34.1;bb90e2aa-9ce7-5bdb-9dc3-5580d0a59687;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:10:31.173893-05:00;T2;No;no;N2;27676;stage iiia;NA;6th;35;not reported;not reported;0;No;not reported;not reported;NA;NA;30;NA;NA;NA;Not Reported;30;f5ca711e-82d2-594d-92b5-f1ed8313fdae;164.383.561.643.836;black or african american;Alive;db6afa58-28d7-5846-9e18-b51c40bfbafb;75;not hispanic or latino;female;-27676;NA;1934;NA;Pharmaceutical Therapy, NOS;cb581f9a-a31a-5cee-90eb-a6da7067ed95;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;60722af1-072d-589a-846c-cb835e320982;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-91-6849;LUAD
TCGA-49-4505;released;M0;8140/3;1996;C34.3;067c116f-104e-5dd9-a0a6-03858d2f7b07;Lower lobe, lung;NA;Lower lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:08:24.604398-05:00;T2;No;no;N1;22628;stage iib;NA;4th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;74;NA;NA;NA;Not Reported;37;9795a85b-6b6a-5284-8aac-c4fbd4af4082;405.479.452.054.795;white;Dead;80c26b12-8fac-5d8f-bea3-91c247f2232d;61;not hispanic or latino;female;-22628;1997;1935;428;Pharmaceutical Therapy, NOS;c17a9b60-3835-5e78-897c-01f333a22fd4;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;4a3e1059-0bbd-5f4a-a372-ededb84951fe;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-49-4505;LUAD
TCGA-49-AAR0;released;MX;8140/3;2002;C34.1;6f50fcfc-034c-5dda-a7c9-378451ecd93c;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:08:24.604398-05:00;T1;No;yes;N0;20932;stage ia;NA;5th;4765;not reported;not reported;0;No;not reported;not reported;NA;NA;37;NA;NA;NA;Not Reported;NA;c664187d-0230-5a52-b262-a3ca52eee695;202.739.726.027.397;black or african american;Alive;9d331b83-e9de-5fc6-8133-a40ef3bc787c;57;not hispanic or latino;male;-20932;NA;1945;NA;Pharmaceutical Therapy, NOS;944dcdb5-211b-5d8d-b915-70059234a2ca;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;022f38d0-182e-5a03-87ac-de9d2779f3ff;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-49-AAR0;LUAD
TCGA-49-AAR9;released;MX;8140/3;1999;C34.1;047c24cd-4e89-52f5-8e9d-ca8f6d7e9ba6;Lung, NOS;NA;Lung, NOS;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:08:24.604398-05:00;T3;No;no;N0;22510;stage iib;NA;5th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;8c66a382-00bd-5700-bc16-b5ba40943bb8;NA;black or african american;Dead;d5bf178f-c507-5549-a57c-1c702b9ee2b5;61;not hispanic or latino;male;-22510;1999;1938;260;Pharmaceutical Therapy, NOS;fcace918-30a9-5782-bfec-23018bc3c9aa;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;f714a5e9-0852-50c9-8155-bdf706e8991a;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-49-AAR9;LUAD
TCGA-78-7163;released;M0;8140/3;1992;C34.3;06c8ee8d-3c9b-5db5-ab50-424492059dd8;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:10:09.373179-05:00;T2;No;no;N0;22002;stage ib;NA;6th;7248;not reported;not reported;0;No;not reported;not reported;NA;NA;41;NA;NA;NA;Not Reported;41;ca9d35fa-8251-568b-8102-7351aaa0a9dc;224.657.534.246.575;white;Alive;42424e03-7ba9-58ba-a770-bcf8467ee17f;60;not reported;male;-22002;NA;1932;NA;Pharmaceutical Therapy, NOS;642b9256-319b-50a3-af0f-7de2a2861bce;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;ef4bfded-6745-5b57-a5f1-ebdcf28ee6a6;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-78-7163;LUAD
TCGA-05-4430;released;M0;8255/3;2008;C34.3;74704674-6949-54e9-ad83-ec8028f45cc0;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Adenocarcinoma with mixed subtypes;2019-08-08T17:07:40.762038-05:00;T2;No;no;N0;21884;stage ib;NA;6th;761;not reported;not reported;0;No;not reported;not reported;NA;NA;80;NA;NA;NA;Not Reported;NA;ad8c7f4b-7ada-5e41-b4f0-ecbe901ad89d;438.356.164.383.562;not reported;Alive;21bf2794-df78-5399-9976-47954c4db38d;59;not reported;female;-21884;NA;1949;NA;Pharmaceutical Therapy, NOS;c68f129e-7a1f-5ac6-8433-9d1b107d1e0d;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;7abb933c-db22-5136-8b97-4fd034e12271;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-05-4430;LUAD
TCGA-55-7724;released;MX;8140/3;2011;C34.1;0cab436d-13d9-589c-9a49-f2792b176380;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:08:47.535141-05:00;T2a;Not Reported;yes;N0;27891;stage ib;NA;7th;705;not reported;not reported;0;No;not reported;not reported;NA;NA;50;NA;NA;NA;Not Reported;50;c9db59b1-a1e3-5418-8263-580e39f364dc;273.972.602.739.726;white;Alive;47771b7f-5c06-538e-836d-a57cae09b77d;76;not hispanic or latino;female;-27891;NA;1935;NA;Pharmaceutical Therapy, NOS;c4740a81-582f-584b-8051-772e63a017cf;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;5b4795c4-3579-512c-a759-4282ab6f8632;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-7724;LUAD
TCGA-55-8207;released;MX;8550/3;2011;C34.3;d9e8c54a-f954-5e23-801b-b855af373290;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Acinar cell carcinoma;2019-08-08T17:09:08.225653-05:00;T2a;Yes;no;N0;26897;stage ib;NA;7th;977;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;8f8c469e-cd6b-51ea-b9b7-38ac6ca1e74b;NA;white;Alive;cce22ab5-ea77-5b92-b9b1-338f17426768;73;not hispanic or latino;male;-26897;NA;1938;NA;Pharmaceutical Therapy, NOS;4e26c051-ef60-5df2-9a82-caeed5eec1de;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;cb8846ea-b8e4-5eb4-90d8-fb28021dc91e;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-8207;LUAD
TCGA-50-8460;released;M0;8260/3;2012;C34.1;87105ffb-a680-53c0-80ce-977494017914;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Papillary adenocarcinoma, NOS;2019-08-08T17:08:47.535141-05:00;T1a;No;no;N0;27270;stage ia;NA;7th;829;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;90be26dd-72e3-5526-966a-26e56f2c99c1;NA;white;Alive;440a0994-82af-549c-b467-570094ef587b;74;not hispanic or latino;male;-27270;NA;1938;NA;Pharmaceutical Therapy, NOS;ea863fcf-f78d-5bb8-b0d3-1e6977b0e765;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;cb9c3316-b42b-5d66-b399-95bb51f893f6;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-50-8460;LUAD
TCGA-50-6590;released;M0;8140/3;2005;C34.1;8aa5f27d-3c63-53ff-9479-ed22aae00ab3;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:08:24.604398-05:00;T2;No;no;N0;26444;stage ib;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;50;NA;NA;NA;Not Reported;NA;37b7f0aa-6995-5292-95e3-88e24d413f03;273.972.602.739.726;white;Dead;ae6f4078-be1f-5ac9-b2ee-43d7eca561bd;72;not hispanic or latino;female;-26444;2008;1933;1288;Pharmaceutical Therapy, NOS;8f92b595-1dcf-5f9f-9aa2-016c327e306b;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;9f802b18-3e7b-5789-9257-40bd128d9aa9;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-50-6590;LUAD
TCGA-50-6592;released;M0;8140/3;2007;C34.3;b89ba4ef-d685-5252-bef2-37da1dcf917f;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:08:47.535141-05:00;T2;No;no;N0;26191;stage ib;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;87dfcdd9-4c8e-58ed-812c-3abc8f3b8029;NA;white;Dead;5c3faf64-6f26-5441-93c5-8d2e159a7aaa;71;not hispanic or latino;female;-26191;2009;1936;777;Pharmaceutical Therapy, NOS;31d08b75-b082-5c7a-b29f-14175cf32259;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;ee3f0f84-5fb8-559b-8dd4-c909568ff240;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-50-6592;LUAD
TCGA-55-7816;released;MX;8140/3;2011;C34.1;b20d3757-8632-544b-8a96-c72fd9aaf189;Upper lobe, lung;NA;Upper lobe, lung;Stage IV;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;TX;No;no;NX;18170;stage iv;NA;7th;44;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;4614de57-7486-5f0b-a229-bc7490ab1020;NA;white;Dead;9aa7914e-3c0f-5961-83dd-84095f4cc2be;49;not hispanic or latino;female;-18170;NA;1962;468;Pharmaceutical Therapy, NOS;29b875aa-3150-51db-9989-4fed56439548;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;44c05cb2-7977-5bb8-b34a-8f837760043c;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-7816;LUAD
TCGA-44-2664;released;M0;8140/3;2009;C34.3;a9fa7a54-5051-560f-bb8d-a4185e39a960;Lower lobe, lung;NA;Lower lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T1;No;no;N0;24468;stage ia;NA;6th;1251;not reported;not reported;0;No;not reported;not reported;NA;NA;23;NA;NA;NA;Not Reported;NA;2a1c5088-53f1-55a3-9179-6c819c48454b;126.027.397.260.274;black or african american;Alive;c02e904c-3886-5633-8d51-5e4c95e06e31;66;not hispanic or latino;female;-24468;NA;1943;NA;Pharmaceutical Therapy, NOS;f6dfa955-be33-56e5-98b0-be4e0b364f71;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;747d10bd-8bf4-5e1c-8415-0f1d554c23cb;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-2664;LUAD
TCGA-91-8496;released;MX;8252/3;2011;C34.3;b3ce35c0-19ef-5f2b-a6f4-33b6ded70426;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Bronchiolo-alveolar carcinoma, non-mucinous;2019-08-08T17:10:31.173893-05:00;T2a;No;no;NX;23358;stage ib;NA;7th;505;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;58f7a8f5-ddd6-5384-a148-a9ed22d63e1c;NA;white;Alive;c9e861cd-8881-5842-a889-50878a68fe35;63;not hispanic or latino;female;-23358;NA;1948;NA;Pharmaceutical Therapy, NOS;4ac1455b-05fa-5194-8f53-42c980376a00;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;a31bd6fe-3141-5dfd-b9e2-1e1b9fa03c0b;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-91-8496;LUAD
TCGA-44-3918;released;M0;8140/3;2010;C34.1;009848db-f39d-5865-859c-8bb1a18292b7;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T1;No;no;N0;22236;stage ia;NA;6th;1036;not reported;not reported;0;No;not reported;not reported;NA;NA;20;NA;NA;NA;Not Reported;20;1975e1ea-81ac-5804-85d2-790f76b4489d;10.958.904.109.589;white;Alive;27dcdf60-4552-5837-a363-3a083d043522;60;not hispanic or latino;female;-22236;NA;1950;NA;Pharmaceutical Therapy, NOS;48c650c6-5573-5dcc-9453-699d8d5719e5;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;92e4d19c-3d5e-5c59-b151-270ed91b969e;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-3918;LUAD
TCGA-44-2655;released;M0;8140/3;2009;C34.1;5672187c-4648-5de5-8cad-903c919ef1f8;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T1;Not Reported;yes;N0;23854;stage ia;NA;6th;1324;not reported;not reported;0;No;not reported;not reported;NA;NA;30;NA;NA;NA;Not Reported;30;74b0ae75-22e9-599b-809c-efd382a1d9cd;164.383.561.643.836;white;Alive;20d4b4f8-697e-5657-acea-ce48bceca1d9;65;not hispanic or latino;female;-23854;NA;1944;NA;Pharmaceutical Therapy, NOS;bbc7a961-f8b7-5538-82b5-c13127e8fcfe;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;212f9202-90a1-55ab-aaac-51271c5d03b0;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-2655;LUAD
TCGA-97-7546;released;MX;8550/3;2008;C34.1;4024dcf2-1acb-5640-9549-5e7d1392b2f0;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Acinar cell carcinoma;2019-08-08T17:10:31.173893-05:00;T1;No;no;N0;27913;stage ia;NA;6th;1285;not reported;not reported;0;No;not reported;not reported;NA;NA;25;NA;NA;NA;Not Reported;20;5c41f28a-d087-5d38-8908-08c0d83621ff;136.986.301.369.863;white;Alive;326556eb-b578-5451-b412-649e3351808e;76;not hispanic or latino;female;-27913;NA;1932;NA;Pharmaceutical Therapy, NOS;db5083c7-b97e-5227-9d0f-bdf7d0729c87;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;0bcdc210-e5f1-5e07-b95b-8eb3be379177;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-97-7546;LUAD
TCGA-55-1592;released;M0;8140/3;2005;C34.1;9258dedd-f0a4-5100-89b6-ce496a7d9b93;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:08:47.535141-05:00;T2;Not Reported;yes;N0;NA;stage ia;NA;NA;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;40;7e60edbf-b941-59de-a86d-efd647437ac2;NA;white;Dead;7101300d-a371-5aa8-bbe5-cb2ca27d1375;65;not hispanic or latino;male;NA;2006;1940;701;Pharmaceutical Therapy, NOS;820a1d1f-7a49-558b-8cf5-dc6fc4861bba;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;dd6d7f05-ab61-5cfb-8168-d4444559a676;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-1592;LUAD
TCGA-55-8507;released;MX;8140/3;2012;C34.1;b44793eb-baab-56bd-96be-5b5aa67b4ccd;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T1a;No;no;N0;19390;stage ia;NA;7th;418;not reported;not reported;0;No;not reported;not reported;NA;NA;120;NA;NA;NA;Not Reported;NA;07d1bd52-7284-533c-929f-493c2d596573;657.534.246.575.342;white;Alive;a21c451b-ca0b-51c1-939b-f04430053dc8;53;not hispanic or latino;male;-19390;NA;1959;NA;Pharmaceutical Therapy, NOS;5d89820d-6bab-5ae5-abf8-27713f21d617;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;a17e53af-2c1b-538e-ba83-ebeef515e013;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-8507;LUAD
TCGA-44-5643;released;M0;8140/3;2010;C34.3;f64eda59-f893-5c25-8323-8f2e4f242e84;Lower lobe, lung;NA;Lower lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T2b;No;no;N2;19426;stage iiia;NA;7th;1013;not reported;not reported;0;No;not reported;not reported;NA;NA;20;NA;NA;NA;Not Reported;NA;2cd81eba-1dee-5e97-8e88-1d842111c8c7;10.958.904.109.589;black or african american;Alive;cd7e4b52-9505-5d35-94b7-1f86a51c3593;53;not hispanic or latino;male;-19426;NA;1957;NA;Pharmaceutical Therapy, NOS;331bca91-d35b-5a01-8433-4da8c7122d81;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;5aafbd21-efa0-5642-98ab-3b2831e00f57;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-5643;LUAD
TCGA-75-5122;released;M0;8140/3;2005;C34.1;9cd9aff0-18d3-5668-9df8-382fa3abc2ef;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:09:51.361836-05:00;T2;No;no;N0;NA;stage ib;NA;NA;NA;not reported;not reported;NA;No;not reported;not reported;NA;NA;20;NA;NA;NA;Not Reported;NA;2c87007e-6e7f-5265-b175-dd5258388c58;10.958.904.109.589;not reported;Dead;2ce0bb26-cba2-5918-94a6-ec802d33a348;NA;not reported;male;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;3a815f85-1330-581d-ad9a-74767d03dc96;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;d8995bc7-bfbe-54e6-aff8-c881935fd3a6;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-75-5122;LUAD
TCGA-49-AAR2;released;MX;8550/3;2009;C34.3;66de4fbb-78b4-55fd-a035-1c3fea6bfb6f;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Acinar cell carcinoma;2019-08-08T17:08:24.604398-05:00;T2;No;no;N0;23479;stage ib;NA;6th;2224;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;a0526040-4bfb-5d91-b054-6e526f38393c;NA;black or african american;Alive;b810b864-c5f3-529c-b3bf-59e92f6ba023;64;not hispanic or latino;male;-23479;NA;1945;NA;Pharmaceutical Therapy, NOS;61a05930-8c02-50bb-8878-9afb1dd4af6c;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;5d193352-bcb2-548b-bf98-84493cf5580f;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-49-AAR2;LUAD
TCGA-55-8614;released;MX;8140/3;2011;C34.1;f58b92f7-b626-5622-97d4-f5f409561c57;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T2a;No;no;N0;27924;stage ib;NA;7th;536;not reported;not reported;0;No;not reported;not reported;NA;NA;40;NA;NA;NA;Not Reported;NA;edd5fba3-e6f5-58d6-b99e-bab67fc21329;219.178.082.191.781;white;Alive;fd20a73b-91c9-53d3-b303-41a73a4249d2;76;not hispanic or latino;male;-27924;NA;1935;NA;Pharmaceutical Therapy, NOS;89946c21-1c73-5dfc-ade6-3204eabdd0e2;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;c09c51f2-635d-531f-8451-fc7465e22ad6;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-8614;LUAD
TCGA-97-8177;released;M0;8255/3;2012;C34.3;06391f78-eb30-5803-87b4-0a0c5a555399;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Adenocarcinoma with mixed subtypes;2019-08-08T17:10:53.779981-05:00;T2a;No;no;N0;21648;stage ib;NA;7th;499;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;e30f73bb-50af-5e71-870b-51379f82ceca;NA;white;Alive;7fcd8882-f338-5643-a7a0-184902014715;59;not hispanic or latino;female;-21648;NA;1953;NA;Pharmaceutical Therapy, NOS;b15fac01-3386-5964-ace4-17fa2cb791e8;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;b7b40225-12e8-544d-8a0c-473eda3c318f;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-97-8177;LUAD
TCGA-49-4486;released;M0;8140/3;1992;C34.3;6b9cc1c5-cd17-5f8c-9784-0bd83f36a78c;Lower lobe, lung;NA;Lower lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T1;No;no;N0;26415;stage ia;NA;3rd;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;17.5;NA;NA;NA;Not Reported;35;7e0abaa9-d8da-5dec-97ce-785b41ece10d;0.958904109589041;white;Dead;bfc9fb80-e9e8-548c-ac95-0e3c258345a8;72;not hispanic or latino;male;-26415;1998;1920;2318;Pharmaceutical Therapy, NOS;83c338a6-81eb-532a-b68c-b041cd787360;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;f7db4cb8-58d2-5f03-a051-629bd9eacacf;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-49-4486;LUAD
TCGA-55-7281;released;M0;8140/3;2011;C34.2;162141dd-71bb-5073-8779-254db57ecf61;Middle lobe, lung;NA;Middle lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:08:47.535141-05:00;T1b;No;no;N0;25870;stage ia;NA;7th;872;not reported;not reported;0;No;not reported;not reported;NA;NA;20;NA;NA;NA;Not Reported;NA;c0f08cba-16b0-5c54-9289-1f3efd91dbf8;10.958.904.109.589;white;Alive;a83da846-9397-5228-9bdd-9820666674a0;70;not reported;female;-25870;NA;1941;NA;Pharmaceutical Therapy, NOS;ef199ee6-c385-5c3e-82b5-e5da7e912080;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;f0487604-787a-53fa-829a-4a6b5401a2dd;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-7281;LUAD
TCGA-97-A4M7;released;M0;8255/3;2012;C34.2;a848d4db-cdba-54b8-b28c-eb74683cbcf0;Middle lobe, lung;NA;Middle lobe, lung;Stage IA;Adenocarcinoma with mixed subtypes;2019-08-08T17:10:53.779981-05:00;T1b;Yes;no;N0;27062;stage ia;NA;7th;629;not reported;not reported;0;No;not reported;not reported;NA;NA;40;NA;NA;NA;Not Reported;20;971228fc-94a4-5aeb-9934-d365743ee625;219.178.082.191.781;white;Alive;e4098a4a-49b2-571f-8b83-3efcbbb7d324;74;not hispanic or latino;male;-27062;NA;1938;NA;Pharmaceutical Therapy, NOS;611a521e-f4ac-5e2e-8ffc-fc9a10adaa6c;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;03ae8af5-be7e-5108-92b9-f4cc148eecf5;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-97-A4M7;LUAD
TCGA-86-8359;released;M0;8140/3;2012;C34.3;d5e70eb3-52de-5bb7-bcc4-62e59205fbc6;Lower lobe, lung;NA;Lower lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:10:09.373179-05:00;T3;No;no;N2;19088;stage iiia;NA;7th;26;not reported;not reported;0;No;not reported;not reported;NA;NA;36;NA;NA;NA;Not Reported;NA;13ad98d6-ef4d-5348-942e-c5918905ab94;197.260.273.972.603;white;Dead;471d2c3d-ae8a-5a05-852d-b8562cf661b0;52;not hispanic or latino;male;-19088;NA;1960;444;Pharmaceutical Therapy, NOS;f93641fe-36ba-561c-962b-5827339fcd9f;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;104d718a-350f-5746-83e4-e3649f64f1bb;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-86-8359;LUAD
TCGA-67-6215;released;M0;8140/3;2010;C34.3;4e2a33e5-452e-584d-b7d9-c001fea8c22f;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:09:29.022095-05:00;T2a;No;no;N0;19310;stage ib;NA;7th;174;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;e5f1142a-d5fe-52eb-8d21-96551c9e9ee9;NA;white;Alive;9d1b24ef-476f-5f71-bee8-c8002d90c841;52;not hispanic or latino;female;-19310;NA;1958;NA;Pharmaceutical Therapy, NOS;806f813b-35a9-58e6-8174-89a48101fd76;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;5f99d7fe-a648-5b39-8dd3-549373fea6fc;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-67-6215;LUAD
TCGA-35-4123;released;M0;8140/3;2010;C34.1;7e107122-58b5-5195-840f-6ea73b3e51fd;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:07:40.762038-05:00;T1;No;no;N0;14064;stage ia;NA;7th;182;not reported;not reported;0;No;not reported;not reported;NA;NA;20;NA;NA;NA;Not Reported;20;339a73ed-8288-58d2-84b8-29f5bd7c6a53;10.958.904.109.589;white;Alive;8974bd6b-c0ec-5ef5-8619-00a89a49b409;38;not hispanic or latino;male;-14064;NA;1972;NA;Pharmaceutical Therapy, NOS;62950d51-c43f-5891-8346-be40a550e1b7;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;9ab41b16-fd3f-5efe-a591-1f7e5e7285cd;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-35-4123;LUAD
TCGA-62-A46R;released;M0;8255/3;2006;C34.3;cb8542b7-3f87-5c7e-95c4-5e05377e080d;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Adenocarcinoma with mixed subtypes;2019-08-08T17:09:29.022095-05:00;T2;No;no;N0;20063;stage ib;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;25;NA;NA;NA;Not Reported;NA;c722348e-19bb-529e-ad49-1316cff8ca9f;136.986.301.369.863;white;Dead;9d325399-028b-5f8d-9c39-f91d3a970b97;54;not hispanic or latino;female;-20063;2010;1952;1725;Pharmaceutical Therapy, NOS;19d12ac8-503e-5223-9625-bf314b889399;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;65dca1d3-347d-5ad3-b658-d3e1b40344ac;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-62-A46R;LUAD
TCGA-55-6970;released;MX;8260/3;2004;C34.1;24fc9ab8-9159-51a7-8ec5-afe69fcafc53;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIA;Papillary adenocarcinoma, NOS;2019-08-08T17:08:47.535141-05:00;T2;No;no;N2;24773;stage iiia;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;f0dc63e2-9986-5c2a-b407-ab735eab4410;NA;white;Dead;c4c98913-18ac-596a-a7e9-815a1dd40354;67;not reported;female;-24773;2005;1937;464;Pharmaceutical Therapy, NOS;3f2940d0-2e51-54bc-9a69-8c7b6e578159;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;d0c96f01-3351-55e7-a13d-e483ea91f498;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-6970;LUAD
TCGA-05-4410;released;M0;8255/3;2007;C34.1;1e1381da-1b32-564e-bf6b-c3609c213f83;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma with mixed subtypes;2019-08-08T17:07:40.762038-05:00;T2;Not Reported;yes;N0;22888;stage ib;NA;6th;0;not reported;not reported;0;No;not reported;not reported;NA;NA;98;NA;NA;NA;Not Reported;49;e71a145e-31b2-55cd-8620-7426e662a2bd;536.986.301.369.863;not reported;Alive;883ee3ec-ddd4-5897-a878-695d42a63b5b;62;not reported;male;-22888;NA;1945;NA;Pharmaceutical Therapy, NOS;92387e07-b237-572c-9a98-0fd14e35aa24;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;b2d884b3-8618-5e27-9c9f-4e9ea5b710c9;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-05-4410;LUAD
TCGA-95-8039;released;MX;8550/3;2012;C34.1;1467b199-8f4f-5122-befa-73ad3823eff2;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Acinar cell carcinoma;2019-08-08T17:10:31.173893-05:00;T1;No;no;N0;26317;stage ia;NA;7th;830;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;87668302-2bc0-509c-a9a7-86a2aa5ebda1;NA;white;Alive;7f2c75ad-d372-586c-a39b-33b16eec7fc4;72;not hispanic or latino;male;-26317;NA;1940;NA;Pharmaceutical Therapy, NOS;a9da25b3-703c-5511-9d8f-529a88fb2581;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;fe1cea89-c9fc-5012-8d44-7340ae8a31b1;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-95-8039;LUAD
TCGA-38-4627;released;M0;8140/3;2003;C34.1;45e29d84-0d87-549d-ae66-5c2172ee5ff6;Upper lobe, lung;NA;Upper lobe, lung;Stage IIA;Adenocarcinoma, NOS;2019-08-08T17:07:40.762038-05:00;T1b;No;no;N1;23510;stage iia;NA;NA;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;6752472f-e0c4-5dd4-b384-9acc71533ee1;NA;white;Dead;c60247f4-f119-521c-910d-fd7ae80de4eb;64;not hispanic or latino;female;-23510;2006;1939;1147;Pharmaceutical Therapy, NOS;208f4c77-1d84-564d-8e1d-85421cea370d;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;088ba3e7-34ac-5370-9604-563d2a369659;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-38-4627;LUAD
TCGA-50-6591;released;M1;8140/3;2007;C34.3;ae16aec0-6593-53a2-bb38-99f9c462588a;Lower lobe, lung;NA;Lower lobe, lung;Stage IV;Adenocarcinoma, NOS;2019-08-08T17:08:24.604398-05:00;T2;No;no;N0;23067;stage iv;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;71135390-695f-5248-8bc2-2707e1e38a4f;NA;white;Dead;361e371d-4f99-5f0e-847b-510892eac584;63;not hispanic or latino;female;-23067;2007;1944;119;Pharmaceutical Therapy, NOS;9aea7b6d-45c5-5076-b687-e15671b9b118;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;6dea8889-5094-59d5-9fe1-4a5b2403719f;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-50-6591;LUAD
TCGA-05-4405;released;M0;8255/3;2006;C34.3;f6413e40-b355-565d-842f-15db3edcf214;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Adenocarcinoma with mixed subtypes;2019-08-08T17:07:40.762038-05:00;T2;Not Reported;yes;N0;27241;stage ib;NA;5th;610;not reported;not reported;0;No;not reported;not reported;NA;NA;65;NA;NA;NA;Not Reported;43;36760844-8d2a-501b-9e22-50f8f31ce0a9;356.164.383.561.644;not reported;Alive;d17b7af8-fdc6-5ce5-9b71-020a46e4376d;74;not reported;female;-27241;NA;1932;NA;Pharmaceutical Therapy, NOS;a9c7389b-f7ba-55a9-ba6b-bf55ef1b0420;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;96d0160b-105b-5bbe-bc99-a3d866ae6bd3;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-05-4405;LUAD
TCGA-49-4506;released;M0;8140/3;1997;C34.1;1c996f83-32e5-54a7-8779-7130ccf1e531;Upper lobe, lung;NA;Upper lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:08:24.604398-05:00;T2;No;no;N1;25132;stage iib;NA;4th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;100;NA;NA;NA;Not Reported;NA;7642c57a-1318-5c58-8525-0aacb055e0da;547.945.205.479.452;white;Dead;316a7066-abc8-5cc2-8948-a0e1f6d93859;68;not hispanic or latino;female;-25132;1999;1929;999;Pharmaceutical Therapy, NOS;91392102-9338-59d3-8b00-68a0f9451d5b;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;b68bd919-605e-58c8-8dec-d73ecb2fcb8a;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-49-4506;LUAD
TCGA-55-A491;released;MX;8140/3;2012;C34.3;460e18c6-3f0c-57c7-a6b7-d7069be055d2;Lower lobe, lung;NA;Lower lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T1b;No;yes;N0;29593;stage ia;NA;7th;626;not reported;not reported;0;No;not reported;not reported;NA;NA;45;NA;NA;NA;Not Reported;30;b279d92b-fc9d-5f94-b96a-c1f66eb9c21e;246.575.342.465.753;white;Alive;acd08ad5-1412-5dd6-8638-776492880a43;81;not hispanic or latino;female;-29593;NA;1931;NA;Pharmaceutical Therapy, NOS;d739a32f-615c-5aba-b389-e78360504550;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;f5ed0bb8-6db7-5dad-88e6-be1fbab3cd25;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-A491;LUAD
TCGA-86-7711;released;M0;8140/3;2011;C34.3;8f242954-9ef0-5f2a-8cd7-b860ddc00374;Lower lobe, lung;NA;Lower lobe, lung;Stage IIA;Adenocarcinoma, NOS;2019-08-08T17:10:09.373179-05:00;T2a;No;no;N1;25719;stage iia;NA;7th;630;not reported;not reported;0;No;not reported;not reported;NA;NA;50;NA;NA;NA;Not Reported;NA;4ffa1e1e-d4ae-5eb9-9573-3a68669ea767;273.972.602.739.726;white;Dead;0e0a923a-2a4b-5137-a828-fc6a76aa57a5;70;hispanic or latino;male;-25719;NA;1941;1046;Pharmaceutical Therapy, NOS;3411cfea-7999-5466-aac9-f6822db1b1b6;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;ec25ee36-412b-549a-a36d-91dd9620a6ad;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-86-7711;LUAD
TCGA-97-7937;released;MX;8265/3;2011;C34.1;5b8f6a01-8816-5b33-b89d-19ef8b3d9720;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Micropapillary carcinoma, NOS;2019-08-08T17:10:31.173893-05:00;T2a;No;no;N0;23919;stage ib;NA;7th;564;not reported;not reported;0;No;not reported;not reported;NA;NA;35;NA;NA;NA;Not Reported;NA;ec7f1040-7cad-513c-bad5-a76b7333b4c2;191.780.821.917.808;white;Alive;894a84b6-6c47-52d4-8eab-12b7fbfc6d28;65;not hispanic or latino;male;-23919;NA;1946;NA;Pharmaceutical Therapy, NOS;ace80166-da3b-5e7b-ad71-b1154004640e;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;dbb1d169-a986-56e1-a8e9-791fdf09da27;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-97-7937;LUAD
TCGA-91-6836;released;MX;8140/3;2010;C34.1;c485bf5a-cb4f-5c44-baab-f366d0da530e;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:10:31.173893-05:00;T2;Not Reported;yes;N0;19216;stage ib;NA;7th;417;not reported;not reported;0;No;not reported;not reported;NA;NA;50;NA;NA;NA;Not Reported;NA;1755598a-ca84-55b8-b74c-2fe3bdb3ab09;273.972.602.739.726;white;Alive;9cdf7d98-55e9-5f7e-91d4-e509fdb3acc0;52;not hispanic or latino;female;-19216;NA;1958;NA;Pharmaceutical Therapy, NOS;e5522df8-726e-5f17-ba41-d885691cbe06;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;8ffa6965-4252-50a9-be5d-261f8d239eb6;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-91-6836;LUAD
TCGA-05-4244;released;M1;8140/3;2009;C34.3;71222be8-573b-5d40-a15e-57649e0aec0a;Lower lobe, lung;NA;Lower lobe, lung;Stage IV;Adenocarcinoma, NOS;2019-08-08T17:07:40.762038-05:00;T2;No;no;N2;25752;stage iv;NA;6th;0;not reported;not reported;0;No;not reported;not reported;NA;NA;38;NA;NA;NA;Not Reported;NA;19e0b9d9-717b-53b1-a0f4-44ca005aeedd;208.219.178.082.192;not reported;Alive;139ab7b9-af85-58e3-ac01-933eeae4afb9;70;not reported;male;-25752;NA;1939;NA;Pharmaceutical Therapy, NOS;0458ca98-2fc5-53a0-aec2-a00470915e48;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;834430fa-3aa8-570c-bac0-0c09865fbb2b;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-05-4244;LUAD
TCGA-75-6203;released;M0;8140/3;2008;C34.3;5a55d698-d6cc-5fcb-905a-a726c8b7f780;Lower lobe, lung;NA;Lower lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:09:51.361836-05:00;T2;No;no;N2;NA;stage iiia;NA;6th;NA;not reported;not reported;NA;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;4a678d53-4abe-50ca-809b-b20d604119ba;NA;not reported;Alive;1e23ed80-8ec0-5c4b-8f8a-7f857b555828;NA;not reported;female;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;50749b2f-1d84-564f-b1eb-0742d4e46a53;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;c184a053-7f87-5e10-9573-d7270db13f7e;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-75-6203;LUAD
TCGA-44-2665;released;M0;8140/3;2009;C34.1;b39aeefd-e2c0-5482-b3be-c9d527169f7a;Upper lobe, lung;NA;Upper lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T2;No;no;N1;20349;stage iib;NA;6th;1301;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;0170a6b5-647e-5e69-a6d7-a33376db6718;NA;white;Alive;8a2a58ad-ac93-5ca4-bde8-89ef17d6076d;55;not hispanic or latino;female;-20349;NA;1954;NA;Pharmaceutical Therapy, NOS;94e5aa5e-f896-5fb6-8b3d-967690edd4fe;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;d01675e5-8b1f-590f-bbec-9e246dc7335a;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-2665;LUAD
TCGA-55-8094;released;M1b;8140/3;2012;C34.1;8e6bb36d-8645-5ec4-b159-5ea76de0e96e;Upper lobe, lung;NA;Upper lobe, lung;Stage IV;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T2b;No;no;N0;18903;stage iv;NA;7th;541;not reported;not reported;0;No;not reported;not reported;NA;NA;70;NA;NA;NA;Not Reported;35;b9360afa-a6ee-55b6-adc4-d5f154754bc9;383.561.643.835.616;white;Alive;cd20be39-6583-5832-87bd-bae177b6d2b8;51;not hispanic or latino;male;-18903;NA;1961;NA;Pharmaceutical Therapy, NOS;29a9a9fa-279f-544e-bf64-735b6ae5bcdc;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;3e6cc041-cd4b-5f74-a236-ba0b849cf94f;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-8094;LUAD
TCGA-86-7701;released;M1;8140/3;2011;C34.1;027193af-bc2e-52fe-8dff-5c224645e1cd;Upper lobe, lung;NA;Upper lobe, lung;Stage IV;Adenocarcinoma, NOS;2019-08-08T17:10:09.373179-05:00;T2;No;no;N0;24209;stage iv;NA;7th;947;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;2f9b3227-96a1-57ff-9e69-2f379bd2d78c;NA;white;Alive;f50a405c-16d5-5bab-ad3d-82e8facc8852;66;not hispanic or latino;male;-24209;NA;1945;NA;Pharmaceutical Therapy, NOS;b96b9d4c-2e85-5a31-bd72-b59abc63d2d9;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;86fbeca2-c061-5618-9f45-77a635e0a894;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-86-7701;LUAD
TCGA-49-4494;released;M0;8140/3;1995;C34.1;72a22beb-7021-5b36-b654-3cb89d97a71f;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:08:24.604398-05:00;T3;No;no;N2;28387;stage iiia;NA;4th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;50;NA;NA;NA;Not Reported;25;5d451192-76af-5e96-a2d5-ca9d97fd72a1;273.972.602.739.726;white;Dead;e6fc1afb-a2e9-55e1-851b-d56448cc27ce;77;not hispanic or latino;male;-28387;1997;1918;1081;Pharmaceutical Therapy, NOS;ec6ffe49-b065-551e-851c-ce78d13651de;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;884cbbc6-82aa-5dcc-9344-a2ac3a6e522c;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-49-4494;LUAD
TCGA-49-4507;released;M0;8140/3;1997;C34.0;80211151-a7ea-50e1-a23d-fd566d85f2b7;Main bronchus;NA;Main bronchus;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:08:24.604398-05:00;T3;No;no;N1;26851;stage iiia;NA;NA;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;78;NA;NA;NA;Not Reported;NA;9a3918b6-0b39-53a9-8329-3073c172ff9e;427.397.260.273.973;white;Dead;b81498da-06d3-5013-a374-39017dc2444e;73;not hispanic or latino;female;-26851;1997;1924;268;Pharmaceutical Therapy, NOS;986025a8-f3c5-5d11-a1e2-f5710bce6be0;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;0c11c159-f2c2-5a0e-b5b4-ee493892446f;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-49-4507;LUAD
TCGA-MP-A4TD;released;M0;8140/3;2008;C34.3;e56fe5b5-29ba-5370-b1f7-7fb93f4e0968;Lower lobe, lung;NA;Lower lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:11:15.269506-05:00;T2;No;yes;N2;25983;stage iiia;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;20;NA;NA;NA;Not Reported;NA;c1bd97c2-702c-5d96-ad37-7cc2ccba8cc1;10.958.904.109.589;white;Dead;87a3df12-0fa8-504f-982d-94d0878c89a5;71;not reported;male;-25983;2008;1937;307;Pharmaceutical Therapy, NOS;e915c521-860f-5bc1-84d7-10f1bc047d8d;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;ff2e9e92-ac0d-5e83-9c45-003d8b8b2bc2;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-MP-A4TD;LUAD
TCGA-05-4395;released;M0;8255/3;2006;C34.1;0d0b1a99-d024-57fb-8517-de831d09934c;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIB;Adenocarcinoma with mixed subtypes;2019-08-08T17:07:40.762038-05:00;T4;No;no;N2;27971;stage iiib;NA;5th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;da5b547e-3f4a-55cb-a93b-9ecfb3e3c642;NA;not reported;Dead;11bc9cf2-76a1-5b47-ab46-934311e2e919;76;not reported;male;-27971;2006;1930;0;Pharmaceutical Therapy, NOS;70dea51a-b9bf-53c5-9b4b-ffe212443915;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;ac6649cc-4792-5bc6-af51-3497178d2645;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-05-4395;LUAD
TCGA-97-8172;released;M0;8550/3;2011;C34.1;1230238f-f315-5b9c-9d6a-f46a92ed34a8;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Acinar cell carcinoma;2019-08-08T17:10:53.779981-05:00;T2a;No;yes;N0;27416;stage ib;NA;7th;545;not reported;not reported;0;No;not reported;not reported;NA;NA;20;NA;NA;NA;Not Reported;20;bb830205-015e-50bb-a8f7-4f3376e33b69;10.958.904.109.589;white;Alive;f03b1c7f-f19d-5d71-8606-eb4cf4825389;75;not hispanic or latino;female;-27416;NA;1936;NA;Pharmaceutical Therapy, NOS;f640dc3b-f513-5f37-b233-35986a9a5046;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;28699788-42fe-5db3-868c-5ab11ffdcb66;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-97-8172;LUAD
TCGA-55-7911;released;MX;8140/3;2011;C34.2;226630d6-0bc6-5f1c-aa96-72d26c65c7a7;Middle lobe, lung;NA;Middle lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T1a;No;no;N0;25746;stage ia;NA;7th;537;not reported;not reported;0;No;not reported;not reported;NA;NA;96;NA;NA;NA;Not Reported;22;725423b7-9acb-5e73-b8ec-50caed5c243e;526.027.397.260.274;white;Alive;80d045b9-bfcd-5500-8814-6356d1a9afc0;70;not hispanic or latino;female;-25746;NA;1941;NA;Pharmaceutical Therapy, NOS;c62a0be6-8212-5c3c-93a0-fb548e3a5bf6;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;05857150-a29f-58d5-9dc1-447e359d06ff;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-7911;LUAD
TCGA-50-6673;released;M0;8140/3;2004;C34.1;15885ef4-0b28-5161-8c59-85fc7b53409a;Upper lobe, lung;NA;Upper lobe, lung;Stage I;Adenocarcinoma, NOS;2019-08-08T17:08:47.535141-05:00;T1;No;no;N0;30689;stage i;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;a5e3725c-1b04-5e58-91be-930ea03e05bf;NA;white;Dead;14836e6f-2e41-5e76-9e44-c253f8d3840e;84;not reported;female;-30689;2004;1920;22;Pharmaceutical Therapy, NOS;bd149ada-2e99-547b-b6b9-11235d8c7295;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;e1bf388d-8fed-57b4-ad0b-590468de6f09;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-50-6673;LUAD
TCGA-38-4625;released;M0;8140/3;2002;C34.1;ce35d76e-7b03-5008-bbcc-2342f465bc74;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:07:40.762038-05:00;T2a;No;no;N0;24241;stage ib;NA;5th;2973;not reported;not reported;0;No;not reported;not reported;NA;NA;50;NA;NA;NA;Not Reported;NA;b7d96d8d-97ba-5629-a3fe-b80b0eab9b23;273.972.602.739.726;white;Alive;aabddee2-26e4-5acc-b96b-3c53c82b5b2a;66;not hispanic or latino;female;-24241;NA;1936;NA;Pharmaceutical Therapy, NOS;bf5b2cb3-fb09-58c4-8e31-5580f698f0ee;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;999361f7-2469-5c78-ba2e-d873fd85514b;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-38-4625;LUAD
TCGA-75-6205;released;M0;8140/3;2006;C34.1;71c494e1-994e-5f94-ad20-1b9ba0db1e4d;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:09:51.361836-05:00;T2a;No;no;N0;NA;stage ib;NA;7th;NA;not reported;not reported;NA;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;e732d909-7da8-5348-ad5f-6cdde6b635fd;NA;not reported;Dead;1a0e7c77-190b-53d2-b433-78571bc4437d;NA;not reported;female;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;93b0b0de-ed3b-5dba-9aac-553a34b9c032;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;34a30b65-3d61-58ff-8f7d-720c7b17b389;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-75-6205;LUAD
TCGA-69-7973;released;M0;8255/3;2011;C34.2;660a76a9-007e-5620-ae63-e38b8eda90b4;Middle lobe, lung;NA;Middle lobe, lung;Stage IB;Adenocarcinoma with mixed subtypes;2019-08-08T17:09:29.022095-05:00;T2a;No;no;N0;15355;stage ib;NA;7th;230;not reported;not reported;0;No;not reported;not reported;NA;NA;25;NA;NA;NA;Not Reported;NA;f9aedeae-9a23-5a86-8e70-b596fcabf4ff;136.986.301.369.863;white;Alive;918b7134-c5db-564b-b48b-6507a9881865;42;not hispanic or latino;female;-15355;NA;1969;NA;Pharmaceutical Therapy, NOS;251eaab9-f06c-52a9-8b8b-89ec50bb99fe;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;d3bb060d-e476-52ae-bb18-687459daa9fc;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-69-7973;LUAD
TCGA-62-A471;released;M0;8140/3;2010;C34.1;9d67b469-c047-55a5-a9df-5637f9f086f8;Upper lobe, lung;NA;Upper lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:09:29.022095-05:00;T2b;No;no;N1;23689;stage iib;NA;7th;1246;not reported;not reported;0;No;not reported;not reported;NA;NA;30;NA;NA;NA;Not Reported;NA;507257be-f92e-5764-9f26-321105f4d871;164.383.561.643.836;white;Alive;407caae1-7c07-52e1-bca7-1e60cac760eb;64;not hispanic or latino;male;-23689;NA;1946;NA;Pharmaceutical Therapy, NOS;3936318a-cdbd-5b71-a903-5b4ca99ef958;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;a5872c92-954a-5007-a67c-79c357655640;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-62-A471;LUAD
TCGA-55-6980;released;M0;8252/3;2006;C34.3;e51edf54-e9d5-53ec-ac36-623ffc7593d0;Lower lobe, lung;NA;Lower lobe, lung;Stage IA;Bronchiolo-alveolar carcinoma, non-mucinous;2019-08-08T17:08:47.535141-05:00;T1;No;no;N0;NA;stage ia;NA;6th;2109;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;5c99c878-0d41-5249-89f6-6e020ade4e0f;NA;white;Alive;455823f7-cebf-5b1f-ad79-0313db98beaa;56;not reported;male;NA;NA;1950;NA;Pharmaceutical Therapy, NOS;37e661cb-df47-5ff9-99a1-e21dd922debe;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;326c7601-2f8d-53bf-a4a9-19119a75d60c;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-6980;LUAD
TCGA-S2-AA1A;released;M0;8253/3;2013;C34.1;2f09467b-ba83-5054-952e-d2b377a72e27;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Bronchio-alveolar carcinoma, mucinous;2019-08-08T17:11:15.269506-05:00;T1b;No;no;N0;24903;stage ia;NA;7th;513;not reported;not reported;0;No;not reported;not reported;NA;NA;95;NA;NA;NA;Not Reported;38;c56e285a-2974-59a0-a33d-46274a7337c4;520.547.945.205.479;black or african american;Alive;e4fee1c1-f2fd-5901-9d8b-b450bcd06794;68;not hispanic or latino;female;-24903;NA;1945;NA;Pharmaceutical Therapy, NOS;5764a467-8a6f-5366-82ce-25e9c1e9a9f4;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;ddf6340b-dc17-5596-af41-5eb342f52390;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-S2-AA1A;LUAD
TCGA-86-8669;released;M0;8140/3;2012;C34.1;6dc5a6df-5a69-5282-91c4-11354be110e8;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:10:09.373179-05:00;T1b;No;no;N0;23443;stage ia;NA;7th;938;not reported;not reported;0;No;not reported;not reported;NA;NA;47;NA;NA;NA;Not Reported;NA;d7b37cbd-daa2-56e6-8134-51788da60853;257.534.246.575.342;white;Alive;ac985419-9a98-599a-9706-17c2c366624d;64;not hispanic or latino;male;-23443;NA;1948;NA;Pharmaceutical Therapy, NOS;be5e2746-23db-5e1f-88a7-e5c4796f2f70;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;80727cb2-0bcd-5b34-bc3a-e424402047b5;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-86-8669;LUAD
TCGA-05-4433;released;M0;8255/3;2008;C34.3;7eae98ef-db69-5204-8f8a-5677bbc8ab7f;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Adenocarcinoma with mixed subtypes;2019-08-08T17:07:40.762038-05:00;T2;No;no;N0;30194;stage ib;NA;6th;730;not reported;not reported;0;No;not reported;not reported;NA;NA;1;NA;NA;NA;Not Reported;2;5f53d30b-7503-5dce-bfc4-e84f0955fce2;0.0547945205479452;not reported;Alive;25ef4502-732f-501a-ac5b-64efe7181115;82;not reported;male;-30194;NA;1926;NA;Pharmaceutical Therapy, NOS;6c805359-dba1-551b-8a02-ad309a8bede7;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;eded1212-28a3-56a5-a3c8-ccd528e5001c;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-05-4433;LUAD
TCGA-44-6778;released;MX;8140/3;2007;C34.1;22bbe635-aa66-5c49-b066-d80722c7d4d6;Lung, NOS;NA;Lung, NOS;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T1;No;no;N0;21725;stage ia;NA;6th;1864;not reported;not reported;0;No;not reported;not reported;NA;NA;15;NA;NA;NA;Not Reported;30;33d8b194-5eeb-51e5-9409-0d41bf96a7fd;0.821917808219178;black or african american;Alive;7df4ee63-943c-582a-840b-dd4c57186e6f;59;not reported;male;-21725;NA;1948;NA;Pharmaceutical Therapy, NOS;ea12eb89-addd-52cf-8ce5-ef5f63328632;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;3f089026-4b2f-5d5f-b34c-fdc8b4a681bd;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-6778;LUAD
TCGA-86-8056;released;M0;8255/3;2011;C34.1;b74531ab-1cfc-58a1-b6c8-a6afa52b215f;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIA;Adenocarcinoma with mixed subtypes;2019-08-08T17:10:09.373179-05:00;T4;No;no;N0;23369;stage iiia;NA;7th;139;not reported;not reported;0;No;not reported;not reported;NA;NA;36;NA;NA;NA;Not Reported;12;9b63326a-867c-5ead-86a4-d990d5902d0d;197.260.273.972.603;white;Alive;f4dc1013-6c1f-5f31-8758-8fc25b5653f7;63;not hispanic or latino;female;-23369;NA;1948;NA;Pharmaceutical Therapy, NOS;f7fa8900-2cad-581b-895d-57690ed104c9;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;1894baca-b975-531a-bac8-5e902aaab445;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-86-8056;LUAD
TCGA-44-A47B;released;M0;8140/3;2012;C34.1;344eb84b-0d71-512d-b309-ac19d77878c9;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T2a;No;no;N0;28869;stage ib;NA;7th;287;not reported;not reported;0;No;not reported;not reported;NA;NA;4.5;NA;NA;NA;Not Reported;9;f9d1a425-9cc4-5667-8b37-db96e77a6221;0.246575342465753;white;Alive;b1ea66c5-f1ca-54a8-b0b9-619b6412921c;79;not hispanic or latino;male;-28869;NA;1933;NA;Pharmaceutical Therapy, NOS;6f87a571-cf0c-5ac0-be7b-0e19890d259e;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;de962ed8-b321-54d1-ba0d-dd5d0f39bad4;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-A47B;LUAD
TCGA-73-7499;released;M0;8255/3;2010;C34.1;210bc386-fe08-5281-828d-f09756e0e765;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma with mixed subtypes;2019-08-08T17:09:51.361836-05:00;T2a;No;no;N0;29683;stage ib;NA;7th;715;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;b360a81e-6bbe-5a5b-bac6-6ec354a2b776;NA;white;Dead;01c817e6-1181-589f-97df-0cfdb06180be;81;not hispanic or latino;female;-29683;NA;1929;1531;Pharmaceutical Therapy, NOS;d9295346-cc8c-5bcc-bc40-4f97238ca96c;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;b3d98ac6-dfc0-5219-9278-33c9fb6438c2;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-73-7499;LUAD
TCGA-55-8512;released;M1b;8252/3;2012;C34.3;6f9f9ac1-7196-5082-ab41-7dbbc241b618;Lower lobe, lung;NA;Lower lobe, lung;Stage IV;Bronchiolo-alveolar carcinoma, non-mucinous;2019-08-08T17:09:08.225653-05:00;T1a;No;no;N1;15266;stage iv;NA;7th;3;not reported;not reported;0;No;not reported;not reported;NA;NA;19;NA;NA;NA;Not Reported;NA;f2f28d01-4f35-51a1-89df-bdeb114d1828;104.109.589.041.096;white;Dead;5a135925-3682-58ea-a02f-df18eb36e0f4;41;not hispanic or latino;male;-15266;NA;1971;607;Pharmaceutical Therapy, NOS;6c74c2bd-3ed7-53ac-b9e4-c1b9631aa592;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;9195aa8b-9c45-5bb4-a18f-bed97a2ae53a;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-8512;LUAD
TCGA-55-8090;released;M0;8140/3;2011;C34.3;dc4593dc-7f70-5db1-8d8d-e2773aa73009;Lower lobe, lung;NA;Lower lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T1a;Yes;no;N0;29235;stage ia;NA;7th;6;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;7b326822-6609-5223-be81-5bda5f9d65b8;NA;white;Dead;7d287232-a790-5a9c-af46-f211c09a360d;80;not hispanic or latino;male;-29235;NA;1931;598;Pharmaceutical Therapy, NOS;878f8a74-cfbf-511c-9ff3-c51d59e36577;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;b74dc3ca-c7d1-5255-8c8c-52790e293730;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-8090;LUAD
TCGA-44-4112;released;M0;8140/3;2010;C34.1;65a20a17-bc12-5f5a-ab5f-003a7fe4846b;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T2a;No;no;N0;22106;stage ib;NA;6th;722;not reported;not reported;0;No;not reported;not reported;NA;NA;30;NA;NA;NA;Not Reported;20;6418b64c-943d-5ef0-9039-09d5b2317d25;164.383.561.643.836;white;Dead;a857f735-50e7-5608-8529-c9d73fe62f5b;60;not hispanic or latino;female;-22106;NA;1950;808;Pharmaceutical Therapy, NOS;3abcf999-7369-58fe-a077-d0db138ee384;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;4a2cd281-573b-5fae-8545-44b3f5595637;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-4112;LUAD
TCGA-35-4122;released;M0;8140/3;2010;C34.1;47b11af9-8c8d-5872-bd97-0aaf6f0c4b68;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:07:40.762038-05:00;T1;No;no;N0;25491;stage ia;NA;7th;225;not reported;not reported;0;No;not reported;not reported;NA;NA;45;NA;NA;NA;Not Reported;45;bd1153b4-a33a-55e0-a30e-f03f5597df57;246.575.342.465.753;white;Alive;81930e25-3f07-5e53-a82f-6be5914dd691;69;not hispanic or latino;male;-25491;NA;1941;NA;Pharmaceutical Therapy, NOS;282b9407-1160-5be4-8dbc-81825483af04;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;99d0c232-7b3e-58d9-b40d-81219c7ff888;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-35-4122;LUAD
TCGA-86-8054;released;M0;8550/3;2011;C34.1;061f07e3-8916-50f9-b18f-f36f18d960f6;Upper lobe, lung;NA;Upper lobe, lung;Stage IIB;Acinar cell carcinoma;2019-08-08T17:10:09.373179-05:00;T2b;No;no;N1;22584;stage iib;NA;7th;1148;not reported;not reported;0;No;not reported;not reported;NA;NA;9;NA;NA;NA;Not Reported;NA;7c92e3c7-2776-5371-87e5-9a091b225c79;0.493150684931507;white;Alive;5d3cceec-bb94-5bc6-8ef6-0528c6e58960;61;not hispanic or latino;male;-22584;NA;1950;NA;Pharmaceutical Therapy, NOS;8ca64fcf-580e-5cb5-bc8d-69065c3cdba9;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;e9960e6f-0228-57c8-ad0e-928cf8903279;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-86-8054;LUAD
TCGA-NJ-A4YF;released;M0;8255/3;2007;C34.1;1813a5e5-353c-5dae-a0fc-f7963c763002;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma with mixed subtypes;2019-08-08T17:11:15.269506-05:00;T1;No;no;N0;18584;stage ia;NA;6th;2161;not reported;not reported;0;No;not reported;not reported;NA;NA;30;NA;NA;NA;Not Reported;NA;9115f597-b265-5167-8a1b-654eda2cf481;164.383.561.643.836;black or african american;Alive;bc7068cd-16c2-57ca-8c86-e7f8a1541d10;50;not hispanic or latino;female;-18584;NA;1957;NA;Pharmaceutical Therapy, NOS;c8fa34f3-ac7e-56a7-954b-3cec41f32dac;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;fdf867ed-b6e9-522d-8415-93cf87b2febd;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-NJ-A4YF;LUAD
TCGA-73-4676;released;M0;8140/3;2010;C34.1;c62947d2-f0d1-532c-a837-472e16667015;Upper lobe, lung;NA;Upper lobe, lung;Stage IIA;Adenocarcinoma, NOS;2019-08-08T17:09:51.361836-05:00;T2a;No;no;N1;16746;stage iia;NA;7th;164;not reported;not reported;0;Yes;not reported;not reported;NA;NA;48;NA;NA;NA;Not Reported;32;faeddb35-ff85-52e9-ba26-11b94fd9a27e;263.013.698.630.137;white;Dead;dc1eb6e7-0e99-52de-86a1-a531b17b5b7b;45;not hispanic or latino;male;-16746;NA;1965;281;Pharmaceutical Therapy, NOS;da5c62d6-c090-5ac8-9963-b090db4db386;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;187de799-5925-5193-a8f7-1350017ab35a;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-73-4676;LUAD
TCGA-49-6743;released;MX;8310/3;2010;C34.1;0d9967b8-03c2-5e4e-a9be-676806fbaf13;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIA;Clear cell adenocarcinoma, NOS;2019-08-08T17:08:24.604398-05:00;T1;No;no;N2;29807;stage iiia;NA;7th;1621;not reported;not reported;0;No;not reported;not reported;NA;NA;50;NA;NA;NA;Not Reported;NA;f33ddc26-39ef-5eb5-b6c0-e3cb0198a314;273.972.602.739.726;white;Alive;a6caf557-7d30-5540-8233-fd19be5a1259;81;not reported;female;-29807;NA;1929;NA;Pharmaceutical Therapy, NOS;35984da8-20c2-510e-8cf8-b5c38aa3d4d6;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;b794ff3c-7448-5df3-bc13-60bba519fe30;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-49-6743;LUAD
TCGA-78-7154;released;M0;8140/3;2003;C34.1;73bb4e25-c5e0-5512-b492-2b639a7b93d0;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:09:51.361836-05:00;T3;No;no;N2;26481;stage iiia;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;112.5;NA;NA;NA;Not Reported;45;95cea015-9e2a-5713-9304-a78fdc2b6860;616.438.356.164.384;white;Dead;4a829f8d-02f5-5e92-888e-f045ba603d8b;72;not reported;male;-26481;2004;1931;593;Pharmaceutical Therapy, NOS;b499ff48-9227-50ef-8972-a74a6c712b95;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;646ff7d7-da92-5889-9460-52ac061c99c6;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-78-7154;LUAD
TCGA-78-7539;released;M0;8255/3;2011;C34.1;9808f1e0-5269-5a65-bfe0-9de2354f2bf1;Upper lobe, lung;NA;Upper lobe, lung;Stage IIA;Adenocarcinoma with mixed subtypes;2019-08-08T17:10:09.373179-05:00;T2b;No;no;N0;27445;stage iia;NA;7th;791;not reported;not reported;0;No;not reported;not reported;NA;NA;2.2;NA;NA;NA;Not Reported;28;cb5117ec-037e-5473-8cca-778fdbd0475e;0.120547945205479;white;Alive;9fe97a10-6ea6-5b0e-9dd9-626a278d5b06;75;not reported;female;-27445;NA;1936;NA;Pharmaceutical Therapy, NOS;61dde223-0209-543f-8fc8-a91cf99732ff;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;e18966a0-851b-5dd3-a639-3c79739a5eec;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-78-7539;LUAD
TCGA-05-4417;released;M0;8255/3;2008;C34.1;099e9c44-b300-506a-9d3f-c74ffb489618;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma with mixed subtypes;2019-08-08T17:07:40.762038-05:00;T2;No;no;N0;18780;stage ib;NA;6th;455;not reported;not reported;0;No;not reported;not reported;NA;NA;56;NA;NA;NA;Not Reported;37;86a67b73-2cca-589d-b4c3-4927db2c7175;306.849.315.068.493;not reported;Alive;fba23ccd-913c-521e-ac07-21ec0bba8986;51;not reported;female;-18780;NA;1957;NA;Pharmaceutical Therapy, NOS;0f15a9e7-3ca6-58a3-9509-ea16938754f6;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;8f85bea6-209d-59fa-9c4e-63a2ca390c7c;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-05-4417;LUAD
TCGA-99-8033;released;M1;8140/3;2011;C34.1;0fe120c3-7b42-5c53-ad08-bf9e7a1ca154;Upper lobe, lung;NA;Upper lobe, lung;Stage IV;Adenocarcinoma, NOS;2019-08-08T17:10:53.779981-05:00;TX;No;no;NX;27342;stage iv;NA;7th;170;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;144ee914-ba8a-5d4d-bf91-b257c12eb162;NA;white;Dead;be35b84c-8c75-5fd5-ad4d-6e7d55ae36c4;74;not hispanic or latino;female;-27342;NA;1937;656;Pharmaceutical Therapy, NOS;a11d16e8-a36c-5286-87b1-bab16f4d4a67;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;0b3f7824-c5a1-55ef-a07d-d453cbf09fa1;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-99-8033;LUAD
TCGA-64-5774;released;M0;8140/3;2004;C34.0;bba06034-4ad4-582a-ac47-c54e2f4ffddf;Main bronchus;NA;Main bronchus;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:09:29.022095-05:00;T2;No;no;N0;22059;stage ib;NA;6th;2676;not reported;not reported;0;No;not reported;not reported;NA;NA;45;NA;NA;NA;Not Reported;45;591b4ddf-17b3-5789-8ae1-b1f4f5d717b0;246.575.342.465.753;white;Alive;c0ac2ec8-afa2-5d50-9022-723da29884d9;60;not hispanic or latino;male;-22059;NA;1944;NA;Pharmaceutical Therapy, NOS;dc3650d9-a060-5076-a728-a83a97445608;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;d26918ae-f043-551d-a1c3-756e82731590;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-64-5774;LUAD
TCGA-86-8585;released;M0;8230/3;2012;C34.1;078482c8-5765-5fdc-9dde-3ebc2cc7d9b0;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Solid carcinoma, NOS;2019-08-08T17:10:09.373179-05:00;T2a;No;no;N0;20918;stage ib;NA;7th;353;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;756f08f3-b096-5216-a6ba-463b3b29f493;NA;white;Alive;31d74813-2f4a-5e7b-bc3e-c064092e386f;57;not hispanic or latino;male;-20918;NA;1955;NA;Pharmaceutical Therapy, NOS;2f4f1546-9128-5265-bf84-2c5b5b5f1a84;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;89e7cc55-43a1-5df1-97a3-120893d1d4fa;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-86-8585;LUAD
TCGA-67-6216;released;M0;8140/3;2010;C34.2;60da3209-a447-5b7b-b8af-c4b69f61a6ca;Middle lobe, lung;NA;Middle lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:09:29.022095-05:00;T1a;No;no;N0;20967;stage ia;NA;7th;141;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;22111773-3308-5196-89e0-287b889457a1;NA;white;Alive;aa915b28-aa8b-54d1-8301-8c6feb0d83fe;57;not hispanic or latino;female;-20967;NA;1953;NA;Pharmaceutical Therapy, NOS;0b65b8fa-f98e-5cf9-a6d1-7780f46bfd1f;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;9755068a-5107-5cd1-be67-d614005408ba;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-67-6216;LUAD
TCGA-55-8096;released;MX;8140/3;2011;C34.1;54081f92-6879-567b-a617-1fb4f2c5351f;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T2a;No;no;N0;24684;stage ib;NA;7th;47;not reported;not reported;0;No;not reported;not reported;NA;NA;104;NA;NA;NA;Not Reported;NA;08331603-b133-5df0-8806-fb1049aa7211;56.986.301.369.863;white;Dead;8dde4198-4ce1-592f-b7e2-7839d5e16478;67;not hispanic or latino;female;-24684;NA;1944;719;Pharmaceutical Therapy, NOS;d2cdf5cf-0f7a-567d-86d3-c4bde7843528;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;709bc3b5-14f9-51bb-b917-0dbd13398850;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-8096;LUAD
TCGA-50-5944;released;M0;8550/3;2010;C34.1;94e55e39-c05e-5ac7-9efb-3946906b2c38;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Acinar cell carcinoma;2019-08-08T17:08:24.604398-05:00;T1;No;no;N0;25440;stage ia;NA;7th;1750;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;0bebb073-5197-5f60-bc8e-1451d4dbd45c;NA;white;Alive;a600f5b0-ae60-54b7-b7af-fc1c69c17c1c;69;not reported;female;-25440;NA;1941;NA;Pharmaceutical Therapy, NOS;6ee40fd5-fda5-550e-9a16-78c18e47d5a7;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;ebf98d9f-188a-57db-be21-ba48d0aea7b8;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-50-5944;LUAD
TCGA-05-4382;released;M0;8255/3;2009;C34.1;eece3e4c-7790-5d2a-bfa5-68bfb23ab769;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma with mixed subtypes;2019-08-08T17:07:40.762038-05:00;T2;Not Reported;yes;N0;24868;stage ib;NA;6th;607;not reported;not reported;0;No;not reported;not reported;NA;NA;62;NA;NA;NA;Not Reported;NA;ef57bd0c-1455-550d-a1eb-06f2d5620c8e;33.972.602.739.726;not reported;Alive;c2f0c511-8275-502d-b819-2405c10d0fbd;68;not reported;male;-24868;NA;1941;NA;Pharmaceutical Therapy, NOS;989ed657-66f0-5c44-9532-333e13a05835;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;4f8e2c3e-77c1-5313-967b-0eac6e3fafac;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-05-4382;LUAD
TCGA-44-7667;released;MX;8140/3;2009;C34.3;8c5f7c86-ca4d-5efe-b188-d733800e8bd2;Lower lobe, lung;NA;Lower lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T3;No;no;N0;18062;stage iib;NA;6th;1097;not reported;not reported;0;No;not reported;not reported;NA;NA;50;NA;NA;NA;Not Reported;NA;be6cda87-e05b-5993-9ff8-5c4a52f56d9e;273.972.602.739.726;white;Alive;e29d7604-eebd-56df-82ef-f477240332c5;49;not hispanic or latino;female;-18062;NA;1960;NA;Pharmaceutical Therapy, NOS;3feac07b-1f57-57b4-9ca3-0a31f134df6f;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;e9a513b8-66e8-5639-a162-02014000242d;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-7667;LUAD
TCGA-55-7573;released;MX;8140/3;2011;C34.1;321b5d8a-3d2b-55a0-9ba1-e24c624188c4;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:08:47.535141-05:00;T1b;Not Reported;yes;N0;26302;stage ia;NA;7th;487;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;db2ac5f1-5ec8-5828-955a-4be6d5852b3e;NA;white;Alive;3812cffc-5a93-5c75-9987-4ec312ad2468;72;not hispanic or latino;female;-26302;NA;1939;NA;Pharmaceutical Therapy, NOS;4843db56-93db-5286-bf84-c602f6c90b1e;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;5ca42e42-0910-5eb5-9724-1c4124269417;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-7573;LUAD
TCGA-69-7978;released;MX;8255/3;2011;C34.1;7daeda03-2ce3-5131-bbbe-863943db20a5;Upper lobe, lung;NA;Upper lobe, lung;Stage IIB;Adenocarcinoma with mixed subtypes;2019-08-08T17:09:51.361836-05:00;T2b;No;no;N1;21785;stage iib;NA;7th;134;not reported;not reported;0;No;not reported;not reported;NA;NA;80;NA;NA;NA;Not Reported;NA;b116a90f-952f-5b8e-8e41-c49298ed7b2e;438.356.164.383.562;white;Alive;da6af0bc-83ee-598b-9ac7-fcd8b4c93d93;59;not hispanic or latino;male;-21785;NA;1952;NA;Pharmaceutical Therapy, NOS;a76c5b9c-2344-583d-9579-e902a94ca1af;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;3ac06809-bac3-50bb-81a6-5cf6c0e177d8;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-69-7978;LUAD
TCGA-55-8206;released;M0;8140/3;2012;C34.1;b61a384a-746b-5d3c-a15d-bf95e4c2a325;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T1b;No;no;N0;20690;stage ia;NA;7th;888;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;0614f7d7-5978-5ea5-85ec-9b4760266d8e;NA;white;Alive;10a7cce6-455d-5e85-81b8-85641200ee45;56;not hispanic or latino;male;-20690;NA;1956;NA;Pharmaceutical Therapy, NOS;36c996de-62f4-5d37-b991-3016bcd26a4c;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;ab77a92a-27b0-5d68-bde2-d0ec44f5db07;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-8206;LUAD
TCGA-NJ-A4YI;released;M0;8550/3;2009;C34.1;af9c219e-d0fe-509f-b2ac-f55010ecdecd;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIA;Acinar cell carcinoma;2019-08-08T17:11:15.269506-05:00;T2;No;no;N2;31867;stage iiia;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;3;NA;NA;NA;Not Reported;40;5f407b7d-55e3-5d0e-9777-d7fdc6f6ef2f;0.164383561643836;white;Dead;a4ec21d9-a4c0-5d08-aca4-a4600fa64a42;87;not reported;female;-31867;2009;1922;4;Pharmaceutical Therapy, NOS;002bef3d-04cd-5a2c-865e-6c498d0be951;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;45ad60ec-e26e-5065-90c2-f13aae187548;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-NJ-A4YI;LUAD
TCGA-75-6206;released;M0;8140/3;NA;C34.1;dc9d9e80-e87c-5900-94a7-eb2967966f58;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:09:51.361836-05:00;T2;No;no;N0;NA;stage ib;NA;6th;2590;not reported;not reported;NA;No;not reported;not reported;NA;NA;20;NA;NA;NA;Not Reported;NA;cd7f46ca-fc05-5907-a584-a0fb26fcad8a;10.958.904.109.589;not reported;Alive;4fd50b11-330a-5ecb-9abe-6b12aaac3fb3;NA;not reported;male;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;c1992529-07fe-5718-9c45-a7451d84eec4;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;a6434e00-31f5-55fc-80af-3a12bb178c37;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-75-6206;LUAD
TCGA-O1-A52J;released;MX;8140/3;2007;C34.3;f579574b-5bce-57c3-95ae-4496f16b8d79;Lower lobe, lung;NA;Lower lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:11:15.269506-05:00;T1;No;no;N0;27223;stage ia;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;45;NA;NA;NA;Not Reported;30;24d83dc1-76d1-5bc7-887b-60aaa6c50188;246.575.342.465.753;white;Dead;4af716fd-37b1-51f4-88bd-c547044d38f8;74;not hispanic or latino;female;-27223;2011;1933;1798;Pharmaceutical Therapy, NOS;3fcfba6c-1106-50ce-8459-b2e4ddfc3380;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;1ad89ca3-d915-51ce-bf28-6fd30cd3c30b;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-O1-A52J;LUAD
TCGA-55-8616;released;M0;8140/3;2012;C34.1;314c85df-99b5-51e1-b766-66c7087b189e;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T2a;No;no;N0;21225;stage ib;NA;7th;48;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;e4e2a3a2-7ecc-5e71-bae7-c533ef60c5c6;NA;white;Alive;09082c79-2303-5525-86d6-f963477b4828;58;not hispanic or latino;female;-21225;NA;1954;NA;Pharmaceutical Therapy, NOS;681da83f-f168-5ceb-ab8a-09f205badaf2;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;11da1884-187c-5f8e-b3ac-ad884ea78c81;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-8616;LUAD
TCGA-L4-A4E6;released;M0;8140/3;2012;C34.1;f9171c82-7835-55ca-85fa-e3f9351a99da;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:10:53.779981-05:00;T1;No;no;N0;24631;stage ia;NA;7th;435;not reported;not reported;0;No;not reported;not reported;NA;NA;30;NA;NA;NA;Not Reported;30;24014162-6063-5588-8483-60d630642cd4;164.383.561.643.836;white;Alive;32609a4d-e274-5a8f-b9ea-aa0f11cdcdef;67;not hispanic or latino;male;-24631;NA;1945;NA;Pharmaceutical Therapy, NOS;91cc161c-4ab5-56c5-9a6f-213be8d505f6;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;58d912b4-8b02-516c-90ee-8422ba754ba3;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-L4-A4E6;LUAD
TCGA-49-4488;released;MX;8140/3;1992;C34.3;2918144e-6399-565d-ae42-7fa9bee71fc2;Lower lobe, lung;NA;Lower lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:08:24.604398-05:00;T1;No;no;N0;27332;stage ia;NA;3rd;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;cac1c2ac-f952-5d78-bf53-39df359cc872;NA;white;Dead;eb7aab18-27de-5ff3-99bb-bfcbb362c2c8;74;not hispanic or latino;female;-27332;1994;1918;869;Pharmaceutical Therapy, NOS;111cc24a-f0c8-5aa6-bdf9-94250f321d41;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;9ee9af52-f81c-5858-a682-23db68828230;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-49-4488;LUAD
TCGA-MP-A4SW;released;M0;8140/3;2002;C34.1;4cf676c8-6ab5-50cc-8a21-3bfe2cc9baa0;Upper lobe, lung;NA;Upper lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:10:53.779981-05:00;T2;No;no;N1;19640;stage iib;NA;5th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;15;NA;NA;NA;Not Reported;15;9dec1882-f326-5b6f-926c-036318ddd2bc;0.821917808219178;white;Dead;00257e88-d0d6-5353-bd34-6a422aefc63c;53;not reported;male;-19640;2006;1949;1778;Pharmaceutical Therapy, NOS;66b2645c-9f30-5580-a197-3ee7e510d774;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;be4d9128-f92d-57af-ab0f-f00d0064e0cb;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-MP-A4SW;LUAD
TCGA-50-5066;released;M0;8255/3;2009;C34.1;1f05d063-3131-5940-9bcf-cdff4c7391d4;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma with mixed subtypes;2019-08-08T17:08:24.604398-05:00;T2;No;no;N0;26385;stage ib;NA;6th;1442;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;18e562bb-507e-59ba-a214-c7ac36a86183;NA;black or african american;Alive;3b5f1bce-4312-57de-a2df-7924103c370e;72;not hispanic or latino;male;-26385;NA;1937;NA;Pharmaceutical Therapy, NOS;7998980c-a9a2-511b-930d-df89ff1561a2;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;34b88baa-fe17-5f2b-ac77-f7d9b52cb01a;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-50-5066;LUAD
TCGA-55-6969;released;M0;8140/3;2004;C34.1;68a2b5c0-0f8a-51bc-8f7a-0c7a07913cf9;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:08:47.535141-05:00;T2;No;no;N0;19270;stage ib;NA;6th;1239;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;c14b0555-250e-57d6-a9f3-50466653f9cd;NA;white;Alive;f7dc54c8-3cee-53a9-8b9f-98e2569e58c3;52;not reported;male;-19270;NA;1952;NA;Pharmaceutical Therapy, NOS;bf23b2e5-ca0b-5483-aaf8-cc4e5fb94528;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;76703540-ee14-5ec1-8dfa-e3fca38c90d3;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-6969;LUAD
TCGA-97-8547;released;MX;8550/3;2012;C34.3;e557ad74-40d2-5460-ada9-54fb6b8b5663;Lower lobe, lung;NA;Lower lobe, lung;Stage IIIA;Acinar cell carcinoma;2019-08-08T17:10:53.779981-05:00;T2a;No;no;N2;28801;stage iiia;NA;7th;657;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;5f393f89-120c-576d-b76d-c7771a06a0e1;NA;not reported;Alive;3102cc07-2af1-559c-af8a-62b0a97f310b;78;not reported;female;-28801;NA;1934;NA;Pharmaceutical Therapy, NOS;d66facef-2714-502c-ba59-91ad2d3198a3;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;20517eb2-7727-56b1-b136-ee91bcf65aa0;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-97-8547;LUAD
TCGA-78-7149;released;M0;8255/3;2002;C34.3;1edf6855-04fa-5e2f-b492-b1e6a0a4d7de;Lower lobe, lung;NA;Lower lobe, lung;Stage IIIB;Adenocarcinoma with mixed subtypes;2019-08-08T17:09:51.361836-05:00;T4;No;no;N0;26285;stage iiib;NA;6th;3940;not reported;not reported;0;No;not reported;not reported;NA;NA;115;NA;NA;NA;Not Reported;NA;69145fa2-041d-58d2-8945-d84bb1f68650;63.013.698.630.137;white;Alive;216dcb98-a462-571b-bcea-fe244b2e7f24;71;not reported;male;-26285;NA;1931;NA;Pharmaceutical Therapy, NOS;0130705a-a68f-5c62-b23a-c4a48c859f8a;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;ed083cb9-0eff-53b2-b6c5-678d7b771999;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-78-7149;LUAD
TCGA-86-A456;released;M0;8260/3;2012;C34.1;3f1aafd6-287b-52a7-aa43-506139486340;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Papillary adenocarcinoma, NOS;2019-08-08T17:10:31.173893-05:00;T1a;No;no;N0;28533;stage ia;NA;7th;896;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;35;d73124b3-0ede-5c67-abf1-44cedfc675d7;NA;asian;Alive;98a54dc4-9e8c-5ac1-9e2b-0ecada9b4ba8;78;not hispanic or latino;female;-28533;NA;1934;NA;Pharmaceutical Therapy, NOS;fa17318f-0332-5253-9ca1-797f570fd792;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;a1331b0c-44d1-5d6e-adf0-3b2ac6041d8d;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-86-A456;LUAD
TCGA-49-AAR3;released;MX;8140/3;2008;C34.1;c09eea7c-e303-50c9-9cf8-6586094714d4;Upper lobe, lung;NA;Upper lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:08:24.604398-05:00;T2;No;no;N1;25469;stage iib;NA;6th;1893;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;aa554f7a-4a14-5618-90c9-77ca3f0e17be;NA;black or african american;Alive;f3aff213-b01f-51fd-a1d9-bdd04c1d1ebf;69;not hispanic or latino;male;-25469;NA;1939;NA;Pharmaceutical Therapy, NOS;c3153863-ec1e-5444-b7da-24f6ccfd9648;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;a8a555bf-b05e-5c45-9c82-4e730866adee;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-49-AAR3;LUAD
TCGA-69-8254;released;NA;8255/3;2012;C34.3;7d0e5844-707d-5b4b-a143-9002c242a21c;Lower lobe, lung;NA;Lower lobe, lung;NA;Adenocarcinoma with mixed subtypes;2019-08-08T17:09:51.361836-05:00;T2b;No;no;NA;31134;not reported;NA;7th;409;not reported;not reported;0;No;not reported;not reported;NA;NA;40;NA;NA;NA;Not Reported;NA;d8d91f2e-b6b8-5ee9-a39a-44c115f2f190;219.178.082.191.781;white;Alive;08ee3cca-2fae-5418-826f-a123494629ea;85;not hispanic or latino;male;-31134;NA;1927;NA;Pharmaceutical Therapy, NOS;8d6c3932-4f0c-583b-b680-a5b5393eb3dc;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;c4a76412-ccf5-53f3-9bd8-d68d8555dece;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-69-8254;LUAD
TCGA-50-5936;released;M0;8480/3;2007;C34.30;1a752045-0992-509a-9685-bb3450df28b1;Lower lobe, lung;NA;Lower lobe, lung;Stage IIIA;Mucinous adenocarcinoma;2019-08-08T17:08:24.604398-05:00;T2;No;no;N2;21238;stage iiia;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;c5338c4d-364e-5e6b-a1cc-c32fe6d02870;NA;white;Dead;9deb2db7-e097-5355-acc6-9702cd119c4c;58;not hispanic or latino;male;-21238;2007;1949;257;Pharmaceutical Therapy, NOS;27961fff-fb64-5dff-b74c-cc0ea578b4c9;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;ccae18c8-ee8f-5579-91d2-ba16efcae692;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-50-5936;LUAD
TCGA-38-6178;released;NA;8140/3;2010;C34.1;d9f9c2dc-8a6d-5397-a9ad-dbc88ce9e3b4;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:07:40.762038-05:00;T2b;Not Reported;yes;N2;25593;stage iiia;NA;NA;448;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;5b21db72-d384-5d21-a3b3-af7b65d6085f;NA;white;Alive;5bd80b7c-54e2-5f82-a6ef-51fbc3222f77;70;not hispanic or latino;female;-25593;NA;1940;NA;Pharmaceutical Therapy, NOS;cb55e1cc-3ef7-527a-b3c5-fecf6c0a2014;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;7303a39b-ac3a-5ca2-a96c-c88bfec26a9e;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-38-6178;LUAD
TCGA-44-A47G;released;M0;8140/3;2012;C34.1;bfd6bbb5-2c1a-513a-8d64-41edd87db64b;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T1;No;no;N0;26800;stage ia;NA;7th;351;not reported;not reported;0;No;not reported;not reported;NA;NA;28;NA;NA;NA;Not Reported;56;c3b37d82-0a93-5e29-a75f-db3517c511ab;153.424.657.534.247;white;Alive;26bf0097-c014-5c3d-9d41-311a1f56232d;73;not hispanic or latino;female;-26800;NA;1939;NA;Pharmaceutical Therapy, NOS;1c25b657-a4d7-5453-92cd-56540f4437ba;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;40c5cc72-9272-598a-8752-afeaf2595e89;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-A47G;LUAD
TCGA-55-6984;released;M0;8140/3;2006;C34.3;24c96d7a-fcf3-540e-9697-ae1bac0e1742;Lower lobe, lung;NA;Lower lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:08:47.535141-05:00;T2;No;no;N1;NA;stage iib;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;da328097-1e79-5443-a059-8d8ba03bc744;NA;white;Dead;017afb43-8abd-53ab-b0e1-fea2eae33666;71;not hispanic or latino;female;NA;2008;1935;760;Pharmaceutical Therapy, NOS;e18f121f-61da-5a81-873e-7dec712a9908;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;09c143ed-f825-5b52-bac5-1da9427da058;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-6984;LUAD
TCGA-50-7109;released;M0;8140/3;2011;C34.3;acc4371c-2b87-53d1-9960-7a3695d7dfdf;Lower lobe, lung;NA;Lower lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:08:47.535141-05:00;T1;No;no;N0;21979;stage ia;NA;7th;255;not reported;not reported;0;No;not reported;not reported;NA;NA;120;NA;NA;NA;Not Reported;NA;c10a6092-f7ab-5b08-95e4-a4acc928d010;657.534.246.575.342;white;Dead;f08df7bd-9737-5bcf-beb0-c0ee763e373e;60;not hispanic or latino;male;-21979;NA;1951;308;Pharmaceutical Therapy, NOS;9286fee7-514d-50b0-9f2b-87747151d585;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;42f10a74-02ae-5cfc-916c-b6b9b3d040a9;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-50-7109;LUAD
TCGA-05-5715;released;M0;8255/3;2010;C34.1;aa5bc36b-d390-5df9-8e50-66931ff72d04;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma with mixed subtypes;2019-08-08T17:07:40.762038-05:00;T2a;No;no;N0;25383;stage ib;NA;7th;62;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;f496de28-c815-5351-a86e-ecb795e43c8b;NA;not reported;Alive;d1425085-fc5f-5ccb-9849-cce52bab92a6;69;not reported;female;-25383;NA;1941;NA;Pharmaceutical Therapy, NOS;6a4ef731-5c6b-53a4-aee9-a3bcd79affeb;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;720ea178-e6fd-5de5-b89b-5b270115dd9f;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-05-5715;LUAD
TCGA-80-5611;released;M0;8230/3;NA;C34.1;60eaee92-7f6d-54ec-8538-1ca752e4b8e7;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Solid carcinoma, NOS;2019-08-08T17:10:09.373179-05:00;T2;Not Reported;yes;N0;NA;stage ib;NA;6th;2595;not reported;not reported;NA;No;not reported;not reported;NA;NA;60;NA;NA;NA;Not Reported;NA;5e581c3c-692d-5668-9bf4-4bb06e1e71e6;328.767.123.287.671;not reported;Alive;6d28d6eb-cb85-5339-9cc6-bd0cac428fbb;NA;not reported;male;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;9b30758e-6588-5974-8971-f88ef671245c;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;55e3783a-b822-5c9d-ae3e-f44ee47150a7;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-80-5611;LUAD
TCGA-MP-A4SY;released;M0;8140/3;2002;C34.3;f708410f-a230-5916-b1e9-2e6dc9e141d4;Lower lobe, lung;NA;Lower lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:10:53.779981-05:00;T2;No;no;N1;22448;stage iib;NA;5th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;40;NA;NA;NA;Not Reported;NA;5ca9d83c-4afd-50df-9627-092b5944df88;219.178.082.191.781;white;Dead;79b4a31f-648d-59ed-8214-89ce055a3802;61;not hispanic or latino;male;-22448;2006;1941;1501;Pharmaceutical Therapy, NOS;02d142bd-3abf-5f90-8d12-684922878725;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;b3d39d6e-899c-5511-9e0a-70c2fcd914c1;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-MP-A4SY;LUAD
TCGA-64-5815;released;M0;8255/3;2009;C34.1;49192421-117f-54c1-970c-9f218f594dc5;Upper lobe, lung;NA;Upper lobe, lung;Stage IIB;Adenocarcinoma with mixed subtypes;2019-08-08T17:09:29.022095-05:00;T2;No;no;N1;27280;stage iib;NA;6th;866;not reported;not reported;0;No;not reported;not reported;NA;NA;30;NA;NA;NA;Not Reported;NA;d6758a5d-f318-53e9-9d8b-68c19117dee0;164.383.561.643.836;white;Alive;7a9f776e-1051-5a55-8d88-d289bf5df801;74;not hispanic or latino;male;-27280;NA;1935;NA;Pharmaceutical Therapy, NOS;ca8746b2-fe01-59dc-8b7a-237b06598cba;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;a440ba92-d523-5778-8380-bcb646f99cba;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-64-5815;LUAD
TCGA-97-8179;released;M0;8550/3;2012;C34.1;a3486809-df24-54e4-b59f-e6aece70eebc;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Acinar cell carcinoma;2019-08-08T17:10:53.779981-05:00;T1a;No;no;N0;26305;stage ia;NA;7th;435;not reported;not reported;0;No;not reported;not reported;NA;NA;60;NA;NA;NA;Not Reported;30;ee003a18-9a22-5ee8-bfa3-8ceab67c2f8e;328.767.123.287.671;white;Alive;37012cee-2b8e-5a4a-b8de-a846d68f7478;72;not hispanic or latino;male;-26305;NA;1940;NA;Pharmaceutical Therapy, NOS;68acbbdd-3497-5120-afa1-1c2c6d359fc0;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;d342e048-d4ef-5535-b9e0-ade32fba00a7;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-97-8179;LUAD
TCGA-78-8655;released;M0;8255/3;2003;C34.3;a197be4d-6a65-5365-990d-6dac6ae3a6ae;Lower lobe, lung;NA;Lower lobe, lung;Stage IA;Adenocarcinoma with mixed subtypes;2019-08-08T17:10:09.373179-05:00;T1;No;no;N0;28379;stage ia;NA;6th;2360;not reported;not reported;0;No;not reported;not reported;NA;NA;10;NA;NA;NA;Not Reported;20;7f3583a6-0a43-5bb3-a68d-a5daff251a19;0.547945205479452;not reported;Alive;8a8f1618-6da1-595d-a44d-db016e688bda;77;not reported;female;-28379;NA;1926;NA;Pharmaceutical Therapy, NOS;c8b06fd8-44fc-5096-bd16-0c216fa7e728;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;92f7684f-9eae-50cd-9594-dfd126c9957e;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-78-8655;LUAD
TCGA-NJ-A7XG;released;M0;8140/3;2013;C34.1;69ddef8c-88d5-51ce-bb91-010fa2059f66;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:11:15.269506-05:00;T4;No;no;N1;18127;stage iiia;NA;7th;617;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;2c7444ec-bda2-5114-b36c-08ca4db90524;NA;black or african american;Alive;ee21825a-40dd-5de1-b004-a94d75b4afa1;49;not hispanic or latino;male;-18127;NA;1964;NA;Pharmaceutical Therapy, NOS;4f6cea32-801d-54e4-a97f-b0c4bcaf09b3;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;34e2f442-ecfd-565d-9050-1fd9142f7337;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-NJ-A7XG;LUAD
TCGA-MP-A4TH;released;M0;8140/3;2012;C34.3;99555f51-9e00-502c-a421-9975c42dc878;Lower lobe, lung;NA;Lower lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:11:15.269506-05:00;T1a;No;no;N0;25759;stage ia;NA;7th;741;not reported;not reported;0;No;not reported;not reported;NA;NA;20;NA;NA;NA;Not Reported;20;11e66531-1eb3-58b1-a941-6f366428236a;10.958.904.109.589;white;Alive;cda074ca-aa64-5b06-ad68-128f82fa832b;70;not hispanic or latino;female;-25759;NA;1942;NA;Pharmaceutical Therapy, NOS;7c013bde-f491-5284-98bf-e76d4b3067ef;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;20313812-37cd-531a-b5da-72237941673d;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-MP-A4TH;LUAD
TCGA-69-7763;released;M0;8255/3;2010;C34.2;b5edede1-4d79-57fa-b759-fa9f57514129;Middle lobe, lung;NA;Middle lobe, lung;Stage IA;Adenocarcinoma with mixed subtypes;2019-08-08T17:09:29.022095-05:00;T1b;No;no;N0;25316;stage ia;NA;7th;690;not reported;not reported;0;No;not reported;not reported;NA;NA;7.5;NA;NA;NA;Not Reported;45;bc1ef384-5256-5bdc-b074-f57f68762640;0.410958904109589;white;Alive;216dcf02-35f9-50ec-a037-ebe93fc93c3b;69;not hispanic or latino;male;-25316;NA;1941;NA;Pharmaceutical Therapy, NOS;e16282f9-db7b-5f77-9281-2f172d3b800a;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;386c2eb6-1615-565a-9e51-f7cda14f6919;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-69-7763;LUAD
TCGA-55-7995;released;M0;8140/3;2012;C34.1;6b7ca755-7559-5daa-954e-1a6bca292c21;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T1b;No;no;N0;26837;stage ia;NA;7th;889;not reported;not reported;0;No;not reported;not reported;NA;NA;60;NA;NA;NA;Not Reported;NA;0fe82751-304f-572f-ae55-a8db91e1b24a;328.767.123.287.671;white;Alive;2e64e46f-bb8c-54f3-a471-c855f8be925f;73;not hispanic or latino;female;-26837;NA;1939;NA;Pharmaceutical Therapy, NOS;acc2af31-de1d-591b-afb6-1a7129955a16;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;e2d53a6d-b609-5194-88e3-deb62c182ed8;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-7995;LUAD
TCGA-69-A59K;released;M0;8255/3;2012;C34.1;bed52277-f8ea-56a3-ae7f-a07f8f7bbc69;Upper lobe, lung;NA;Upper lobe, lung;Stage IIB;Adenocarcinoma with mixed subtypes;2019-08-08T17:09:51.361836-05:00;T3;No;no;N0;22093;stage iib;NA;7th;591;not reported;not reported;0;No;not reported;not reported;NA;NA;25;NA;NA;NA;Not Reported;13;409875fe-9180-5b51-9bc7-708f1a3de355;136.986.301.369.863;black or african american;Alive;c56f35a1-7e2a-5695-bbeb-7c4f2f2d9b73;60;not hispanic or latino;female;-22093;NA;1952;NA;Pharmaceutical Therapy, NOS;232138d9-8fa0-5b24-ae65-a86e4138ca3c;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;f3d20848-0248-509c-bf49-f734eea2f5e7;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-69-A59K;LUAD
TCGA-67-4679;released;M0;8140/3;2009;C34.3;124e50cd-fb62-51f8-a554-7e12e5c2533e;Lower lobe, lung;NA;Lower lobe, lung;NA;Adenocarcinoma, NOS;2019-08-08T17:09:29.022095-05:00;T3;No;no;N0;25202;not reported;NA;NA;448;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;89fcf328-93c3-5092-ad34-b60811701d43;NA;white;Alive;b7684fed-3503-5d6d-8912-df6a45563ec3;69;not hispanic or latino;male;-25202;NA;1940;NA;Pharmaceutical Therapy, NOS;3732a1d9-fe85-5a91-a037-6b0d097ad738;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;805aae27-5607-5802-b031-f156e457e5e0;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-67-4679;LUAD
TCGA-50-5941;released;M0;8140/3;2010;C34.1;4482ef51-004f-5ed7-a775-1c7c6aedc198;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:08:24.604398-05:00;T2a;No;no;N2;20350;stage iiia;NA;7th;1474;not reported;not reported;0;No;not reported;not reported;NA;NA;25;NA;NA;NA;Not Reported;NA;8bbd8b65-c4ce-5e5e-b821-d218d6981e65;136.986.301.369.863;white;Alive;e8267781-5e4a-52d9-9061-5e3cca625629;55;not reported;female;-20350;NA;1955;NA;Pharmaceutical Therapy, NOS;382d9473-84fd-5695-8ae4-a8e4c42ba472;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;6737fb9a-0997-54e0-a5a4-bf91f6f0211b;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-50-5941;LUAD
TCGA-55-A48Z;released;MX;8255/3;2012;C34.1;46b945ea-68aa-52d4-8fe2-d6886e4c7e16;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIB;Adenocarcinoma with mixed subtypes;2019-08-08T17:09:08.225653-05:00;T1a;No;no;N3;22056;stage iiib;NA;7th;651;not reported;not reported;0;No;not reported;not reported;NA;NA;40;NA;NA;NA;Not Reported;40;3ca550e6-7f58-50a2-93fd-c4fb15deccea;219.178.082.191.781;white;Alive;f6e8fc6a-9338-5156-9ccc-371d37beca7f;60;not hispanic or latino;female;-22056;NA;1952;NA;Pharmaceutical Therapy, NOS;ac0bd54b-10bb-5e0b-a681-9aacbdb3e757;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;ddc5ee0a-eefc-56d7-9ddf-75f5757e7b43;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-A48Z;LUAD
TCGA-73-4677;released;M0;8140/3;2010;C34.1;75628f1d-03f8-5e64-bcd4-7ffbc7d54fd5;Upper lobe, lung;NA;Upper lobe, lung;NA;Adenocarcinoma, NOS;2019-08-08T17:09:51.361836-05:00;T2a;No;no;N0;27381;not reported;NA;NA;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;ea6ecc96-ce27-5a80-a264-76fb06974810;NA;white;Dead;c27ea253-5c73-5863-8f8a-c4b6074d72e9;74;not hispanic or latino;male;-27381;2010;1936;38;Pharmaceutical Therapy, NOS;f2e92942-f661-5de4-ab1c-2a334fbad17d;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;872e3096-dc7f-509a-8b73-45cdceb461f6;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-73-4677;LUAD
TCGA-NJ-A55A;released;M0;8550/3;2009;C34.3;2e76ac6f-52b7-5da2-b564-180446cfe90c;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Acinar cell carcinoma;2019-08-08T17:11:15.269506-05:00;T2;No;no;N0;28022;stage ib;NA;6th;15;not reported;not reported;0;No;not reported;not reported;NA;NA;25;NA;NA;NA;Not Reported;NA;42c8d406-30db-5281-a22e-4f965b410f96;136.986.301.369.863;white;Alive;913c5d19-34a6-5cb8-bc36-6bad07f17dce;76;not hispanic or latino;female;-28022;NA;1933;NA;Pharmaceutical Therapy, NOS;70207a05-df8e-5dca-823f-73e69935bb10;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;0936c9d5-b96e-50ec-8c92-4cf68592d8a8;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-NJ-A55A;LUAD
TCGA-38-4631;released;M0;8140/3;1997;C34.1;071ab696-7bad-5db0-b23b-d3dc176f4560;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:07:40.762038-05:00;T2;Not Reported;yes;N0;26538;stage ib;NA;NA;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;40;NA;NA;NA;Not Reported;NA;c75ff252-3e77-5e5b-9a8d-664f3262a275;219.178.082.191.781;white;Dead;03dc8f12-cfed-52bf-afe7-7397a1b7a3ac;72;not hispanic or latino;female;-26538;1997;1925;354;Pharmaceutical Therapy, NOS;05f8be25-c631-5cf9-82f7-be4a5e839bd2;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;7803642b-3e18-59fb-b207-726758afba47;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-38-4631;LUAD
TCGA-86-7713;released;M0;8140/3;2011;C34.2;9a00eba3-4b62-5160-9187-ace5051627f8;Middle lobe, lung;NA;Middle lobe, lung;Stage IIA;Adenocarcinoma, NOS;2019-08-08T17:10:09.373179-05:00;T2b;No;no;N0;25791;stage iia;NA;7th;1157;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;1834eaac-e595-5c1b-8af5-f8e321630e89;NA;white;Alive;df8fe597-d4c0-535d-9f98-b2d8efca4e7d;70;not hispanic or latino;male;-25791;NA;1941;NA;Pharmaceutical Therapy, NOS;d281984f-246b-5cc2-87d9-8110899e3c09;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;f956e021-689a-5713-acad-7c64b4ee7561;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-86-7713;LUAD
TCGA-55-5899;released;M0;8140/3;2010;C34.1;e71b7a45-0278-59d4-bdb8-deef718376fd;Upper lobe, lung;NA;Upper lobe, lung;NA;Adenocarcinoma, NOS;2019-08-08T17:08:47.535141-05:00;T1a;No;no;N1;NA;not reported;NA;7th;930;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;31d4ec2a-0289-58b0-ae83-9afa8b8e67f8;NA;white;Alive;3e120a70-0fd7-53df-979b-4d0c4b4d1439;58;not hispanic or latino;male;NA;NA;1952;NA;Pharmaceutical Therapy, NOS;655b31bc-09d7-5d78-a3d0-8236332ad901;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;80175096-365e-5428-a669-2469d3863b2d;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-5899;LUAD
TCGA-97-8176;released;M0;8550/3;2012;C34.3;4144f3b6-8fcb-5fef-a485-3d698052b251;Lower lobe, lung;NA;Lower lobe, lung;Stage IIIA;Acinar cell carcinoma;2019-08-08T17:10:53.779981-05:00;T3;No;no;N1;23170;stage iiia;NA;7th;252;not reported;not reported;0;No;not reported;not reported;NA;NA;40;NA;NA;NA;Not Reported;40;118bbbbb-528c-5489-9af9-34c770e6c0e6;219.178.082.191.781;white;Dead;ad8e8d0e-5eea-5ae6-81cd-84cb081b7361;63;not hispanic or latino;male;-23170;NA;1949;468;Pharmaceutical Therapy, NOS;7015f7d8-7ff7-5ff9-89e7-984e0af3bbc9;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;67f5cedf-388e-59ce-9f58-1a24fc2eccf3;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-97-8176;LUAD
TCGA-49-AARN;released;MX;8140/3;2000;C34.3;608ccff3-aee3-563f-9d3f-569c7a666af6;Lower lobe, lung;NA;Lower lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:08:24.604398-05:00;T1;Yes;no;N0;20605;stage ia;NA;5th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;1b3c4bb9-ed27-550e-9eb3-446f87297ec3;NA;black or african american;Dead;4d4f3e23-3121-5391-9887-db0dd6dd1406;56;not hispanic or latino;female;-20605;2003;1944;1135;Pharmaceutical Therapy, NOS;4d3019e2-612d-5eaa-a1a8-41c0676a0e93;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;06eab369-5013-53ce-a807-01f85931f8a1;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-49-AARN;LUAD
TCGA-93-A4JO;released;MX;8255/3;2012;C34.3;f4223802-a76b-5dde-8ec5-0e82114711d1;Lower lobe, lung;NA;Lower lobe, lung;Stage IA;Adenocarcinoma with mixed subtypes;2019-08-08T17:10:31.173893-05:00;T1a;No;no;N0;25898;stage ia;NA;7th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;50;NA;NA;NA;Not Reported;50;117ce084-dcb7-5f9f-896a-d33220a415d4;273.972.602.739.726;white;Dead;083c00df-8520-5001-9a59-9916e4114927;70;not hispanic or latino;male;-25898;2012;1942;33;Pharmaceutical Therapy, NOS;25aa89e7-81dc-58ea-81cc-80446b6addaa;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;f71cb03a-e13f-5fd3-a8ac-eb27138331f1;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-93-A4JO;LUAD
TCGA-50-5051;released;M0;8140/3;2007;C34.1;a42c1a52-f54b-59a7-a1e6-8a7e3a9f8031;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:08:24.604398-05:00;T2;No;no;N2;15585;stage iiia;NA;6th;455;not reported;not reported;0;No;not reported;not reported;NA;NA;30;NA;NA;NA;Not Reported;NA;e6a10462-a7cb-5d21-ac7f-c0b39984af30;164.383.561.643.836;white;Dead;d9211ca6-8432-5cdf-aad9-72a141f5e1a7;42;not hispanic or latino;female;-15585;NA;1965;478;Pharmaceutical Therapy, NOS;6b7c2489-b20b-5a26-aedc-76c2ecd40223;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;14ae7fc5-9417-5f99-a074-10c0aa479d97;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-50-5051;LUAD
TCGA-62-A46O;released;M0;8140/3;2006;C34.3;a2b7d3c3-8a8b-5d91-8440-6a28daf136b2;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:09:29.022095-05:00;T2;No;no;N0;24050;stage ib;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;48;NA;NA;NA;Not Reported;NA;a1c7025b-0952-5ade-a0a2-1a445f600f93;263.013.698.630.137;white;Dead;9b58c7ed-99e7-53c2-98c3-9059f8a1afdd;65;not hispanic or latino;female;-24050;2009;1941;1454;Pharmaceutical Therapy, NOS;aaa2e7a0-5265-55db-b7f5-e8f80bea9f40;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;abf39466-2cae-58b1-b4eb-7e484b740474;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-62-A46O;LUAD
TCGA-44-6146;released;M0;8480/3;2010;C34.30;2f032269-4670-5aa1-bf10-9fd2f2f38265;Lower lobe, lung;NA;Lower lobe, lung;Stage IIB;Mucinous adenocarcinoma;2019-08-08T17:08:02.187456-05:00;T3;Not Reported;yes;N0;23378;stage iib;NA;7th;728;not reported;not reported;0;No;not reported;not reported;NA;NA;15;NA;NA;NA;Not Reported;NA;86642c17-27dd-5995-a0be-a2922074adf4;0.821917808219178;white;Alive;d0bfd66b-9e46-58f9-9ba9-1d98d9dd5d7d;64;not hispanic or latino;male;-23378;NA;1946;NA;Pharmaceutical Therapy, NOS;e6190dde-6a16-5742-b249-8b6e62e2b4b1;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;6e41249d-ffde-545f-a83e-7f9cc6cac613;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-6146;LUAD
TCGA-62-A46Y;released;M0;8255/3;2008;C34.3;f2664da6-bf48-5600-8383-5b5b591d3789;Lower lobe, lung;NA;Lower lobe, lung;Stage IIIA;Adenocarcinoma with mixed subtypes;2019-08-08T17:09:29.022095-05:00;T2;No;no;N2;25905;stage iiia;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;ee2ae7a4-585e-556d-8ead-f04d3761656f;NA;white;Dead;c37d1188-a100-5a34-9535-d8461861efc0;70;not hispanic or latino;female;-25905;2009;1938;414;Pharmaceutical Therapy, NOS;e20ce9ff-d43b-505a-8c3d-b06eb3cb9ef2;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;4cce4b80-4f54-52aa-9c8b-a7f639431ae2;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-62-A46Y;LUAD
TCGA-71-8520;released;M0;8140/3;2011;C34.1;a130c25a-6f37-58e9-b32a-d8a2e4db79ff;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:09:51.361836-05:00;T2;No;no;N0;21921;stage ib;NA;7th;3;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;c13dd024-854f-5218-8622-bbfb844cd237;NA;asian;Dead;b239ce8c-dc25-565a-adce-0f8a95992f39;60;not hispanic or latino;female;-21921;NA;1951;210;Pharmaceutical Therapy, NOS;2c85f3a6-5255-5e81-a65f-b8b9bcadd919;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;2238b95a-f4fa-5fa9-810b-5b0787d3ccf9;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-71-8520;LUAD
TCGA-L9-A5IP;released;M1b;8140/3;2012;C34.1;367c677e-8f69-577c-81f8-0b490bf6b4f3;Upper lobe, lung;NA;Upper lobe, lung;Stage IV;Adenocarcinoma, NOS;2019-08-08T17:10:53.779981-05:00;T3;No;no;N2;14681;stage iv;NA;7th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;0d071421-b69b-58d7-a373-2fd4835dd89e;NA;black or african american;Dead;827e1e33-6c20-5130-9ce4-ecca1f9fb1ff;40;not hispanic or latino;female;-14681;2012;1972;58;Pharmaceutical Therapy, NOS;091491be-39b7-581c-b0a8-46c17113c676;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;b5f5d1ba-636b-5f8e-b61e-e82554fca2d3;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-L9-A5IP;LUAD
TCGA-44-5645;released;NA;8140/3;2010;C34.1;bc350e21-463f-5381-acc1-ea667fc13cdb;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T1;No;no;NX;22471;stage ia;NA;7th;852;not reported;not reported;0;No;not reported;not reported;NA;NA;5;NA;NA;NA;Not Reported;10;b1b908db-6c89-5218-8cba-81216c6bf3f2;0.273972602739726;black or african american;Alive;99944f55-267f-5d61-b860-194e1cca2cbb;61;not hispanic or latino;female;-22471;NA;1949;NA;Pharmaceutical Therapy, NOS;d976b486-5777-5f60-a4f4-00cfcc6be7c0;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;0a75ec6a-6f2d-504a-aa74-6423da973fc2;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-5645;LUAD
TCGA-86-8076;released;M0;8260/3;2011;C34.1;0623766e-992a-5e6e-9712-aaf67c235428;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Papillary adenocarcinoma, NOS;2019-08-08T17:10:09.373179-05:00;T1;No;no;N0;15605;stage ia;NA;7th;993;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;3bf61fd4-df70-5885-bf0f-05d9ec629aad;NA;white;Alive;9cb726d6-99f8-50e7-ad25-d443d90fcd38;42;not hispanic or latino;male;-15605;NA;1969;NA;Pharmaceutical Therapy, NOS;e56b08c4-f3a1-5327-a430-af707d515d9e;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;551978e9-773a-567d-b578-98859b3c1ed9;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-86-8076;LUAD
TCGA-MP-A4TI;released;M0;8140/3;2010;C34.3;79f3488a-9448-573b-977f-bb7a769487ea;Lower lobe, lung;NA;Lower lobe, lung;Stage IIA;Adenocarcinoma, NOS;2019-08-08T17:11:15.269506-05:00;T2a;No;no;N1;26565;stage iia;NA;7th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;35;NA;NA;NA;Not Reported;35;cb33ca1c-5cb5-5bad-9644-79f8bdea8098;191.780.821.917.808;white;Dead;48b071ad-ce05-5630-b41a-1634cf0c2f94;72;not hispanic or latino;male;-26565;2011;1938;429;Pharmaceutical Therapy, NOS;e88833ef-afd9-534a-9d32-eebcdf0cf28c;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;ed985a92-43bd-5441-9cbe-13f33f9686ca;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-MP-A4TI;LUAD
TCGA-J2-A4AG;released;MX;8140/3;2012;C34.1;ae0ea1d2-617a-5261-8643-84879758a648;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:10:53.779981-05:00;T1b;No;no;N0;24224;stage ia;NA;7th;988;not reported;not reported;0;No;not reported;not reported;NA;NA;25;NA;NA;NA;Not Reported;25;037f005e-1ec2-5b95-ba6e-e8c815c3ae4f;136.986.301.369.863;white;Alive;e16de832-4947-57da-8593-6a34e281d780;66;not hispanic or latino;female;-24224;NA;1946;NA;Pharmaceutical Therapy, NOS;215553bf-fdaf-50cc-a28f-73cedd0f75d7;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;add6bccd-7f76-56ce-8174-c88473ac756e;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-J2-A4AG;LUAD
TCGA-95-A4VK;released;M0;8255/3;2012;C34.1;5468024a-6d83-5849-b59d-52a167eabf4a;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIA;Adenocarcinoma with mixed subtypes;2019-08-08T17:10:31.173893-05:00;T2b;No;yes;N2;27040;stage iiia;NA;7th;651;not reported;not reported;0;No;not reported;not reported;NA;NA;45;NA;NA;NA;Not Reported;30;b1d57222-a564-5ca5-8ea1-b9f83ab47a28;246.575.342.465.753;white;Alive;b0dbea01-94e9-5d48-beb3-092ba893ab4f;74;not hispanic or latino;female;-27040;NA;1938;NA;Pharmaceutical Therapy, NOS;c83e6ca6-3b7a-507e-bfc8-667506a93936;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;9f2e311b-10c1-5ebe-b1d4-7d232077d909;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-95-A4VK;LUAD
TCGA-55-6987;released;M0;8140/3;2006;C34.3;10de9d0c-8af2-5d13-b24e-a535f66c71e8;Lower lobe, lung;NA;Lower lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:08:47.535141-05:00;T1;No;no;N0;28382;stage ia;NA;6th;2137;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;30a6d01e-9fba-5923-a129-30ddb9dfd70c;NA;white;Alive;1e8c8a78-b0b8-5708-b2e7-a71608dffa9b;77;not hispanic or latino;male;-28382;NA;1929;NA;Pharmaceutical Therapy, NOS;d4885dc6-77f4-5f3f-8ec6-55e1cb2c9a24;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;5fb6d709-3b07-5675-967b-db1216cf47c6;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-6987;LUAD
TCGA-78-7540;released;M0;8253/3;1999;C34.3;ae43688c-a21e-53af-9704-abcd6cd72db3;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Bronchio-alveolar carcinoma, mucinous;2019-08-08T17:10:09.373179-05:00;T2;No;no;N0;24440;stage ib;NA;6th;881;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;ace17e5e-bd43-5667-9f65-ca445af569e5;NA;white;Dead;6ef63a78-1326-575c-8a64-95f8057c2007;66;not reported;female;-24440;NA;1933;1197;Pharmaceutical Therapy, NOS;e869d042-d884-5a15-9176-07844259a9e3;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;190b4edf-4ab4-5f27-b130-47f098a53d6b;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-78-7540;LUAD
TCGA-95-7947;released;M0;8255/3;2011;C34.1;8f9d1140-b278-57db-bda1-a79e0a0d2685;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma with mixed subtypes;2019-08-08T17:10:31.173893-05:00;T1a;Not Reported;yes;N0;24752;stage ia;NA;7th;477;not reported;not reported;0;No;not reported;not reported;NA;NA;100;NA;NA;NA;Not Reported;50;764a17a9-1078-54bf-8eec-0d838c4aa08c;547.945.205.479.452;white;Alive;d3d64a9e-1b32-51a3-a30e-529027d399a4;67;not hispanic or latino;male;-24752;NA;1944;NA;Pharmaceutical Therapy, NOS;5a596ae7-65b4-50df-a296-7fd0e88e0043;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;6af0e427-51fd-5247-9106-88bc886e1a24;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-95-7947;LUAD
TCGA-69-7974;released;MX;8255/3;2011;C34.1;8285b0b6-9484-52ed-b473-65c9fab90376;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIA;Adenocarcinoma with mixed subtypes;2019-08-08T17:09:29.022095-05:00;T2a;No;no;N2;20021;stage iiia;NA;7th;184;not reported;not reported;0;No;not reported;not reported;NA;NA;30;NA;NA;NA;Not Reported;30;b595526e-cb83-58fa-8cf0-b754f28ddd6d;164.383.561.643.836;white;Alive;aabaf95f-ffe0-5191-bbd0-f4173d82df73;54;not hispanic or latino;female;-20021;NA;1957;NA;Pharmaceutical Therapy, NOS;587ffd0d-2cf8-53e3-80f4-9d5d3537fd28;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;0fca7fb7-567b-5314-a6e8-45d292df7c71;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-69-7974;LUAD
TCGA-50-6593;released;M0;8255/3;2008;C34.1;46e52e8f-8283-5091-b268-a0fe40a13e7a;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIA;Adenocarcinoma with mixed subtypes;2019-08-08T17:08:47.535141-05:00;T1;No;no;N2;18152;stage iiia;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;4bb2efc6-c2ce-5162-bbab-977820ffd220;NA;white;Dead;0f8475f0-34f5-5bcb-8fa3-5dfdfa3a8344;49;not hispanic or latino;female;-18152;2008;1959;336;Pharmaceutical Therapy, NOS;6a37b721-a767-56fa-957a-e1a648f429bf;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;5a736a2b-6a0e-5a4d-b22e-9367d72374f2;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-50-6593;LUAD
TCGA-05-5420;released;M0;8140/3;2008;C34.1;a3a7cc14-b5eb-5b97-a1d3-bf5824e04e00;Lung, NOS;NA;Lung, NOS;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:07:40.762038-05:00;T2;Not Reported;yes;N2;24472;stage iiia;NA;6th;457;not reported;not reported;0;No;not reported;not reported;NA;NA;40;NA;NA;NA;Not Reported;40;714cb35c-70ab-5904-81cf-c1d50ec611ae;219.178.082.191.781;not reported;Alive;9650f432-c6cf-578f-ac8b-ced9be3e1b4d;67;not reported;male;-24472;NA;1941;NA;Pharmaceutical Therapy, NOS;56e83eb6-b653-5721-b9e9-e8e8ba876b01;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;3a46379f-cfb5-5b33-9127-f0a8f4b270df;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-05-5420;LUAD
TCGA-75-7027;released;M0;8140/3;NA;C34.3;121bf179-a530-513f-88e2-0334cadacec1;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:09:51.361836-05:00;T2;No;no;N0;NA;stage ib;NA;6th;3059;not reported;not reported;NA;No;not reported;not reported;NA;NA;50;NA;NA;NA;Not Reported;NA;630347b9-3e76-5210-ab29-eba15c295017;273.972.602.739.726;not reported;Alive;5a9d85d2-022a-5cbb-8345-f29516e8a55d;NA;not reported;male;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;1fd8b95e-92ca-5dc0-9664-8bcfacc97f15;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;d99839be-4376-5ae3-8d41-84eacb76fc87;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-75-7027;LUAD
TCGA-49-AAQV;released;MX;8255/3;2012;C34.3;e3a15fd6-410b-5b00-9075-65667538c5e5;Lower lobe, lung;NA;Lower lobe, lung;Stage II;Adenocarcinoma with mixed subtypes;2019-08-08T17:08:24.604398-05:00;T1;No;no;N1;23370;stage ii;NA;7th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;17cedca2-84b8-506a-8ee2-e5b57d4c6f22;NA;black or african american;Dead;5460ee3e-20c5-5060-b9ec-6ae211500fa1;63;not hispanic or latino;female;-23370;2013;1949;677;Pharmaceutical Therapy, NOS;08be9c00-fc25-5298-9946-4d0516d9f51d;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;72d2c166-0b54-54c1-8dea-6ca3b95c9efe;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-49-AAQV;LUAD
TCGA-69-7764;released;M0;8255/3;2010;C34.1;1e1593d3-3806-53fb-8402-33ce19ad9ba9;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma with mixed subtypes;2019-08-08T17:09:29.022095-05:00;T1b;No;no;N0;27693;stage ia;NA;7th;414;not reported;not reported;0;No;not reported;not reported;NA;NA;30;NA;NA;NA;Not Reported;14;3f4dd6eb-cc07-58d2-9892-54d47d2be1bd;164.383.561.643.836;white;Alive;651de13e-b00e-5aa6-80cc-c1bf9ff0719a;75;not hispanic or latino;male;-27693;NA;1935;NA;Pharmaceutical Therapy, NOS;2d427475-1f6a-5eae-b7bb-e7ec63169342;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;043323e2-fa25-5075-b7cb-c0e7f6633bda;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-69-7764;LUAD
TCGA-93-A4JP;released;M1b;8260/3;2012;C34.3;e7e8a97c-8b10-5bb3-9de2-f73180293080;Lower lobe, lung;NA;Lower lobe, lung;Stage IV;Papillary adenocarcinoma, NOS;2019-08-08T17:10:31.173893-05:00;TX;No;no;NX;23620;stage iv;NA;7th;578;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;680d0d51-0cab-557a-8a95-f9dadf24353a;NA;asian;Alive;5772671a-b7ce-5d1b-948b-db696dcbee1a;64;not hispanic or latino;male;-23620;NA;1948;NA;Pharmaceutical Therapy, NOS;be56e28d-cda2-5c7e-a18f-5e040a574213;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;af5a7abc-dfa5-52b7-8e6b-67a609247848;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-93-A4JP;LUAD
TCGA-78-7156;released;M1;8255/3;2006;C34.9;97664a21-64b8-5b98-b584-69cd01992ec2;Lung, NOS;NA;Lung, NOS;Stage IV;Adenocarcinoma with mixed subtypes;2019-08-08T17:09:51.361836-05:00;T4;No;no;N1;22720;stage iv;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;84;NA;NA;NA;Not Reported;28;235df91d-dab6-57ad-8e18-3148a8c37059;46.027.397.260.274;white;Dead;6bf0bb30-7521-5c0d-9e33-52a4da2f7ab7;62;not reported;male;-22720;2008;1944;976;Pharmaceutical Therapy, NOS;78167ee8-283f-5a75-95a5-9001f78999dc;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;fc4321b6-66f1-543c-8340-340a9ad8b50d;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-78-7156;LUAD
TCGA-53-7626;released;M0;8140/3;2008;C34.1;7066be41-d6dc-5385-8c11-332c13c3fc99;Upper lobe, lung;NA;Upper lobe, lung;Stage IIA;Adenocarcinoma, NOS;2019-08-08T17:08:47.535141-05:00;T1;No;no;N1;28024;stage iia;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;35;NA;NA;NA;Not Reported;35;d332e5fe-1c0e-54f5-a6b3-fea82e749e04;191.780.821.917.808;white;Dead;8e490bf9-3da9-5197-9f19-2969563327d9;76;not hispanic or latino;female;-28024;2010;1932;929;Pharmaceutical Therapy, NOS;db7aeff0-e251-5604-a3d0-e9916f5b8bb5;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;c776ddb8-4cff-53ce-aee3-1d289768e087;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-53-7626;LUAD
TCGA-MP-A4T8;released;M0;8140/3;2006;C34.1;6bc9bea6-7892-5078-9c40-913621448bcd;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:10:53.779981-05:00;T2;No;yes;N2;25069;stage iiia;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;25;NA;NA;NA;Not Reported;15;5c13fd98-69e8-5544-8765-0bbae33e6626;136.986.301.369.863;not reported;Dead;ee219a6a-618a-533a-b5c7-a114ad9100f3;68;not reported;male;-25069;2006;1938;161;Pharmaceutical Therapy, NOS;4abc558e-94ac-5378-ada7-f2d6238cc4f0;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;5ee7f886-a763-58ef-a94f-c34d3586a6f2;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-MP-A4T8;LUAD
TCGA-55-8299;released;MX;8140/3;2012;C34.1;1124d16c-368e-542e-b2f3-3ef0bb0fba50;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T1b;No;no;N0;22626;stage ia;NA;7th;216;not reported;not reported;0;No;not reported;not reported;NA;NA;20;NA;NA;NA;Not Reported;41;2e9d3118-2940-57b0-96da-f6d238ccb753;10.958.904.109.589;white;Dead;74f32004-7449-59e0-8aef-d1a908075782;61;not hispanic or latino;female;-22626;NA;1951;469;Pharmaceutical Therapy, NOS;ab769843-c13a-5bcf-9d7b-792a395214bf;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;09bb7544-59a7-5f9b-9b18-5cdf8e223391;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-8299;LUAD
TCGA-86-6562;released;M0;8140/3;2011;C34.1;78196193-10e2-5e04-8d7b-742fb00295c4;Upper lobe, lung;NA;Upper lobe, lung;Stage IIA;Adenocarcinoma, NOS;2019-08-08T17:10:09.373179-05:00;T2a;No;no;N1;19301;stage iia;NA;7th;0;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;d0fd8e3f-3e5d-5666-bbbf-71b7aba98c25;NA;white;Dead;2c2b77ca-a909-52ae-a465-3f6b5c466abe;52;not hispanic or latino;male;-19301;NA;1959;376;Pharmaceutical Therapy, NOS;8fd1e6d9-bcc9-58ba-a998-039cd6b13bf2;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;a462b6ab-7ddc-58fc-ac26-847299bf5283;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-86-6562;LUAD
TCGA-86-8073;released;M0;8250/3;2011;C34.1;ee363bf4-fd32-5882-a41f-d23c04cb4b92;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Bronchiolo-alveolar adenocarcinoma, NOS;2019-08-08T17:10:09.373179-05:00;T2a;No;no;N0;21214;stage ib;NA;7th;740;not reported;not reported;0;No;not reported;not reported;NA;NA;40;NA;NA;NA;Not Reported;NA;f4fc3d00-9fb6-5173-a373-4047a726e7d5;219.178.082.191.781;white;Alive;a7f73687-5e40-53d9-a2d9-6512eb86f33d;58;not hispanic or latino;male;-21214;NA;1953;NA;Pharmaceutical Therapy, NOS;d923a831-0197-5f10-be6d-914d8ae8387d;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;ac5ff6dd-43f8-5fcf-a08e-14e6a0975f7b;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-86-8073;LUAD
TCGA-55-7576;released;M0;8140/3;2011;C34.1;21a3220a-2919-5653-8c9a-42b49b2c8f2b;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:08:47.535141-05:00;T2a;No;no;N0;19917;stage ib;NA;7th;670;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;056ecd13-311d-5fb0-9556-467f71171527;NA;black or african american;Alive;5f5b5d26-4dc8-5e9c-88e8-75326a26a97e;54;not hispanic or latino;male;-19917;NA;1957;NA;Pharmaceutical Therapy, NOS;f4769caf-bf00-54ca-9448-521e37782c8d;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;4e09e973-b1c2-5ab7-ad6e-14c32bb42db3;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-7576;LUAD
TCGA-05-4424;released;M0;8255/3;2008;C34.1;5a43f918-0c02-5c0b-b8ff-40b0eed416e2;Upper lobe, lung;NA;Upper lobe, lung;Stage IIB;Adenocarcinoma with mixed subtypes;2019-08-08T17:07:40.762038-05:00;T3;No;no;N0;25689;stage iib;NA;6th;913;not reported;not reported;0;No;not reported;not reported;NA;NA;50;NA;NA;NA;Not Reported;50;fefa08c7-2fd2-5070-89d7-5f58058e50a0;273.972.602.739.726;not reported;Alive;4dd3d381-bab8-5bdd-9aa0-e12ce470f8e9;70;not reported;male;-25689;NA;1938;NA;Pharmaceutical Therapy, NOS;6532d45b-9933-551a-b333-9a68177af9bb;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;6410e122-75b3-5ab9-8f0a-dc788512a598;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-05-4424;LUAD
TCGA-69-7765;released;MX;8255/3;2011;C34.1;dda7c0d9-9b82-57ab-abf9-f89745ea1f0b;Upper lobe, lung;NA;Upper lobe, lung;NA;Adenocarcinoma with mixed subtypes;2019-08-08T17:09:29.022095-05:00;T4;No;no;N0;20625;not reported;NA;7th;165;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;30;9f06ea35-4a8f-55b8-8794-0171467ce45f;NA;black or african american;Alive;ffb07643-9e89-5410-974b-d3f404bef3b9;56;not hispanic or latino;male;-20625;NA;1955;NA;Pharmaceutical Therapy, NOS;9c3a17fc-779f-5edc-bc28-1cf35cc837f8;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;944a62e9-22b5-5b83-bee7-d381472026e2;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-69-7765;LUAD
TCGA-95-7043;released;MX;8255/3;2011;C34.1;e9bccdce-1518-5c2c-860f-b585bf00cfb6;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma with mixed subtypes;2019-08-08T17:10:31.173893-05:00;T1a;Not Reported;yes;N0;23165;stage ia;NA;7th;37;not reported;not reported;0;No;not reported;not reported;NA;NA;40;NA;NA;NA;Not Reported;39;a6756656-a14c-596c-856a-38276fe976e9;219.178.082.191.781;white;Dead;5bf9ddab-e5a6-5e06-9c5b-746b029471de;63;not hispanic or latino;female;-23165;NA;1948;503;Pharmaceutical Therapy, NOS;f46a8aa3-55f9-5d0c-b286-4ecdf3c23f20;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;03f4e5cd-fb0a-576e-9a3b-1633643ebaac;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-95-7043;LUAD
TCGA-67-3772;released;M0;8140/3;2009;C34.1;3bc27c15-deeb-5c14-a644-00f112160060;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:09:29.022095-05:00;T2;No;no;N0;29989;stage ib;NA;6th;573;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;2b895ef2-a6e6-51e2-91e0-4f43e60386a9;NA;white;Alive;11f4b12c-5504-524a-a36b-f38c30dfbe89;82;not hispanic or latino;female;-29989;NA;1927;NA;Pharmaceutical Therapy, NOS;b37ad20d-8528-5b3d-a0bd-f92b429ab179;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;0e9a1f7a-1c9e-57ed-9faf-230c4e581a5f;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-67-3772;LUAD
TCGA-55-7914;released;MX;8140/3;2011;C34.1;719e74f6-bfc8-565d-8f04-d705fbc51e4d;Upper lobe, lung;NA;Upper lobe, lung;Stage IIA;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T1b;Not Reported;yes;N1;26105;stage iia;NA;7th;3;not reported;not reported;0;No;not reported;not reported;NA;NA;5;NA;NA;NA;Not Reported;NA;a3800817-f82c-5158-b792-89ea8d748201;0.273972602739726;white;Dead;4a3e3095-198f-5b9c-a0df-947b62d5db42;71;not hispanic or latino;female;-26105;NA;1940;187;Pharmaceutical Therapy, NOS;d0268545-61cd-50ee-ab50-71ffcee6378d;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;7da6aa5b-e62f-500d-9555-34af69037840;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-7914;LUAD
TCGA-55-7574;released;M0;8140/3;2011;C34.1;1cb1cd21-aeba-5c95-bd56-709b5d468257;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:08:47.535141-05:00;T2a;No;no;N0;23703;stage ib;NA;7th;95;not reported;not reported;0;No;not reported;not reported;NA;NA;2;NA;NA;NA;Not Reported;40;f13f97f7-b11c-51ae-99bd-e416656e4dee;0.10958904109589;white;Dead;639d7216-cbca-5f59-8de3-7fd48916a108;64;not hispanic or latino;female;-23703;NA;1947;995;Pharmaceutical Therapy, NOS;0f98fedd-e7a5-5e9c-a01a-ab428f5b80d7;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;41960028-2a09-518c-b8ff-8b76191f4db4;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-7574;LUAD
TCGA-L4-A4E5;released;M0;8140/3;2012;C34.1;3499c77e-1d25-5ea3-9465-94216b079e8c;Upper lobe, lung;NA;Upper lobe, lung;Stage I;Adenocarcinoma, NOS;2019-08-08T17:10:53.779981-05:00;T1;No;no;N0;17680;stage i;NA;7th;578;not reported;not reported;0;No;not reported;not reported;NA;NA;33;NA;NA;NA;Not Reported;33;cf5b462c-20c1-55df-9a08-f04933090ecc;180.821.917.808.219;white;Alive;e6a231ed-e267-5fe6-80e1-86f3c660f507;48;not hispanic or latino;female;-17680;NA;1964;NA;Pharmaceutical Therapy, NOS;04b4b259-b7c2-546f-bec5-45bf99cc3965;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;f8ba718a-9bb6-5b06-a79a-ec74471a4b54;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-L4-A4E5;LUAD
TCGA-86-7953;released;M0;8250/3;2011;C34.1;a0d1ec57-e0bd-5c1f-8939-1947c769afb2;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Bronchiolo-alveolar adenocarcinoma, NOS;2019-08-08T17:10:09.373179-05:00;T1b;No;no;N0;25315;stage ia;NA;7th;997;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;91b4f314-b496-5f2e-bae9-a98044081a67;NA;white;Alive;1df00baa-cc61-5c70-9abb-9055f8c08636;69;not hispanic or latino;female;-25315;NA;1942;NA;Pharmaceutical Therapy, NOS;88c22263-ce1a-5358-a696-ae570ed56b9c;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;77b33545-050d-58a7-8931-87a7766a75b2;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-86-7953;LUAD
TCGA-78-7145;released;M1;8140/3;2000;C34.2;96303884-5c42-5b04-b05a-d811ecc338c3;Middle lobe, lung;NA;Middle lobe, lung;Stage IV;Adenocarcinoma, NOS;2019-08-08T17:09:51.361836-05:00;T4;No;no;N1;19080;stage iv;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;25;NA;NA;NA;Not Reported;25;67502b7a-dbc1-54bc-86cd-30d8985c32d0;136.986.301.369.863;white;Dead;ce8c003b-3be0-5dd2-b870-5e1e4d84360e;52;not reported;female;-19080;2002;1948;826;Pharmaceutical Therapy, NOS;1cec8d42-d73d-58f0-909d-e7ac280f78f9;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;a1250094-da96-5b88-abee-da18b4b2e027;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-78-7145;LUAD
TCGA-55-8510;released;MX;8140/3;2012;C34.3;a9117477-ee48-564f-b57d-141e83666a38;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T2a;No;no;N0;20410;stage ib;NA;7th;539;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;d5993dc1-235b-55a8-8d51-2a5f84cda699;NA;white;Alive;bed91d27-b7ea-5f09-a253-0d02a5794671;55;not hispanic or latino;female;-20410;NA;1957;NA;Pharmaceutical Therapy, NOS;389bab75-6378-55ce-9680-6303b3be34de;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;70038b40-d1e5-5dba-a15b-10b4ad72d961;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-8510;LUAD
TCGA-86-A4P7;released;M0;8140/3;2012;C34.3;4429bbd4-2ee7-512e-8a5c-232e37c9e569;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:10:31.173893-05:00;T2a;No;no;N0;23330;stage ib;NA;7th;415;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;19b565fd-81a3-5980-b321-c01c83a08770;NA;white;Alive;1104f41e-44ae-515a-8661-e1a30230999c;63;not hispanic or latino;female;-23330;NA;1949;NA;Pharmaceutical Therapy, NOS;acbd4e09-ba19-547b-9515-063b0fe9d2f6;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;22944d8f-b850-5046-964a-bd450f0b4567;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-86-A4P7;LUAD
TCGA-38-4629;released;M0;8140/3;2003;C34.1;9381672b-0c48-55a7-8712-ad58483c1f69;Upper lobe, lung;NA;Upper lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:07:40.762038-05:00;T3;Not Reported;yes;N0;25104;stage iib;NA;NA;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;100;NA;NA;NA;Not Reported;NA;f7b08a8e-d22b-5cb0-be9f-b922c9ca87d2;547.945.205.479.452;white;Dead;9ea1f795-9510-5acc-a9a5-bf1379e6635a;68;not hispanic or latino;male;-25104;2005;1935;864;Pharmaceutical Therapy, NOS;bd0ff9cc-6c97-5b90-b8b3-a23b7cce7878;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;2b8bd926-f6fa-5509-a8ee-4fa5371f6e0f;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-38-4629;LUAD
TCGA-44-6144;released;M0;8140/3;2011;C34.1;69fa6b22-98e5-5f03-9e91-363e1e8fffbb;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T1a;No;no;N0;21283;stage ia;NA;7th;723;not reported;not reported;0;No;not reported;not reported;NA;NA;67.5;NA;NA;NA;Not Reported;NA;16ebbb2d-7c52-578e-bfeb-27ff6fad7bac;36.986.301.369.863;white;Alive;f5d20dcd-18f0-590f-b34a-3c72b8680fe3;58;not hispanic or latino;male;-21283;NA;1953;NA;Pharmaceutical Therapy, NOS;dbe200d9-39b5-5ba8-aa42-20ce28c4a8da;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;c76a9f4c-ee91-59fe-ab53-796759167612;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-6144;LUAD
TCGA-MP-A4TJ;released;M0;8490/3;2006;C34.1;9efa862a-24ec-5378-b0ee-e1ceb195b4b6;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Signet ring cell carcinoma;2019-08-08T17:11:15.269506-05:00;T1;No;no;N0;22875;stage ia;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;88fba67a-dc0b-52a1-9341-571fbcc19f38;NA;not reported;Dead;9360994a-f205-5107-bb6a-18b4511a7eb8;62;not reported;female;-22875;2006;1944;339;Pharmaceutical Therapy, NOS;b1f0606b-a10e-549f-aa9b-7525bfbc0621;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;e2e13267-ed3f-547d-8b6d-9d3202bd81c4;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-MP-A4TJ;LUAD
TCGA-86-A4P8;released;MX;8140/3;2012;C34.3;cff5b508-2d4c-5cf5-8dbc-0443a996a2ee;Lower lobe, lung;NA;Lower lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:10:31.173893-05:00;T1b;No;no;N2;21738;stage iiia;NA;7th;805;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;3039135d-d989-5617-9a1c-9616121c80f3;NA;white;Alive;f6f8850a-9ef8-55c3-9da2-4ce24d11c4fb;59;not hispanic or latino;female;-21738;NA;1953;NA;Pharmaceutical Therapy, NOS;d60f569e-cc03-5ae6-aaa4-66c9e145c7cc;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;108606ab-6e09-5315-b643-38bd85c47720;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-86-A4P8;LUAD
TCGA-78-7158;released;M0;8255/3;2007;C34.3;d790de49-2bd7-563a-87c4-4e7914498be9;Lower lobe, lung;NA;Lower lobe, lung;Stage IIIB;Adenocarcinoma with mixed subtypes;2019-08-08T17:10:09.373179-05:00;T4;No;no;N2;21742;stage iiib;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;14;NA;NA;NA;Not Reported;42;9b59ddb7-a702-5cc8-832a-dd3a02b3b4c0;0.767123287671233;white;Dead;be4a13cc-5e86-5c34-8b11-cb0847116d85;59;not reported;female;-21742;2007;1948;179;Pharmaceutical Therapy, NOS;f6d75ab8-6504-50b5-961d-eb042d6d1382;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;ca7c5a47-cc95-5d70-a1ad-849f88df546a;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-78-7158;LUAD
TCGA-55-8203;released;M0;8140/3;2011;C34.3;075648f3-341b-59ac-b98b-53ecd4f029c5;Lower lobe, lung;NA;Lower lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T1b;No;yes;N0;25477;stage ia;NA;7th;547;not reported;not reported;0;No;not reported;not reported;NA;NA;50;NA;NA;NA;Not Reported;NA;a11bc478-3c84-50a0-83c5-2e8bf4a3476b;273.972.602.739.726;white;Alive;00490453-093a-529e-9313-5ac90ec23bd2;69;not hispanic or latino;female;-25477;NA;1942;NA;Pharmaceutical Therapy, NOS;0fbcb3f5-82d0-5b2c-906f-7333ca2e43b3;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;c39ee862-ac22-5ea0-84f4-003413d1d249;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-8203;LUAD
TCGA-69-8253;released;MX;8255/3;2012;C34.3;1960ade3-e423-50ec-8664-de7f0cd12b76;Lower lobe, lung;NA;Lower lobe, lung;Stage IIA;Adenocarcinoma with mixed subtypes;2019-08-08T17:09:51.361836-05:00;T1a;No;no;N1;21771;stage iia;NA;7th;426;not reported;not reported;0;No;not reported;not reported;NA;NA;7.8;NA;NA;NA;Not Reported;39;e99d2873-5a7b-5b24-a9b0-b8c29a64f740;0.427397260273973;black or african american;Alive;5f632719-d9e2-5de2-a5ab-d97865b9dc6d;59;not hispanic or latino;female;-21771;NA;1953;NA;Pharmaceutical Therapy, NOS;00ead095-baa6-55ae-abd9-50f47038a234;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;d8d9a6ad-a9d7-524f-a200-6db7f2a08694;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-69-8253;LUAD
TCGA-75-6212;released;M0;8265/3;NA;C34.3;8291b2be-60f4-5e54-849d-a3942a268aec;Lower lobe, lung;NA;Lower lobe, lung;Stage IIB;Micropapillary carcinoma, NOS;2019-08-08T17:09:51.361836-05:00;T2;No;no;N1;NA;stage iib;NA;6th;NA;not reported;not reported;NA;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;9e665361-53b5-5400-a66d-338f33c22c14;NA;not reported;Dead;5016e82c-d591-5df5-8a14-e62af5bc184c;NA;not reported;female;NA;NA;NA;1516;Pharmaceutical Therapy, NOS;fbb4444e-9078-5cf9-8a03-1336b48d9aa5;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;2082d5e0-dfe1-5e7c-a603-bd779d2567ba;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-75-6212;LUAD
TCGA-95-7562;released;M0;8140/3;2011;C34.3;61057583-c7a0-59e9-bd5d-fb4377596695;Lower lobe, lung;NA;Lower lobe, lung;Stage IIA;Adenocarcinoma, NOS;2019-08-08T17:10:31.173893-05:00;T2a;No;yes;N1;26000;stage iia;NA;7th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;10;NA;NA;NA;Not Reported;10;a0394de1-1d1d-5334-ae7d-86f5437d5bcc;0.547945205479452;black or african american;Dead;c33d8bcf-eeb4-54dc-9b06-4b2f26c7803a;71;not hispanic or latino;male;-26000;2011;1940;87;Pharmaceutical Therapy, NOS;fa2cf070-862d-5277-a966-29ac94f34a0b;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;3e839fb7-8442-5928-8f86-533374e98405;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-95-7562;LUAD
TCGA-50-6594;released;M0;8140/3;2009;C34.1;73a7bae1-6039-50c6-a14d-8163d20dbc78;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:08:47.535141-05:00;T3;No;no;N2;28924;stage iiia;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;72792dde-c6c8-5308-b46c-2c7003f35d64;NA;black or african american;Dead;485c4dff-5e4c-5886-ac31-ae68ff15c192;79;not hispanic or latino;female;-28924;2010;1930;370;Pharmaceutical Therapy, NOS;fff745a7-ad72-5665-a256-d9942c63f525;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;c19305b3-951a-57b7-b365-3cb647a777cb;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-50-6594;LUAD
TCGA-86-A4D0;released;M0;8140/3;2012;C34.1;ad92c9c5-ec25-5e86-b611-41df4fd41e1a;Upper lobe, lung;NA;Upper lobe, lung;Stage IIA;Adenocarcinoma, NOS;2019-08-08T17:10:31.173893-05:00;T2b;No;no;N0;17607;stage iia;NA;7th;30;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;4892fb5c-c5a6-5795-9da5-7ad62f75dbc7;NA;white;Dead;9a67a93d-c302-5fd4-8d45-2463fcde771c;48;not hispanic or latino;male;-17607;NA;1964;116;Pharmaceutical Therapy, NOS;abdecef5-45c6-5592-9e04-cb148ce8177c;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;ee5c10ae-51dc-57b0-8dd4-deabc238c52b;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-86-A4D0;LUAD
TCGA-44-2656;released;M0;8140/3;2009;C34.1;6737f52c-ac28-5c60-aa8c-b1deca5eb3a0;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T2;No;no;N0;21766;stage ib;NA;6th;1429;not reported;not reported;0;No;not reported;not reported;NA;NA;23;NA;NA;NA;Not Reported;15;ed8b7fe8-02cf-5895-8986-9759190cd5c7;126.027.397.260.274;white;Alive;d118d77d-b3f5-592d-be04-d4b229010e91;59;not hispanic or latino;male;-21766;NA;1950;NA;Pharmaceutical Therapy, NOS;fb6d08d6-f6f0-559f-936e-5f4314cc1de1;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;36b11917-8664-5db0-816f-b6d636da7624;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-2656;LUAD
TCGA-J2-A4AE;released;MX;8140/3;2012;C34.1;85897235-21d3-5fba-8505-5aac154087b0;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:10:53.779981-05:00;T1a;No;no;N0;28163;stage ia;NA;7th;1079;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;6aa30cf1-d08c-5dfc-a071-3300f9f68e1f;NA;white;Alive;053ffdab-4e45-55e0-ac86-c656502314de;77;not hispanic or latino;female;-28163;NA;1935;NA;Pharmaceutical Therapy, NOS;514c9458-1fc8-5c35-89e4-9c02d69d63cb;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;9ede9d23-07e5-579e-9f39-0d4d9647eabb;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-J2-A4AE;LUAD
TCGA-53-A4EZ;released;MX;8550/3;2012;C34.1;5739ed3b-ccef-56f1-87ef-94d81b78c7b2;Upper lobe, lung;NA;Upper lobe, lung;Stage IIA;Acinar cell carcinoma;2019-08-08T17:08:47.535141-05:00;T2a;No;no;N1;23201;stage iia;NA;7th;1071;not reported;not reported;0;No;not reported;not reported;NA;NA;40;NA;NA;NA;Not Reported;40;9ade2d3e-01f2-5c97-8acf-b9bd1739f09c;219.178.082.191.781;white;Alive;87ea7db2-7ccf-57be-8d20-fd442627d5a3;63;hispanic or latino;male;-23201;NA;1949;NA;Pharmaceutical Therapy, NOS;516e437b-9838-5c7b-9330-7c05f62c3dea;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;2ed7aef8-9d9a-51dd-a6bf-ce72e058378c;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-53-A4EZ;LUAD
TCGA-05-4434;released;M1;8255/3;2008;C34.3;1bb95593-a778-5bed-8790-a70bf19ecbb2;Lower lobe, lung;NA;Lower lobe, lung;Stage IV;Adenocarcinoma with mixed subtypes;2019-08-08T17:07:40.762038-05:00;T4;Not Reported;yes;N1;24472;stage iv;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;15;NA;NA;NA;Not Reported;NA;d471c618-b6dc-5f08-873f-c979c55ee6bc;0.821917808219178;not reported;Dead;03a1f867-574e-5c83-9421-ea3a8a9801e8;67;not reported;female;-24472;2009;1941;457;Pharmaceutical Therapy, NOS;7a2f1fab-eaa8-594d-a0c6-c8da3fcbeb55;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;af47990b-4f40-5bc5-b993-ed5c6633bca6;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-05-4434;LUAD
TCGA-95-A4VP;released;M0;8550/3;2012;C34.3;6894b70f-da36-5723-afd5-a31eb7c674d8;Lower lobe, lung;NA;Lower lobe, lung;Stage IIIA;Acinar cell carcinoma;2019-08-08T17:10:31.173893-05:00;T2b;No;no;N2;24130;stage iiia;NA;7th;605;not reported;not reported;0;No;not reported;not reported;NA;NA;20;NA;NA;NA;Not Reported;40;d387abfa-8ad9-5bd4-a174-94791a8adb76;10.958.904.109.589;white;Alive;521c9a5f-9555-5183-8f92-914fdc4c331e;66;not reported;female;-24130;NA;1946;NA;Pharmaceutical Therapy, NOS;03c475b1-f26c-52fc-8a8d-be81f341a4d4;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;2fb1175b-f615-57cd-a7ef-976ea4c3d00f;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-95-A4VP;LUAD
TCGA-86-8075;released;M0;8140/3;2011;C34.1;2883b33f-f1da-52ae-8622-822395d2105d;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:10:09.373179-05:00;T2;No;no;N0;24402;stage ib;NA;7th;479;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;52c77f37-1b9c-5077-b05f-da84c2508c23;NA;white;Dead;dedbb4dd-64f3-514c-aaeb-677c28c5546a;66;not hispanic or latino;female;-24402;NA;1945;694;Pharmaceutical Therapy, NOS;8fae60c1-a335-5cda-85a1-63e968673383;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;3977b0b1-c768-5b37-b2eb-90142d8ba9b8;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-86-8075;LUAD
TCGA-95-7567;released;M0;8255/3;2011;C34.1;1f0b06cb-03db-5027-a304-74f7eb9a6de1;Upper lobe, lung;NA;Upper lobe, lung;Stage IIB;Adenocarcinoma with mixed subtypes;2019-08-08T17:10:31.173893-05:00;T2b;No;no;N1;22437;stage iib;NA;7th;568;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;41;1829175f-9a03-5b79-bb5c-c6583e0f9be4;NA;white;Alive;03a19794-cc3e-54af-bab8-a9e081a99c63;61;not hispanic or latino;male;-22437;NA;1950;NA;Pharmaceutical Therapy, NOS;bfc52ccc-60c2-55b6-a568-71fb0338c874;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;1c980d4e-e612-5ac2-871e-43bfb9f813f5;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-95-7567;LUAD
TCGA-MN-A4N1;released;M0;8140/3;2011;C34.1;d70eeda5-8288-53c4-b82d-9df1d4f005b2;Upper lobe, lung;NA;Upper lobe, lung;Stage IIA;Adenocarcinoma, NOS;2019-08-08T17:10:53.779981-05:00;T2a;No;yes;N1;21939;stage iia;NA;7th;827;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;dc7c7aa2-f482-5eed-ac2e-da60b8e85cb4;NA;black or african american;Alive;ae552d53-287a-545d-b13c-81d9863f90dc;60;not hispanic or latino;male;-21939;NA;1951;NA;Pharmaceutical Therapy, NOS;7f1554b8-c47c-5c9c-b26a-e53a1135f301;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;1d14f01e-dbeb-56e5-9aa2-5ffed512d799;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-MN-A4N1;LUAD
TCGA-86-8672;released;M0;8140/3;2012;C34.1;68eee202-0ad0-59fa-adb9-484b9e72a4ce;Upper lobe, lung;NA;Upper lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:10:31.173893-05:00;T3;No;no;N0;21682;stage iib;NA;7th;15;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;b601f168-da9d-5b4d-bc02-2310ab815ed0;NA;white;Dead;394426f6-6045-5537-9fe6-f367ba490442;59;not hispanic or latino;male;-21682;NA;1953;19;Pharmaceutical Therapy, NOS;befe5bbb-2f64-533a-8ad2-32f0014e1dc9;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;562b57a6-7abe-5bcd-b53a-58744333d720;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-86-8672;LUAD
TCGA-86-8281;released;M0;8140/3;2011;C34.3;f8f81ccb-8b71-5b41-9efa-c5cd2fc1729a;Lower lobe, lung;NA;Lower lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:10:09.373179-05:00;T1;No;no;NX;27409;stage ia;NA;7th;0;not reported;not reported;0;No;not reported;not reported;NA;NA;30;NA;NA;NA;Not Reported;30;7d14656d-52e1-51e5-b95e-a0c97213d9e8;164.383.561.643.836;white;Alive;4436c869-b9ea-510e-932b-3a1b565225e2;75;not hispanic or latino;male;-27409;NA;1936;NA;Pharmaceutical Therapy, NOS;4bbcf77a-eabf-5c1c-afb0-180444c8f0d9;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;6e34ed94-c0c9-5f2b-b64c-b721c71917da;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-86-8281;LUAD
TCGA-80-5608;released;M0;8140/3;NA;C34.1;01ba99c3-ec89-57df-b596-6bf327aab26e;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:10:09.373179-05:00;T1;No;no;N0;NA;stage ia;NA;6th;2832;not reported;not reported;NA;No;not reported;not reported;NA;NA;26;NA;NA;NA;Not Reported;NA;5259e321-6781-5d44-abfc-451c1aea1c04;142.465.753.424.658;not reported;Alive;13c5edd5-8bd3-5f6e-a681-f2da56315734;NA;not reported;female;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;d57a4967-0324-5ec9-aff9-22f10b8d1ef7;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;ff57c355-af02-5d71-8073-f8c2ee2c8aa7;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-80-5608;LUAD
TCGA-49-4487;released;M0;8140/3;1992;C34.1;0a96b278-90d2-5228-9e7d-3e5154da0ca6;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:08:24.604398-05:00;T1;No;no;N0;26583;stage ia;NA;3rd;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;40;NA;NA;NA;Not Reported;NA;db9a0790-883e-59ca-890e-24c288ee8543;219.178.082.191.781;white;Dead;53f0ab49-87ae-5805-96cc-ea82fd72eecc;72;not hispanic or latino;female;-26583;1994;1920;855;Pharmaceutical Therapy, NOS;0a878b8a-1002-58ff-93b8-28af062599ef;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;5706126d-a5ae-52a2-ae28-38f4c3fb9b6e;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-49-4487;LUAD
TCGA-55-6982;released;M0;8140/3;2004;C34.3;78008708-c100-5080-8d97-4666f0840a4b;Lower lobe, lung;NA;Lower lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:08:47.535141-05:00;T2;No;no;N1;NA;stage iib;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;1d9b9b61-89f3-5b30-8ee2-1ecaf1498ea8;NA;white;Dead;0fe268b0-fcba-5ee9-a593-d484d7e9324d;79;not reported;female;NA;2006;1925;995;Pharmaceutical Therapy, NOS;a243f05f-4bf6-527d-85ad-490725b3d104;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;e1329d9a-9160-586c-a231-51d4de73af02;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-6982;LUAD
TCGA-97-8171;released;M1a;8260/3;2011;C34.8;29b91989-0436-5fa5-80b0-ddfe2eea3116;Overlapping lesion of lung;NA;Overlapping lesion of lung;Stage IV;Papillary adenocarcinoma, NOS;2019-08-08T17:10:53.779981-05:00;T2a;No;no;N2;29627;stage iv;NA;7th;568;not reported;not reported;0;No;not reported;not reported;NA;NA;65;NA;NA;NA;Not Reported;NA;bd346ebe-b199-52e7-a217-a95757da46b9;356.164.383.561.644;asian;Alive;5db4f68e-66b5-5838-ae52-3d71bbe93778;81;not hispanic or latino;male;-29627;NA;1930;NA;Pharmaceutical Therapy, NOS;79dcafa3-f4a4-5b9c-8135-e31514989e63;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;ecfb1365-6e2c-5e99-ab71-7bbf7410fb3b;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-97-8171;LUAD
TCGA-69-7761;released;MX;8550/3;2011;C34.3;9ff1cd3e-a85d-52a3-a14d-69ded8fcae1d;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Acinar cell carcinoma;2019-08-08T17:09:29.022095-05:00;T2a;No;no;N0;31041;stage ib;NA;7th;186;not reported;not reported;0;No;not reported;not reported;NA;NA;20;NA;NA;NA;Not Reported;20;b1ab22f5-80ab-51a4-b10a-21cb9e406f85;10.958.904.109.589;white;Alive;7c2b0c0d-b6cc-5f43-b3c0-c314c5283065;84;not hispanic or latino;male;-31041;NA;1927;NA;Pharmaceutical Therapy, NOS;2cbbdb0b-6172-561b-b39c-fe96a0b7ee21;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;54241e2c-64c0-585d-b7eb-ccf22382eff2;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-69-7761;LUAD
TCGA-44-5644;released;NA;8140/3;2010;C34.3;a584fdee-e0b5-5dc5-8e46-5129d9ea5f02;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T2a;No;no;N0;18644;stage ib;NA;7th;863;not reported;not reported;0;No;not reported;not reported;NA;NA;17.5;NA;NA;NA;Not Reported;NA;a0a25f0d-2081-5cb0-b43b-dd7102d7e30f;0.958904109589041;white;Alive;2c838b0d-8ec3-5287-9e96-8754af942186;51;not hispanic or latino;female;-18644;NA;1959;NA;Pharmaceutical Therapy, NOS;1edd073e-5123-55fe-a97c-2fd4df4c4906;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;c9c4ecc6-c295-5850-9ca8-9bb731e19c8d;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-5644;LUAD
TCGA-44-3398;released;M0;8140/3;2009;C34.3;9e7e4689-929c-5c1d-a1ed-5efcdf3edee3;Lower lobe, lung;NA;Lower lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T1b;No;no;N0;28392;stage ia;NA;6th;1163;not reported;not reported;0;No;not reported;not reported;NA;NA;60;NA;NA;NA;Not Reported;50;069c4cb3-72a2-502b-9391-8d4441c67987;328.767.123.287.671;white;Alive;18e7ccc6-feff-5f40-b633-98f85ee2f6c9;77;not hispanic or latino;female;-28392;NA;1932;NA;Pharmaceutical Therapy, NOS;0802d4bb-4bbc-548b-a531-25e6263cf38d;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;618b2cab-ad73-5787-92e0-c754545feeec;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-3398;LUAD
TCGA-86-8358;released;M0;8140/3;2012;C34.1;508c5f4e-0e67-5914-9236-49f917cfa6d2;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:10:09.373179-05:00;T2a;No;no;N0;16409;stage ib;NA;7th;653;not reported;not reported;0;No;not reported;not reported;NA;NA;20;NA;NA;NA;Not Reported;NA;327121b9-66d5-54ac-92d4-0e37189f3be1;10.958.904.109.589;white;Alive;eb154e63-06b0-540e-858c-ccec75e53d91;44;not hispanic or latino;male;-16409;NA;1968;NA;Pharmaceutical Therapy, NOS;117ff778-1f3d-5245-b570-56ff0000a1e5;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;8833f322-c537-5ed4-9a50-05fb3a0e9f54;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-86-8358;LUAD
TCGA-86-8280;released;M0;8252/3;2011;C34.3;c0af29b0-e813-5566-b9e0-1ba811bea22c;Lower lobe, lung;NA;Lower lobe, lung;Stage IIA;Bronchiolo-alveolar carcinoma, non-mucinous;2019-08-08T17:10:09.373179-05:00;T2b;No;no;N0;19977;stage iia;NA;7th;701;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;b7e7a08c-f658-5b95-8bb3-5c44a04b45e0;NA;white;Alive;66e2a36e-ddae-5ef2-bf01-c142ae2b6958;54;not hispanic or latino;female;-19977;NA;1957;NA;Pharmaceutical Therapy, NOS;940ffb37-4eeb-54a0-a35a-0c30d2ea4fb4;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;fddac721-867c-5861-b5e5-1adf3354a654;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-86-8280;LUAD
TCGA-64-5778;released;M0;8252/3;2008;C34.1;0ac00a93-c50e-5079-bc67-9445ef67da6f;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Bronchiolo-alveolar carcinoma, non-mucinous;2019-08-08T17:09:29.022095-05:00;T2;No;no;N0;21927;stage ib;NA;6th;1305;not reported;not reported;0;No;not reported;not reported;NA;NA;68;NA;NA;NA;Not Reported;34;1971638f-6c2e-59b7-84e6-c2138da49d55;372.602.739.726.027;white;Alive;a14935a1-37e8-5b99-b730-1b1faa66f1fe;60;not hispanic or latino;male;-21927;NA;1948;NA;Pharmaceutical Therapy, NOS;c19cb3c6-f558-54ec-b5d6-595c2a9f2607;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;4e0d80ae-2156-5c7c-8a67-b9d9ae44ed5f;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-64-5778;LUAD
TCGA-55-6968;released;M1;8140/3;2004;C34.3;b5d8e411-22f8-503f-a151-394ceb3ebdf0;Lower lobe, lung;NA;Lower lobe, lung;Stage IV;Adenocarcinoma, NOS;2019-08-08T17:08:47.535141-05:00;T1;No;no;N0;22344;stage iv;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;6be732d6-504b-5023-b16c-30ad5155122f;NA;white;Dead;9442080e-3081-52da-92ca-116b2fefd353;61;not hispanic or latino;male;-22344;2007;1943;1293;Pharmaceutical Therapy, NOS;ee915171-f563-5816-b78d-b7838dd9c1f7;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;c27577e8-1407-5f87-891b-d15be42c8486;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-6968;LUAD
TCGA-80-5607;released;M0;8140/3;2007;C34.1;1fae78ae-d165-526f-ac22-2de95d0046ed;Upper lobe, lung;NA;Upper lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:10:09.373179-05:00;T2;Not Reported;yes;N1;NA;stage iib;NA;6th;NA;not reported;not reported;NA;No;not reported;not reported;NA;NA;15;NA;NA;NA;Not Reported;20;1b03e24b-6df8-5854-9466-49d860cd60c4;0.821917808219178;not reported;Alive;1db2c0de-6c5a-5949-acde-6899fd293014;NA;not reported;female;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;cf4bbf70-a7b3-505f-8da1-392fd5dfad7e;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;f0424090-4e21-5a1c-89ec-ca5794f1435d;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-80-5607;LUAD
TCGA-55-8085;released;M0;8260/3;2011;C34.3;76478ed3-e7d9-5406-bbc3-75ca2d5a12dc;Lower lobe, lung;NA;Lower lobe, lung;Stage IA;Papillary adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T1b;No;no;N0;23596;stage ia;NA;7th;904;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;71a3f9a1-e506-5d70-b774-5104b970b663;NA;white;Alive;9ac8816d-dce5-5649-b62b-18a50f046dd1;64;not hispanic or latino;male;-23596;NA;1947;NA;Pharmaceutical Therapy, NOS;36f4475a-88e6-5d16-a393-d6c8d3a25e36;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;9bb75441-d319-5513-aa4b-9a66a7b9af98;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-8085;LUAD
TCGA-05-4390;released;M0;8255/3;2005;C34.1;66b76eb8-c791-57aa-b3b4-2bc70c5eb323;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma with mixed subtypes;2019-08-08T17:07:40.762038-05:00;T2;No;no;N0;21430;stage ib;NA;5th;1126;not reported;not reported;0;No;not reported;not reported;NA;NA;15;NA;NA;NA;Not Reported;30;902990ca-673b-5406-9098-eaa412198275;0.821917808219178;not reported;Alive;40b1cd07-8d93-542f-ac05-447a08812dfb;58;not reported;female;-21430;NA;1947;NA;Pharmaceutical Therapy, NOS;4d6f30a5-42ac-550a-8e59-7d832ac4b26d;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;0e0dcb24-732c-59c5-a958-f2789737abc4;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-05-4390;LUAD
TCGA-86-6851;released;M0;8255/3;2011;C34.1;4ae81c97-6be6-57ab-9b3f-7384aedeaa02;Upper lobe, lung;NA;Upper lobe, lung;Stage IIA;Adenocarcinoma with mixed subtypes;2019-08-08T17:10:09.373179-05:00;T1b;No;no;N1;26808;stage iia;NA;7th;179;not reported;not reported;0;No;not reported;not reported;NA;NA;52;NA;NA;NA;Not Reported;NA;96eeab74-be07-5421-94c5-06898b0e2147;284.931.506.849.315;white;Alive;16c96efd-37eb-5252-b4d3-15240417dd78;73;not hispanic or latino;female;-26808;NA;1938;NA;Pharmaceutical Therapy, NOS;6ff21e2b-45d7-5f85-969f-935a8ce69274;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;cc6d362a-e0fc-5ab7-8716-ef60116e1b1b;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-86-6851;LUAD
TCGA-78-7536;released;M0;8140/3;2001;C34.1;f09aa542-c593-5fcd-b79a-f2cc1edc56e4;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:10:09.373179-05:00;T2;No;no;N2;25558;stage iiia;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;44;NA;NA;NA;Not Reported;44;34de06c0-5697-5aaf-a446-2abf12a93f95;241.095.890.410.959;white;Dead;d2717fde-35c3-5174-aded-e6ac1b84acaf;69;not reported;male;-25558;2001;1932;244;Pharmaceutical Therapy, NOS;7448d807-39b8-521f-aa32-72305e3b9aa5;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;a87373c5-4c30-533a-ade7-45148364319b;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-78-7536;LUAD
TCGA-93-A4JN;released;M1a;8550/3;2012;C34.1;14180627-fdc7-5e23-906e-ad09b9c9414a;Upper lobe, lung;NA;Upper lobe, lung;Stage IV;Acinar cell carcinoma;2019-08-08T17:10:31.173893-05:00;T2a;No;no;N0;26273;stage iv;NA;7th;718;not reported;not reported;0;No;not reported;not reported;NA;NA;40;NA;NA;NA;Not Reported;20;e069c263-f60c-5924-8d1a-01cbded4258b;219.178.082.191.781;white;Alive;f09de39b-9c00-54a8-b0d8-0bcf55de224b;71;not hispanic or latino;male;-26273;NA;1941;NA;Pharmaceutical Therapy, NOS;7bd2daf7-f872-594d-a462-93563135da0b;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;0de92c1f-7bcd-5359-ba1d-2e5c0af6c7a9;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-93-A4JN;LUAD
TCGA-55-8511;released;MX;8140/3;2012;C34.1;8af20d6d-40a9-5ef5-91fb-cf8f2b67f61d;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T2a;No;yes;N0;26986;stage ib;NA;7th;552;not reported;not reported;0;No;not reported;not reported;NA;NA;58;NA;NA;NA;Not Reported;NA;03e9e063-3f8b-57f2-a829-54ec4325dbde;317.808.219.178.082;white;Alive;7c71ea2d-ffa9-54d8-8ec1-9af7d2c868c2;73;not hispanic or latino;female;-26986;NA;1939;NA;Pharmaceutical Therapy, NOS;0b96fcaa-38e8-5794-85fc-ed6f008e906e;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;7acaaa3a-f4fb-55e1-8e43-053a5d9a0d87;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-8511;LUAD
TCGA-55-7726;released;MX;8140/3;2011;C34.3;6faa9287-f15a-5428-81dc-d3c862e9604a;Lower lobe, lung;NA;Lower lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:08:47.535141-05:00;T1b;Not Reported;yes;N0;26451;stage ia;NA;7th;652;not reported;not reported;0;No;not reported;not reported;NA;NA;30;NA;NA;NA;Not Reported;24;4a5f97d3-b511-5df3-af79-bc0a579ffbb0;164.383.561.643.836;white;Alive;c8b925cb-2614-56b0-a5d7-ae838ffbc3c0;72;not hispanic or latino;female;-26451;NA;1939;NA;Pharmaceutical Therapy, NOS;5811b95e-3bcc-51b6-b5eb-c737c28d7233;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;d4236d30-d907-5e1e-86d9-1d2b07b6d940;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-7726;LUAD
TCGA-86-8074;released;M0;8260/3;2011;C34.3;e178ebc2-6b71-5624-a685-64c239260104;Lower lobe, lung;NA;Lower lobe, lung;Stage IIA;Papillary adenocarcinoma, NOS;2019-08-08T17:10:09.373179-05:00;T1b;No;no;N1;22862;stage iia;NA;7th;24;not reported;not reported;0;No;not reported;not reported;NA;NA;40;NA;NA;NA;Not Reported;NA;962276d9-aa81-5717-8b8a-c92c4d6e3c74;219.178.082.191.781;white;Alive;0f2db51a-7c78-5138-b101-e68cafba56ac;62;not hispanic or latino;female;-22862;NA;1949;NA;Pharmaceutical Therapy, NOS;1207c6fc-36a4-594a-9112-ce124ba1a162;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;036409de-4bf9-55a1-8f53-4291c7ad823d;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-86-8074;LUAD
TCGA-78-7162;released;M0;8255/3;1991;C34.1;b35db765-a1e7-58c6-ad85-2c368e7c24c2;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma with mixed subtypes;2019-08-08T17:10:09.373179-05:00;T1;No;no;N0;27593;stage ia;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;12;NA;NA;NA;Not Reported;NA;410a12b0-0189-5376-9347-01d7a7c6deb3;0.657534246575342;white;Dead;698c38d0-80d8-57a7-9067-1af35d48b109;75;not reported;male;-27593;1999;1916;3169;Pharmaceutical Therapy, NOS;f2bd64ba-2c89-557c-8a09-34ac3d50a652;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;5731c23a-1710-5b63-a45c-72f46876baf5;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-78-7162;LUAD
TCGA-55-7727;released;MX;8140/3;2011;C34.1;3a536d91-2298-5bd4-ae01-0691e839e782;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:08:47.535141-05:00;T1a;No;no;N2;25929;stage iiia;NA;7th;119;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;0eac3897-2f0b-5ba2-add0-76288b49e273;NA;white;Alive;0ae20e22-9a87-59dd-9292-5e3e877f7e5c;70;not hispanic or latino;male;-25929;NA;1941;NA;Pharmaceutical Therapy, NOS;e9c99f3d-19f7-53c2-9a2d-eeb372351932;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;bddecec6-1d96-5dd5-9ea6-8823edd0ac4d;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-7727;LUAD
TCGA-78-8640;released;M0;8140/3;1994;C34.1;2ac56abc-1dc9-5582-af8e-7da4d87cf5d4;Upper lobe, lung;NA;Upper lobe, lung;Stage IIA;Adenocarcinoma, NOS;2019-08-08T17:10:09.373179-05:00;T1;No;no;N1;21832;stage iia;NA;6th;7062;not reported;not reported;0;No;not reported;not reported;NA;NA;45;NA;NA;NA;Not Reported;NA;96028520-0779-528c-9a9b-50b561d4a682;246.575.342.465.753;not reported;Alive;4702b786-e026-5f0c-92da-b633119f7bdf;59;not reported;male;-21832;NA;1935;NA;Pharmaceutical Therapy, NOS;0adc66c7-7d24-5708-92af-9b2384746a9a;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;dcc231f7-90bc-513c-9045-5f1d0782dbad;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-78-8640;LUAD
TCGA-97-7552;released;MX;8253/3;2007;C34.3;6f14f84a-0f24-5da2-bb30-47e3554cdc40;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Bronchio-alveolar carcinoma, mucinous;2019-08-08T17:10:31.173893-05:00;T2;No;no;N0;25578;stage ib;NA;6th;1932;not reported;not reported;0;No;not reported;not reported;NA;NA;40;NA;NA;NA;Not Reported;NA;45c6d31a-4496-53de-b64e-cafc87098f3d;219.178.082.191.781;white;Alive;307a671d-e9ed-5e9c-8fec-8aa8bdbb2b60;70;not hispanic or latino;male;-25578;NA;1937;NA;Pharmaceutical Therapy, NOS;73408917-c980-5ecf-b5b6-1b448c7f697e;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;0df206cd-67e7-57f6-b9d8-911b40234868;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-97-7552;LUAD
TCGA-67-3770;released;M0;8140/3;2009;C34.1;f355dc76-e602-5007-8151-8ba0ae1c1929;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:09:29.022095-05:00;T1;No;no;N0;25658;stage ia;NA;NA;610;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;3dc0f58c-59cb-5193-b760-2b6d012abf70;NA;white;Alive;42e35199-18d8-5ad7-8565-7654fbe4f4d5;70;not hispanic or latino;female;-25658;NA;1939;NA;Pharmaceutical Therapy, NOS;35d9036f-05bf-5f51-a2a5-732c8ad1f5a8;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;b73baa2c-4c66-5eec-9921-75799e9c5323;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-67-3770;LUAD
TCGA-49-4514;released;M0;8260/3;2007;C34.1;df42ea3b-8252-5d4f-af13-0f7559df99bf;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Papillary adenocarcinoma, NOS;2019-08-08T17:08:24.604398-05:00;T1;No;no;N0;28908;stage ia;NA;6th;1700;not reported;not reported;0;No;not reported;not reported;NA;NA;65;NA;NA;NA;Not Reported;NA;01e10a04-dcf5-5097-bd12-a58631a7a619;356.164.383.561.644;white;Alive;d1b0d9dd-84fd-518a-9f58-5ef6d87f1be2;79;not reported;female;-28908;NA;1928;NA;Pharmaceutical Therapy, NOS;91b8e532-b1f2-54a1-a218-def326e5d86a;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;0d2601b6-d104-5d19-b02f-838a4dbc78be;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-49-4514;LUAD
TCGA-55-6642;released;MX;8140/3;2006;C34.3;01c652a0-b98e-549e-8a1f-fd09ea8c06ed;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:08:47.535141-05:00;T2;No;no;N0;23107;stage ib;NA;6th;2449;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;25ec9805-495b-5998-a2e3-8210aec71988;NA;white;Alive;d0fc6788-7b80-58ac-a9e8-89d851ee4b4b;63;not reported;male;-23107;NA;1943;NA;Pharmaceutical Therapy, NOS;69a367b1-993b-5d91-ac16-6e02af6014da;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;aa39f77b-f392-5586-82fd-8321b561a811;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-6642;LUAD
TCGA-55-8091;released;MX;8140/3;2011;C34.3;bce965b0-d099-5a8b-927c-d90c7364d02a;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T2;No;yes;N0;27385;stage ib;NA;7th;600;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;a4b001f6-0cb6-5bb2-b74a-cd5964f02fd0;NA;white;Alive;db06d45d-91f0-5f44-9489-9c1d8004d2f7;74;not hispanic or latino;male;-27385;NA;1937;NA;Pharmaceutical Therapy, NOS;6b25359e-4e3f-5060-b200-38fb8cd8cc2d;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;45b239f3-38d7-5053-b7f4-bab7c1f75ac6;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-8091;LUAD
TCGA-50-5932;released;M0;8140/3;2001;C34.1;c97501f7-0fa5-5768-8a06-fa8750bd4d4b;Upper lobe, lung;NA;Upper lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:08:24.604398-05:00;T2;Not Reported;yes;N1;27454;stage iib;NA;5th;1091;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;c4e6cf35-fc95-5ca6-9a86-546bd710aa39;NA;white;Dead;7d799fb3-4baf-5194-825a-ce1d4614f75c;75;not hispanic or latino;male;-27454;2004;1926;1235;Pharmaceutical Therapy, NOS;2c71ef58-2965-51de-8f08-1ff7232940df;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;d102c72b-e143-5606-80e7-2771c0fde9e9;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-50-5932;LUAD
TCGA-55-6981;released;M0;8140/3;2005;C34.1;b820c514-c82e-5e8b-b77b-27770a72268e;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:08:47.535141-05:00;T1;No;no;N2;19497;stage iiia;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;addf93d7-7855-56c4-9914-bb9a2a5922bc;NA;white;Dead;b83b4b15-c0b6-540b-837d-884f7d5010b8;53;not hispanic or latino;female;-19497;2008;1952;1379;Pharmaceutical Therapy, NOS;79e9a1ba-e40e-5064-b31b-f6e8660f9003;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;ad53f76e-6f19-5365-b2d4-998344a41f61;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-6981;LUAD
TCGA-71-6725;released;M0;8260/3;2011;C34.1;71b3c9c2-e113-506c-ab80-1b5c13dd0ff6;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Papillary adenocarcinoma, NOS;2019-08-08T17:09:51.361836-05:00;T2;No;no;N0;17793;stage ib;NA;6th;256;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;0668841b-8d9c-5fbe-b377-781326034024;NA;asian;Alive;926be778-dafa-583b-ab44-194c2a63cef3;48;not hispanic or latino;female;-17793;NA;1963;NA;Pharmaceutical Therapy, NOS;b642fbea-38b9-5034-95a0-43733ad93022;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;35331b88-01a5-5052-97bd-eef72a9c266b;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-71-6725;LUAD
TCGA-05-4384;released;M0;8255/3;2009;C34.3;13607a4a-be8f-5e01-abe5-4fd8a498e4d2;Lower lobe, lung;NA;Lower lobe, lung;Stage IIIA;Adenocarcinoma with mixed subtypes;2019-08-08T17:07:40.762038-05:00;T2;Not Reported;yes;N2;24411;stage iiia;NA;6th;426;not reported;not reported;0;No;not reported;not reported;NA;NA;20;NA;NA;NA;Not Reported;24;1b33927e-58d8-555a-a919-4d87e4ee231d;10.958.904.109.589;not reported;Alive;362996f3-6cee-5bc6-af4a-1037c6ed8a4b;66;not reported;male;-24411;NA;1943;NA;Pharmaceutical Therapy, NOS;d0570add-2d69-50d2-902d-96ab7575efad;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;8d570fe3-a9e3-59d7-906c-8ca720860a68;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-05-4384;LUAD
TCGA-50-5946;released;MX;8255/3;2010;C34.1;fd90fd05-50b3-5816-8d56-b0f0c7b37c59;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma with mixed subtypes;2019-08-08T17:08:24.604398-05:00;T1;No;no;N0;22852;stage ia;NA;NA;1617;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;1c7b8b5d-0cf8-5b78-8f5e-ecb58069bdcd;NA;white;Alive;b3cc11b6-5267-5158-92fa-3903195e41e6;62;not reported;male;-22852;NA;1948;NA;Pharmaceutical Therapy, NOS;8cabb8c0-4c4f-5e80-8f14-1fa6716650a8;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;2d8c4486-8912-551f-b95d-d27728ac75b4;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-50-5946;LUAD
TCGA-55-8505;released;MX;8140/3;2012;C34.3;09a609af-35ee-5587-8c44-80f8ae83e937;Lower lobe, lung;NA;Lower lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T1a;No;no;N2;22676;stage iiia;NA;7th;440;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;2206129a-6437-5284-b7cc-65ccb5ecbd0a;NA;white;Alive;c22fbbfb-36d5-5276-b42f-4b37e38bbdbd;62;not hispanic or latino;male;-22676;NA;1950;NA;Pharmaceutical Therapy, NOS;585cf922-abfa-5058-aaa7-8a12895ed056;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;681d3e30-fd3f-512c-8fe8-2313b248495d;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-8505;LUAD
TCGA-86-A4JF;released;M0;8140/3;2012;C34.1;fc754412-d232-5a96-bbe1-411fac2d6c6b;Upper lobe, lung;NA;Upper lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:10:31.173893-05:00;T3;No;no;N0;20491;stage iib;NA;7th;536;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;208058ba-1f02-5f60-b033-c6174041a18f;NA;white;Dead;0d966974-c3f3-55fb-be18-9003201d902e;56;not hispanic or latino;male;-20491;NA;1956;737;Pharmaceutical Therapy, NOS;3856cb39-3428-567b-ac31-dfef2a2db4cf;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;35cd8e73-75b4-5da1-b1ed-149baa134eee;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-86-A4JF;LUAD
TCGA-55-7570;released;MX;8140/3;2011;C34.1;f026c5e8-d485-593f-af5c-38080d0ea4f9;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:08:47.535141-05:00;T1a;No;no;N0;22218;stage ia;NA;7th;824;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;0e236124-675f-51cf-9da2-5513536674f0;NA;black or african american;Alive;eed6cb01-7084-5a52-802c-e7c51ab4f11c;60;not hispanic or latino;male;-22218;NA;1951;NA;Pharmaceutical Therapy, NOS;b48b5438-ab74-513c-8a96-830380a5bd8e;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;1128205d-e79b-5ab5-a125-ca4470795ca8;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-7570;LUAD
TCGA-93-7347;released;MX;8255/3;2011;C34.1;553029e5-6e87-586f-934e-b403497ad364;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma with mixed subtypes;2019-08-08T17:10:31.173893-05:00;T1a;No;no;N0;27949;stage ia;NA;7th;683;not reported;not reported;0;No;not reported;not reported;NA;NA;11;NA;NA;NA;Not Reported;15;cfff0378-4bfd-56b8-b725-03f33e4c39b7;0.602739726027397;white;Alive;89732cc9-7d2e-5ca2-a288-e9b306c26743;76;not hispanic or latino;female;-27949;NA;1935;NA;Pharmaceutical Therapy, NOS;60da91b8-985c-5e5b-afb0-91ae3ec23b09;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;27a55348-2b2e-50cf-b821-63038ec22e02;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-93-7347;LUAD
TCGA-55-A492;released;MX;8140/3;2012;C34.1;47ca2ddb-ce79-5bfe-bb82-e627df77391d;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T1a;No;yes;N0;25719;stage ia;NA;7th;596;not reported;not reported;0;No;not reported;not reported;NA;NA;35;NA;NA;NA;Not Reported;33;4565b5a5-7988-5c67-b660-249575acf191;191.780.821.917.808;white;Alive;abe0ff65-042f-5ca8-a2ca-d03042c0707a;70;not hispanic or latino;female;-25719;NA;1942;NA;Pharmaceutical Therapy, NOS;97b2d414-dc67-5db2-9a3e-decc53cd36f5;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;d1a3f38b-4772-5c0f-8d71-e3fa67f8eb86;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-A492;LUAD
TCGA-97-7938;released;MX;8252/3;2011;C34.1;85fd52fd-2ab4-5759-a2ff-15ddbfd10452;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Bronchiolo-alveolar carcinoma, non-mucinous;2019-08-08T17:10:53.779981-05:00;T1a;No;no;N0;27980;stage ia;NA;7th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;40;NA;NA;NA;Not Reported;NA;d14fd077-f2c5-5571-8761-ec15388c7a3a;219.178.082.191.781;white;Dead;309574ea-6ca0-5d39-919d-ec6d0915800a;76;not hispanic or latino;female;-27980;2011;1935;18;Pharmaceutical Therapy, NOS;d219472e-6ce4-55fd-8d04-cbcb6e9ce0b3;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;1f753a51-d415-5d2d-9631-689711eba0a8;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-97-7938;LUAD
TCGA-50-5939;released;M0;8255/3;2008;C34.1;6cfa3dca-9733-57cf-bfb9-5b44e0da6357;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma with mixed subtypes;2019-08-08T17:08:24.604398-05:00;T2;No;no;N0;31236;stage ib;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;15;NA;NA;NA;Not Reported;NA;c19167a2-44af-5999-ab2d-22080d372bd3;0.821917808219178;white;Dead;b868f8d3-6c2c-519b-9d63-6d7a244c80bd;85;not hispanic or latino;male;-31236;2009;1923;460;Pharmaceutical Therapy, NOS;a7f79f63-f682-5fa9-9ce5-da2bbef63c45;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;0cdc4e5b-f937-51b4-b4b9-7bb9854ef0c9;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-50-5939;LUAD
TCGA-MP-A4T4;released;M0;8140/3;2004;C34.3;4be9a6da-961b-5fe3-99ed-b69c5b1dff39;Lower lobe, lung;NA;Lower lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:10:53.779981-05:00;T2;No;no;N1;25052;stage iib;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;50;NA;NA;NA;Not Reported;NA;8c63b704-537a-56e4-a9c4-c1b122f8ee77;273.972.602.739.726;white;Dead;b528c492-808d-5baf-9f37-068bf6f97bbc;68;not reported;female;-25052;2011;1936;2617;Pharmaceutical Therapy, NOS;e19c4664-407a-5dfc-96f3-e80492404cf4;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;cfbedf72-c351-54a6-8f50-7997b6dccc17;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-MP-A4T4;LUAD
TCGA-05-4396;released;M0;8255/3;2006;C34.3;d0e11de6-e9ff-590c-b8c5-92caa5042412;Lower lobe, lung;NA;Lower lobe, lung;Stage IIIB;Adenocarcinoma with mixed subtypes;2019-08-08T17:07:40.762038-05:00;T4;Not Reported;yes;N1;28094;stage iiib;NA;5th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;19;NA;NA;NA;Not Reported;37;e360c182-f67e-5ac1-810d-0a0132f8ae88;104.109.589.041.096;not reported;Dead;dcb3644b-5ea1-5c2f-abd4-a6ff5df99bd3;76;not reported;male;-28094;2006;1930;303;Pharmaceutical Therapy, NOS;005e9b26-a3a5-5116-82cb-4b38219ae51c;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;b7aa5d9e-d752-5f4f-9c4f-8d94d727a22b;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-05-4396;LUAD
TCGA-55-6985;released;MX;8140/3;2004;C34.1;e52b1fe0-2352-5bdb-a324-efccc000bfec;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:08:47.535141-05:00;T2;No;no;N0;21381;stage ib;NA;6th;1233;not reported;not reported;0;No;not reported;not reported;NA;NA;50;NA;NA;NA;Not Reported;NA;8a025865-4759-503f-97c5-8366541d706c;273.972.602.739.726;white;Alive;8a352ce7-36ec-59e9-99c8-c813247c272d;58;not reported;female;-21381;NA;1946;NA;Pharmaceutical Therapy, NOS;0cd4f745-9758-50e8-a1e3-840568ea7d81;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;97d1b31a-e358-59ce-bc40-91533a99464f;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-6985;LUAD
TCGA-73-4668;released;M0;8265/3;2009;C34.1;45441cf2-bc3a-58ef-b8bc-fa3694e9b2e9;Upper lobe, lung;NA;Upper lobe, lung;Stage IIB;Micropapillary carcinoma, NOS;2019-08-08T17:09:51.361836-05:00;T2;No;no;N1;24255;stage iib;NA;NA;467;not reported;not reported;0;No;not reported;not reported;NA;NA;55;NA;NA;NA;Not Reported;37;c10ef4f0-3525-5fb9-aeb5-a5aa74d06d9a;301.369.863.013.699;american indian or alaska native;Alive;d4f125be-32d0-5ef4-a88f-b6e526d7717b;66;not hispanic or latino;female;-24255;NA;1943;NA;Pharmaceutical Therapy, NOS;4ade1a07-d0ae-5936-ae6f-fdc49255f1b0;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;9407d91c-ccac-5bd5-90c9-dbc6e80dc491;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-73-4668;LUAD
TCGA-91-8499;released;MX;8140/3;2011;C34.3;d72fed61-3633-5cdb-acc4-be8763dfac85;Lower lobe, lung;NA;Lower lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:10:31.173893-05:00;T1b;No;no;N0;27853;stage ia;NA;7th;36;not reported;not reported;0;No;not reported;not reported;NA;NA;90;NA;NA;NA;Not Reported;NA;c26fe6dc-2051-5768-8909-d48cc25fde4b;493.150.684.931.507;white;Alive;b3e19ce2-786f-54be-be21-25358a061d2f;76;not hispanic or latino;female;-27853;NA;1935;NA;Pharmaceutical Therapy, NOS;77f32751-108f-505a-a42e-b43438b01bb6;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;3bcdd613-b449-5d2b-b38b-96ea8d7183c7;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-91-8499;LUAD
TCGA-86-7955;released;M0;8140/3;2011;C34.3;5203d103-43ce-5799-b6b6-07aa9cf959bd;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:10:09.373179-05:00;T2a;No;no;N0;22772;stage ib;NA;7th;1072;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;93325f9f-96aa-5b2a-8ec6-9b48f49caed1;NA;white;Alive;1abb3b3f-3a1e-5b0a-92b5-afb8907a9a8e;62;not hispanic or latino;male;-22772;NA;1949;NA;Pharmaceutical Therapy, NOS;0e30bb55-53ac-5eb4-bc3a-36b36b10bf76;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;2113b478-7c10-5f77-9e21-f7a70cfa16f5;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-86-7955;LUAD
TCGA-49-6742;released;M0;8480/3;2010;C34.1;4cab7bb7-bb86-5420-a1da-ca533f3c701a;Upper lobe, lung;NA;Upper lobe, lung;Stage IIA;Mucinous adenocarcinoma;2019-08-08T17:08:24.604398-05:00;T2a;Not Reported;yes;N1;25839;stage iia;NA;7th;445;not reported;not reported;0;No;not reported;not reported;NA;NA;10;NA;NA;NA;Not Reported;NA;8cc19ea2-98bb-50e8-9db3-c6fafca4a79d;0.547945205479452;white;Dead;1c1ef8f9-8850-52b2-a367-233addd65369;70;not hispanic or latino;male;-25839;NA;1940;488;Pharmaceutical Therapy, NOS;ef752ff9-2e82-51c9-b9b7-8e8d3ccc9894;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;d0274205-f04d-5400-9233-0a55aa6edc76;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-49-6742;LUAD
TCGA-MP-A4TA;released;M0;8140/3;2006;C34.1;e2b38802-3ebf-5b1b-9c3f-bc50432dca2b;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:11:15.269506-05:00;T1;No;yes;N0;27513;stage ia;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;55;NA;NA;NA;Not Reported;55;bf79574c-5cb4-5786-b4d9-162bfa2e8986;301.369.863.013.699;white;Dead;ae5be67c-f7a5-5862-9927-700c93386839;75;not hispanic or latino;female;-27513;2008;1931;950;Pharmaceutical Therapy, NOS;73488bc4-483f-5084-8c25-44be3fa9dc63;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;4a84e47c-7dbb-5e6d-8a8f-de7a14544792;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-MP-A4TA;LUAD
TCGA-50-8457;released;M0;8255/3;2011;C34.1;9635969b-01a5-5cbb-9116-aec2e98aca48;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma with mixed subtypes;2019-08-08T17:08:47.535141-05:00;T1a;No;no;N0;23055;stage ia;NA;7th;1125;not reported;not reported;0;No;not reported;not reported;NA;NA;30;NA;NA;NA;Not Reported;NA;1736e160-6844-58b9-8ab2-cc135c8bd991;164.383.561.643.836;black or african american;Alive;c4a49121-f73f-5ce6-99a2-974398b12a77;63;not hispanic or latino;female;-23055;NA;1948;NA;Pharmaceutical Therapy, NOS;83a5faa3-96d3-5ce7-a9da-fbe68f7a86a7;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;2b0c7146-6961-5f32-97d0-c3f0a1a3389a;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-50-8457;LUAD
TCGA-97-8552;released;MX;8252/3;2012;C34.3;3015dff7-2c80-59ea-ae7a-34a4a0a75dd8;Lower lobe, lung;NA;Lower lobe, lung;Stage I;Bronchiolo-alveolar carcinoma, non-mucinous;2019-08-08T17:10:53.779981-05:00;T1a;No;no;N0;20331;stage i;NA;7th;626;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;49ec2eee-69ad-5974-8403-effc99cd97c8;NA;white;Alive;21f29b38-cc78-57ac-9504-0c9fb40326c3;55;not hispanic or latino;female;-20331;NA;1957;NA;Pharmaceutical Therapy, NOS;a1c9f491-47ed-5112-a6e4-eff4e716a457;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;ec9677b2-277e-56c5-8801-d0ed594b367f;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-97-8552;LUAD
TCGA-44-6148;released;M0;8480/3;2011;C34.30;9c0d92a8-b75f-53b8-a5f2-57cd7a8bb8b5;Lower lobe, lung;NA;Lower lobe, lung;Stage IA;Mucinous adenocarcinoma;2019-08-08T17:08:02.187456-05:00;T1b;No;no;N0;22138;stage ia;NA;7th;704;not reported;not reported;0;No;not reported;not reported;NA;NA;60;NA;NA;NA;Not Reported;31;3f7c416a-4487-5195-b7e0-bb03d2b14fbd;328.767.123.287.671;white;Alive;21331063-9e38-5918-81e2-e3412c68dc3a;60;not hispanic or latino;male;-22138;NA;1951;NA;Pharmaceutical Therapy, NOS;b3a62abf-9046-5a2f-a9cc-4a260721d0c2;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;72e54820-f603-53ff-9c89-f98c00e023ea;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-6148;LUAD
TCGA-05-4432;released;M0;8255/3;2008;C34.1;0556644d-ff91-5c64-8d38-3918e4cb3136;Upper lobe, lung;NA;Upper lobe, lung;Stage IIB;Adenocarcinoma with mixed subtypes;2019-08-08T17:07:40.762038-05:00;T2;No;no;N1;24350;stage iib;NA;6th;761;not reported;not reported;0;No;not reported;not reported;NA;NA;58;NA;NA;NA;Not Reported;NA;092fa600-3372-5557-b0e2-41af79bd1033;317.808.219.178.082;not reported;Alive;c393b056-ba8c-586c-8b10-e9a0d4a0471d;66;not reported;male;-24350;NA;1942;NA;Pharmaceutical Therapy, NOS;90c72258-36df-545f-bfd8-0586869f9762;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;3adce2a5-7607-5796-8077-ae5d59d70474;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-05-4432;LUAD
TCGA-44-6145;released;M0;8140/3;2011;C34.1;bd5a3c1a-fb57-5da3-954c-273512e6858c;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T1;No;no;N0;22745;stage ia;NA;7th;595;not reported;not reported;0;No;not reported;not reported;NA;NA;75;NA;NA;NA;Not Reported;36;5de55cf5-047b-5898-8a8f-1cb26c1fca17;410.958.904.109.589;white;Alive;592254fc-6c4f-56e3-92db-8b3e3d3906ed;62;not hispanic or latino;female;-22745;NA;1949;NA;Pharmaceutical Therapy, NOS;354a8f86-fb07-5fa6-ab41-0d9b3e07beec;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;15a602a5-f6bb-5e75-9aef-39150f6f99f8;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-6145;LUAD
TCGA-78-7159;released;M0;8255/3;2008;C34.1;10da95ae-ab8c-5ecb-bef8-a6ba28b2e22a;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma with mixed subtypes;2019-08-08T17:10:09.373179-05:00;T1;No;no;NX;22261;stage ia;NA;6th;1974;not reported;not reported;0;No;not reported;not reported;NA;NA;21;NA;NA;NA;Not Reported;42;26ead08a-fce4-568f-8457-e368335826ca;115.068.493.150.685;white;Alive;9d623b7f-13c5-5e0d-b0f0-614c0a6716ec;60;not reported;female;-22261;NA;1948;NA;Pharmaceutical Therapy, NOS;e69c547e-16cf-5654-961a-26abc29e318e;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;a646b213-4249-59b1-a624-f63493ba6bde;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-78-7159;LUAD
TCGA-49-AAR4;released;MX;8140/3;2006;C34.1;74ed8003-731a-5cf0-8539-93a7ccb9b7be;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:08:24.604398-05:00;T2;No;no;N2;18939;stage iiia;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;35;NA;NA;NA;Not Reported;NA;fae7c36d-fb64-543e-bcd5-f3133150adb6;191.780.821.917.808;black or african american;Dead;730745eb-bc2e-5a07-bb0a-a9dfb6e847b3;51;not hispanic or latino;male;-18939;2008;1955;879;Pharmaceutical Therapy, NOS;7398f952-8784-5513-9eea-4f4e1824ef5f;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;9e298d03-e2ff-5336-ac9b-8922e61a03cb;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-49-AAR4;LUAD
TCGA-78-7166;released;M0;8140/3;2002;C34.3;bb420358-3559-58a3-b6cd-5ef7a337fc8c;Lower lobe, lung;NA;Lower lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:10:09.373179-05:00;T2;Not Reported;yes;N1;30869;stage iib;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;38;NA;NA;NA;Not Reported;38;97722cc0-e23b-5163-b350-4cf4fc14197b;208.219.178.082.192;white;Dead;df28f80e-e489-54f4-ac2b-7a7852a05284;84;not reported;male;-30869;2002;1918;258;Pharmaceutical Therapy, NOS;84fc2542-7dc5-510e-8a52-e303caaace3f;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;2439f823-2687-5fe4-9837-e58d5ad373dd;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-78-7166;LUAD
TCGA-50-5072;released;M0;8140/3;2009;C34.1;d2580490-8128-5fe3-91ce-b9f142e936f9;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:08:24.604398-05:00;T2;No;no;N2;27036;stage iiia;NA;6th;246;not reported;not reported;0;Yes;not reported;not reported;NA;NA;15;NA;NA;NA;Not Reported;NA;39a3cd03-0e33-593a-8acf-8c0ac04dd8e4;0.821917808219178;white;Dead;22d244c9-79a3-5df2-8709-086253cd595f;74;not hispanic or latino;male;-27036;NA;1935;250;Pharmaceutical Therapy, NOS;2e89069c-f79d-53e8-99c8-e0219b8fb185;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;295d784f-f1ca-59e7-8c16-578f555e3ad0;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-50-5072;LUAD
TCGA-73-4658;released;M0;8140/3;2004;C34.3;6e678430-a27c-5412-b531-49b344cadb05;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:09:51.361836-05:00;T2;Not Reported;yes;N0;29508;stage ib;NA;6th;1600;not reported;not reported;0;No;not reported;not reported;NA;NA;25;NA;NA;NA;Not Reported;NA;80ac17a4-ed8b-5c3b-a85e-72dfab59fda8;136.986.301.369.863;white;Dead;21d19606-f883-5be3-adbb-20b41c95627b;80;not hispanic or latino;female;-29508;2008;1924;1600;Pharmaceutical Therapy, NOS;eb5f3873-4fa5-5cb0-aca2-0aa724de9614;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;fb2ca36d-b0c5-58c7-80fb-56e83e5998c2;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-73-4658;LUAD
TCGA-67-3771;released;M0;8140/3;2009;C34.1;ab934a99-5aef-5a9b-af8b-72e47f4823a6;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:09:29.022095-05:00;T1;No;no;N0;28406;stage ia;NA;6th;610;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;12db0fa2-cae8-5a2f-a12a-3dca18542f32;NA;black or african american;Alive;3c6aa20d-a39a-527e-801a-84b39a65cd3a;77;not hispanic or latino;female;-28406;NA;1932;NA;Pharmaceutical Therapy, NOS;0456c66f-eff7-523e-8460-2072fdf8679c;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;4dea526c-e7af-5513-9761-4783e564bf3f;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-67-3771;LUAD
TCGA-91-6840;released;M0;8140/3;2011;C34.1;911bc8bc-c4ad-5c68-997e-26ed70ee82c0;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:10:31.173893-05:00;T1b;No;no;N0;21854;stage ia;NA;7th;372;not reported;not reported;0;No;not reported;not reported;NA;NA;50;NA;NA;NA;Not Reported;25;4e9d56b9-f31b-54e6-93da-0adfa0e6e6ee;273.972.602.739.726;white;Alive;397af860-3b05-5070-9e20-96a1b2a3e28e;59;not hispanic or latino;female;-21854;NA;1952;NA;Pharmaceutical Therapy, NOS;2bddcfa6-1a6e-5f72-b39f-cdf442a07a51;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;b817df2c-6ada-586b-b1df-2168cd95c047;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-91-6840;LUAD
TCGA-91-A4BD;released;MX;8140/3;2012;C34.3;e003e871-9b5f-5ebd-9ce7-b6fc9e4bf18c;Lower lobe, lung;NA;Lower lobe, lung;Stage IIA;Adenocarcinoma, NOS;2019-08-08T17:10:31.173893-05:00;T1b;No;no;N1;28544;stage iia;NA;7th;603;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;6d682b23-07cd-5d8b-8e5f-9e9d1d3858ad;NA;white;Alive;d8f62981-7ba3-59c9-a194-721cec2c1c9c;78;not hispanic or latino;male;-28544;NA;1934;NA;Pharmaceutical Therapy, NOS;388c74b3-59d3-54e2-a96f-077c4b400ed2;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;f3cf86fe-3d61-5985-9aad-61df67dcb9e5;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-91-A4BD;LUAD
TCGA-55-8615;released;MX;8140/3;2012;C34.2;6dbc0170-58ff-560a-800e-781837e97b76;Middle lobe, lung;NA;Middle lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T3;No;no;N2;24786;stage iiia;NA;7th;446;not reported;not reported;0;No;not reported;not reported;NA;NA;67;NA;NA;NA;Not Reported;NA;4f7281f1-2b5e-5885-b53d-6306a02d5f19;367.123.287.671.233;white;Alive;0948c018-0a80-5822-b435-758d4ba23af5;67;not hispanic or latino;male;-24786;NA;1945;NA;Pharmaceutical Therapy, NOS;bf290655-8141-5450-9da8-4041e7620931;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;8f1597e7-bbd8-560d-bc63-ceaffdfaaee3;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-8615;LUAD
TCGA-91-6835;released;M0;8140/3;2010;C34.3;c0c58186-4b17-5cba-bd56-5de255a664bb;Lower lobe, lung;NA;Lower lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:10:31.173893-05:00;T1;No;no;N0;29887;stage ia;NA;7th;79;not reported;not reported;0;No;not reported;not reported;NA;NA;25;NA;NA;NA;Not Reported;NA;301a7bf9-e914-5b5a-932f-eb819889a40d;136.986.301.369.863;white;Alive;0b03a690-750a-5645-85f8-e73456109315;81;not hispanic or latino;female;-29887;NA;1929;NA;Pharmaceutical Therapy, NOS;dd508875-34bf-5bae-a99e-e468bb986c21;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;677d1aea-8113-56dc-94ec-a2b5ec871794;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-91-6835;LUAD
TCGA-55-8204;released;MX;8140/3;2011;C34.1;76a0306b-af08-5cdc-863a-622dc095d7ee;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T2a;No;yes;N0;31818;stage ib;NA;7th;515;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;168afe80-79ba-50bc-9a2f-47a12f80ead9;NA;white;Alive;118e4b61-8cac-52e6-8d08-66bcacc5a0f4;87;not hispanic or latino;female;-31818;NA;1924;NA;Pharmaceutical Therapy, NOS;ba28c79f-fe5a-58db-bd53-ff0530fcd739;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;b5d140f5-82d0-50d8-b77d-6ed86930645d;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-8204;LUAD
TCGA-78-7153;released;M0;8255/3;2003;C34.8;7f45ece4-7dbf-5a39-8467-1fa8e96bd043;Overlapping lesion of lung;NA;Overlapping lesion of lung;Stage IB;Adenocarcinoma with mixed subtypes;2019-08-08T17:09:51.361836-05:00;T2;No;no;N0;23922;stage ib;NA;6th;3635;not reported;not reported;0;No;not reported;not reported;NA;NA;20;NA;NA;NA;Not Reported;40;9cc1b885-f461-5318-86e4-43eb1e644bdf;10.958.904.109.589;white;Alive;c7b2da5d-c823-5941-8aae-07ab5face609;65;not reported;female;-23922;NA;1938;NA;Pharmaceutical Therapy, NOS;29e5d205-a188-592c-b9c4-5340d43d4e3b;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;d390a7b7-f0b8-5be3-b3af-58eedaf2f422;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-78-7153;LUAD
TCGA-73-4670;released;M1;8140/3;2010;C34.1;30c0f977-3d80-57c1-83b5-cbb91935790a;Upper lobe, lung;NA;Upper lobe, lung;Stage IV;Adenocarcinoma, NOS;2019-08-08T17:09:51.361836-05:00;T2;No;no;N0;25526;stage iv;NA;NA;131;not reported;not reported;0;Not Reported;not reported;not reported;NA;NA;30;NA;NA;NA;Not Reported;30;4dc6943e-1972-51c4-8256-232d528bb83d;164.383.561.643.836;white;Alive;6ea84966-1f86-5292-87e8-488178baf244;69;not hispanic or latino;female;-25526;NA;1941;NA;Pharmaceutical Therapy, NOS;2f16d13e-c7f2-5f49-aa06-e8cb20e5bf3d;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;90520b59-100c-5b84-94f0-b5019d533ac8;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-73-4670;LUAD
TCGA-78-7150;released;M0;8140/3;2002;C34.3;9d225683-87bc-57aa-82a2-54bcd2cdd26f;Lower lobe, lung;NA;Lower lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:09:51.361836-05:00;T2;No;no;N1;21891;stage iib;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;37;NA;NA;NA;Not Reported;37;bb83f585-d691-52e4-954b-25c419cee932;202.739.726.027.397;white;Dead;a363d78d-a441-55e1-9798-34217afee837;59;not reported;male;-21891;2003;1943;666;Pharmaceutical Therapy, NOS;c607445c-7cc6-5cd3-b0e0-0cc109c11268;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;96d11e56-bfb9-560e-9f9c-3273609a5d52;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-78-7150;LUAD
TCGA-55-8506;released;MX;8140/3;2012;C34.1;da00435d-d08b-5cff-a5cb-e450ac38b4a5;Upper lobe, lung;NA;Upper lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T3;No;no;N0;22850;stage iib;NA;7th;11;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;7a6ca693-6bf9-58bb-a585-54b93041d550;NA;white;Alive;9a307bd1-a3de-570d-8093-a744620305e0;62;not hispanic or latino;female;-22850;NA;1950;NA;Pharmaceutical Therapy, NOS;e42d00cf-11df-56e2-a2ab-65dda12028b4;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;978bdeb9-13d4-50dd-ba6e-e406c9645009;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-8506;LUAD
TCGA-44-7672;released;M0;8140/3;2010;C34.1;eb4f5f7f-1497-55ea-b8b0-fb666839ea12;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T1b;No;no;N0;19200;stage ia;NA;7th;719;not reported;not reported;0;No;not reported;not reported;NA;NA;20;NA;NA;NA;Not Reported;NA;8800d970-c011-5795-a8a6-d184df2b8b45;10.958.904.109.589;white;Alive;115b6c10-0c47-5bbe-928c-42cdf44d54d0;52;not hispanic or latino;female;-19200;NA;1958;NA;Pharmaceutical Therapy, NOS;86b513a7-13da-5c58-803a-d2c36529504b;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;7cc855c5-190b-54b4-b0d8-dbfbc114d41d;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-7672;LUAD
TCGA-64-1678;released;M0;8140/3;2006;C34.1;46265c2f-93dc-5a82-bfe5-2019e1421c4e;Middle lobe, lung;NA;Middle lobe, lung;NA;Adenocarcinoma, NOS;2019-08-08T17:09:29.022095-05:00;T2b;No;no;N0;25931;not reported;NA;6th;1189;not reported;not reported;0;No;not reported;not reported;NA;NA;20;NA;NA;NA;Not Reported;20;0451bc1a-7100-5edd-8440-8d5993267c1b;10.958.904.109.589;white;Alive;be0e76a7-31b2-51e9-b9bb-20d5a93cc106;70;not hispanic or latino;female;-25931;NA;1936;NA;Pharmaceutical Therapy, NOS;4237d82c-c15e-59a2-b03f-d6ca35795cfe;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;5e7b32e3-d153-528b-9400-e27c40e95ea0;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-64-1678;LUAD
TCGA-50-6595;released;M0;8140/3;2009;C34.1;915defd8-0947-5db1-8222-0ea77d808b37;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:08:47.535141-05:00;T2;No;no;N2;27197;stage iiia;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;a73c6da4-ab1e-507b-bade-26380716b93f;NA;white;Dead;9936423d-72b7-5358-a38d-a4c21bc938f0;74;not hispanic or latino;female;-27197;2009;1935;189;Pharmaceutical Therapy, NOS;c1b2470d-8275-50b2-ac4b-2d2ae52f1ce6;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;52c92075-612d-56dc-ae77-83f16fbd89a4;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-50-6595;LUAD
TCGA-NJ-A4YP;released;M0;8255/3;2011;C34.3;7e57e93c-f465-5090-917a-f2d9acaf64b2;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Adenocarcinoma with mixed subtypes;2019-08-08T17:11:15.269506-05:00;T2a;No;no;N0;19106;stage ib;NA;7th;50;not reported;not reported;0;No;not reported;not reported;NA;NA;60;NA;NA;NA;Not Reported;NA;76f097fc-d304-5534-953d-4542f781bf55;328.767.123.287.671;white;Alive;6a5fd2ae-f86f-5c75-adcb-627abd999e62;52;not hispanic or latino;male;-19106;NA;1959;NA;Pharmaceutical Therapy, NOS;4f936807-e401-5a44-8263-f2e9d51a8637;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;dce77a3d-8eb7-5db9-884e-9a210a0264cb;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-NJ-A4YP;LUAD
TCGA-MP-A4T7;released;M1;8140/3;2005;C34.3;0a5d9d72-1d94-50dd-ab41-295ede29bd15;Lower lobe, lung;NA;Lower lobe, lung;Stage IV;Adenocarcinoma, NOS;2019-08-08T17:10:53.779981-05:00;T2;No;no;N0;27603;stage iv;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;50;NA;NA;NA;Not Reported;50;7401529d-679b-5743-bac3-b099b9650b8d;273.972.602.739.726;not reported;Dead;93d9011b-1780-5bbe-935e-39287122bb21;75;not reported;female;-27603;2005;1930;167;Pharmaceutical Therapy, NOS;5072ee32-19bf-55b6-a395-924edc7376cc;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;53ed19f4-3b1a-50de-b81c-ee11decf246f;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-MP-A4T7;LUAD
TCGA-44-6147;released;M0;8140/3;2010;C34.1;37538544-ef28-5c73-99ab-43472e510485;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T1b;Not Reported;yes;NX;24631;stage ia;NA;7th;845;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;4;69247a43-c242-514a-bfce-98a7b359f55c;NA;white;Alive;2c74e074-e9dc-5e2b-8284-7de2efa903f0;67;not hispanic or latino;female;-24631;NA;1943;NA;Pharmaceutical Therapy, NOS;bb1ba7b8-55fe-52c5-93dd-630c2e7405c9;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;6b97a9d8-e3c3-5622-a452-dfefc7cad61c;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-6147;LUAD
TCGA-55-6983;released;M0;8480/3;2005;C34.30;3377a3ed-2d60-5d32-b546-ddfa73564aa6;Lower lobe, lung;NA;Lower lobe, lung;Stage IIB;Mucinous adenocarcinoma;2019-08-08T17:08:47.535141-05:00;T2;No;no;N1;NA;stage iib;NA;6th;2823;not reported;not reported;0;No;not reported;not reported;NA;NA;60;NA;NA;NA;Not Reported;NA;1fb47ec6-4b06-5cc7-bdcf-1ef38010cf9f;328.767.123.287.671;white;Alive;346e013f-b034-5536-8f2c-c3674d39dc1e;81;not hispanic or latino;male;NA;NA;1924;NA;Pharmaceutical Therapy, NOS;33193e5f-5e06-5218-8671-4b5a7226db4e;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;1764121a-3e23-5039-8050-9a1147fe1239;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-6983;LUAD
TCGA-73-4666;released;M1;8140/3;2009;C34.1;1b23581a-b60b-54f5-a4ec-5c07bc278a10;Upper lobe, lung;NA;Upper lobe, lung;Stage IV;Adenocarcinoma, NOS;2019-08-08T17:09:51.361836-05:00;T1;No;no;N0;19074;stage iv;NA;NA;800;not reported;not reported;0;No;not reported;not reported;NA;NA;10;NA;NA;NA;Not Reported;20;1dc9a008-50f5-5e57-ae1e-a8e58cca30ae;0.547945205479452;white;Alive;63bc2ee0-7b89-5ef8-a2ee-0d878468a51e;52;not hispanic or latino;female;-19074;NA;1957;NA;Pharmaceutical Therapy, NOS;59becf2d-74f3-5b3c-b878-e5445611dfca;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;4d61825d-a173-5945-a1c2-c387c49b4c74;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-73-4666;LUAD
TCGA-86-8278;released;M0;8480/3;2011;C34.30;1ba819cd-9f8f-5db1-a8d5-9be7804856ad;Lower lobe, lung;NA;Lower lobe, lung;Stage IIB;Mucinous adenocarcinoma;2019-08-08T17:10:09.373179-05:00;T2;No;no;N1;23117;stage iib;NA;7th;944;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;362545cb-6954-553b-8fe9-ea490598dcda;NA;white;Alive;2b060dab-2aeb-51ee-a00b-6a3aa642834e;63;not hispanic or latino;female;-23117;NA;1948;NA;Pharmaceutical Therapy, NOS;374463f3-9a58-5eb6-b9db-b1ac5515dcec;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;0d1b7be3-9331-556b-a4ab-96a95e274362;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-86-8278;LUAD
TCGA-55-1596;released;M0;8140/3;2004;C34.1;0739cd68-912e-57a9-b686-98d51a38cecc;Upper lobe, lung;NA;Upper lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:08:47.535141-05:00;T2;No;no;N1;20381;stage iib;NA;6th;2065;not reported;not reported;0;No;not reported;not reported;NA;NA;50;NA;NA;NA;Not Reported;NA;cc4cadd4-8da3-5bc8-bd98-5d5543a703a5;273.972.602.739.726;asian;Alive;7c7fd12f-84c7-56aa-b172-8d17eef37e9d;55;not hispanic or latino;male;-20381;NA;1949;NA;Pharmaceutical Therapy, NOS;2ab76a9f-6bb3-5720-83af-424f9b6e58bd;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;dde7bd8d-3cf9-5ca5-b0d0-47af225d6fe6;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-1596;LUAD
TCGA-62-8402;released;M0;8255/3;2008;C34.1;5ad10d3b-89a4-52d0-8144-5d5b49af8753;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIA;Adenocarcinoma with mixed subtypes;2019-08-08T17:09:29.022095-05:00;T2;No;no;N2;26934;stage iiia;NA;6th;1445;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;d740048e-b7dc-565b-aff0-82b692f8b03d;NA;white;Dead;667d2f41-3c4d-5e3f-8859-f0d751a6ed2e;73;not hispanic or latino;female;-26934;NA;1935;1498;Pharmaceutical Therapy, NOS;08138c55-fb65-5a3e-8473-ec31c2b0545a;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;167c440e-3464-5a64-b9a1-11e886c780f3;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-62-8402;LUAD
TCGA-05-5423;released;M0;8255/3;2006;C34.9;0f0eeb38-d54e-579f-972e-fd361e4ac218;Lung, NOS;NA;Lung, NOS;Stage IIB;Adenocarcinoma with mixed subtypes;2019-08-08T17:07:40.762038-05:00;T2;No;no;N1;23863;stage iib;NA;6th;151;not reported;not reported;0;No;not reported;not reported;NA;NA;72;NA;NA;NA;Not Reported;24;3e2da5e8-93ea-59d1-9d3c-4450c9cf6706;394.520.547.945.205;not reported;Alive;f1d0f75a-b1b1-59d3-bdea-5d26cfc5003f;65;not reported;male;-23863;NA;1941;NA;Pharmaceutical Therapy, NOS;bcae4bdc-477c-58fa-af6d-55d95ca789ea;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;cd953cf4-01ce-5d42-9693-b3be25950070;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-05-5423;LUAD
TCGA-67-3773;released;M0;8140/3;2009;C34.3;cc1a07f6-2771-53a6-a02b-d2a52e063776;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:09:29.022095-05:00;T2;No;no;N0;30706;stage ib;NA;6th;427;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;22f1b1fc-e35b-54f5-890d-34c2d4a6edad;NA;white;Alive;22e32c54-e038-5b18-8f1e-8184b923c34d;84;not hispanic or latino;female;-30706;NA;1925;NA;Pharmaceutical Therapy, NOS;ad1e0a6b-5be1-5c3b-aa52-35b515d40d7c;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;52c81aa3-14cc-5752-9677-ed0eb9cb95e2;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-67-3773;LUAD
TCGA-44-6777;released;MX;8140/3;2006;C34.1;80c9783a-3449-5a05-80c7-8b3d3ae0529b;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T2;No;no;NX;31234;stage ib;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;64;NA;NA;NA;Not Reported;64;63e1c3fc-e942-5380-9025-52b8207e0f6e;350.684.931.506.849;white;Dead;d5a9284a-4c59-524e-b16a-034372f38c0a;85;not reported;female;-31234;2008;1921;987;Pharmaceutical Therapy, NOS;fa8c680d-c4bb-5164-9063-429f9c6b71d7;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;d55cde2d-062f-5c82-b5d1-81ac644fc120;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-6777;LUAD
TCGA-97-A4M3;released;M0;8255/3;2012;C34.1;8e3a7e81-9afb-5009-a120-f75724e34693;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma with mixed subtypes;2019-08-08T17:10:53.779981-05:00;T1b;No;yes;N0;25384;stage ia;NA;7th;540;not reported;not reported;0;No;not reported;not reported;NA;NA;37.5;NA;NA;NA;Not Reported;25;3cae46f7-81bc-58c7-b3ab-f1b73f8119bf;205.479.452.054.795;white;Alive;bd36cb1c-13ff-5618-b435-74cd1765ba05;69;not hispanic or latino;female;-25384;NA;1943;NA;Pharmaceutical Therapy, NOS;9173d48c-7688-5932-8d2d-226a01961378;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;e741b24e-36f0-5b83-846e-44532705e4f8;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-97-A4M3;LUAD
TCGA-55-8092;released;MX;8140/3;2012;C34.1;0b0c066b-927f-5a1f-9701-075211ab5f33;Upper lobe, lung;NA;Upper lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T3;No;no;N0;27597;stage iib;NA;7th;26;not reported;not reported;0;No;not reported;not reported;NA;NA;40;NA;NA;NA;Not Reported;40;754ff8f6-a382-5890-bb7b-c4b4e8a83119;219.178.082.191.781;white;Dead;2a25d38d-1bc7-5f4c-a662-6b1202364dfa;75;not hispanic or latino;male;-27597;NA;1937;154;Pharmaceutical Therapy, NOS;9cae7d9f-1d1a-5653-acd1-0910bba589bd;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;a3b9e153-aafd-51e5-87a1-fb05f7c47b58;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-8092;LUAD
TCGA-44-6774;released;M0;8140/3;2011;C34.3;fd8ad6ea-9ebc-57d4-8d4a-5d07d5b69bf5;Lower lobe, lung;NA;Lower lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T1;No;no;N2;20462;stage iiia;NA;7th;658;not reported;not reported;0;No;not reported;not reported;NA;NA;20;NA;NA;NA;Not Reported;NA;129e89bf-5e69-5ab2-a366-5ba27a36f807;10.958.904.109.589;white;Alive;955fd29d-7a28-5c9a-a5f1-6ef7a891dcd1;56;not hispanic or latino;female;-20462;NA;1955;NA;Pharmaceutical Therapy, NOS;159a1117-56ff-5745-be2d-1a8f062db430;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;ab06adbc-c878-5a8e-9bfe-6065eef72362;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-6774;LUAD
TCGA-86-8055;released;M0;8140/3;2011;C34.1;04088d4f-55ec-5c32-9dc1-eb6af85f2883;Upper lobe, lung;NA;Upper lobe, lung;Stage IIA;Adenocarcinoma, NOS;2019-08-08T17:10:09.373179-05:00;T2a;No;no;N1;29124;stage iia;NA;7th;10;not reported;not reported;0;No;not reported;not reported;NA;NA;60;NA;NA;NA;Not Reported;NA;86b8505c-f81e-514c-b4a7-24d171add17c;328.767.123.287.671;white;Dead;0b1ac271-b27c-5146-b73c-32bf223229c8;79;not hispanic or latino;male;-29124;NA;1932;124;Pharmaceutical Therapy, NOS;6da2ce9f-24b5-51b7-81fe-90e0a29d201e;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;9f084500-14eb-5579-9023-a19935ebdc6f;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-86-8055;LUAD
TCGA-L9-A444;released;MX;8140/3;2012;C34.1;55ed2a57-44cf-5190-ab0e-af71ec48e0c0;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:10:53.779981-05:00;T1a;No;yes;N0;22202;stage ia;NA;7th;307;not reported;not reported;0;No;not reported;not reported;NA;NA;10;NA;NA;NA;Not Reported;NA;064cb9ea-d643-5b39-8004-6eae23c998e3;0.547945205479452;white;Alive;d4b52ec5-0be9-5f31-9c12-3f84893df656;60;not hispanic or latino;female;-22202;NA;1952;NA;Pharmaceutical Therapy, NOS;4a30d696-bf52-59f7-8bdb-2234289e1e57;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;d168db03-8911-5029-887c-92b566c5b1e0;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-L9-A444;LUAD
TCGA-05-4402;released;M1;8255/3;2007;C34.3;60eca695-2f82-5e6e-bbe1-54fe4c42cb09;Lower lobe, lung;NA;Lower lobe, lung;Stage IV;Adenocarcinoma with mixed subtypes;2019-08-08T17:07:40.762038-05:00;T2;Not Reported;yes;NX;20819;stage iv;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;86bed1a0-abe7-542a-bd9a-80da38e0e81e;NA;not reported;Dead;45355a25-5ae9-51ff-a828-e312a0bef1d0;57;not reported;female;-20819;2007;1950;244;Pharmaceutical Therapy, NOS;2f503142-769b-5981-939e-8349ce9a12bc;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;9c8209cb-6199-5c90-aadf-26fdcb844339;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-05-4402;LUAD
TCGA-78-7542;released;M0;8140/3;1993;C34.1;d1d15f1e-57d9-5b74-b37a-32228cf63cf4;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:10:09.373179-05:00;T2;No;no;N0;20763;stage ib;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;60;NA;NA;NA;Not Reported;NA;c24ecf41-e2b6-5c40-adf6-7dacfa6519e2;328.767.123.287.671;white;Dead;c0ae101c-b643-5333-86bf-6c2484db38ac;56;not reported;male;-20763;1993;1937;321;Pharmaceutical Therapy, NOS;e383c756-06fe-59a9-978b-3d7ce5670d65;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;237c99fe-77c3-50dd-8ebf-f0deb3ba3618;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-78-7542;LUAD
TCGA-55-7227;released;MX;8140/3;2011;C34.3;dbfb84ca-a01c-5a96-8fd3-99f3e3314902;Lower lobe, lung;NA;Lower lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:08:47.535141-05:00;T3;No;no;N1;28458;stage iiia;NA;7th;53;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;40;c12027e6-41be-5d2c-a7fd-80fe8425bffe;NA;white;Dead;451546ca-3ae1-5e07-8beb-7a7c4fab3896;77;not hispanic or latino;male;-28458;NA;1934;952;Pharmaceutical Therapy, NOS;03cb66cd-a566-569a-897a-243c1be8f764;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;dc44e753-4e15-5515-9f6c-53d09643d94c;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-7227;LUAD
TCGA-97-A4M6;released;M0;8255/3;2012;C34.3;79b1427f-979b-5284-9661-a18c237f8b32;Lower lobe, lung;NA;Lower lobe, lung;Stage IA;Adenocarcinoma with mixed subtypes;2019-08-08T17:10:53.779981-05:00;T1a;No;no;N0;16764;stage ia;NA;7th;568;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;89eed3c8-3bda-5ec3-b56f-197b1fec4475;NA;white;Alive;ca17a86b-7423-5e2b-a843-2199a3b89d62;45;not hispanic or latino;female;-16764;NA;1967;NA;Pharmaceutical Therapy, NOS;9059ca29-affb-55ea-9723-dc40613acd6d;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;d3f6b4f9-530e-56ab-a27b-f59e6bc3f909;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-97-A4M6;LUAD
TCGA-86-8671;released;M0;8260/3;2012;C34.1;f0d10c1b-6df7-5e1e-92bd-c07305dd2e26;Upper lobe, lung;NA;Upper lobe, lung;Stage IIB;Papillary adenocarcinoma, NOS;2019-08-08T17:10:31.173893-05:00;T2b;No;no;N1;26448;stage iib;NA;7th;839;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;8da63d3f-77b0-5efd-87f9-5ce5d5be923a;NA;white;Alive;de4ee0f3-fd4b-57ec-8cb9-199ed3109a07;72;not hispanic or latino;female;-26448;NA;1940;NA;Pharmaceutical Therapy, NOS;032d34e5-9579-53a4-8c05-f0d1e9226d59;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;d72624b4-6a7e-567f-87ee-3eb71e969cbe;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-86-8671;LUAD
TCGA-05-4389;released;M0;8255/3;2005;C34.1;0d1ac83d-d6c8-5d30-b654-207cbaad6c7b;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma with mixed subtypes;2019-08-08T17:07:40.762038-05:00;T1;No;no;N0;25660;stage ia;NA;5th;1369;not reported;not reported;0;No;not reported;not reported;NA;NA;43;NA;NA;NA;Not Reported;NA;854e2a22-b720-5185-a44b-7fd23f115465;235.616.438.356.164;not reported;Alive;e427c240-7c5a-5083-8a17-ce54219a8b11;70;not reported;male;-25660;NA;1935;NA;Pharmaceutical Therapy, NOS;473ccafe-ff5e-5587-b4c9-50cd4bfb29bd;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;f524ac40-ebff-57db-ac28-952be70ac14f;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-05-4389;LUAD
TCGA-78-7167;released;M1;8260/3;2002;C34.9;ae743f10-d7fa-59d1-8f88-2c704924730d;Lung, NOS;NA;Lung, NOS;Stage IV;Papillary adenocarcinoma, NOS;2019-08-08T17:10:09.373179-05:00;T2;No;no;N0;28295;stage iv;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;64;NA;NA;NA;Not Reported;NA;4d45ef29-28bc-5123-9c5b-b3e03beaae45;350.684.931.506.849;white;Dead;2a5a18f0-6944-5f02-a018-e7d7b3b9dd12;77;not reported;male;-28295;2009;1925;2681;Pharmaceutical Therapy, NOS;bd99c02f-7743-5fde-b3d9-d47bca433c4f;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;ae4fd33e-bda0-5dd4-8ed1-de71bb8513df;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-78-7167;LUAD
TCGA-67-6217;released;M0;8140/3;2010;C34.1;4933f703-8512-55e4-b887-9045a402b0b8;Upper lobe, lung;NA;Upper lobe, lung;Stage IIA;Adenocarcinoma, NOS;2019-08-08T17:09:29.022095-05:00;T2a;Not Reported;yes;N1;26920;stage iia;NA;7th;422;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;201d0442-f951-5a1a-917a-cdd88b237504;NA;white;Alive;468502cd-b9e7-5c70-bcf8-3622ddd59f08;73;not hispanic or latino;female;-26920;NA;1937;NA;Pharmaceutical Therapy, NOS;b8f0a161-5c67-514e-bdd4-ff82ded52c19;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;810143e1-f660-5efa-ac3b-3126954d5ff2;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-67-6217;LUAD
TCGA-44-6779;released;MX;8140/3;2008;C34.1;150dea56-8a22-5dd1-bc74-49a4db018b72;Lung, NOS;NA;Lung, NOS;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T2;No;no;N1;18469;stage iib;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;15;NA;NA;NA;Not Reported;30;61a11991-e7a3-5e76-8ac0-43a958c43dda;0.821917808219178;white;Dead;ac5430ab-508e-5901-8f55-a2e11f6f91a0;50;not reported;female;-18469;2009;1958;500;Pharmaceutical Therapy, NOS;cea3462e-96f3-5342-a46f-5ea0fb17a134;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;16141d63-8779-5928-846c-57550ce96982;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-6779;LUAD
TCGA-64-1679;released;M0;8140/3;2007;C34.1;c5e8ddb5-2800-534a-a327-151bcd9ac2cc;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:09:29.022095-05:00;T1;No;no;N2;21310;stage iiia;NA;6th;2488;not reported;not reported;0;No;not reported;not reported;NA;NA;40;NA;NA;NA;Not Reported;NA;5c3b337d-61f8-531c-b0c6-c93b7bd13348;219.178.082.191.781;white;Alive;d9d32430-d1f3-5a27-8c56-afc29a77e26d;58;not hispanic or latino;female;-21310;NA;1949;NA;Pharmaceutical Therapy, NOS;e65d97fa-8328-50fb-867b-f9c7d3716cea;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;408f814e-26b3-5e8c-b310-62e7f893fc0f;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-64-1679;LUAD
TCGA-49-AARQ;released;MX;8140/3;1996;C34.1;17e5f0f7-d965-57f2-b849-cd5f2f6284e3;Upper lobe, lung;NA;Upper lobe, lung;Stage I;Adenocarcinoma, NOS;2019-08-08T17:08:24.604398-05:00;T2;No;no;N0;15065;stage i;NA;4th;6732;not reported;not reported;0;No;not reported;not reported;NA;NA;60;NA;NA;NA;Not Reported;NA;14561e11-f213-5118-80f1-5a219bcf0d6c;328.767.123.287.671;black or african american;Alive;e1323da5-97f3-5d8c-a4d7-c73783ebb4d3;41;not hispanic or latino;female;-15065;NA;1955;NA;Pharmaceutical Therapy, NOS;7eadd133-3281-5021-b62e-ec1bc4c0cbe5;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;5c01c1c8-76ec-5621-9977-bd028067b815;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-49-AARQ;LUAD
TCGA-78-7537;released;M0;8255/3;2002;C34.1;7617c2e3-f023-5ce5-b8ba-a0f6f142da74;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma with mixed subtypes;2019-08-08T17:10:09.373179-05:00;T2;No;no;N0;26610;stage ib;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;20;NA;NA;NA;Not Reported;40;ae764f28-2be1-5b58-ad87-7d425d4303f6;10.958.904.109.589;not reported;Dead;e90be817-c47b-5637-a381-116f50c01706;72;not reported;male;-26610;2006;1930;1622;Pharmaceutical Therapy, NOS;e58d8641-3346-5a14-9adc-18f95effdbc2;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;cf30a159-5290-50b4-9fcb-ebe700407d9d;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-78-7537;LUAD
TCGA-44-2666;released;M0;8140/3;2009;C34.1;81aac5d5-517e-5772-acf7-c28f5b2dff46;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T2;No;no;N0;15970;stage ib;NA;6th;97;not reported;not reported;0;No;not reported;not reported;NA;NA;30;NA;NA;NA;Not Reported;NA;5280c1a5-4be8-564f-b69a-f62446b4ac0d;164.383.561.643.836;white;Dead;ff677bbc-29e7-5824-8389-a2fa0ec0d9b3;43;hispanic or latino;male;-15970;2009;1966;97;Pharmaceutical Therapy, NOS;dd16103e-774c-5d31-90f0-1e57911db635;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;bed1c650-8067-5a63-858f-15a740f8febb;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-2666;LUAD
TCGA-93-A4JQ;released;MX;8550/3;2012;C34.1;56869005-7eb0-583f-a55b-c06856b622c1;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Acinar cell carcinoma;2019-08-08T17:10:31.173893-05:00;T1b;No;yes;N0;17951;stage ia;NA;7th;526;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;20;7dadb40c-5963-5f4b-85a7-1b4fa0f8d554;NA;white;Alive;5930ec0e-f54f-5692-bc0c-d9b6c98bd3e6;49;not hispanic or latino;male;-17951;NA;1963;NA;Pharmaceutical Therapy, NOS;07bda11f-9fc1-5383-8fbb-b593a0feb1ae;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;3a1be7c4-8b5b-5ec5-9a2e-769459b14a0e;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-93-A4JQ;LUAD
TCGA-55-1594;released;M0;8140/3;2005;C34.3;9713e2e3-c7ed-5c84-b394-699a2c1fd360;Lower lobe, lung;NA;Lower lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:08:47.535141-05:00;T2;No;no;N2;25008;stage iiia;NA;NA;1178;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;ed2c220a-71f3-5938-a4f6-1fc9ba8d7b5a;NA;white;Alive;e2476c10-4ccb-5a62-bc62-3025e649438d;68;not hispanic or latino;male;-25008;NA;1937;NA;Pharmaceutical Therapy, NOS;bbddd1e8-9bc8-5703-b94f-6ce240428688;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;600ca092-aca9-59d6-8dd9-14deb272638b;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-1594;LUAD
TCGA-75-5126;released;M0;8260/3;2007;C34.1;389482d1-7400-5b4b-8497-5855d1bde98a;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIA;Papillary adenocarcinoma, NOS;2019-08-08T17:09:51.361836-05:00;T3;No;no;N2;NA;stage iiia;NA;NA;NA;not reported;not reported;NA;No;not reported;not reported;NA;NA;40;NA;NA;NA;Not Reported;NA;f99ed031-653f-5b80-8897-222a7d8ce33a;219.178.082.191.781;not reported;Alive;a65ae387-93e7-5788-ac03-7ae0c78afc76;NA;not reported;female;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;22925f61-7e87-5856-b147-2d2bd81339c9;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;f6433158-f812-5e4b-b3a4-88a51b23eccc;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-75-5126;LUAD
TCGA-44-3917;released;M0;8140/3;2009;C34.1;81de2dc7-ddb4-5b5d-a9ae-29b6eae69f57;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T2;No;no;N0;12179;stage ib;NA;6th;1183;not reported;not reported;0;No;not reported;not reported;NA;NA;16;NA;NA;NA;Not Reported;NA;f1ee04d7-caa9-5338-b8c7-5253c2e70d67;0.876712328767123;white;Alive;61b35222-2521-55c8-8ae7-178a77294bfb;33;not hispanic or latino;female;-12179;NA;1976;NA;Pharmaceutical Therapy, NOS;9903e0aa-d7de-501c-9f07-6e21adad9d1d;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;2d3f1c59-2c61-5925-b370-268871ebab4c;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-3917;LUAD
TCGA-78-8648;released;M0;8140/3;2002;C34.1;62708d61-1152-5bc9-92b4-5889fb7452d0;Upper lobe, lung;NA;Upper lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:10:09.373179-05:00;T3;No;no;N0;21443;stage iib;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;45;NA;NA;NA;Not Reported;NA;7386fad0-dec7-53c5-ba5e-af203eb15769;246.575.342.465.753;not reported;Dead;61c984b3-e40b-5749-841b-030385b2d769;58;not reported;female;-21443;2005;1944;1209;Pharmaceutical Therapy, NOS;796b127c-15f7-51a9-beb7-33e76e4a7c97;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;621581f4-4da1-5a6d-9f82-b8b668585911;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-78-8648;LUAD
TCGA-MP-A4T9;released;MX;8140/3;2006;C34.1;4534b5fa-4e21-5598-96b9-e9c0b073fb74;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:11:15.269506-05:00;T2;No;no;N2;19767;stage iiia;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;24;NA;NA;NA;Not Reported;24;85d87a28-fb00-55cf-b98e-38ca1ba6dd9e;131.506.849.315.068;white;Dead;166fb5f8-67eb-5e90-81ad-5c02d3cd08b6;54;not hispanic or latino;female;-19767;2009;1952;1265;Pharmaceutical Therapy, NOS;a3137ddd-0c9a-5e10-b63c-3677205d0d01;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;52eeff7a-a624-5dfe-84ff-267fa0934682;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-MP-A4T9;LUAD
TCGA-55-8302;released;MX;8140/3;2012;C34.3;cffab17b-e16f-52bb-b807-5b86eb8e8f90;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T2;No;no;N0;20011;stage ib;NA;7th;478;not reported;not reported;0;No;not reported;not reported;NA;NA;59;NA;NA;NA;Not Reported;NA;c7533e2f-c16f-5116-9d11-cf3dca8d3206;323.287.671.232.877;white;Alive;1c738e49-a19a-5439-9725-79bc8b17a233;54;not reported;male;-20011;NA;1958;NA;Pharmaceutical Therapy, NOS;90b69086-49c2-54bb-a7af-f161300216fd;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;f35f643d-66de-529d-9d6b-fa7ad21a8295;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-8302;LUAD
TCGA-75-5146;released;M0;8252/3;NA;C34.3;2c3a37f2-2037-5260-ab7a-d4ca3e3e2dd6;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Bronchiolo-alveolar carcinoma, non-mucinous;2019-08-08T17:09:51.361836-05:00;T2;No;no;N0;NA;stage ib;NA;6th;2368;not reported;not reported;NA;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;64ea896d-2f63-556e-85a5-fa666658e4a0;NA;not reported;Alive;52706201-23eb-52c9-85b9-8c44ea591368;NA;not reported;male;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;56ee9638-e466-5c75-b652-bad3075cbd68;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;6b9c84e0-1497-5b8a-9d40-1e63b3113039;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-75-5146;LUAD
TCGA-93-7348;released;MX;8140/3;2011;C34.1;c033f3c4-2fb9-5349-8ab4-a9ed0b8863cb;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:10:31.173893-05:00;T1a;No;no;N0;27456;stage ia;NA;7th;531;not reported;not reported;0;No;not reported;not reported;NA;NA;42;NA;NA;NA;Not Reported;42;8076d562-9892-5f3e-8114-22f77b854590;23.013.698.630.137;white;Alive;648d4c36-a337-5d09-a2d2-0de44d4daf12;75;not hispanic or latino;female;-27456;NA;1936;NA;Pharmaceutical Therapy, NOS;1ccc051b-a224-56d6-bc2f-8765e18977c2;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;571db393-c06a-5446-bc5b-c8ec28492ac5;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-93-7348;LUAD
TCGA-L9-A8F4;released;MX;8140/3;2013;C34.1;b4308ca4-d6dd-51d1-a3ee-913e0b54b9be;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:10:53.779981-05:00;T2a;No;no;N0;23617;stage ib;NA;7th;476;not reported;not reported;0;No;not reported;not reported;NA;NA;14;NA;NA;NA;Not Reported;NA;650a807b-3cf5-5ab8-9d9c-25e76d7852de;0.767123287671233;black or african american;Alive;c4de4cce-360f-5a80-bf5e-332bc6a1f20f;64;not hispanic or latino;female;-23617;NA;1949;NA;Pharmaceutical Therapy, NOS;19f6198c-195f-5396-ab04-5543ce837910;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;bff0908b-8871-54a9-884e-100872747443;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-L9-A8F4;LUAD
TCGA-38-4628;released;M0;8140/3;2002;C34.1;f4b0df2c-5c72-5720-97ec-f4a06f3b065e;Upper lobe, lung;NA;Upper lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:07:40.762038-05:00;T2;No;no;N1;24057;stage iib;NA;5th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;cdaf1c4b-288e-5043-b496-4efc553991f2;NA;white;Dead;68676fa7-4bfb-54b8-a507-62d90b393239;65;not hispanic or latino;female;-24057;2006;1937;1492;Pharmaceutical Therapy, NOS;b0960c19-3b18-5a28-8b68-bbb961b70056;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;31080afd-07b5-50d2-b0f2-e329a4b25de7;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-38-4628;LUAD
TCGA-44-A47A;released;MX;8140/3;2012;C34.1;027dc0f9-67eb-5ece-800b-e9061b2fe096;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T2a;No;no;N0;28782;stage ib;NA;7th;466;not reported;not reported;0;No;not reported;not reported;NA;NA;80;NA;NA;NA;Not Reported;40;64e5e157-1dc3-54ca-b894-4c69f205c26e;438.356.164.383.562;white;Alive;1cfac920-ddcd-55d4-9733-de8966f8d2a0;78;not hispanic or latino;female;-28782;NA;1934;NA;Pharmaceutical Therapy, NOS;51d6d2ed-3b7b-5d57-8f3a-f5fd4d9db58b;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;fab975a4-81a9-5548-8d89-80bff562b649;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-A47A;LUAD
TCGA-44-6776;released;MX;8140/3;2005;C34.1;81b2458e-450a-5466-83d4-483aad174803;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T1;Not Reported;yes;N0;22150;stage ia;NA;6th;2616;not reported;not reported;0;No;not reported;not reported;NA;NA;45;NA;NA;NA;Not Reported;45;a66599e1-dca7-5307-b9a7-6c27cda6e774;246.575.342.465.753;white;Alive;99b8e07b-4d7c-5505-bac1-7907edaf329e;60;not reported;female;-22150;NA;1945;NA;Pharmaceutical Therapy, NOS;29cd8665-e1d4-5d7b-9c0b-9b097fc75298;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;f8afd24b-4d45-5365-98b6-290f01cdd8cb;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-6776;LUAD
TCGA-50-5931;released;M0;8140/3;2001;C34.1;092609c0-775f-5e17-b321-19bb903bc65d;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:08:24.604398-05:00;T2;No;no;N0;27733;stage ib;NA;5th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;40;NA;NA;NA;Not Reported;NA;36492316-0120-53af-93aa-5e81edfdc05b;219.178.082.191.781;white;Dead;33fdf1e3-0bc7-5f09-bc2c-950ff85dac27;75;not hispanic or latino;female;-27733;2002;1926;434;Pharmaceutical Therapy, NOS;0e7fb04f-d4af-55b8-b814-f2dd453fbcfb;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;5137f897-1702-5370-8593-f6e165a556c3;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-50-5931;LUAD
TCGA-75-6211;released;M0;8140/3;2009;C34.1;32701a28-c6c0-53d9-87ad-83e700e9af4a;Lung, NOS;NA;Lung, NOS;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:09:51.361836-05:00;T2;No;no;N0;NA;stage ib;NA;6th;NA;not reported;not reported;NA;No;not reported;not reported;NA;NA;34;NA;NA;NA;Not Reported;NA;da2e0fb4-3212-5733-81c6-2d362ed85f3b;186.301.369.863.014;not reported;Dead;a1c31b47-c1aa-51c4-b868-6e736c2fd25a;NA;not reported;female;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;1339bcaa-90c4-5889-a286-3c809a384295;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;844513ff-458f-50e4-b8f8-2809f7d21fbf;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-75-6211;LUAD
TCGA-62-8395;released;M0;8255/3;2009;C34.1;670282dd-3508-58ca-bee0-47851419bc47;Upper lobe, lung;NA;Upper lobe, lung;Stage IIB;Adenocarcinoma with mixed subtypes;2019-08-08T17:09:29.022095-05:00;T3;No;no;N0;29311;stage iib;NA;6th;1216;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;6f372a61-f37e-55e8-9669-3f1a46d9b797;NA;white;Alive;acfabbbc-cec6-5604-8ddb-62b2497099a1;80;not hispanic or latino;female;-29311;NA;1929;NA;Pharmaceutical Therapy, NOS;5a825c36-ed84-5d56-aa93-3737128cbc4e;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;ab289755-f68c-5228-8510-6245b99af33d;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-62-8395;LUAD
TCGA-55-6971;released;MX;8140/3;2010;C34.3;5953c141-2cf8-5965-8457-5d74db8e5720;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:08:47.535141-05:00;T2;No;no;N0;21734;stage ib;NA;7th;1400;not reported;not reported;0;No;not reported;not reported;NA;NA;60;NA;NA;NA;Not Reported;40;7cb27ef4-c0a7-5ee6-af99-a6342a65182b;328.767.123.287.671;white;Alive;db2f841d-3976-50d8-9810-89a5b928dda5;59;not reported;female;-21734;NA;1951;NA;Pharmaceutical Therapy, NOS;b7aca8b2-b843-59a7-83c6-506864a774ef;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;a9796ae0-b459-57ee-a8b4-9e9075ff7d0b;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-6971;LUAD
TCGA-55-8205;released;M0;8140/3;2012;C34.3;94d3d4e8-69cf-5ae9-9679-91f2c8efc36f;Lower lobe, lung;NA;Lower lobe, lung;Stage IIA;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T2b;No;yes;N0;28063;stage iia;NA;7th;599;not reported;not reported;0;No;not reported;not reported;NA;NA;30;NA;NA;NA;Not Reported;61;0acc5fe4-fc94-5b8a-8ccb-3e8880043c0f;164.383.561.643.836;white;Alive;d92b2e0f-691e-57c5-9247-c66e7992903a;76;not hispanic or latino;female;-28063;NA;1936;NA;Pharmaceutical Therapy, NOS;22fe6471-733e-5d89-983f-f9925cdf2a84;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;ab91cc8c-9f28-5d8b-bebc-802df93e8f40;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-8205;LUAD
TCGA-50-5933;released;M0;8140/3;2001;C34.3;7e6fd4a9-b2ed-5db3-b684-8cf065483351;Lower lobe, lung;NA;Lower lobe, lung;Stage IIIB;Adenocarcinoma, NOS;2019-08-08T17:08:24.604398-05:00;T4;No;no;N2;26377;stage iiib;NA;5th;2370;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;575e5472-d146-506e-890b-a3d83e45d1fe;NA;white;Dead;665672bd-7f0f-5a4e-8969-e5f43861d39a;72;not hispanic or latino;male;-26377;2007;1929;2393;Pharmaceutical Therapy, NOS;37201a50-54ff-5b08-8206-28f13c139605;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;32d35992-52d0-50ee-baf8-b367bca71b60;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-50-5933;LUAD
TCGA-55-7728;released;MX;8480/3;2011;C34.1;7ba0f252-dbd0-5834-9ad7-ad6ef471abe0;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Mucinous adenocarcinoma;2019-08-08T17:09:08.225653-05:00;T2a;No;no;N0;23505;stage ib;NA;7th;704;not reported;not reported;0;No;not reported;not reported;NA;NA;30;NA;NA;NA;Not Reported;16;acf51601-dc07-5064-af7f-eb9493bd0d89;164.383.561.643.836;white;Alive;052dbde9-b730-5001-bb67-c2e944bc9b52;64;not hispanic or latino;female;-23505;NA;1947;NA;Pharmaceutical Therapy, NOS;f71426fd-02ca-5975-8e98-c8a14c86151b;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;13cfec82-3da3-57b2-844a-31b74ae3f432;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-7728;LUAD
TCGA-55-6986;released;M0;8252/3;2004;C34.3;8f6f13a3-c7f2-5028-b188-909c5cc21afe;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Bronchiolo-alveolar carcinoma, non-mucinous;2019-08-08T17:08:47.535141-05:00;T2;No;no;N0;NA;stage ib;NA;6th;3261;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;2d802058-cd51-5d81-b522-97cd56503224;NA;white;Alive;da8cdcae-beae-5745-b739-df6f304f4973;74;not reported;female;NA;NA;1930;NA;Pharmaceutical Therapy, NOS;7e6ccac2-fbfa-5319-95a9-54a5b35a5309;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;53aa0c70-1494-5911-a9e8-01aaf0c51bf7;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-6986;LUAD
TCGA-62-8399;released;M0;8255/3;2006;C34.1;d5f52504-752a-5a44-bee8-cde3eb953665;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIA;Adenocarcinoma with mixed subtypes;2019-08-08T17:09:29.022095-05:00;T2;No;no;N2;22952;stage iiia;NA;6th;2696;not reported;not reported;0;No;not reported;not reported;NA;NA;70;NA;NA;NA;Not Reported;NA;39ebea93-4bb3-5d48-87ca-e7793974f38f;383.561.643.835.616;white;Alive;891e6a44-2fb9-57e9-81e4-bc00012bfcf1;62;not hispanic or latino;male;-22952;NA;1944;NA;Pharmaceutical Therapy, NOS;dc968c68-2522-5d09-b6ef-f3f61bc71b64;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;6af4cee0-9091-5ce5-8131-5784bc5bc1fb;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-62-8399;LUAD
TCGA-75-7025;released;M0;8140/3;NA;C34.1;97101227-3fa7-5704-b746-8cc7304565b9;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:09:51.361836-05:00;T2;No;no;N0;NA;stage ib;NA;6th;3305;not reported;not reported;NA;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;19;c2cf80e0-5a62-551e-b71e-9866d6162135;NA;not reported;Alive;419aeb65-b963-5c9d-bc12-45c5116c3000;NA;not reported;male;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;4f51d4c4-60fb-51c7-b3c2-5957b0f05890;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;72a36fb2-eef2-5620-ac97-3eb8c4844e08;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-75-7025;LUAD
TCGA-78-7160;released;M1;8255/3;2008;C34.3;03b90fd8-9e17-5a88-b6ee-9d3f65137692;Lower lobe, lung;NA;Lower lobe, lung;Stage IV;Adenocarcinoma with mixed subtypes;2019-08-08T17:10:09.373179-05:00;T4;No;no;N2;22385;stage iv;NA;6th;678;not reported;not reported;0;No;not reported;not reported;NA;NA;43.8;NA;NA;NA;Not Reported;35;27b27ec0-c440-5ea3-a3cd-a98f392756b1;2.4;white;Dead;e156e6fb-c5de-5a71-b91b-b3318c34a2e4;61;not reported;male;-22385;NA;1947;697;Pharmaceutical Therapy, NOS;eac060bc-8571-5516-a37b-8688b2ae7a49;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;f5a52f2f-fb22-53ce-af7d-b7d3183de8b9;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-78-7160;LUAD
TCGA-55-7910;released;M0;8140/3;2011;C34.3;529d8e32-bb4e-5146-b61d-8f9b118e1fea;Lower lobe, lung;NA;Lower lobe, lung;Stage IIA;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T2b;No;no;N0;18289;stage iia;NA;7th;1040;not reported;not reported;0;No;not reported;not reported;NA;NA;15;NA;NA;NA;Not Reported;15;c2c6c3c4-84b8-5ecd-9104-2dc6630e9c6f;0.821917808219178;black or african american;Alive;8a99b94d-ae94-5aaa-890b-fa394cd0b028;50;not hispanic or latino;female;-18289;NA;1961;NA;Pharmaceutical Therapy, NOS;7b396c5f-07b9-5efc-833c-9a2d759ea4a5;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;57ff687c-c2d6-507c-9436-4b1a529f704d;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-7910;LUAD
TCGA-05-4250;released;M0;8140/3;2007;C34.3;e3e1b5bf-7f8d-52dc-9a43-fcd54b78cb3d;Lower lobe, lung;NA;Lower lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:07:40.762038-05:00;T3;No;no;N1;29068;stage iiia;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;47;NA;NA;NA;Not Reported;NA;279ff4b8-40e5-57fb-9926-6bfbae474bc0;257.534.246.575.342;not reported;Dead;5f0a2b7e-0263-5480-a6f7-2c1f434693ed;79;not reported;female;-29068;2007;1928;121;Pharmaceutical Therapy, NOS;03aa756f-219d-519c-b537-4311c50cd7a3;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;cf2c4caa-1bf5-5a80-9c8c-ba63bca72cda;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-05-4250;LUAD
TCGA-44-3919;released;M0;8140/3;2010;C34.1;a355eae9-c742-533d-96dd-f68d0b6f5df7;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T1;No;no;N0;26081;stage ia;NA;7th;190;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;cbfe0478-006e-521c-9962-7630d58b14d1;NA;white;Dead;a6190cba-783a-5387-a88a-13a20d64ae1e;71;not hispanic or latino;female;-26081;NA;1939;1026;Pharmaceutical Therapy, NOS;33f6f07f-9078-5b3d-b613-2fa65b27109c;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;9d9cf820-1274-52b7-bbea-93898a54bb36;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-3919;LUAD
TCGA-44-3396;released;M0;8140/3;2009;C34.1;c115f80b-56a4-54e6-b67f-e40ad3e57d67;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T2;No;no;N2;27073;stage iiia;NA;7th;1130;not reported;not reported;0;No;not reported;not reported;NA;NA;50;NA;NA;NA;Not Reported;NA;6d7d363d-22d2-562d-a93c-af52d7f73056;273.972.602.739.726;white;Alive;a54ecb19-24f7-50cd-8d5d-8ac3985ef3ef;74;not hispanic or latino;female;-27073;NA;1935;NA;Pharmaceutical Therapy, NOS;4dfdf112-33c3-5e8b-9853-84120a52628b;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;3a61dffd-2937-5f8c-a709-d6f772f5a43e;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-3396;LUAD
TCGA-L9-A50W;released;MX;8255/3;2012;C34.3;80dfcec1-956f-51c8-b80e-887886e7ddd4;Lower lobe, lung;NA;Lower lobe, lung;Stage IIA;Adenocarcinoma with mixed subtypes;2019-08-08T17:10:53.779981-05:00;T1b;No;no;N1;27414;stage iia;NA;7th;266;not reported;not reported;0;No;not reported;not reported;NA;NA;19;NA;NA;NA;Not Reported;19;7cb673c0-d3b0-5451-954d-ed589ebbf294;104.109.589.041.096;black or african american;Dead;f87c17ea-3bdb-5654-bf49-d181aae214f5;75;not hispanic or latino;male;-27414;NA;1937;442;Pharmaceutical Therapy, NOS;e8ed5447-ed14-5aef-b290-729a15d28966;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;a8a74e89-1ee2-5353-9c0f-4d72d36430ca;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-L9-A50W;LUAD
TCGA-78-7155;released;M0;8140/3;2005;C34.1;8e8965dc-87d2-5cd7-a6c4-54dc3bfa9c34;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:09:51.361836-05:00;T2;No;no;N0;24863;stage ib;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;48;NA;NA;NA;Not Reported;48;294f21e4-117d-542e-90aa-d26fab75a5d9;263.013.698.630.137;white;Dead;5e9f31d2-5857-544b-8111-f754d64d1eb0;68;not reported;male;-24863;2008;1937;1171;Pharmaceutical Therapy, NOS;cd99049e-6d96-56eb-9549-5ae83a044e79;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;b3c413d1-4cf4-5ec7-a6e7-cf773852a81e;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-78-7155;LUAD
TCGA-78-7161;released;M0;8255/3;2011;C34.1;04bafd62-334b-5f2b-a476-d404e8e4295f;Upper lobe, lung;NA;Upper lobe, lung;Stage IIB;Adenocarcinoma with mixed subtypes;2019-08-08T17:10:09.373179-05:00;T3;No;no;N0;25294;stage iib;NA;7th;215;not reported;not reported;0;No;not reported;not reported;NA;NA;27.8;NA;NA;NA;Not Reported;37;b9499319-cc1c-5503-9dd1-5f05cd98bf54;152.328.767.123.288;white;Dead;602066ca-85df-5c4a-a832-d7dd2aff25be;69;not reported;female;-25294;NA;1942;291;Pharmaceutical Therapy, NOS;e730e599-b129-597c-9ada-0c149b47054e;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;a94f9c3c-f790-5824-9061-cbc1a0d3d6c7;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-78-7161;LUAD
TCGA-49-AARE;released;MX;8140/3;1999;C34.1;52a07365-bfff-5715-81a2-6bf6143108eb;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:08:24.604398-05:00;T1;No;no;N0;18893;stage ia;NA;5th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;15;NA;NA;NA;Not Reported;15;126897f0-7377-5cab-889a-8563dbf926e0;0.821917808219178;black or african american;Dead;383e2b8e-b3c9-59d7-85a8-445d698fdf34;51;not hispanic or latino;female;-18893;2002;1948;1229;Pharmaceutical Therapy, NOS;b86e05ba-c162-5d42-8f9e-ecfad2193af4;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;cfe01cdb-deb3-53b3-b309-94d90c05be4d;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-49-AARE;LUAD
TCGA-44-7660;released;MX;8140/3;2011;C34.1;a53f2846-a4e2-5760-9aee-6516914ee907;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T2;No;no;N0;26594;stage ib;NA;7th;592;not reported;not reported;0;No;not reported;not reported;NA;NA;124;NA;NA;NA;Not Reported;NA;340d5de8-2c94-586c-b58a-536ddfb1455b;679.452.054.794.521;white;Alive;4de4119b-7cf6-5fb7-a677-9c8a71377635;72;not hispanic or latino;male;-26594;NA;1939;NA;Pharmaceutical Therapy, NOS;3f0c5306-e898-5ad9-9ced-e7871536541b;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;30f0ed9a-7ac5-5929-86f7-a1657d333111;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-7660;LUAD
TCGA-MN-A4N5;released;M0;8140/3;2011;C34.1;748e8de2-a428-5538-bd63-53e5e86c8811;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:10:53.779981-05:00;T1a;No;no;N0;23257;stage ia;NA;7th;84;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;40;f14d919a-ed6b-5cc2-82f8-214022c61b5b;NA;white;Alive;15b2b231-873e-5c9b-9855-7b737013f229;63;not hispanic or latino;male;-23257;NA;1948;NA;Pharmaceutical Therapy, NOS;831c892f-60d0-558d-a1d9-0a2234eec6fe;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;dfae418f-91d4-5ae8-b40b-ccc2ef6caaf4;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-MN-A4N5;LUAD
TCGA-86-8279;released;M0;8140/3;2011;C34.1;1ce170a2-177a-5d2f-8c16-289164954105;Upper lobe, lung;NA;Upper lobe, lung;Stage IIA;Adenocarcinoma, NOS;2019-08-08T17:10:09.373179-05:00;T2a;No;no;N1;17032;stage iia;NA;7th;949;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;ca03b412-347b-5dfc-8f24-de4f96029e48;NA;white;Alive;6a3c8ab8-04cb-5092-8931-49fe9cd25fc4;46;not hispanic or latino;male;-17032;NA;1965;NA;Pharmaceutical Therapy, NOS;a702300c-357b-539c-a983-5ed2f9ce4192;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;ebb409a1-0498-5ce2-827d-d4d03426ad56;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-86-8279;LUAD
TCGA-78-7148;released;M0;8255/3;2001;C34.1;1bbb99a8-be22-5116-b539-2c95dae3dfcb;Upper lobe, lung;NA;Upper lobe, lung;Stage IIB;Adenocarcinoma with mixed subtypes;2019-08-08T17:09:51.361836-05:00;T2;No;no;N1;25990;stage iib;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;57;NA;NA;NA;Not Reported;NA;b5839fb7-462d-56c0-87c6-c43d9ed58b1e;312.328.767.123.288;white;Dead;ac28c474-ce5e-55e5-bb17-35ed03872bf1;71;not reported;male;-25990;2002;1930;626;Pharmaceutical Therapy, NOS;fbb570cf-325e-5869-91a1-76ff1a760846;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;69c6bdf8-9bc7-5f5e-b91b-880c0976b621;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-78-7148;LUAD
TCGA-55-8619;released;MX;8480/3;2012;C34.30;36efb06f-5000-5265-910f-67f1b3070d81;Lower lobe, lung;NA;Lower lobe, lung;Stage IIB;Mucinous adenocarcinoma;2019-08-08T17:09:08.225653-05:00;T3;No;yes;N0;26616;stage iib;NA;7th;416;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;6d40d0cb-3555-5faf-accb-199f16a80e3b;NA;white;Alive;fff7adcb-b16b-5d8a-82be-6643e3ed7844;72;not hispanic or latino;female;-26616;NA;1940;NA;Pharmaceutical Therapy, NOS;8b326518-2ca2-5b92-aed0-dc4092e1b134;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;dfe25492-1ab3-5307-9ed3-e46ff4d4c5f9;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-8619;LUAD
TCGA-93-8067;released;MX;8140/3;2011;C34.3;cebd6b0a-119a-5847-b2ac-897bde972c23;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:10:31.173893-05:00;T2a;No;yes;N0;28453;stage ib;NA;7th;186;not reported;not reported;0;No;not reported;not reported;NA;NA;20;NA;NA;NA;Not Reported;40;8fd4fb14-b362-569d-825f-f2f572f17c28;10.958.904.109.589;asian;Alive;4b850d67-395b-5818-8139-c23b36156fe0;77;not hispanic or latino;male;-28453;NA;1934;NA;Pharmaceutical Therapy, NOS;ceef6af5-de81-566d-9db5-88f5c1f0686b;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;dffafdee-5785-5876-8947-4a6f7f27d4bd;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-93-8067;LUAD
TCGA-64-1681;released;M0;8140/3;2008;C34.1;6a9b3344-d488-56e4-835c-7458c92ade4b;Lung, NOS;NA;Lung, NOS;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:09:29.022095-05:00;T1;No;no;N0;22525;stage ia;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;20;43881ffd-ef3d-5d28-b9dd-0d8532dd2723;NA;white;Dead;6291f336-0676-5c03-ab39-1461f73c1a4c;61;not hispanic or latino;female;-22525;2011;1947;1167;Pharmaceutical Therapy, NOS;3c65520b-5fb2-551f-a8a0-079b7fd615d0;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;3314582d-e4a8-51aa-9a9a-4d35720773a1;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-64-1681;LUAD
TCGA-67-3776;released;M0;8140/3;2009;C34.3;fa24d4fd-b966-52d2-bce5-47546ebf182e;Lower lobe, lung;NA;Lower lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:09:29.022095-05:00;T2;No;no;N1;20940;stage iib;NA;NA;61;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;30f55a31-9b3c-5f8e-99d4-8896fa4bd079;NA;white;Alive;6cac6e6f-e267-5329-832f-1d6ce99ac768;57;not hispanic or latino;female;-20940;NA;1952;NA;Pharmaceutical Therapy, NOS;15b3f2ab-7d69-59f3-b98c-612d05e65718;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;a9958a64-f701-5eaf-9a48-738b64459bf3;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-67-3776;LUAD
TCGA-99-8028;released;M0;8140/3;2011;C34.1;1b1903f3-c763-55c7-a932-70281a80279a;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:10:53.779981-05:00;T1a;No;no;N0;18542;stage ia;NA;7th;1118;not reported;not reported;0;No;not reported;not reported;NA;NA;30;NA;NA;NA;Not Reported;30;c4df15ca-3f79-5a72-9685-fdf503b6e907;164.383.561.643.836;black or african american;Alive;1febe41d-2c57-5f8f-a1f5-3876977fabe3;50;not hispanic or latino;female;-18542;NA;1961;NA;Pharmaceutical Therapy, NOS;ad8e1dbe-7ddd-51a7-a308-0100d03d2a38;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;94d96f66-4a50-592e-8b04-38074c06604b;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-99-8028;LUAD
TCGA-55-8513;released;MX;8480/3;2012;C34.30;9ef4f6a3-caab-5d46-b2a4-6478fd027081;Lower lobe, lung;NA;Lower lobe, lung;Stage IIB;Mucinous adenocarcinoma;2019-08-08T17:09:08.225653-05:00;T3;No;no;N0;28284;stage iib;NA;7th;791;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;18399dc9-8be1-536b-b2b1-7569b8f0b886;NA;white;Alive;d7443b04-aa3b-5738-ac7d-85dc615a03b6;77;not hispanic or latino;female;-28284;NA;1935;NA;Pharmaceutical Therapy, NOS;79813cdd-db81-52f6-bd95-a5b5bd2a4e01;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;a3fd4efd-8731-57f5-8d0f-500daa0771c9;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-8513;LUAD
TCGA-44-7662;released;MX;8140/3;2011;C34.1;4f044b1f-79b0-519f-84b3-3b6c9750636b;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T2a;No;no;N0;22543;stage ib;NA;7th;218;not reported;not reported;0;No;not reported;not reported;NA;NA;50;NA;NA;NA;Not Reported;NA;17beaa9f-f01d-5dd7-add0-20bc61404f16;273.972.602.739.726;white;Alive;730c725f-2094-59c0-a896-e9e13d43bbdd;61;not hispanic or latino;male;-22543;NA;1950;NA;Pharmaceutical Therapy, NOS;cb3321bd-1cd7-55ca-a581-1549ab21bc1e;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;e18a2258-cd6d-5321-ac98-39c75efdaaad;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-7662;LUAD
TCGA-MP-A4T2;released;M0;8140/3;2003;C34.3;6d5474f0-cd3c-5fb7-94da-70f4348d06c4;Lower lobe, lung;NA;Lower lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:10:53.779981-05:00;T1;No;no;N0;26010;stage ia;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;75;NA;NA;NA;Not Reported;50;9df788df-01a0-5b43-8aca-f88bb02fa712;410.958.904.109.589;white;Dead;8470b8dc-9635-5680-bc54-f9ca53efef45;71;not hispanic or latino;male;-26010;2006;1932;1136;Pharmaceutical Therapy, NOS;05a47ae9-5b01-5f8d-8d92-8abcf41c85c1;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;51d9cea4-9b83-590c-b8e1-96de6f2914ca;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-MP-A4T2;LUAD
TCGA-99-AA5R;released;M0;8140/3;2013;C34.3;83a7e788-05c9-5fe2-881e-15037124d503;Lower lobe, lung;NA;Lower lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:10:53.779981-05:00;T1a;No;no;N0;25778;stage ia;NA;7th;658;not reported;not reported;0;No;not reported;not reported;NA;NA;46;NA;NA;NA;Not Reported;NA;9667849a-3289-5884-bf33-48d3aefd387c;252.054.794.520.548;black or african american;Alive;b261abbd-3943-5f92-bbe5-934885493fbb;70;not hispanic or latino;female;-25778;NA;1943;NA;Pharmaceutical Therapy, NOS;92a89af0-3828-558b-93ce-4e3b2b9c1a16;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;fd85cf15-5999-5069-916e-1cb4f1b327d3;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-99-AA5R;LUAD
TCGA-05-4426;released;M0;8255/3;2008;C34.3;2de5d1c1-2942-505e-8081-471f45188690;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Adenocarcinoma with mixed subtypes;2019-08-08T17:07:40.762038-05:00;T2;No;no;N0;26084;stage ib;NA;6th;791;not reported;not reported;0;No;not reported;not reported;NA;NA;20;NA;NA;NA;Not Reported;NA;6a30bac8-da69-5b13-9313-9e49cee3ca44;10.958.904.109.589;not reported;Alive;2dcc0d6b-0fb4-5d50-82c5-2b3000fd02d5;71;not reported;male;-26084;NA;1937;NA;Pharmaceutical Therapy, NOS;e09b80ef-53cb-5c58-9def-bae2224eb8e8;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;14377244-d169-5a3e-a8bc-d12968b4c50a;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-05-4426;LUAD
TCGA-MP-A4TK;released;MX;8140/3;2002;C34.3;c105fe5e-b554-5e09-a872-fedc9220a72c;Lower lobe, lung;NA;Lower lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:11:15.269506-05:00;T2;No;no;N1;20581;stage iib;NA;5th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;28;NA;NA;NA;Not Reported;28;6725972d-4bfd-533d-b374-773c5e65b5d0;153.424.657.534.247;not reported;Dead;abceadc1-f5b1-5644-a5ba-2d0049f1a642;56;not reported;female;-20581;2003;1946;582;Pharmaceutical Therapy, NOS;7fda1cae-4963-537f-acac-27a1dd535758;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;26ca25ad-09c7-5b35-81b6-fe73567b1c2f;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-MP-A4TK;LUAD
TCGA-50-5942;released;M0;8140/3;2009;C34.1;841e3378-7fc1-582a-8e10-b32da1fa4cf7;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:08:24.604398-05:00;T1;No;no;N0;24781;stage ia;NA;7th;1847;not reported;not reported;0;No;not reported;not reported;NA;NA;30;NA;NA;NA;Not Reported;NA;1fd7a7e2-acfe-5b24-bb38-3e90161b2006;164.383.561.643.836;white;Alive;5571a03f-dfe7-5bc3-bff8-cdbeda1fc077;67;not hispanic or latino;female;-24781;NA;1942;NA;Pharmaceutical Therapy, NOS;2f024526-af1b-5f36-8b3a-14a146ae2adc;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;32f4986b-8384-5ae3-ac83-0cf8f4051c03;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-50-5942;LUAD
TCGA-55-6978;released;MX;8140/3;2010;C34.2;81664726-52e2-55f5-8e93-af5facbc7922;Middle lobe, lung;NA;Middle lobe, lung;Stage IIA;Adenocarcinoma, NOS;2019-08-08T17:08:47.535141-05:00;T2b;Not Reported;yes;N0;NA;stage iia;NA;7th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;6191cb90-7288-5b82-94cd-f28c861eaea2;NA;white;Dead;00e3632b-e860-5b1e-bfa8-eba5fc3d3f3f;81;not hispanic or latino;male;NA;2010;1929;176;Pharmaceutical Therapy, NOS;34d75b3d-c506-5e92-9cd6-ca58e6bde7fd;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;94dc54fa-fefa-52af-89a2-ee00455b008d;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-6978;LUAD
TCGA-97-7941;released;MX;8550/3;2011;C34.1;61f4318d-3f77-59fd-9629-016a899026c0;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Acinar cell carcinoma;2019-08-08T17:10:53.779981-05:00;T1b;No;no;N0;26298;stage ia;NA;7th;484;not reported;not reported;0;No;not reported;not reported;NA;NA;22.5;NA;NA;NA;Not Reported;25;89ea9734-59d0-5ebe-bdc1-c554def961d9;123.287.671.232.877;white;Alive;c6e7b870-61cd-5a6b-acfd-26007fc39813;72;not hispanic or latino;female;-26298;NA;1939;NA;Pharmaceutical Therapy, NOS;5bc48e98-f82c-5e3c-b996-01d63e5a201f;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;0db0e2d8-8f90-5d6f-ba94-b9ac2a61f722;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-97-7941;LUAD
TCGA-50-6597;released;M0;8140/3;2007;C34.3;9babcfd6-a4de-5b90-9aa9-feb27a873807;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:08:47.535141-05:00;T2;No;no;N0;29195;stage ib;NA;6th;1015;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;6840df79-0764-5bc2-b131-eed5a9370e68;NA;white;Dead;820f1280-2833-5942-9e9a-d331ab1d835a;79;not hispanic or latino;female;-29195;NA;1928;1268;Pharmaceutical Therapy, NOS;0d032c34-029d-51ed-984e-16365c2917f0;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;cc810e81-0fa6-5db5-9a1c-02ce09b19530;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-50-6597;LUAD
TCGA-MP-A5C7;released;M0;8140/3;2008;C34.1;d09656e9-03cd-58e6-b9d2-2afbe24d04e3;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:11:15.269506-05:00;T2;No;no;N0;28015;stage ib;NA;6th;2248;not reported;not reported;0;No;not reported;not reported;NA;NA;15;NA;NA;NA;Not Reported;15;ed014f35-99b9-5c91-939c-3ad0b0952806;0.821917808219178;white;Alive;b45d5702-8d38-574e-bc70-bf4686bf7d27;76;not hispanic or latino;female;-28015;NA;1932;NA;Pharmaceutical Therapy, NOS;0d7fbf54-b84f-5e6d-bd85-4217a91c88c8;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;fde29055-9bf2-5d2f-b9ac-0149367d510b;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-MP-A5C7;LUAD
TCGA-53-7624;released;M1;8140/3;2008;C34.1;dea71bba-b373-5d9e-ada2-856caa91338d;Upper lobe, lung;NA;Upper lobe, lung;Stage IV;Adenocarcinoma, NOS;2019-08-08T17:08:47.535141-05:00;T2;No;no;N0;14794;stage iv;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;50;NA;NA;NA;Not Reported;NA;8475a4f4-a1de-565f-8c50-221765ad0b7e;273.972.602.739.726;white;Dead;cc6b2140-2358-5184-b24a-4a7cad3daef4;40;hispanic or latino;female;-14794;2010;1968;1043;Pharmaceutical Therapy, NOS;ee5d0dd4-7e03-5a12-b016-1dd90aca2974;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;a01b0fbf-630e-553e-86a2-5379b4885f5d;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-53-7624;LUAD
TCGA-05-5425;released;M0;8255/3;2009;C34.9;f6215c8a-cc36-5e6a-8bea-1e7ec89c3093;Lung, NOS;NA;Lung, NOS;Stage IIB;Adenocarcinoma with mixed subtypes;2019-08-08T17:07:40.762038-05:00;T2b;No;no;N1;25020;stage iib;NA;7th;882;not reported;not reported;0;No;not reported;not reported;NA;NA;40;NA;NA;NA;Not Reported;20;9e74bef9-1855-5272-b051-80a587c6b769;219.178.082.191.781;not reported;Alive;a5a0448d-6255-558d-a34a-3bdd0f6912d0;68;not reported;male;-25020;NA;1941;NA;Pharmaceutical Therapy, NOS;a1763b7b-6cc0-570c-9891-1e6c01825f47;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;76c74da2-1a3d-5b2c-9f91-80db92937722;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-05-5425;LUAD
TCGA-73-A9RS;released;M0;8140/3;2013;C34.1;0712357d-8c2c-5649-93c6-698532352122;Upper lobe, lung;NA;Upper lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:09:51.361836-05:00;T3;No;no;N0;15162;stage iib;NA;7th;305;not reported;not reported;0;No;not reported;not reported;NA;NA;11;NA;NA;NA;Not Reported;NA;16dd542a-855f-503c-9d94-a106ce4ca4ab;0.602739726027397;black or african american;Dead;87e12b9f-8a72-553f-bd89-9cc4e39c5023;41;not hispanic or latino;male;-15162;NA;1972;340;Pharmaceutical Therapy, NOS;07ff344e-3a6d-58f6-9e4a-abcc3043d0ca;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;74df6fc6-fa5e-548f-a979-5f68d1dc77ae;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-73-A9RS;LUAD
TCGA-62-A470;released;M0;8550/3;2009;C34.1;7ed45c21-23fc-5fad-8729-cdee5dce09bd;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Acinar cell carcinoma;2019-08-08T17:09:29.022095-05:00;T2;No;no;N0;30689;stage ib;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;30;NA;NA;NA;Not Reported;NA;f5d9402b-bf6e-59e7-9fa1-d6862140f744;164.383.561.643.836;white;Dead;29055b33-2111-5a2a-8985-ce831bd06f4b;84;not hispanic or latino;male;-30689;2012;1925;1194;Pharmaceutical Therapy, NOS;86e37c72-6855-5b5c-aeec-d86eeaee6bd3;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;f11aefb9-76d6-5179-a7b7-ef9be6b2b38f;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-62-A470;LUAD
TCGA-91-6828;released;M0;8140/3;2011;C34.3;1cb57e0f-04dc-55a0-b7a7-efded807ef84;Lower lobe, lung;NA;Lower lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:10:31.173893-05:00;T1a;No;no;N0;25870;stage ia;NA;7th;323;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;ee95d90a-cd15-5d71-82b6-eb00a0f3e93a;NA;white;Alive;d56d84ed-3e9c-5d14-8842-4fb95f6fb195;70;not hispanic or latino;male;-25870;NA;1941;NA;Pharmaceutical Therapy, NOS;adbd162f-4d12-5b31-bb0d-eea7ebeea75b;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;3f0e3e63-e208-58a6-9ac7-0a0079a7969c;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-91-6828;LUAD
TCGA-78-7535;released;M0;8140/3;2000;C34.1;d68fb3ef-ec0f-5fb2-ad5f-a347a3e736ed;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:10:09.373179-05:00;T2;No;no;N0;16571;stage ib;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;35;NA;NA;NA;Not Reported;NA;762b846e-1cb9-50a9-914b-c18583c04585;191.780.821.917.808;white;Dead;964f7631-37b8-5566-b118-d5d5b0c0f01c;45;not reported;male;-16571;2002;1955;949;Pharmaceutical Therapy, NOS;c53cd5a4-d470-5ee2-8202-91fb508a65ee;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;92fc4a6c-3bec-5e73-9ee6-810a4d95757b;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-78-7535;LUAD
TCGA-49-4512;released;MX;8140/3;2007;C34.2;9eeeef23-15d3-52c7-aca3-22b77161dfb9;Middle lobe, lung;NA;Middle lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:08:24.604398-05:00;T2;No;no;N2;25502;stage iiia;NA;6th;157;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;5270b67a-14e1-5826-8470-850751bf3167;NA;white;Dead;d1cc924a-2e5f-52bf-a115-f50f44daa25a;69;not hispanic or latino;female;-25502;2009;1938;905;Pharmaceutical Therapy, NOS;fe23fe67-678a-5cd8-abab-fa4d3c2416ba;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;c00ef007-7ebf-5cd5-b0aa-eac96b15fbd8;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-49-4512;LUAD
TCGA-97-A4M1;released;M0;8255/3;2012;C34.1;98303964-0d1b-548f-97ab-491600988907;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma with mixed subtypes;2019-08-08T17:10:53.779981-05:00;T1a;No;no;N0;19272;stage ia;NA;7th;601;not reported;not reported;0;No;not reported;not reported;NA;NA;3;NA;NA;NA;Not Reported;3;e8b8d866-9388-58cc-a31f-7a0d3e6826a2;0.164383561643836;white;Alive;d87fdc36-3ed2-594c-83b7-15eec4733761;52;not hispanic or latino;female;-19272;NA;1960;NA;Pharmaceutical Therapy, NOS;926a5ffd-a000-5506-9131-f86e6acac93c;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;27736246-e359-5ca7-a7cf-d51bd5a9d4da;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-97-A4M1;LUAD
TCGA-05-4422;released;M0;8255/3;2008;C34.3;c06d2d33-16a2-5075-a9a2-2c7ad44c7f43;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Adenocarcinoma with mixed subtypes;2019-08-08T17:07:40.762038-05:00;T2;No;no;N0;24837;stage ib;NA;6th;365;not reported;not reported;0;No;not reported;not reported;NA;NA;147;NA;NA;NA;Not Reported;NA;7a038fb8-c56b-5c42-8d14-74c6ea04bb38;805.479.452.054.795;not reported;Alive;ce2bfd12-41fa-57bc-aa81-f0cee843dfe3;68;not reported;male;-24837;NA;1940;NA;Pharmaceutical Therapy, NOS;8f7cfef7-b828-5892-a705-55162c2dae42;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;dbdb2258-da33-5653-890e-00bcdff4ece4;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-05-4422;LUAD
TCGA-55-6975;released;M0;8255/3;2004;C34.3;0834d418-acca-52cf-97e5-c9d63375848a;Lower lobe, lung;NA;Lower lobe, lung;Stage IIB;Adenocarcinoma with mixed subtypes;2019-08-08T17:08:47.535141-05:00;T2;No;no;N1;NA;stage iib;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;a31c21c5-e97a-54f2-a513-98bd530e8554;NA;white;Dead;c71eef1d-ab92-502f-b861-87ddb9977730;61;not hispanic or latino;male;NA;2004;1943;118;Pharmaceutical Therapy, NOS;b0f505fa-3244-5626-aa07-d9f1713e879f;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;bc3886fe-83dd-5822-b14c-ecfb2f95ad4b;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-6975;LUAD
TCGA-55-8514;released;MX;8140/3;2012;C34.1;5164e66d-05a4-5657-ab59-77a4c9c13057;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T2a;No;no;N0;25608;stage ib;NA;7th;520;not reported;not reported;0;No;not reported;not reported;NA;NA;20;NA;NA;NA;Not Reported;40;4c68a32c-f672-58af-8c11-a63a73d1a7b5;10.958.904.109.589;black or african american;Alive;02ec80ed-7928-5022-90f6-bc5f54c645c6;70;not hispanic or latino;female;-25608;NA;1942;NA;Pharmaceutical Therapy, NOS;5e3ac225-4bef-5b4e-a572-40a82f3735ff;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;9856f0fa-5bdd-5319-84d8-6c9d812ae9d1;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-8514;LUAD
TCGA-86-8673;released;M0;8252/3;2011;C34.1;501bcf19-55bf-5360-a66a-fe147f7533af;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Bronchiolo-alveolar carcinoma, non-mucinous;2019-08-08T17:10:31.173893-05:00;T2;No;no;N0;22571;stage ib;NA;7th;862;not reported;not reported;0;No;not reported;not reported;NA;NA;54;NA;NA;NA;Not Reported;NA;ffc0f811-694d-53c9-a46e-2081f1a61476;295.890.410.958.904;white;Alive;cb44581c-64b4-5a13-bc65-400d75088e83;61;not hispanic or latino;male;-22571;NA;1950;NA;Pharmaceutical Therapy, NOS;c1baa60c-8d01-5da0-a771-ec2873c07a10;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;54ea1070-36b5-5411-becb-3268565b4e07;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-86-8673;LUAD
TCGA-50-5068;released;MX;8140/3;2003;C34.3;472ac503-de3f-5918-8c48-71a8542cbbec;Lower lobe, lung;NA;Lower lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:08:24.604398-05:00;T2;No;no;N1;21728;stage iib;NA;6th;1499;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;bdf9ac33-0278-53a2-be44-c764077a1a29;NA;white;Dead;95fcab07-1ed9-5508-bd0f-038e2dc49628;59;not hispanic or latino;female;-21728;2007;1944;1499;Pharmaceutical Therapy, NOS;f32f70fb-dc6f-5f4b-b013-971403ee6520;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;9d515939-b51f-57f7-90f7-ff3f831b70f7;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-50-5068;LUAD
TCGA-55-7907;released;MX;8140/3;2011;C34.1;6db0e61f-6df2-5b6c-ac6d-19618c35b230;Upper lobe, lung;NA;Upper lobe, lung;Stage IIA;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T2a;No;no;N1;28201;stage iia;NA;7th;16;not reported;not reported;0;No;not reported;not reported;NA;NA;80;NA;NA;NA;Not Reported;40;2f351b5d-3c89-5738-b91f-7023ef6629ef;438.356.164.383.562;white;Dead;096e3d58-b967-51a9-9c78-d6cc36dbc10e;77;not hispanic or latino;male;-28201;NA;1934;343;Pharmaceutical Therapy, NOS;15728518-e019-5574-9d01-5ca788cac888;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;dc7cacc5-3f4d-5e60-878e-eb66180fd4bf;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-7907;LUAD
TCGA-55-A48Y;released;M0;8140/3;2012;C34.3;6fb13ae9-37d4-5cdc-a372-9ca0fb8cf696;Lower lobe, lung;NA;Lower lobe, lung;Stage IIA;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T2b;No;no;N0;25384;stage iia;NA;7th;630;not reported;not reported;0;No;not reported;not reported;NA;NA;50;NA;NA;NA;Not Reported;NA;99e23d20-3543-5d07-b26e-4c5c0c8147e6;273.972.602.739.726;white;Alive;eaf3468c-18b6-5688-8f83-3cfcf26e16fb;69;not hispanic or latino;male;-25384;NA;1943;NA;Pharmaceutical Therapy, NOS;03fcdb5c-e0e6-59e3-953e-80906e19e2bf;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;700dfce4-5a35-5237-8cc6-176bf7d637dc;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-A48Y;LUAD
TCGA-62-A46V;released;M0;8255/3;2007;C34.3;f73727a4-b2ed-5928-94fd-ccd64dd2bf49;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Adenocarcinoma with mixed subtypes;2019-08-08T17:09:29.022095-05:00;T2;No;no;N0;28495;stage ib;NA;6th;2199;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;9d78d580-e034-56c8-bc38-8e66d5cb21bc;NA;white;Alive;190035d4-ff6e-5ae3-adbc-1acbcec973c7;78;not hispanic or latino;female;-28495;NA;1929;NA;Pharmaceutical Therapy, NOS;e204a6ed-265e-5747-addf-23117e0caa0a;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;fc1049c4-502e-5b5d-a27b-6b543183fe64;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-62-A46V;LUAD
TCGA-95-7948;released;M0;8255/3;2011;C34.3;7f7755a8-2822-5a19-811e-71aa6d7885a0;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Adenocarcinoma with mixed subtypes;2019-08-08T17:10:31.173893-05:00;T2a;Not Reported;yes;N0;15363;stage ib;NA;7th;476;not reported;not reported;0;No;not reported;not reported;NA;NA;0.15;NA;NA;NA;Not Reported;2;55a12f44-19ce-5c45-9abc-b9edcb6fd819;0.00821917808219178;white;Alive;0a36d497-ad2d-5bac-8235-6729e1e1b789;42;not hispanic or latino;female;-15363;NA;1969;NA;Pharmaceutical Therapy, NOS;9771c8eb-76d5-5836-a16f-e223a307d586;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;7c94929d-ea58-538a-b224-e1f9c8d2c2aa;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-95-7948;LUAD
TCGA-50-5930;released;M0;8255/3;2001;C34.3;228f4e4e-28cb-5d4b-896d-adba54b0c856;Lower lobe, lung;NA;Lower lobe, lung;Stage IIIA;Adenocarcinoma with mixed subtypes;2019-08-08T17:08:24.604398-05:00;T2;No;no;N2;17238;stage iiia;NA;5th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;bb0fa226-56dd-51d8-beb0-abc860e5fc8a;NA;white;Dead;305f22ba-d378-52e8-9f52-a53a111b0ed6;47;not hispanic or latino;male;-17238;2001;1954;282;Pharmaceutical Therapy, NOS;bd559b33-2f9a-59f1-b601-0b01f67fc309;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;3dc1cb30-fd51-59a8-983f-919c4d222cb4;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-50-5930;LUAD
TCGA-69-7979;released;MX;8550/3;2011;C34.1;fac52320-451f-5e0b-95dc-e907f83f8f14;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Acinar cell carcinoma;2019-08-08T17:09:51.361836-05:00;T2a;No;no;N0;26180;stage ib;NA;7th;408;not reported;not reported;0;No;not reported;not reported;NA;NA;28;NA;NA;NA;Not Reported;NA;e16251c1-c742-558b-bb32-cb980ec414e3;153.424.657.534.247;white;Alive;708eacd3-4558-55a9-8fcd-836b599e9d63;71;not hispanic or latino;female;-26180;NA;1940;NA;Pharmaceutical Therapy, NOS;7f85726c-4bfc-5c9e-b581-063596184e73;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;e716d73a-d935-5777-8d76-13641a38ecda;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-69-7979;LUAD
TCGA-62-8394;released;M0;8255/3;2008;C34.3;cb7f9046-46c7-57ad-8a17-634cfcb56f80;Lower lobe, lung;NA;Lower lobe, lung;Stage IIIB;Adenocarcinoma with mixed subtypes;2019-08-08T17:09:29.022095-05:00;T4;No;no;N2;23758;stage iiib;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;6ee0a755-b351-5fce-9a59-a2a120a408f3;NA;white;Dead;5d23259c-a9f2-59d6-9ff1-41437ff520e2;65;not hispanic or latino;female;-23758;2008;1943;139;Pharmaceutical Therapy, NOS;1415a4e0-2535-5fd4-b6d6-f134e3816f8e;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;cffe3805-8977-5045-aff3-2b83439afcc0;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-62-8394;LUAD
TCGA-44-A4SS;released;M0;8140/3;2012;C34.1;a2d576ba-85a3-5eea-9c6d-c712a0e7ce34;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T1b;No;no;N0;26991;stage ia;NA;7th;415;not reported;not reported;0;No;not reported;not reported;NA;NA;90;NA;NA;NA;Not Reported;60;ba0fadd0-fb1b-5099-8619-ff5eb0386e89;493.150.684.931.507;white;Alive;042f7aba-5d22-54cb-bc08-8fdf0405c456;73;not hispanic or latino;male;-26991;NA;1939;NA;Pharmaceutical Therapy, NOS;b7db324a-64e6-5873-8a67-f2c1f527d7b5;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;28d0ee5c-ab35-5a44-9d66-cdc674c0fcfe;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-A4SS;LUAD
TCGA-83-5908;released;M0;8140/3;2009;C34.1;fc4e4284-d2d0-5574-ab4b-3540fc619feb;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:10:09.373179-05:00;T1;No;no;N0;21760;stage ia;NA;6th;824;not reported;not reported;0;No;not reported;not reported;NA;NA;69;NA;NA;NA;Not Reported;45;937cc1ec-83e2-58c7-866f-ee829ef489c8;378.082.191.780.822;white;Alive;46a2dc0b-b1ad-5523-a34c-d980f4ff152f;59;not hispanic or latino;female;-21760;NA;1950;NA;Pharmaceutical Therapy, NOS;70d4527f-611c-5d5d-b73b-7728a7b2bd18;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;99e3c665-409b-58d8-8e95-6733b9969013;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-83-5908;LUAD
TCGA-75-7030;released;M0;8140/3;2007;C34.3;3d095c27-4f5e-5f47-94aa-5d775edc7385;Lower lobe, lung;NA;Lower lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:09:51.361836-05:00;T3;No;no;N0;NA;stage iib;NA;6th;NA;not reported;not reported;NA;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;6b605c65-0015-5d79-8b2d-723768a31330;NA;not reported;Alive;e23ee442-f97f-5880-bd41-b2d49305443a;NA;not reported;male;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;b4d8d697-9618-5332-b9a9-45bddcf83901;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;76c908bf-98d2-5168-b8e5-146c4095971d;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-75-7030;LUAD
TCGA-49-4510;released;M0;8140/3;2001;C34.1;4a94eb8d-939a-567e-9051-15519961fc73;Upper lobe, lung;NA;Upper lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:08:24.604398-05:00;T2;No;no;N1;18762;stage iib;NA;5th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;55.5;NA;NA;NA;Not Reported;NA;18f67404-92c2-5215-92f2-0f81d8f407a3;304.109.589.041.096;black or african american;Dead;0bf011e3-73bf-5590-a100-2fbb453a18b5;51;not hispanic or latino;female;-18762;2003;1950;896;Pharmaceutical Therapy, NOS;788e29e8-e04a-5d99-9f18-e95c5096a016;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;f16b9072-3bdc-5ec4-9cb5-017e8f1d7cac;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-49-4510;LUAD
TCGA-38-7271;released;M0;8140/3;2006;C34.1;e405bb3f-169e-5148-9c9f-46bf2cdf1b81;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:07:40.762038-05:00;T1;Not Reported;yes;N0;26440;stage ia;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;25;NA;NA;NA;Not Reported;28;1366b584-478f-51ec-861d-e995109b97eb;136.986.301.369.863;white;Dead;3081168f-d6ae-54cd-b182-db7c052b4c04;72;not hispanic or latino;female;-26440;2008;1934;800;Pharmaceutical Therapy, NOS;1dcec31f-43c7-5eed-9bd2-dc05318eb36e;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;efb9e09e-36e7-5c3f-8aa2-563d548af2c5;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-38-7271;LUAD
TCGA-44-8120;released;M0;8140/3;2011;C34.1;bd28099c-519b-5069-93d1-31d654f47482;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T2a;No;no;N0;21188;stage ib;NA;7th;260;not reported;not reported;0;No;not reported;not reported;NA;NA;30;NA;NA;NA;Not Reported;NA;39743272-8e4b-5f23-aa0c-da372d79d10a;164.383.561.643.836;black or african american;Alive;7f993051-5040-5315-9d4a-9f8bec908e84;58;not hispanic or latino;male;-21188;NA;1953;NA;Pharmaceutical Therapy, NOS;5af2a27c-7dc3-5466-b6b3-6db4e7de0b65;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;ee994c84-8dd8-5420-a753-2a20eb2d10b3;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-8120;LUAD
TCGA-05-4420;released;M0;8255/3;2008;C34.3;4d16c466-c1d0-52e9-b3ce-a7a867c527f4;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Adenocarcinoma with mixed subtypes;2019-08-08T17:07:40.762038-05:00;T2;No;no;N0;15159;stage ib;NA;6th;912;not reported;not reported;0;No;not reported;not reported;NA;NA;38;NA;NA;NA;Not Reported;NA;255a7439-f0f2-5280-b879-13ebd6846d69;208.219.178.082.192;not reported;Alive;18e816f3-2dd0-53e8-aa68-de7dc0f5bfca;41;not reported;male;-15159;NA;1967;NA;Pharmaceutical Therapy, NOS;05739d1e-0af4-56c6-8203-c4665cba49c0;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;2b1557d5-90fa-5cc5-87ff-7c53225359b7;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-05-4420;LUAD
TCGA-44-2662;released;M0;8140/3;2009;C34.1;5d03f15b-da09-5567-baac-d198f7478421;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T2;Not Reported;yes;N0;24014;stage ib;NA;6th;1280;not reported;not reported;0;No;not reported;not reported;NA;NA;56;NA;NA;NA;Not Reported;28;f1ad3c6a-c192-5b6b-8cf3-4cf300e688bf;306.849.315.068.493;white;Alive;74437697-a86d-50cf-a76e-f7ee7b48113b;65;not hispanic or latino;male;-24014;NA;1944;NA;Pharmaceutical Therapy, NOS;e5fbb2e0-6e9e-5d47-9ff0-3444f6dd0986;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;73219191-118c-5c17-a830-0f30474cecef;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-2662;LUAD
TCGA-97-A4M2;released;M0;8255/3;2012;C34.2;5fa9e24c-3e7a-5caf-959f-9951e9916040;Middle lobe, lung;NA;Middle lobe, lung;Stage IA;Adenocarcinoma with mixed subtypes;2019-08-08T17:10:53.779981-05:00;T1a;No;yes;N0;24313;stage ia;NA;7th;624;not reported;not reported;0;No;not reported;not reported;NA;NA;100;NA;NA;NA;Not Reported;NA;59c5b6eb-3e76-52f7-a1fb-ef5b22671f97;547.945.205.479.452;white;Alive;7c805bb3-1050-5a84-8739-51ca25988358;66;not hispanic or latino;male;-24313;NA;1946;NA;Pharmaceutical Therapy, NOS;f44fd30a-b831-535c-884d-98b82054855b;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;24361b72-8b36-5ad1-b6bc-b1d2d8a82655;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-97-A4M2;LUAD
TCGA-91-6829;released;MX;8252/3;2001;C34.3;2efc8eba-e7c5-5d91-9b2a-90c8e24a40ae;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Bronchiolo-alveolar carcinoma, non-mucinous;2019-08-08T17:10:31.173893-05:00;T2;No;no;N0;28841;stage ib;NA;5th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;94.5;NA;NA;NA;Not Reported;63;2a147ab2-a0ee-5bcf-81f0-fa2a8e32cd9e;517.808.219.178.082;white;Dead;8e582293-9ff2-532d-b1a7-8cb53102d06c;78;not hispanic or latino;male;-28841;2004;1923;1258;Pharmaceutical Therapy, NOS;cbe95bb9-f17c-575f-9175-10be3a4e2b5b;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;9fe41aa6-2b28-5edf-8747-89f6e7477a54;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-91-6829;LUAD
TCGA-35-5375;released;M0;8140/3;2010;C34.1;469b13f1-2748-563e-8031-1a3122608ae0;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:07:40.762038-05:00;T2;No;no;N2;22628;stage iiia;NA;NA;264;not reported;not reported;0;No;not reported;not reported;NA;NA;35;NA;NA;NA;Not Reported;35;e068f000-4404-5ff9-9c01-816885490c86;191.780.821.917.808;white;Alive;c8ad7b77-7783-5b5e-9eac-8ae1582300a8;61;not hispanic or latino;male;-22628;NA;1949;NA;Pharmaceutical Therapy, NOS;fa68f3df-099a-5f26-81b0-d78a1d3f79c8;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;bdf9fa43-b9a6-53be-837c-03e073fb182b;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-35-5375;LUAD
TCGA-75-7031;released;M0;8140/3;2008;C34.1;dcc856d9-2a2c-5541-b9c3-a9c7157e62f0;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:09:51.361836-05:00;T2;No;no;N0;NA;stage ib;NA;6th;NA;not reported;not reported;NA;No;not reported;not reported;NA;NA;5;NA;NA;NA;Not Reported;10;e2807014-34c3-58ec-8e48-cf0b45c3cc84;0.273972602739726;not reported;Alive;3a5a7b6f-bfbf-5919-88e4-99020b8cf69b;NA;not reported;female;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;701db776-3179-5b35-b8af-01f0120bd044;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;11cd5e38-9099-5894-b7c2-b0884d9f2cd6;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-75-7031;LUAD
TCGA-55-A494;released;MX;8140/3;2012;C34.3;45708845-c1af-5a02-ba3b-4c85cbd7be4d;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:09:29.022095-05:00;T2a;No;no;N0;22540;stage ib;NA;7th;481;not reported;not reported;0;No;not reported;not reported;NA;NA;7;NA;NA;NA;Not Reported;13;1ecd4735-8b1a-59fb-a793-21958eabc21e;0.383561643835616;white;Alive;58ba9997-b0e1-5dbd-9bc8-aa025d89c003;61;not hispanic or latino;female;-22540;NA;1951;NA;Pharmaceutical Therapy, NOS;e9b4af82-be83-5f6b-ac48-0a755a721e15;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;ed319e15-4ed3-5fa1-9b20-914ffc66d1a6;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-A494;LUAD
TCGA-62-A46P;released;M0;8255/3;2006;C34.1;ba355f69-be35-55f4-b4ad-aa06f614698f;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma with mixed subtypes;2019-08-08T17:09:29.022095-05:00;T2;No;no;N0;23993;stage ib;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;40;NA;NA;NA;Not Reported;NA;74dfce3a-b4a6-54b6-8ddf-2f407b2a8f8f;219.178.082.191.781;white;Dead;f712a4a0-8c9c-55f8-9628-75a83809e7f8;65;not hispanic or latino;male;-23993;2007;1941;594;Pharmaceutical Therapy, NOS;a2fc2f37-45ed-5d8e-98e8-a11070dba267;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;b29d7932-9154-5937-a775-3de78e3307f8;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-62-A46P;LUAD
TCGA-64-5775;released;M0;8140/3;2005;C34.1;0cb61081-598d-5a15-b89e-5cfd7b0123c9;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:09:29.022095-05:00;T4;No;no;N0;26058;stage iiia;NA;NA;NA;not reported;not reported;0;Yes;not reported;not reported;NA;NA;110;NA;NA;NA;Not Reported;NA;c7ac454e-0d24-5c74-afc3-926003c72451;602.739.726.027.397;white;Dead;5c165dad-73d5-5297-96d9-30fa0bffa53a;71;not hispanic or latino;male;-26058;2005;1934;62;Pharmaceutical Therapy, NOS;ff634fe6-9fe6-58dd-8bf1-78185ae6c7b4;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;7454b085-ff3c-5fae-8ef9-b5a82540054f;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-64-5775;LUAD
TCGA-95-7039;released;MX;8140/3;2011;C34.1;cbaa0507-87ce-5818-a855-104907c94f31;Upper lobe, lung;NA;Upper lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:10:31.173893-05:00;T3;No;no;N0;19981;stage iib;NA;7th;1272;not reported;not reported;0;No;not reported;not reported;NA;NA;34;NA;NA;NA;Not Reported;NA;7e3953be-beb7-5c79-ae27-3788d73cc8a0;186.301.369.863.014;white;Alive;84f2d225-3dfd-5c62-a44e-dd1cf54557c4;54;not hispanic or latino;female;-19981;NA;1957;NA;Pharmaceutical Therapy, NOS;55118c78-0628-5e5f-a05f-6e1bf8216dc5;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;5f152ded-d5ce-5c8e-8ad2-7a62c867f8b9;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-95-7039;LUAD
TCGA-55-A490;released;MX;8140/3;2012;C34.1;353c4378-17ec-5040-8a72-f0ba4fc2251e;Upper lobe, lung;NA;Upper lobe, lung;Stage IIA;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T2b;No;no;N0;28728;stage iia;NA;7th;48;not reported;not reported;0;No;not reported;not reported;NA;NA;34;NA;NA;NA;Not Reported;34;f795fb0f-b4d2-511a-b188-53ffbdaffe31;186.301.369.863.014;white;Dead;b39f73e0-fafd-55d3-bdac-64f66ccfa90d;78;not hispanic or latino;male;-28728;NA;1934;99;Pharmaceutical Therapy, NOS;67a6acdd-26eb-5662-9872-3d03a8952389;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;5e7dd790-4bf3-5285-94a3-28b1369a1fe8;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-A490;LUAD
TCGA-MP-A4TE;released;MX;8140/3;2010;C34.3;324176a1-4ead-58fc-b41f-501e6f12e5c6;Lower lobe, lung;NA;Lower lobe, lung;Stage IIA;Adenocarcinoma, NOS;2019-08-08T17:11:15.269506-05:00;T2b;No;no;N0;20627;stage iia;NA;7th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;40;NA;NA;NA;Not Reported;40;b2867218-38c0-5b14-bbb1-8fabc2b2e118;219.178.082.191.781;white;Dead;13d16998-fbeb-561c-8750-71479e7b4e04;56;not hispanic or latino;male;-20627;2012;1954;896;Pharmaceutical Therapy, NOS;35fb9b66-4d45-5156-9c11-b06f845618d3;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;104fa549-ee18-5bfa-9a91-2e2ad9165383;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-MP-A4TE;LUAD
TCGA-55-A493;released;M0;8140/3;2012;C34.1;d55da43b-bd56-5b14-8def-437e784b39eb;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:09:29.022095-05:00;T2a;No;no;N0;20027;stage ib;NA;7th;28;not reported;not reported;0;No;not reported;not reported;NA;NA;53;NA;NA;NA;Not Reported;NA;e8f58448-d7c5-5e45-b84a-5f0b5a049901;29.041.095.890.411;white;Alive;6888b498-fd7f-564f-8623-85227461663b;54;not hispanic or latino;female;-20027;NA;1958;NA;Pharmaceutical Therapy, NOS;8858866b-230d-5d53-a37c-8e4bf6da35c4;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;b5e1eb0b-d4c6-5ef6-b17e-f33634b73fd3;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-A493;LUAD
TCGA-78-7633;released;M0;8255/3;2009;C34.1;4c3871ca-bf56-5db5-9f9e-0c76146c0e78;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma with mixed subtypes;2019-08-08T17:10:09.373179-05:00;T2;Not Reported;yes;N0;24713;stage ib;NA;6th;994;not reported;not reported;0;No;not reported;not reported;NA;NA;94;NA;NA;NA;Not Reported;47;f8ebfd58-3f62-5dee-9cb7-00b3b394557d;515.068.493.150.685;white;Dead;39da446c-66c3-52fe-b75a-496fcb33c028;67;not reported;male;-24713;NA;1942;1528;Pharmaceutical Therapy, NOS;aba1ba17-441d-5d4b-a4dd-d3ca240e52d1;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;0c7c8b8d-12c8-5541-a219-0b8c7f5455a0;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-78-7633;LUAD
TCGA-38-A44F;released;M0;8550/3;2012;C34.1;da0e718e-d622-5e8a-874f-b7f3d74832cd;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Acinar cell carcinoma;2019-08-08T17:07:40.762038-05:00;T2a;No;no;N0;29534;stage ib;NA;7th;133;not reported;not reported;0;No;not reported;not reported;NA;NA;12;NA;NA;NA;Not Reported;12;6e5a723e-37c2-5f59-a502-8335b30af5e6;0.657534246575342;white;Alive;0d71918d-d17d-5726-a5ce-c9e65d7ae4dc;80;not hispanic or latino;male;-29534;NA;1932;NA;Pharmaceutical Therapy, NOS;572db11b-8a60-5940-bb7c-fa6d349ab4e9;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;8061d45a-3a27-5e60-8069-6a5dca2af5b9;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-38-A44F;LUAD
TCGA-38-4630;released;M0;8260/3;2000;C34.1;8b58b4ed-0c9d-5b60-8407-85dec7202749;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Papillary adenocarcinoma, NOS;2019-08-08T17:07:40.762038-05:00;T2;Not Reported;yes;N0;27667;stage ib;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;ddaa8660-4a8b-567e-b6f2-19d85f8541bf;NA;white;Dead;73045831-df4b-5fb6-bf2f-a35e07715e5a;75;not hispanic or latino;female;-27667;2002;1925;1073;Pharmaceutical Therapy, NOS;e8907b83-3af1-54d7-9d89-3d1e4cfb88c5;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;61c3420c-ab0a-5bbf-8fa3-9e309ed581f8;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-38-4630;LUAD
TCGA-05-4397;released;M0;8255/3;2006;C34.2;e06998d3-3212-584e-9154-2727fb52e7c8;Middle lobe, lung;NA;Middle lobe, lung;Stage IIB;Adenocarcinoma with mixed subtypes;2019-08-08T17:07:40.762038-05:00;T2;No;no;N1;23833;stage iib;NA;5th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;45;NA;NA;NA;Not Reported;NA;02ec9aca-3313-5570-a0f2-f58a58220aa3;246.575.342.465.753;not reported;Dead;25f09b29-7d2b-58fe-8c05-c931ded41f9f;65;not reported;male;-23833;2008;1941;731;Pharmaceutical Therapy, NOS;893ac734-3568-55b8-8953-7ea129d58059;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;bc6b4afd-ee53-5d80-b27e-1f604d6125db;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-05-4397;LUAD
TCGA-44-2661;released;M0;8140/3;2009;C34.1;62584f05-9d54-5926-8d4e-2e3787dd6508;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T1;Not Reported;yes;N0;25313;stage ia;NA;6th;1159;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;ccbe3e80-fbcc-51a2-a70f-ec92252879cc;NA;white;Alive;58e2c036-94cc-5ebf-a3e3-1e0e28182c8d;69;not hispanic or latino;female;-25313;NA;1940;NA;Pharmaceutical Therapy, NOS;8da488ca-21eb-5d81-b924-d0cf9e2aa015;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;8a366bb6-3f9b-546c-989a-7049e7c5317e;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-2661;LUAD
TCGA-73-4675;released;M0;8140/3;2010;C34.3;696a6f6f-c605-565f-86d0-b0a11a25a0c1;Lower lobe, lung;NA;Lower lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:09:51.361836-05:00;T3;No;no;N1;21614;stage iiia;NA;7th;40;not reported;not reported;0;No;not reported;not reported;NA;NA;41;NA;NA;NA;Not Reported;41;ef932c90-8c5f-5203-b6d0-16cb4a7e06b9;224.657.534.246.575;white;Dead;bc0b37a1-8f87-5961-91ab-7f5c3b0b975b;59;not hispanic or latino;male;-21614;NA;1951;922;Pharmaceutical Therapy, NOS;295a63a4-1d13-5c08-a72b-b6a5cb1761f7;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;3ceeba6b-f1d1-57e8-b081-0d940c6a8fb2;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-73-4675;LUAD
TCGA-97-A4LX;released;M0;8255/3;2012;C34.1;6d7700ef-d3a8-59ac-9a58-cd96f8929486;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma with mixed subtypes;2019-08-08T17:10:53.779981-05:00;T2a;Yes;no;N0;29915;stage ib;NA;7th;614;not reported;not reported;0;No;not reported;not reported;NA;NA;120;NA;NA;NA;Not Reported;40;c84f3a13-34dc-5678-910c-5d0829221707;657.534.246.575.342;white;Alive;58a999f3-f9e3-5b96-8030-059ab1b7c9a1;81;not hispanic or latino;male;-29915;NA;1931;NA;Pharmaceutical Therapy, NOS;87579852-0a41-5761-98fc-2d826ca97ec6;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;4c10aa67-887b-5e14-a976-7d7025ad7ded;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-97-A4LX;LUAD
TCGA-J2-8194;released;MX;8255/3;2011;C34.3;edbf63ba-10a3-5800-8ad8-f4e06e596370;Lower lobe, lung;NA;Lower lobe, lung;Stage IIB;Adenocarcinoma with mixed subtypes;2019-08-08T17:10:53.779981-05:00;T3;No;yes;N0;25441;stage iib;NA;7th;724;not reported;not reported;0;No;not reported;not reported;NA;NA;20;NA;NA;NA;Not Reported;26;d993fc6a-b5c8-5f18-b0ea-af4de74d16aa;10.958.904.109.589;white;Alive;485118d7-fbdd-5b4d-aeda-bcb84afeea51;69;not hispanic or latino;female;-25441;NA;1942;NA;Pharmaceutical Therapy, NOS;6170e3cf-cd18-597a-91c5-48524e1e4ac6;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;951c6d62-527e-5490-954d-b27677ed79d6;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-J2-8194;LUAD
TCGA-05-4249;released;M0;8140/3;2007;C34.3;c53e1e0c-f270-5739-badb-81ae50b90d15;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:07:40.762038-05:00;T2;No;no;N0;24532;stage ib;NA;6th;1523;not reported;not reported;0;No;not reported;not reported;NA;NA;52;NA;NA;NA;Not Reported;NA;bdccc445-fd6d-5623-9693-ac3cf30d1da5;284.931.506.849.315;not reported;Alive;e7595506-7ece-5135-8271-17f3b1b340bd;67;not reported;male;-24532;NA;1940;NA;Pharmaceutical Therapy, NOS;a6465353-ab6f-52c4-a9e7-4bc32be9470e;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;7e0ec2e5-724b-5661-9b44-92b73528531a;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-05-4249;LUAD
TCGA-55-8620;released;M1b;8140/3;2012;C34.1;33c66148-14bf-5acd-b2cf-9981dc81e702;Upper lobe, lung;NA;Upper lobe, lung;Stage IV;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T1a;No;no;N1;22091;stage iv;NA;7th;66;not reported;not reported;0;No;not reported;not reported;NA;NA;154;NA;NA;NA;Not Reported;47;b59f922c-716e-50ed-aef7-d1b5da7c084c;843.835.616.438.356;white;Dead;ff2ea5b3-8ea4-53ba-9d7f-0542e9dc3f72;60;not hispanic or latino;male;-22091;NA;1952;375;Pharmaceutical Therapy, NOS;f27137fa-53d2-5732-9c4a-4fddd92eb4c2;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;5a6f1473-9c70-593f-b6ee-32215807d1f8;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-8620;LUAD
TCGA-64-5781;released;M0;8255/3;2007;C34.1;48c591c9-e727-5bee-83d2-a3091864178d;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma with mixed subtypes;2019-08-08T17:09:29.022095-05:00;T2;No;no;N0;20219;stage ib;NA;6th;1559;not reported;not reported;0;No;not reported;not reported;NA;NA;25;NA;NA;NA;Not Reported;25;0da8e460-f2e3-5c88-b554-a14de0698ba4;136.986.301.369.863;white;Alive;4afc640f-9d5c-5dea-8e29-b1acbe37f5fc;55;not hispanic or latino;female;-20219;NA;1952;NA;Pharmaceutical Therapy, NOS;ddab9894-de4a-54bd-8ef0-73a2c13b2905;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;ea000239-5230-59d1-9ba0-2603367efe8d;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-64-5781;LUAD
TCGA-55-8621;released;MX;8140/3;2012;C34.3;d4f85871-d994-55fa-a294-4819ae155f28;Lower lobe, lung;NA;Lower lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T1a;No;yes;N0;27485;stage ia;NA;7th;515;not reported;not reported;0;No;not reported;not reported;NA;NA;30;NA;NA;NA;Not Reported;30;a684c476-15b0-571b-abf6-4ef19f8aaaf2;164.383.561.643.836;white;Alive;41bcd369-366b-52ec-950b-0a60e5277c2e;75;not hispanic or latino;female;-27485;NA;1937;NA;Pharmaceutical Therapy, NOS;9eee5299-1c3f-569b-b939-12fb36a1c798;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;f81fc704-8f7e-5df9-b7e1-3c1c4a7ebcc4;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-8621;LUAD
TCGA-4B-A93V;released;M0;8140/3;2013;C34.3;9f9b0d4c-2ebf-5993-a54c-8d6fb404c956;Lower lobe, lung;NA;Lower lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:08:24.604398-05:00;T1b;No;no;N0;19035;stage ia;NA;7th;254;not reported;not reported;0;No;not reported;not reported;NA;NA;30;NA;NA;NA;Not Reported;29;218500ae-c851-5e56-8b6c-171b6a8f9c3c;164.383.561.643.836;black or african american;Dead;86fc362c-4b84-596e-9eda-e66af29d7c7d;52;not hispanic or latino;female;-19035;NA;1961;300;Pharmaceutical Therapy, NOS;1744400a-b82f-560f-9c46-d0a9192bb849;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;40d17e46-0608-5744-a6a8-bef73adefb23;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-4B-A93V;LUAD
TCGA-64-1677;released;M0;8140/3;2005;C34.1;988eae39-1a05-52fd-b4ef-10bc1185956a;Lower lobe, lung;NA;Lower lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:09:29.022095-05:00;T2;Not Reported;yes;N2;28482;stage iiia;NA;NA;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;50;NA;NA;NA;Not Reported;NA;5c6b6b0e-a6e2-5120-8afa-ad044d638405;273.972.602.739.726;white;Dead;1f7b27b5-d506-5b71-ad36-59f18c9c9afb;77;not hispanic or latino;female;-28482;2006;1928;628;Pharmaceutical Therapy, NOS;7d05d3f6-ff40-5683-bd50-892c7f250e7c;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;859bcc01-5803-5c99-957c-d851b1717b96;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-64-1677;LUAD
TCGA-44-7661;released;M0;8140/3;2011;C34.3;e101de53-dfa9-5905-bd7a-54fe4e51ec2e;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T2a;Not Reported;yes;N0;25483;stage ib;NA;7th;366;not reported;not reported;0;No;not reported;not reported;NA;NA;22;NA;NA;NA;Not Reported;15;95e86d69-820a-527e-a924-5657e4fdde82;120.547.945.205.479;white;Dead;bc703056-2351-508c-9da6-42d3e4ce1cdf;69;not hispanic or latino;female;-25483;NA;1942;557;Pharmaceutical Therapy, NOS;0861cdaf-40cc-591b-abc0-79c792085dae;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;5e66d924-1b32-5a10-86e9-b59f866131ba;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-7661;LUAD
TCGA-NJ-A55R;released;MX;8230/3;2011;C34.1;7bb70138-52ef-5255-9b2f-45f920605127;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Solid carcinoma, NOS;2019-08-08T17:11:15.269506-05:00;T1b;No;no;N0;24738;stage ia;NA;7th;603;not reported;not reported;0;No;not reported;not reported;NA;NA;5;NA;NA;NA;Not Reported;NA;ddd265f2-c14f-5744-8212-6a42f63187c8;0.273972602739726;white;Alive;c52c986f-e6fc-55f7-b030-9d171f0c0841;67;not hispanic or latino;male;-24738;NA;1944;NA;Pharmaceutical Therapy, NOS;0a9cd21d-461a-5661-912e-875b0c86bc9e;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;5e6c9810-6fc5-58d8-b32c-c780f124ab07;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-NJ-A55R;LUAD
TCGA-44-7669;released;MX;8140/3;2010;C34.1;896e1bf2-350d-5a47-95ba-38f010ea99b3;Upper lobe, lung;NA;Upper lobe, lung;Stage IIA;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T1b;No;no;N1;21893;stage iia;NA;7th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;20;NA;NA;NA;Not Reported;NA;0d45575e-1726-5583-aeab-653671a5f2b9;10.958.904.109.589;black or african american;Dead;1d8e1ef9-4672-5c0f-a666-10d2e0767d4d;59;not hispanic or latino;male;-21893;2011;1951;574;Pharmaceutical Therapy, NOS;67babe3a-6f1e-56fe-a715-82608e8ca6f7;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;33f6988d-70d1-5265-986b-3bcac1a62283;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-7669;LUAD
TCGA-44-2659;released;M0;8140/3;2009;C34.3;056b4bf9-1989-5543-a0b8-3eeaaa772c63;Lower lobe, lung;NA;Lower lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T1;No;no;N1;23808;stage iib;NA;6th;1367;not reported;not reported;0;No;not reported;not reported;NA;NA;57;NA;NA;NA;Not Reported;38;da6f68a0-9a33-5e0b-a33c-f594767e7a04;312.328.767.123.288;white;Alive;3f2db12e-7bf1-5cd1-8110-0cb855a69766;65;not hispanic or latino;female;-23808;NA;1944;NA;Pharmaceutical Therapy, NOS;6a6f2ae5-1b0c-54ca-8728-bfe81bc49a5e;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;a198be22-f499-5d45-ad97-bc8a365bc150;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-2659;LUAD
TCGA-05-4427;released;M0;8255/3;2008;C34.1;26f6e290-47ca-59b2-a7cf-d61e52f4a6e3;Upper lobe, lung;NA;Upper lobe, lung;Stage IIB;Adenocarcinoma with mixed subtypes;2019-08-08T17:07:40.762038-05:00;T2;Not Reported;yes;N1;23893;stage iib;NA;6th;791;not reported;not reported;0;No;not reported;not reported;NA;NA;8;NA;NA;NA;Not Reported;15;11b0c6cc-5cb9-51a6-8465-d0214be4681e;0.438356164383562;not reported;Alive;f3f5cae2-f37f-5348-9e5e-ce1a595dcc7e;65;not reported;female;-23893;NA;1943;NA;Pharmaceutical Therapy, NOS;02b0780b-2b07-57ef-ac0d-3060b4681244;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;f77afdc9-d3d0-532a-b8e7-a60079ddbec2;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-05-4427;LUAD
TCGA-55-7284;released;MX;8252/3;2011;C34.8;2c7b5588-2db0-532a-a441-3951f93b40e6;Overlapping lesion of lung;NA;Overlapping lesion of lung;Stage IIB;Bronchiolo-alveolar carcinoma, non-mucinous;2019-08-08T17:08:47.535141-05:00;T3;Yes;no;N0;27087;stage iib;NA;7th;121;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;3f74328f-b251-5d3d-880c-eea80b388a42;NA;white;Dead;e66795ef-93ed-527f-a215-30a941446f50;74;not hispanic or latino;male;-27087;NA;1937;243;Pharmaceutical Therapy, NOS;60a62e37-8391-5c16-96c5-f9ad554b8147;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;94540d7f-b16e-5ba2-ba24-1794212b620f;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-7284;LUAD
TCGA-55-6972;released;M0;8260/3;2005;C34.1;01a23057-05f3-53fd-8858-f52c5258411e;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Papillary adenocarcinoma, NOS;2019-08-08T17:08:47.535141-05:00;T2;No;no;N0;26625;stage ib;NA;6th;1475;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;8adda62f-0b17-562b-8948-221a9389b7fe;NA;white;Dead;149e50ed-49b8-5519-83f6-fe4997b18f2a;72;not hispanic or latino;male;-26625;NA;1933;1632;Pharmaceutical Therapy, NOS;5efd806e-d95e-5afe-be90-b410e219e469;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;fb14af2b-bbe8-5bf7-a294-be0e44dc9b81;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-6972;LUAD
TCGA-99-8025;released;M0;8140/3;2010;C34.1;91e14e03-b16e-5462-ba79-e92bc27ae9c6;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:10:53.779981-05:00;T3;No;no;N2;26634;stage iiia;NA;7th;1060;not reported;not reported;0;No;not reported;not reported;NA;NA;20;NA;NA;NA;Not Reported;40;91be8ced-b31d-5124-b200-fd9e63ebcb16;10.958.904.109.589;black or african american;Alive;91e8b562-83a3-5bae-b082-ffae59f3525b;72;not hispanic or latino;female;-26634;NA;1938;NA;Pharmaceutical Therapy, NOS;a04fc3d4-dcc2-5c2b-8672-6e004fedf1bf;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;0956c709-c7be-589e-bbf3-5bd413fa72b3;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-99-8025;LUAD
TCGA-78-8660;released;M0;8140/3;2005;C34.3;b8da40af-b10c-56d7-8dd5-941a106bd179;Lower lobe, lung;NA;Lower lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:10:09.373179-05:00;T2;No;yes;N1;25422;stage iib;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;11;NA;NA;NA;Not Reported;51;c4cfc70d-f39a-5028-a099-2fe7944065b1;0.602739726027397;not reported;Dead;469d2eb8-0c1a-5c86-87dd-f7c00d30ddfb;69;not reported;male;-25422;2005;1936;321;Pharmaceutical Therapy, NOS;cbd22eac-8a17-5281-b56b-fb902f3d56c4;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;d4db6971-5524-5696-b6ec-465ddfb2d708;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-78-8660;LUAD
TCGA-75-5125;released;M0;8140/3;NA;C34.1;e59a8484-7219-5bde-922e-45c227837d46;Upper lobe, lung;NA;Upper lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:09:51.361836-05:00;T2;No;no;N1;NA;stage iib;NA;6th;NA;not reported;not reported;NA;No;not reported;not reported;NA;NA;25;NA;NA;NA;Not Reported;NA;ed5824ad-a0d0-53a1-81b8-8da97ee98c25;136.986.301.369.863;not reported;Dead;432e85d9-462a-559b-9c57-5db0138ce3c8;NA;not reported;male;NA;NA;NA;2027;Pharmaceutical Therapy, NOS;10bb7271-ba85-5ccb-a20e-23c54bca4c7b;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;7c676dd5-1bb4-5ec3-9bee-742651926d60;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-75-5125;LUAD
TCGA-91-7771;released;MX;8140/3;2011;C34.1;17726be7-a6ce-59f1-8775-4f2e15af3e01;Upper lobe, lung;NA;Upper lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:10:31.173893-05:00;T3;Not Reported;yes;N0;22926;stage iib;NA;7th;492;not reported;not reported;0;No;not reported;not reported;NA;NA;75;NA;NA;NA;Not Reported;NA;c51890c3-aff4-530b-90d7-165ad0c35959;410.958.904.109.589;white;Alive;b333acb0-0721-5323-86db-c311aabde567;62;not hispanic or latino;male;-22926;NA;1949;NA;Pharmaceutical Therapy, NOS;1ecfc8d5-4adc-5c95-b667-58995a220628;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;ed8a62fd-c9e3-53b6-b6eb-a22e3e586fbc;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-91-7771;LUAD
TCGA-86-7954;released;M0;8250/3;2011;C34.3;e535e3e2-9698-5f2e-9497-32c556c09f49;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Bronchiolo-alveolar adenocarcinoma, NOS;2019-08-08T17:10:09.373179-05:00;T2;No;no;N0;25062;stage ib;NA;7th;605;not reported;not reported;0;No;not reported;not reported;NA;NA;8;NA;NA;NA;Not Reported;8;7a86b1bd-294b-5329-9ab2-7ad84a17abb3;0.438356164383562;white;Alive;4a936274-cbc3-5d09-bf42-db14c6eb59a3;68;not hispanic or latino;female;-25062;NA;1943;NA;Pharmaceutical Therapy, NOS;7a200b39-487d-5c6e-b70e-e9b8162c8780;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;bb7ab458-3a7e-5c08-a221-00c8c577b11f;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-86-7954;LUAD
TCGA-55-A4DF;released;MX;8140/3;2012;C34.3;b45126e3-d938-5845-ac4f-2ebcabbfe03e;Lower lobe, lung;NA;Lower lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:09:29.022095-05:00;T1b;Yes;no;N0;32432;stage ia;NA;7th;47;not reported;not reported;0;No;not reported;not reported;NA;NA;60;NA;NA;NA;Not Reported;NA;25b4abae-bc88-557d-829d-122ecc7e298a;328.767.123.287.671;white;Dead;307dffc4-ab2f-52b2-b1bb-c2ebfab9caef;88;not hispanic or latino;male;-32432;NA;1924;440;Pharmaceutical Therapy, NOS;83ae4a83-3ef4-5a96-bd17-436e3e9918ce;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;845e717a-fb21-5830-b644-c3822bd33ba4;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-A4DF;LUAD
TCGA-78-7220;released;M0;8255/3;2000;C34.1;d70c4164-ccf1-5e1a-880d-2a5e7c762fe9;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIA;Adenocarcinoma with mixed subtypes;2019-08-08T17:10:09.373179-05:00;T2;No;no;N2;19480;stage iiia;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;35;NA;NA;NA;Not Reported;NA;11a0c215-9075-55a2-8912-e7a9c6076257;191.780.821.917.808;white;Dead;a53548be-4a55-5c59-82b9-2c8d93818dc1;53;not reported;female;-19480;2002;1947;807;Pharmaceutical Therapy, NOS;9d02dc75-17e3-5f58-8985-25fe54955052;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;ba031555-b354-5a71-b39b-654fd56706de;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-78-7220;LUAD
TCGA-69-7980;released;M0;8140/3;2011;C34.1;c9a8df02-44b3-5c04-aded-98c21cb17fc0;Upper lobe, lung;NA;Upper lobe, lung;Stage I;Adenocarcinoma, NOS;2019-08-08T17:09:51.361836-05:00;T1b;No;no;N0;25583;stage i;NA;7th;411;not reported;not reported;0;No;not reported;not reported;NA;NA;80;NA;NA;NA;Not Reported;NA;54ee3708-dd5f-514c-830a-878450c7ad63;438.356.164.383.562;white;Alive;b3e82034-4df5-5532-b3d8-4ad8ee48027b;70;not hispanic or latino;female;-25583;NA;1941;NA;Pharmaceutical Therapy, NOS;97db7208-a09a-5cc8-ab5f-23b9c76f169b;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;e7d2c346-9750-5325-a880-a5b200277a3a;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-69-7980;LUAD
TCGA-MP-A4T6;released;MX;8140/3;2005;C34.3;024827f3-e59c-5c4e-802e-b4e712d9a2e8;Lower lobe, lung;NA;Lower lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:10:53.779981-05:00;T1;No;no;N2;27993;stage iiia;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;50;NA;NA;NA;Not Reported;NA;dc021c97-680f-5af8-9d7d-df573f20ba1d;273.972.602.739.726;white;Dead;db9bfbbd-39c4-5c3a-ae9f-c3175206227b;76;not hispanic or latino;female;-27993;2009;1929;1790;Pharmaceutical Therapy, NOS;4e6c5097-c1f5-5f87-89c9-d6c42f715e2b;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;97f462a2-74d6-5b71-bf28-fb4ed1a2eb0f;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-MP-A4T6;LUAD
TCGA-44-6775;released;MX;8140/3;2011;C34.1;9091c61b-4cbb-5536-b743-d932aa15f9df;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T2a;No;no;N0;26415;stage ib;NA;7th;705;not reported;not reported;0;No;not reported;not reported;NA;NA;25;NA;NA;NA;Not Reported;50;15a115b7-f984-5c3f-90a5-c27c23aedc97;136.986.301.369.863;white;Alive;deeef152-7fe9-569b-bf26-70aac2d5aa75;72;hispanic or latino;female;-26415;NA;1939;NA;Pharmaceutical Therapy, NOS;285f5ad4-be06-5721-87a4-9c327adebe36;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;67945b56-67b4-561a-955e-17bec8ba70a7;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-6775;LUAD
TCGA-49-6761;released;MX;8140/3;2009;C34.1;f346fa45-ef61-5ff7-9e8a-242fa8cbd5a2;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:08:24.604398-05:00;T1;Not Reported;yes;N2;24849;stage iiia;NA;6th;354;not reported;not reported;0;No;not reported;not reported;NA;NA;50;NA;NA;NA;Not Reported;NA;18254897-58fa-5c33-8953-38a1a878c5e5;273.972.602.739.726;white;Alive;30882d0d-1d34-5ef3-bfe6-49cf6d22f345;68;not hispanic or latino;female;-24849;NA;1941;NA;Pharmaceutical Therapy, NOS;4afcd1c2-f69e-5640-8947-9bbfb5859c31;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;4217bcf4-5b9e-5d64-8f43-5438eb065dcb;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-49-6761;LUAD
TCGA-62-A46U;released;M0;8255/3;2007;C34.3;1951f39f-56b0-5f0d-b33b-474d12023894;Lower lobe, lung;NA;Lower lobe, lung;Stage IIB;Adenocarcinoma with mixed subtypes;2019-08-08T17:09:29.022095-05:00;T2;No;no;N1;25998;stage iib;NA;6th;2067;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;caea6b79-b287-5985-8c10-da5ffb7fc368;NA;white;Alive;5faa44d0-66b8-54ba-8f17-d7c130257df4;71;not hispanic or latino;female;-25998;NA;1936;NA;Pharmaceutical Therapy, NOS;679d438d-2119-5d1f-bcae-8434ed29ad90;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;c230d895-9aa7-5a9a-82fc-e8663614325a;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-62-A46U;LUAD
TCGA-49-AARO;released;MX;8260/3;2003;C34.1;05b6bdaa-2900-5044-841f-7d861b9ec907;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Papillary adenocarcinoma, NOS;2019-08-08T17:08:24.604398-05:00;T1a;No;no;N0;14527;stage ia;NA;6th;3759;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;ad785c00-5f9f-5dc8-8aae-0de8b723117b;NA;black or african american;Alive;b3d47408-1a9f-5b79-9ea8-b9994f655f53;39;not hispanic or latino;female;-14527;NA;1964;NA;Pharmaceutical Therapy, NOS;c8ff1148-0c98-5dcb-9e16-120f62785149;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;b17b2937-df90-5827-a5ec-35ef8dca7075;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-49-AARO;LUAD
TCGA-86-8674;released;M0;8260/3;2012;C34.2;4c0e582e-885b-55e5-821c-d814fab28660;Middle lobe, lung;NA;Middle lobe, lung;Stage IIA;Papillary adenocarcinoma, NOS;2019-08-08T17:10:31.173893-05:00;T2a;No;no;N1;18479;stage iia;NA;7th;806;not reported;not reported;0;No;not reported;not reported;NA;NA;37.5;NA;NA;NA;Not Reported;30;e75466c0-2572-5bcc-b67e-9e1a46cb7776;205.479.452.054.795;white;Alive;ad6667b4-3628-544e-88b1-e293e30ab0a7;50;not hispanic or latino;male;-18479;NA;1962;NA;Pharmaceutical Therapy, NOS;3b4e5aff-16c4-5956-860f-40d3d4d2fd42;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;88080c80-d79b-52c4-8bac-2239b62a206a;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-86-8674;LUAD
TCGA-55-8097;released;MX;8140/3;2012;C34.1;ffd8d6e3-cd0d-5597-846d-1e6b92c0afbd;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T1a;No;no;N0;22260;stage ia;NA;7th;476;not reported;not reported;0;No;not reported;not reported;NA;NA;35;NA;NA;NA;Not Reported;35;62baf223-53b9-5dfd-99d0-43ab002425d6;191.780.821.917.808;white;Alive;edf3676b-2fb1-53c9-8e42-cbe827f3d408;60;not hispanic or latino;female;-22260;NA;1952;NA;Pharmaceutical Therapy, NOS;25cbbff1-8b53-5671-a413-e6e9f09f8092;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;2cfdd9a7-6172-5085-9250-1bb915fb3587;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-8097;LUAD
TCGA-44-7671;released;M0;8255/3;2010;C34.2;4379f787-a241-5f23-86a9-6c960b6b78be;Middle lobe, lung;NA;Middle lobe, lung;Stage IB;Adenocarcinoma with mixed subtypes;2019-08-08T17:08:02.187456-05:00;T2a;Not Reported;yes;N0;23538;stage ib;NA;7th;889;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;71c1def0-ff44-5a8f-8e60-598d98e43dc4;NA;black or african american;Alive;1bb33216-7547-53ce-95a8-c7e16704eb29;64;not hispanic or latino;male;-23538;NA;1946;NA;Pharmaceutical Therapy, NOS;4ad0554a-8980-516b-be55-1711c08e159f;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;0d88ab6c-813a-5b16-9e30-15414a382292;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-7671;LUAD
TCGA-44-A4SU;released;MX;8140/3;2012;C34.3;1d2191be-0843-5557-9129-0998079df0bf;Lower lobe, lung;NA;Lower lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T1a;No;no;N0;24820;stage ia;NA;7th;76;not reported;not reported;0;No;not reported;not reported;NA;NA;50;NA;NA;NA;Not Reported;50;bd57d44b-7ac0-5ef5-8c2f-ea15c70ab672;273.972.602.739.726;white;Dead;f852f5de-7d56-58e9-a9b4-80bcbdca119f;67;not hispanic or latino;female;-24820;NA;1945;409;Pharmaceutical Therapy, NOS;4a1aaa50-31ed-5147-9c38-d6fd5bcffc44;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;65e40332-32a1-5f9c-8695-6a8360b98830;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-A4SU;LUAD
TCGA-49-6767;released;MX;8140/3;2010;C34.2;7266a073-3136-5348-85d6-04625138a28a;Middle lobe, lung;NA;Middle lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:08:24.604398-05:00;T3;No;no;N0;17108;stage iib;NA;7th;677;not reported;not reported;0;No;not reported;not reported;NA;NA;30;NA;NA;NA;Not Reported;NA;41270366-24bb-5315-a254-22cd7c74fa2c;164.383.561.643.836;white;Alive;fcadd633-ccce-577d-a1a3-be171e9128df;46;not reported;female;-17108;NA;1964;NA;Pharmaceutical Therapy, NOS;01c49746-1a5c-50c0-809d-8b6226eebcfd;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;96260148-39c7-5bee-8a62-0603d8d8839c;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-49-6767;LUAD
TCGA-91-6847;released;MX;8140/3;2002;C34.3;daa938a2-150b-582d-8c41-d03c0ca539d5;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:10:31.173893-05:00;T2;No;no;N0;22862;stage ib;NA;5th;842;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;a2059567-c9d0-527b-950f-67d5b1b5ef0d;NA;white;Alive;ccb0e01c-e419-5236-8f9a-dbdf47551869;62;not hispanic or latino;female;-22862;NA;1940;NA;Pharmaceutical Therapy, NOS;6eee68cd-c2c2-5ee6-b773-60297c8f7010;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;68e7225b-9e48-5c9d-ac66-abc7effd2e42;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-91-6847;LUAD
TCGA-78-8662;released;M0;8140/3;2000;C34.1;232bb62b-8eee-5677-8272-b8f2bf929f8d;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:10:09.373179-05:00;T2;No;no;N0;19563;stage ib;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;45;NA;NA;NA;Not Reported;NA;ea1614d0-5476-5007-a3a6-e09888bca9e2;246.575.342.465.753;not reported;Dead;a3cfa3f4-22d3-56b3-875a-003820834fad;53;not reported;female;-19563;2009;1947;3361;Pharmaceutical Therapy, NOS;20f1fcb6-4528-5a3f-9e3b-2b920c5873b8;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;5c202de0-c13f-5012-a9a6-7339fa94500f;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-78-8662;LUAD
TCGA-05-4415;released;M0;8255/3;2008;C34.3;b4072c25-08c6-5917-9698-ba8de9fda8b8;Lower lobe, lung;NA;Lower lobe, lung;Stage IIIB;Adenocarcinoma with mixed subtypes;2019-08-08T17:07:40.762038-05:00;T4;No;no;N2;20880;stage iiib;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;29;NA;NA;NA;Not Reported;10;006657eb-c3ec-50dc-a517-45e00d4ab917;158.904.109.589.041;not reported;Dead;1dd704b0-9fd5-50f2-a3be-f9655f0e9e32;57;not reported;male;-20880;2008;1951;91;Pharmaceutical Therapy, NOS;f0f27d55-d685-5260-892b-d587f17beb03;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;29e50887-0b98-5886-a68c-11c7648527b7;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-05-4415;LUAD
TCGA-91-8497;released;MX;8140/3;2012;C34.1;e8e2df0d-b8d7-5d30-b10f-75b0adc57671;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:10:31.173893-05:00;T1a;No;no;N0;27632;stage ia;NA;7th;174;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;b149cfd0-2569-5e8c-a750-e1461a1dfafe;NA;white;Dead;20c62420-c29e-52b7-a3a4-dec52516c28d;75;not hispanic or latino;female;-27632;NA;1937;434;Pharmaceutical Therapy, NOS;72604c9f-2d6c-5a3c-9ed4-e0405c63a096;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;03ec0d99-6013-5c54-a319-21c9786ce8be;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-91-8497;LUAD
TCGA-J2-8192;released;MX;8140/3;2011;C34.1;0b243d04-60c0-5961-8df7-2485f29fbb3b;Upper lobe, lung;NA;Upper lobe, lung;Stage IIA;Adenocarcinoma, NOS;2019-08-08T17:10:53.779981-05:00;T2a;No;yes;N1;23892;stage iia;NA;7th;739;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;e8e9a9e5-85cc-5513-b8b7-6ddf2efbc507;NA;white;Alive;9e1d6085-d578-5c88-9fbb-6fc8ca114a72;65;not hispanic or latino;female;-23892;NA;1946;NA;Pharmaceutical Therapy, NOS;1e68ee35-42b1-5d5e-abf4-1a62e1a9a8c4;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;a13c1418-9393-5735-89ae-c4f92cbda679;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-J2-8192;LUAD
TCGA-55-8087;released;MX;8140/3;2011;C34.1;c14ad3bb-b7d3-5007-b4ca-4f54f7de4981;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T2a;No;no;N0;21655;stage ib;NA;7th;462;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;8b09f9ba-8bea-538c-8f9f-3f12873ecd7f;NA;white;Alive;f1a5d7f9-cf9e-5bca-9dcf-b49d87aa4199;59;not hispanic or latino;female;-21655;NA;1952;NA;Pharmaceutical Therapy, NOS;e014b18d-7e50-512d-b76b-36638a559ca7;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;9f173b35-d252-5e47-b505-47141b944ced;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-8087;LUAD
TCGA-35-3615;released;M0;8140/3;2007;C34.1;30de0928-a4d8-51e5-93af-fc4261fb3f97;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:07:40.762038-05:00;T2;No;no;N0;21076;stage ib;NA;NA;14;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;6ba93f75-7c38-5238-875e-b2683403d7b6;NA;white;Alive;ed17db80-fac6-5df6-9563-74e1cb27cf92;57;not hispanic or latino;male;-21076;NA;1950;NA;Pharmaceutical Therapy, NOS;ab1988b2-6872-5af7-9822-bb0cd811a3d4;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;143142a6-737d-5a71-a455-fbc55c7f729e;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-35-3615;LUAD
TCGA-55-7815;released;MX;8140/3;2011;C34.3;22ff963c-dcab-5136-ba27-f9a1583a10ed;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T2a;No;no;N0;28119;stage ib;NA;7th;773;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;5990dbec-da67-53c9-800f-eb7cd0293f02;NA;not reported;Alive;259a5c2e-4d0c-545b-8ca9-14eab931050c;76;not reported;male;-28119;NA;1935;NA;Pharmaceutical Therapy, NOS;9e97c2ea-39dd-5706-a0d4-342abca71443;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;119a6066-241b-52d7-b479-cefe78b8c996;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-7815;LUAD
TCGA-44-2657;released;M0;8140/3;2009;C34.1;7982fa01-64e5-508d-9bc7-fa962a4d4b47;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T2;No;no;NX;27298;stage ib;NA;6th;1351;not reported;not reported;0;No;not reported;not reported;NA;NA;25;NA;NA;NA;Not Reported;47;51a5b058-8e1f-5b50-a568-798c72fe813b;136.986.301.369.863;white;Alive;f9ecfdd0-5d6f-5f0a-a990-b7d5167143b5;74;not hispanic or latino;female;-27298;NA;1935;NA;Pharmaceutical Therapy, NOS;b86e458e-e358-5d6b-b4dc-3135f9ffaa0a;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;93d097b5-0fb6-59f1-98dd-b719b1b69091;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-2657;LUAD
TCGA-55-8089;released;M0;8140/3;2011;C34.1;343a9122-61c4-5172-a24f-2908b03c6ae5;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T1a;No;no;N0;20576;stage ia;NA;7th;100;not reported;not reported;0;No;not reported;not reported;NA;NA;97;NA;NA;NA;Not Reported;NA;7b6324c2-dfc5-5144-8082-59e6db678191;531.506.849.315.068;white;Dead;c5204a17-1d50-54fa-94e5-0f4c03fa560c;56;not hispanic or latino;male;-20576;NA;1955;702;Pharmaceutical Therapy, NOS;ed86b115-d891-5e78-9b7d-2b1acbd28838;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;f8881c99-bd49-5858-aa5e-f93c8455771d;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-8089;LUAD
TCGA-69-7760;released;M0;8255/3;2011;C34.3;36a19602-d337-521c-909c-0afd7cdfd06d;Lower lobe, lung;NA;Lower lobe, lung;Stage IIB;Adenocarcinoma with mixed subtypes;2019-08-08T17:09:29.022095-05:00;T3;No;no;N0;26777;stage iib;NA;7th;202;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;edb21998-29d2-5dc6-b941-b42f7a418bb6;NA;white;Alive;985590df-66c0-5b89-a958-b38f6efacd90;73;not hispanic or latino;male;-26777;NA;1938;NA;Pharmaceutical Therapy, NOS;76f73f1d-ebe8-5c3d-a512-45897ff6a309;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;2b2fe94a-513c-556a-830f-247b86b99c8c;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-69-7760;LUAD
TCGA-55-7913;released;MX;8140/3;2011;C34.3;fc139c55-5494-5202-bcd4-2a0e94cd0d71;Lower lobe, lung;NA;Lower lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T1b;No;no;N0;22326;stage ia;NA;7th;62;not reported;not reported;0;No;not reported;not reported;NA;NA;40;NA;NA;NA;Not Reported;NA;4cb3214a-44be-55bf-9dd4-89d144485317;219.178.082.191.781;black or african american;Dead;19b8093e-b421-54c1-b9ed-f6d050138df0;61;not hispanic or latino;female;-22326;NA;1950;561;Pharmaceutical Therapy, NOS;b5935926-758b-5318-ba3d-0c33ae0947dc;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;ca8a45b6-3565-5938-b6a7-9870b7b33bcb;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-7913;LUAD
TCGA-69-8453;released;MX;8480/3;2012;C34.30;0aa59438-6843-5585-ae48-0a9ed4165c27;Lower lobe, lung;NA;Lower lobe, lung;Stage IIB;Mucinous adenocarcinoma;2019-08-08T17:09:51.361836-05:00;T3;No;no;N0;28413;stage iib;NA;7th;813;not reported;not reported;0;No;not reported;not reported;NA;NA;12;NA;NA;NA;Not Reported;NA;acb67336-092e-5bf1-aa91-6871867a05f8;0.657534246575342;white;Alive;4f662a08-c1f2-5723-a751-996de381cb05;77;not hispanic or latino;male;-28413;NA;1935;NA;Pharmaceutical Therapy, NOS;80f3f7b4-cdb3-54d9-9ae0-68f7dc8dd90b;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;3b0fdb16-8514-593d-932a-9aa80f3ea317;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-69-8453;LUAD
TCGA-55-A57B;released;M0;8255/3;2012;C34.1;4a33e80e-26c6-5740-89f1-a806245cdee4;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma with mixed subtypes;2019-08-08T17:09:29.022095-05:00;T1b;No;no;N0;29452;stage ia;NA;7th;546;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;4d2307f8-5f01-55f1-9054-f71342ce4cc4;NA;black or african american;Alive;fc758e79-2d45-5ae0-a153-f3392c8f9f5a;80;not hispanic or latino;female;-29452;NA;1932;NA;Pharmaceutical Therapy, NOS;ca7a27d0-e3be-5ab7-ada9-4616e1205177;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;40ef46bd-f960-564b-b71e-f75a2aecb20f;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-A57B;LUAD
TCGA-50-5044;released;M0;8140/3;2002;C34.3;3aacaa75-46a2-581e-becf-6f1cfaf83750;Lower lobe, lung;NA;Lower lobe, lung;Stage IIIB;Adenocarcinoma, NOS;2019-08-08T17:08:24.604398-05:00;T4;No;no;N1;26567;stage iiib;NA;5th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;5c4ac3b2-d192-5e12-8311-7812fdaa3513;NA;white;Dead;f475320d-a242-5d5f-b95d-523ad3e60bc6;72;not hispanic or latino;female;-26567;2003;1930;624;Pharmaceutical Therapy, NOS;746db23f-5098-576c-aaba-4bf4ce261d13;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;78f1ed4e-f332-5622-b098-25ccd8a77cf5;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-50-5044;LUAD
TCGA-62-8398;released;M0;8255/3;2007;C34.3;ae904d7e-f854-52e2-98fe-0ac8ecf1500e;Lower lobe, lung;NA;Lower lobe, lung;Stage IIIA;Adenocarcinoma with mixed subtypes;2019-08-08T17:09:29.022095-05:00;T2;No;no;N2;20197;stage iiia;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;20;NA;NA;NA;Not Reported;29;78cc425c-90d4-5e4c-9de4-27fc981c18b4;10.958.904.109.589;white;Dead;a9f71f08-7c0e-5370-abd5-ca4916855bd9;55;not hispanic or latino;male;-20197;2008;1952;444;Pharmaceutical Therapy, NOS;2dccda00-10cd-5be9-b6d4-0acd812f3c5b;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;eedb688c-5766-59ee-be06-c6752a1ef780;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-62-8398;LUAD
TCGA-44-7659;released;MX;8140/3;2010;C34.1;e3ca48ad-6dd1-5e75-a16b-fc6b7a21e357;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T1b;No;no;N0;25730;stage ia;NA;7th;691;not reported;not reported;0;No;not reported;not reported;NA;NA;40;NA;NA;NA;Not Reported;NA;b3a59b12-8703-5c6a-aad7-eb46b917e6c2;219.178.082.191.781;white;Alive;d50bf0b3-c820-500e-8218-b307f2ba1d86;70;not hispanic or latino;male;-25730;NA;1940;NA;Pharmaceutical Therapy, NOS;2e662743-9f45-550c-b011-e20ae5f16919;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;f92d90ce-f7f6-5f54-bf51-c5ee6863c568;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-7659;LUAD
TCGA-97-8175;released;M0;8230/3;2011;C34.1;40d8542e-cef4-5868-904d-57fb3be69d83;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Solid carcinoma, NOS;2019-08-08T17:10:53.779981-05:00;T2a;No;no;N0;20206;stage ib;NA;7th;551;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;d95330f8-04f6-582a-8b44-7053e2479c50;NA;white;Alive;f7d173f0-a63f-5ce1-b3f2-ab2673ef96c0;55;not hispanic or latino;female;-20206;NA;1956;NA;Pharmaceutical Therapy, NOS;ec11aa2a-46d8-594a-87c6-819343cdba43;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;e3ad7cf6-ac2d-549e-9b9a-903f01ea0a8b;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-97-8175;LUAD
TCGA-44-7670;released;M0;8140/3;2010;C34.1;bd72aa09-8c33-5744-a8d3-b86f8a73ce16;Upper lobe, lung;NA;Upper lobe, lung;Stage IIA;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T1b;Not Reported;yes;N1;17392;stage iia;NA;7th;882;not reported;not reported;0;No;not reported;not reported;NA;NA;30;NA;NA;NA;Not Reported;NA;4fe11862-1a4d-58d9-954c-2ee94e5b95f6;164.383.561.643.836;white;Alive;78f5b5b4-1057-53e3-9cfd-d2924e887e08;47;hispanic or latino;female;-17392;NA;1963;NA;Pharmaceutical Therapy, NOS;100e1158-30df-5cad-8d8a-dff9fc79d1ff;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;e4ae2638-fced-5bbe-8dcd-1bf1d01f904c;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-7670;LUAD
TCGA-49-6744;released;MX;8255/3;2010;C34.1;4a84a8c9-ca7d-5349-b914-fc25cac0c101;Upper lobe, lung;NA;Upper lobe, lung;Stage IIA;Adenocarcinoma with mixed subtypes;2019-08-08T17:08:24.604398-05:00;T2a;No;no;N1;23484;stage iia;NA;7th;1683;not reported;not reported;0;No;not reported;not reported;NA;NA;20;NA;NA;NA;Not Reported;NA;5e2340a9-165e-541d-b36f-01ae61b4d497;10.958.904.109.589;white;Alive;d0e66cc5-32bd-5a01-8057-4ac557d5f5a9;64;not reported;female;-23484;NA;1946;NA;Pharmaceutical Therapy, NOS;6d86a52f-2cb4-584f-ae4d-8ff6270b2c07;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;5ede5d3f-3af4-53a8-9a83-9c0e9b4924bb;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-49-6744;LUAD
TCGA-50-5055;released;M0;8255/3;2008;C34.3;38c706ff-7826-5e95-bf08-984c3bb89d10;Lower lobe, lung;NA;Lower lobe, lung;Stage IIA;Adenocarcinoma with mixed subtypes;2019-08-08T17:08:24.604398-05:00;T1;No;no;N1;28988;stage iia;NA;6th;785;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;05290003-becc-5ca3-b7c3-1b431bd8d7d0;NA;white;Dead;eef115d0-6802-57a1-a63a-f094df964c6e;79;not hispanic or latino;female;-28988;NA;1929;1830;Pharmaceutical Therapy, NOS;c06d997e-3c8f-5050-b203-af356ea0860a;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;90cb3911-4a99-5ab1-9379-f69126afec7e;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-50-5055;LUAD
TCGA-50-5935;released;M0;8140/3;2006;C34.1;c71f111f-9128-56cb-954b-cb853f3f6247;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:08:24.604398-05:00;T1;Not Reported;yes;N0;31610;stage ia;NA;6th;653;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;fc292cb1-5013-5f27-b02b-515b02e49fc1;NA;white;Dead;a226e070-84ae-5168-aaa5-785a27a906a1;86;not hispanic or latino;female;-31610;2007;1920;653;Pharmaceutical Therapy, NOS;ee420e44-ef88-5d28-ba89-8b47b8169cd0;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;c56d526a-6b83-53c2-9372-5ad5038c8a27;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-50-5935;LUAD
TCGA-NJ-A4YQ;released;M0;8255/3;2011;C34.1;d604a933-ff13-5933-a6ed-ece785f7a270;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma with mixed subtypes;2019-08-08T17:11:15.269506-05:00;T1b;No;no;N0;25427;stage ia;NA;7th;1432;not reported;not reported;0;No;not reported;not reported;NA;NA;40;NA;NA;NA;Not Reported;NA;822a4f11-bbe5-5610-a2de-246c544bbf5b;219.178.082.191.781;white;Alive;7ce298f8-a1dd-5871-9b10-9d87d79a2b18;69;not hispanic or latino;female;-25427;NA;1942;NA;Pharmaceutical Therapy, NOS;9dfce564-4b7f-5f6b-b335-18d63f807e70;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;d69dbe4a-e8b9-5777-97e3-2f404b2b6505;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-NJ-A4YQ;LUAD
TCGA-50-5049;released;M0;8140/3;2006;C34.1;58ee1e34-4b16-5409-8d47-463355c72cac;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:08:24.604398-05:00;T2;No;no;N0;25577;stage ia;NA;6th;3094;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;5a74ca37-3b59-5649-baab-7d258275581e;NA;white;Alive;6d3ec257-9033-52c7-9c4c-de8cdf922cf0;70;not hispanic or latino;male;-25577;NA;1936;NA;Pharmaceutical Therapy, NOS;5da81c40-6fd8-548b-8fca-37bbb6c867bc;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;ce2503d6-20b0-528f-a4b1-412fd81a6d40;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-50-5049;LUAD
TCGA-97-A4M0;released;M0;8255/3;2012;C34.1;52b12b5e-e43d-5770-84d7-e68a82b36c51;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma with mixed subtypes;2019-08-08T17:10:53.779981-05:00;T2a;No;no;N0;22206;stage ib;NA;7th;652;not reported;not reported;0;No;not reported;not reported;NA;NA;34;NA;NA;NA;Not Reported;34;071285d0-6b66-530d-92d4-5b8fabaad122;186.301.369.863.014;white;Alive;06734217-29ca-59f3-91a0-7419fcf87b60;60;not hispanic or latino;female;-22206;NA;1952;NA;Pharmaceutical Therapy, NOS;9ac41dd4-0311-5767-ae3e-d92cedcf679d;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;1f607364-f4d8-5987-9034-8b20618ddc9d;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-97-A4M0;LUAD
TCGA-44-2668;released;M0;8140/3;2009;C34.1;62552a9f-3f39-5833-b1c6-6466e93a530e;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T2;No;no;N0;18856;stage ib;NA;6th;246;not reported;not reported;0;No;not reported;not reported;NA;NA;60;NA;NA;NA;Not Reported;30;4dc4f5a1-6db4-5f88-ae28-8c27a1cb3c60;328.767.123.287.671;white;Dead;8c08c48a-dee8-5400-9e26-9c968a47702f;51;not hispanic or latino;male;-18856;NA;1958;761;Pharmaceutical Therapy, NOS;6294c69c-e2c5-55af-b86f-d468333449a0;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;db7c40c8-d870-5c7c-bf9c-478abde6f2f7;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-2668;LUAD
TCGA-55-7283;released;MX;8252/3;2011;C34.1;67451eed-b29f-5da0-9cf8-e89c614b9b21;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIA;Bronchiolo-alveolar carcinoma, non-mucinous;2019-08-08T17:08:47.535141-05:00;T3;No;no;N2;27946;stage iiia;NA;7th;609;not reported;not reported;0;No;not reported;not reported;NA;NA;5;NA;NA;NA;Not Reported;11;c840b84c-1ad0-5275-8e9f-e07e40d524a9;0.273972602739726;white;Alive;9beaebfc-c95e-5746-87ad-8442ee7e977b;76;not hispanic or latino;female;-27946;NA;1935;NA;Pharmaceutical Therapy, NOS;eb5baccd-4a75-5ce5-8343-d58bed667315;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;4bdbbe96-11a8-5c1b-8e1e-2ed87c2f6382;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-7283;LUAD
TCGA-49-4501;released;M0;8140/3;1996;C34.1;74e75f07-36d4-5da6-be38-ec398f1923f9;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:08:24.604398-05:00;T2;Not Reported;yes;N0;24817;stage ib;NA;NA;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;306bbb57-b775-57e1-b4c9-fad1a889a35f;NA;white;Dead;4471689a-e8f3-53d8-8454-82d16ae6ca5c;67;not hispanic or latino;female;-24817;1999;1929;1421;Pharmaceutical Therapy, NOS;6ae9bfb7-13eb-5e16-88a4-265ddfb99787;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;b8d506c0-15e0-5632-b298-7fdce3ea4417;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-49-4501;LUAD
TCGA-55-7994;released;MX;8140/3;2011;C34.1;24c02c6b-fa32-513b-9ba0-e3efee7cf25b;Upper lobe, lung;NA;Upper lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T3;No;no;N0;29858;stage iib;NA;7th;603;not reported;not reported;0;No;not reported;not reported;NA;NA;28;NA;NA;NA;Not Reported;NA;c6c2192e-192f-5784-8b4a-667ddcde0bef;153.424.657.534.247;white;Alive;fde1ca64-8a6a-5b99-b8bf-43dd3a4a0302;81;not hispanic or latino;male;-29858;NA;1930;NA;Pharmaceutical Therapy, NOS;cb3dd84b-4a05-570f-8f9b-4ff727b19094;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;cba4f96d-d9d2-5649-aabd-162cc4df8fa9;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-7994;LUAD
TCGA-L9-A7SV;released;M0;8140/3;2013;C34.3;4fda9f89-8fe6-5072-aa28-068f8188dcd1;Lower lobe, lung;NA;Lower lobe, lung;Stage IIA;Adenocarcinoma, NOS;2019-08-08T17:10:53.779981-05:00;T2a;No;no;N1;25298;stage iia;NA;7th;565;not reported;not reported;0;No;not reported;not reported;NA;NA;93;NA;NA;NA;Not Reported;31;81a72a4c-9fa3-5e1c-a6ec-de86d1733899;50.958.904.109.589;black or african american;Alive;baf8d896-ff23-5478-b919-63bf1c0703db;69;not hispanic or latino;male;-25298;NA;1944;NA;Pharmaceutical Therapy, NOS;75c48496-9048-5e13-8514-5f7038bdc54e;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;6294aa06-4f7f-5d09-80f2-32b337d9d5d1;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-L9-A7SV;LUAD
TCGA-95-A4VN;released;M0;8230/3;2012;C34.3;6ba6b2a9-31ed-5ec2-b918-9b337b796c12;Lower lobe, lung;NA;Lower lobe, lung;Stage IIA;Solid carcinoma, NOS;2019-08-08T17:10:31.173893-05:00;T2a;No;yes;N1;22927;stage iia;NA;7th;553;not reported;not reported;0;No;not reported;not reported;NA;NA;42;NA;NA;NA;Not Reported;42;55a0663f-379d-53ba-b9bd-623992c401b4;23.013.698.630.137;white;Alive;0f6fdab7-f076-58ff-af92-321a4e44ed05;62;not hispanic or latino;female;-22927;NA;1950;NA;Pharmaceutical Therapy, NOS;d9b59452-946e-5b44-bfa1-1b2569dc89cf;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;2591968e-cc42-5483-a023-1f2f1e102840;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-95-A4VN;LUAD
TCGA-44-8119;released;M0;8140/3;2012;C34.1;020a308e-3a52-56c1-bc28-109b7c47af01;Upper lobe, lung;NA;Upper lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T3;No;yes;N0;27003;stage iib;NA;7th;285;not reported;not reported;0;No;not reported;not reported;NA;NA;50;NA;NA;NA;Not Reported;NA;80033174-3585-5bd3-81f7-2436e55597a3;273.972.602.739.726;white;Alive;9e5df9af-504d-5b60-881e-0557f2f15dfd;73;not hispanic or latino;male;-27003;NA;1939;NA;Pharmaceutical Therapy, NOS;2fefc00b-a756-511b-b73b-16d3ede895fb;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;0f8fbb86-16a5-5787-aab7-f20764e0e9be;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-8119;LUAD
TCGA-50-8459;released;M0;8480/3;2012;C34.30;e91e1381-690d-5eba-803c-d88ced6fc695;Lower lobe, lung;NA;Lower lobe, lung;Stage IIB;Mucinous adenocarcinoma;2019-08-08T17:08:47.535141-05:00;T3;No;no;N0;24859;stage iib;NA;7th;1119;not reported;not reported;0;No;not reported;not reported;NA;NA;10;NA;NA;NA;Not Reported;NA;ee68db90-e55f-5718-90a1-0521537225ae;0.547945205479452;white;Alive;e5662c53-d81b-541b-95cd-4b7f44e25a10;68;not hispanic or latino;male;-24859;NA;1944;NA;Pharmaceutical Therapy, NOS;4d3e6940-9bac-578d-8e15-cbfe42d7dca8;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;f2f2d2f9-b1ab-5e07-a4b1-fd95aeeff22d;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-50-8459;LUAD
TCGA-38-4632;released;M1;8140/3;1998;C34.1;c6be4b88-44e7-595a-817c-5839df811846;Upper lobe, lung;NA;Upper lobe, lung;Stage IV;Adenocarcinoma, NOS;2019-08-08T17:07:40.762038-05:00;T2;No;no;N1;15418;stage iv;NA;5th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;10;NA;NA;NA;Not Reported;NA;3deaee0b-7fb5-5234-9111-d7bf095e487c;0.547945205479452;black or african american;Dead;b981e477-aae4-5e51-8ac7-51686ea43a89;42;not hispanic or latino;male;-15418;2001;1956;1357;Pharmaceutical Therapy, NOS;fe6c9aaa-d19f-5852-a374-dcb63f67df73;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;9595e0c9-0c6c-5b07-8fc8-86fa80011f90;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-38-4632;LUAD
TCGA-55-8208;released;M0;8140/3;2012;C34.1;359759ce-2abe-52dd-8b33-6b328cf7eae2;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T1b;No;no;N0;26716;stage ia;NA;7th;674;not reported;not reported;0;No;not reported;not reported;NA;NA;50;NA;NA;NA;Not Reported;NA;fe043dd9-f646-5fb1-82cc-2aa94b13ef0c;273.972.602.739.726;white;Alive;e82790e2-ccdf-5d67-bfe3-971be629bd99;73;not hispanic or latino;female;-26716;NA;1939;NA;Pharmaceutical Therapy, NOS;ec0c19cf-438b-5d54-9c77-67e42a491a91;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;13d58739-2bf4-58ae-ad2f-9e2190f0629b;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-8208;LUAD
TCGA-78-7146;released;M0;8255/3;1999;C34.3;8f95399b-ac7f-55fc-8b9c-388cdbe45b8f;Lower lobe, lung;NA;Lower lobe, lung;Stage IIIA;Adenocarcinoma with mixed subtypes;2019-08-08T17:09:51.361836-05:00;T2;No;no;N2;26272;stage iiia;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;6;NA;NA;NA;Not Reported;10;6f02ab8e-451f-5a8c-ab75-298a606d4eb1;0.328767123287671;white;Dead;30a2647f-cbb9-53a8-8a5d-6b05682caabc;71;not reported;female;-26272;1999;1928;173;Pharmaceutical Therapy, NOS;b035f38f-0b2e-5b3b-a86a-804f2d5f8243;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;1990c0f8-746f-5934-a5ac-fe7e48831901;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-78-7146;LUAD
TCGA-05-4418;released;M0;8255/3;2008;C34.3;8b9860c6-68e4-5efe-af6b-3e78d5bd83c2;Lower lobe, lung;NA;Lower lobe, lung;Stage IIIA;Adenocarcinoma with mixed subtypes;2019-08-08T17:07:40.762038-05:00;T3;Not Reported;yes;N2;25417;stage iiia;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;25;NA;NA;NA;Not Reported;NA;6435ab5e-ea10-55e2-9ae0-7099f3103b7f;136.986.301.369.863;not reported;Dead;6c38e4a5-bbb0-5672-8541-ea208a915ac6;69;not reported;male;-25417;2008;1939;274;Pharmaceutical Therapy, NOS;13a7d353-ba5e-52fa-9ea7-53f3b31a09ab;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;bf954670-a03b-5573-b968-f9fea3abcd56;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-05-4418;LUAD
TCGA-97-7554;released;M0;8260/3;2010;C34.3;e93f1e4c-d375-5de5-bc71-e46734740284;Lower lobe, lung;NA;Lower lobe, lung;Stage IIIA;Papillary adenocarcinoma, NOS;2019-08-08T17:10:31.173893-05:00;T2a;No;no;N2;30327;stage iiia;NA;7th;775;not reported;not reported;0;No;not reported;not reported;NA;NA;30;NA;NA;NA;Not Reported;38;d15ef2a5-80ad-5a0c-a407-32bf6a876f7b;164.383.561.643.836;white;Alive;4dda3905-28b0-5737-b0db-32430ce22bd7;83;not hispanic or latino;female;-30327;NA;1927;NA;Pharmaceutical Therapy, NOS;f2544daa-d81e-58dd-a6ee-f8a880b98868;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;b5d801c3-70ef-5a9d-a3b2-68f77eb716b9;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-97-7554;LUAD
TCGA-91-6831;released;MX;8140/3;2001;C34.2;e4204556-0e97-5250-a786-29b00b4e7743;Middle lobe, lung;NA;Middle lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:10:31.173893-05:00;T2;No;no;N0;24436;stage ib;NA;5th;310;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;0b75f1ff-edcf-5c2c-9246-8373fce766b0;NA;white;Alive;00b3ab06-a364-580d-a544-231219b640a2;66;not hispanic or latino;male;-24436;NA;1935;NA;Pharmaceutical Therapy, NOS;ca716ee1-ee3d-5c19-8b59-13ec27f64db3;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;6c20e2d7-89a4-5966-843c-d9b715ec64a1;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-91-6831;LUAD
TCGA-64-5779;released;M0;8550/3;2009;C34.3;c5d1f02d-fc4a-5cac-8f62-b67807532d62;Lower lobe, lung;NA;Lower lobe, lung;Stage IIIA;Acinar cell carcinoma;2019-08-08T17:09:29.022095-05:00;T2;No;no;N2;22305;stage iiia;NA;6th;864;not reported;not reported;0;No;not reported;not reported;NA;NA;40;NA;NA;NA;Not Reported;40;2ae6a920-d8b5-5a43-b028-7735d7be125c;219.178.082.191.781;white;Alive;8a22f732-2b83-5d29-8201-056ac0b36f0c;61;not hispanic or latino;male;-22305;NA;1948;NA;Pharmaceutical Therapy, NOS;4d2f6d66-3b5a-52c8-aa6e-fce2c26fc9f2;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;ae653ac6-03f6-5f27-83e9-8e0ae6880ebe;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-64-5779;LUAD
TCGA-44-A47F;released;M0;8140/3;2012;C34.1;81353cb1-9267-5fc1-8c24-31b50272ce35;Upper lobe, lung;NA;Upper lobe, lung;Stage IIB;Adenocarcinoma, NOS;2019-08-08T17:08:02.187456-05:00;T2b;No;yes;N1;27122;stage iib;NA;7th;337;not reported;not reported;0;No;not reported;not reported;NA;NA;20;NA;NA;NA;Not Reported;32;3e1cb8c1-cf84-5c41-a4b4-8f995572971e;10.958.904.109.589;white;Alive;e6040ce5-3774-56a3-bd6a-52b3f5731cf4;74;not hispanic or latino;male;-27122;NA;1938;NA;Pharmaceutical Therapy, NOS;686d2225-b94b-54b9-aa3c-c8d3a9003130;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;5aa70321-8537-5494-917e-6f6967d5e172;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-44-A47F;LUAD
TCGA-55-6712;released;MX;8140/3;2010;C34.1;0d259420-2ae5-502e-8f4f-7e40fa61d571;Upper lobe, lung;NA;Upper lobe, lung;Stage IIA;Adenocarcinoma, NOS;2019-08-08T17:08:47.535141-05:00;T2a;No;no;N1;NA;stage iia;NA;7th;24;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;33;1c3dc483-aa5d-588b-92c9-b77f725d6d2a;NA;white;Dead;ee6088c3-5197-5379-a8db-4a5362bd01eb;71;not reported;male;NA;NA;1939;171;Pharmaceutical Therapy, NOS;7aa454fb-8465-5d85-b0a9-5684e3787c56;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;c3d3741e-6734-52ce-936e-b9cb6f176b28;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-6712;LUAD
TCGA-05-5429;released;M0;8140/3;2010;C34.1;06eed07a-e385-5f1c-a0e6-c57bbe8a5aae;Lung, NOS;NA;Lung, NOS;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:07:40.762038-05:00;T3;No;no;N2;22066;stage iiia;NA;7th;30;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;9b1bed7c-7b43-5fa5-9cfc-630d620435d0;NA;not reported;Dead;97dbd192-260d-5a7b-a942-2f5117d24934;60;not reported;male;-22066;NA;1950;275;Pharmaceutical Therapy, NOS;d6264eb3-5717-5b9e-a58c-51bf43484e86;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;38042830-ed8d-571e-8c6a-921e9c75eace;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-05-5429;LUAD
TCGA-91-6848;released;MX;8140/3;2009;C34.1;34dc1c12-dcc9-5753-b1ae-39ef95eb3d17;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:10:31.173893-05:00;T2;No;no;N2;21829;stage iiia;NA;6th;224;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;c601ba5b-192c-5dc4-9515-5486ee14c1a0;NA;white;Alive;11393761-c520-5389-9d2a-e6ce8821cad4;59;not hispanic or latino;male;-21829;NA;1950;NA;Pharmaceutical Therapy, NOS;cd5bf5be-e353-58c7-8873-fd56b979256b;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;ce75b61d-ec8f-5c73-b2a5-f02062c93d47;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-91-6848;LUAD
TCGA-99-8032;released;M0;8140/3;2011;C34.1;f800f9cd-c2bc-5eff-85f3-e8569f42746d;Upper lobe, lung;NA;Upper lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:10:53.779981-05:00;T1a;No;no;N0;22635;stage ia;NA;7th;44;not reported;not reported;0;No;not reported;not reported;NA;NA;90;NA;NA;NA;Not Reported;NA;ad54be65-f3d8-546e-8e26-d55ce953e79c;493.150.684.931.507;white;Alive;00a54e74-5fb7-51cd-8936-d38e8dde689a;61;not hispanic or latino;male;-22635;NA;1950;NA;Pharmaceutical Therapy, NOS;bf517e73-493a-52bc-941f-f4b1582de2cd;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;a67d57a7-9313-5d59-b738-88d0896b122f;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-99-8032;LUAD
TCGA-49-6745;released;M0;8260/3;2011;C34.1;f17af2ab-6e23-55d4-946b-99873bc2e707;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIA;Papillary adenocarcinoma, NOS;2019-08-08T17:08:24.604398-05:00;T2a;Not Reported;yes;N2;30133;stage iiia;NA;7th;522;not reported;not reported;0;No;not reported;not reported;NA;NA;20;NA;NA;NA;Not Reported;NA;b6e58fb2-f1ec-539f-a467-c8394af02460;10.958.904.109.589;white;Alive;96208e4a-c1c5-5e28-b8e5-c6e6e4e096c8;82;not reported;male;-30133;NA;1929;NA;Pharmaceutical Therapy, NOS;83e57549-71a1-5ad2-86ad-b84ce566019d;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;fffc5502-3fa8-57a9-9d18-26e6277a2623;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-49-6745;LUAD
TCGA-75-6214;released;M0;8140/3;NA;C34.1;cfb2c98a-8d39-51da-be16-ca3bc885942b;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:09:51.361836-05:00;T2;No;no;N2;NA;stage iiia;NA;6th;NA;not reported;not reported;NA;No;not reported;not reported;NA;NA;40;NA;NA;NA;Not Reported;NA;268552ce-1379-50ef-944e-fd3670816672;219.178.082.191.781;not reported;Dead;f7e66da1-3d10-5cf1-9152-9fb12dd7d505;NA;not reported;female;NA;NA;NA;1115;Pharmaceutical Therapy, NOS;8b85e0e6-5100-5e05-b3cf-ccc4d34f783e;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;e3ba2da0-87b6-5459-abcb-2ef9aa2e4f87;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-75-6214;LUAD
TCGA-55-7903;released;MX;8140/3;2011;C34.3;5e41971f-b23b-501c-9dca-ec978959c0d4;Lower lobe, lung;NA;Lower lobe, lung;Stage IA;Adenocarcinoma, NOS;2019-08-08T17:09:08.225653-05:00;T1b;No;no;N0;23509;stage ia;NA;7th;567;not reported;not reported;0;No;not reported;not reported;NA;NA;40;NA;NA;NA;Not Reported;NA;01d549bf-0232-5ad7-a4b2-e2f081f65e03;219.178.082.191.781;white;Alive;1dff7864-7427-5412-98b1-1a24aeff6067;64;not hispanic or latino;male;-23509;NA;1947;NA;Pharmaceutical Therapy, NOS;160750e4-9569-56e1-b544-3427b7d77c3f;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;85652344-0161-577f-b917-c88235c5b0c2;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-55-7903;LUAD
TCGA-05-4245;released;M0;8140/3;2009;C34.1;e2fb63d6-2eac-535c-bcd0-e9575ebaf006;Upper lobe, lung;NA;Upper lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:07:40.762038-05:00;T2;Not Reported;yes;N2;29647;stage iiia;NA;6th;730;not reported;not reported;0;No;not reported;not reported;NA;NA;32;NA;NA;NA;Not Reported;NA;8d858a93-54e3-5432-9589-68c6b90a24c8;175.342.465.753.425;not reported;Alive;3ec79286-1857-5eeb-a778-0c86ff2a13f6;81;not reported;male;-29647;NA;1928;NA;Pharmaceutical Therapy, NOS;c516601c-0c71-596a-837f-86814e57c1fe;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;85506557-5c39-5d73-ba25-228aee1aea2a;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-05-4245;LUAD
TCGA-67-3774;released;M0;8140/3;2009;C34.3;7eea3d05-c171-5706-baea-d2c1cb1179ef;Lower lobe, lung;NA;Lower lobe, lung;Stage IB;Adenocarcinoma, NOS;2019-08-08T17:09:29.022095-05:00;T2;No;no;N0;26704;stage ib;NA;6th;385;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;2e95ff1a-c26d-542e-9922-ef004446058a;NA;white;Alive;dc8df7d5-f087-5c8f-b2b7-2edaf2b11cb9;73;not hispanic or latino;female;-26704;NA;1936;NA;Pharmaceutical Therapy, NOS;2e913e58-c3b6-5893-ae36-097276970e54;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;248f4d0e-1fd4-52a9-a2fc-4d1e060a3fb1;not reported;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-67-3774;LUAD
TCGA-NJ-A4YG;released;M0;8255/3;2008;C34.1;1135b193-cec7-5c5f-b620-f6c2ae0ce484;Upper lobe, lung;NA;Upper lobe, lung;Stage IB;Adenocarcinoma with mixed subtypes;2019-08-08T17:11:15.269506-05:00;T2;No;no;N0;23812;stage ib;NA;6th;2261;not reported;not reported;0;No;not reported;not reported;NA;NA;104;NA;NA;NA;Not Reported;52;e5609b2e-23fa-5358-8240-487a2877bf86;56.986.301.369.863;white;Alive;5851180c-3b8e-56bf-99e6-4eada9479cf9;65;not reported;male;-23812;NA;1943;NA;Pharmaceutical Therapy, NOS;360a6efe-e7b2-572a-9991-88a87dd5dcdd;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;e52a2607-6b84-56a8-a8a6-9cfa1401375f;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-NJ-A4YG;LUAD
TCGA-95-8494;released;M0;8140/3;2012;C34.2;63732e87-50c8-5d82-be56-e5d902140a93;Middle lobe, lung;NA;Middle lobe, lung;Stage IIA;Adenocarcinoma, NOS;2019-08-08T17:10:31.173893-05:00;T2a;No;no;N1;24773;stage iia;NA;7th;84;not reported;not reported;0;No;not reported;not reported;NA;NA;NA;NA;NA;NA;Not Reported;NA;0e87eeea-de26-503c-a35f-7ddb488585bc;NA;white;Alive;908b0692-f28c-5786-b5ee-62f265b5e711;67;not hispanic or latino;male;-24773;NA;1945;NA;Pharmaceutical Therapy, NOS;46113486-ad01-5e80-ab96-1024512fdd55;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;dd5b26bf-0b7e-55dc-bab8-3bf5ec657876;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-95-8494;LUAD
TCGA-MP-A4TC;released;M0;8140/3;2008;C34.2;8720849f-1233-5597-82b1-0805342c26a5;Middle lobe, lung;NA;Middle lobe, lung;Stage IIIA;Adenocarcinoma, NOS;2019-08-08T17:11:15.269506-05:00;T1;No;yes;N2;28471;stage iiia;NA;6th;NA;not reported;not reported;0;No;not reported;not reported;NA;NA;125;NA;NA;NA;Not Reported;32;2e36e44b-f32f-5e9c-b2b8-aef4623ae826;684.931.506.849.315;white;Dead;a16c2726-59d5-57b4-8576-921a2b7d4e80;77;not hispanic or latino;male;-28471;2008;1931;74;Pharmaceutical Therapy, NOS;c712193f-f54a-5d29-a62b-3f960d97481a;yes;NA;NA;NA;NA;NA;NA;NA;NA;NA;Radiation Therapy, NOS;c0d35c20-6478-580d-b85d-38b5deaab59b;no;NA;NA;NA;NA;NA;NA;NA;NA;NA;TCGA-MP-A4TC;LUAD